
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Coverage Report : A summary of credit analyst recommendations in the Healthcare sector</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.O / BSX.N / BAX.N / BDX.N / BMY.N / CAH.N / CI.N / CVS.N / JNJ.N / LLY.N / MCK.N / MRK.N / TMO.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / ABC.N / BIIB.O / ABBV.N / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Amerisourcebergen Corp / Biogen Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1255</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Key takeaways from recent investor calls on China healthcare sector 2022 outlook</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / NOVN.S / CHRS.OQ / SGEN.OQ / CTLT.N / BGNE.OQ / 2269.HK / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">Eli Lilly and Co / Novartis AG / Coherus BioSciences Inc / Seagen Inc / Catalent Inc / Beigene Ltd / WuXi Biologics (Cayman) Inc / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Divergent Returns for ESG in 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">A.N / AAP.N / AEE.N / AES.N / AIG.N / ALB.N / ALK.N / ALL.N / APD.N / AXP.N / BAX.N / BBY.N / BEN.AX / BMY.N / BSX.N / C.N / CCI.N / CCL.N / CI.N / CL.N / ECL.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / FMC.N / HLT.N / IP.N / IR.N / KMB.N / LLY.N / LMT.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PNC.N / PNW.N / RHI.N / RL.N / SEE.N / SLB.N / SO.N / SWK.N / TAP.N / TMO.N / TRV.N / TXT.N / WFC.N / PG.N / WY.N / NUE.N / ROK.N / CPB.N / ETR.N / AAL.L / ADML.L / ETN.N / DHR.N / DIS.N / UNH.N / TFX.N / CMI.N / URI.N / AIZ.N / DE.N / IEX.N / PH.N / PGR.N / IPG.N / KIM.N / UNP.N / CLX.N / CAG.N / VNO.N / LOW.N / GLW.N / LH.N / UPS.N / KR.N / MMM.N / GIS.N / NI.N / XOM.N / AMT.N / WHR.N / RMD.N / DTEGN.F / IT.N / TGT.N / AVY.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / WST.N / COO.N / XEL.N / STZ.N / VFC.N / LNC.N / APH.N / AZO.N / FDS.N / EFX.N / PSA.N / EW.N / OKE.N / BXP.N / ACN.N / ARE.N / RSG.N / SNA.N / CHD.N / TWTR.N / ESS.N / UDR.N / FRT.N / HRL.N / PVH.N / BLK.N / AJG.N / ABC.N / CVX.N / MCO.N / JNPR.N / IRM.N / COP.N / CNP.N / INTC.OQ / CTSH.OQ / AOS.N / ABMD.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CINF.OQ / CTAS.OQ / CSCO.OQ / FAST.OQ / JKHY.OQ / JBHT.OQ / LRCX.OQ / ATVI.OQ / NTRS.OQ / PCAR.OQ / PAYX.OQ / PBCT.OQ / TROW.OQ / ROST.OQ / SJM.N / TECH.OQ / ZION.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / ODFL.OQ / INTU.OQ / COST.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / NTAP.OQ / TPR.N / ANSS.OQ / GL.N / AMZN.OQ / TTWO.OQ / VRSN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / ILMN.OQ / EQIX.OQ / GPN.N / WYNN.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / TFC.N / SBNY.OQ / DPZ.N / MOS.N / MKTX.OQ / MPWR.OQ / VIAC.OQ / NDAQ.OQ / ICE.N / LYV.N / MS.N / CMG.N / FIS.N / ADP.PA / AON.N / ULTA.OQ / WRB.N / CME.OQ / NWSA.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / LYB.N / MSI.N / NLSN.N / MPC.N / FBHS.N / XYL.N / ENPH.OQ / EPAM.N / FANG.OQ / CDW.OQ / FOXA.O / LDOS.N / ALLE.N / PTC.OQ / SYF.N / KEYS.N / ANTM.N / QRVO.OQ / SEDG.OQ / ETSY.OQ / ZBH.N / CSX.OQ / SPGI.K / FTV.N / LW.N / BKNG.OQ / CBRE.N / CDAY.N / EVRG.N / TER.OQ / NWL.OQ / LNT.OQ / LHX.N / EXC.OQ / NLOK.OQ / RTX.N / OTIS.N / APA.OQ / VTRS.OQ / BBWI.N / BKR.OQ</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Ameren Corp / AES Corp / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Allstate Corp / Air Products and Chemicals Inc / American Express Co / Baxter International Inc / Best Buy Co Inc / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Crown Castle International Corp / Carnival Corp / Cigna Corp / Colgate-Palmolive Co / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / FMC Corp / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Schlumberger NV / Southern Co / Stanley Black & Decker Inc / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Textron Inc / Wells Fargo & Co / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Entergy Corp / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Cummins Inc / United Rentals Inc / Assurant Inc / Deere & Co / IDEX Corp / Parker-Hannifin Corp / Progressive Corp / Interpublic Group of Companies Inc / Kimco Realty Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Lowe's Companies Inc / Corning Inc / Laboratory Corporation of America Holdings / United Parcel Service Inc / Kroger Co / 3M Co / General Mills Inc / NiSource Inc / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Resmed Inc / Deutsche Telekom AG / Gartner Inc / Target Corp / Avery Dennison Corp / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / West Pharmaceutical Services Inc / Cooper Companies Inc / Xcel Energy Inc / Constellation Brands Inc / VF Corp / Lincoln National Corp / Amphenol Corp / Autozone Inc / Factset Research Systems Inc / Equifax Inc / Public Storage / Edwards Lifesciences Corp / ONEOK Inc / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / Twitter Inc / Essex Property Trust Inc / UDR Inc / Federal Realty Investment Trust / Hormel Foods Corp / PVH Corp / BlackRock Inc / Arthur J Gallagher & Co / Amerisourcebergen Corp / Chevron Corp / Moody's Corp / Juniper Networks Inc / Iron Mountain Inc / Conocophillips / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / A O Smith Corp / ABIOMED Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Cincinnati Financial Corp / Cintas Corp / Cisco Systems Inc / Fastenal Co / Jack Henry & Associates Inc / J B Hunt Transport Services Inc / Lam Research Corp / Activision Blizzard Inc / Northern Trust Corp / Paccar Inc / Paychex Inc / People's United Financial Inc / T Rowe Price Group Inc / Ross Stores Inc / J M Smucker Co / Bio-Techne Corp / Zions Bancorporation NA / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Old Dominion Freight Line Inc / Intuit Inc / Costco Wholesale Corp / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / NetApp Inc / Tapestry Inc / ANSYS Inc / Globe Life Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Illumina Inc / Equinix Inc / Global Payments Inc / Wynn Resorts Ltd / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Signature Bank / Domino's Pizza Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / ViacomCBS Inc / Nasdaq Inc / Intercontinental Exchange Inc / Live Nation Entertainment Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Ulta Beauty Inc / W R Berkley Corp / CME Group Inc / News Corp / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Nielsen Holdings PLC / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / Enphase Energy Inc / Epam Systems Inc / Diamondback Energy Inc / CDW Corp / Fox Corp / Leidos Holdings Inc / Allegion PLC / PTC Inc / Synchrony Financial / Keysight Technologies Inc / Anthem Inc / Qorvo Inc / Solaredge Technologies Inc / ETSY Inc / Zimmer Biomet Holdings Inc / CSX Corp / S&P Global Inc / Fortive Corp / Lamb Weston Holdings Inc / Booking Holdings Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Evergy Inc / Teradyne Inc / Newell Brands Inc / Alliant Energy Corp / L3harris Technologies Inc / Exelon Corp / NortonLifeLock Inc / Raytheon Technologies Corp / Otis Worldwide Corp / APA Corp (US) / Viatris Inc / Bath & Body Works Inc / Baker Hughes Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / France / United Kingdom / Ireland / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Could Gantenerumab Escape CMS Guidelines?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US5324571083 / US7711951043 / CH0012032048</td><td class="leftalignment">Eli Lilly and Co / Roche Holding AG / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0925288 / 2516152 / 2023607 / 2050832 / 2222631 / 2270726 / 2542049 / 2317087 / 2670519 / 2455965 / 2457864 / 2471950 / 2689560 / 2048804 / 2440637 / 2799351 / 2829601 / 2980906 / B3D7K31 / B03PGL4 / 2390817 / B783TY6 / B7VD3F2 / BFDV8K0 / BVVN4Q8 / BYY8XK8 / BJ1FD74 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYQHPK7 / BWY52P3 / BYY88Y7 / BL71K91 / BYNQ369 / BMXXBD9 / BMYRFV6 / BMFPHK2 / BMBSNX0</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Amgen Inc / Ameren Corp / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Biogen Inc / ImmunoGen Inc / Incyte Corp / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / Southern Co / Foot Locker Inc / Discovery Inc / NorthWestern Corp / Gray Television Inc / Aptiv PLC / Duke Energy Corp / MacroGenics Inc / Eversource Energy / WEC Energy Group Inc / Revolve Group Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zymeworks Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Albertsons Companies Inc / Figs Inc / Procept Biorobotics Corp / ThredUp Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : JPM Healthcare Conf Takeaways – Best In Class Growth Outlook, CMS CED Decision Likely Has Limited Impact To Donanemab</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">2022 HC Conf Day 2 Recap : Credit Takeaways from the 40th Annual J.P. Morgan Conference</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.N / AMGN.O / BDX.N / CI.N / CVS.N / LLY.N / MCK.N / TMO.N / LH.N</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Becton Dickinson and Co / Cigna Corp / CVS Health Corp / Eli Lilly and Co / Mckesson Corp / Thermo Fisher Scientific Inc / Laboratory Corporation of America Holdings</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2022's Opening Salvo from Our Coverage Companies: Day 2 Color at Competitor Conference</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 0925288 / 2516152</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">CMS decision appears worse than expected, in our view; we spoke with BIIB mgmt for more color</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / LLY=US / BIIB=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">VRTX/ABBV/LLY/AMGN — Day 2 Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N / ABBV.N / AMGN.O / VRTX.OQ / VRTX.O</td><td class="leftalignment">Eli Lilly and Co / Abbvie Inc / Amgen Inc / Vertex Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">It's really no meaningful reimbursement; sending waves across biotech</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NCD Proposed Decision Memo; Let's See What's Next With CED Proposal</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Takeaways From JPM; Bullish for Short & Long-Term Growth Drivers</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB/LLY—Could CMS Decision Make the FDA Rethink the Early approval of Other Anti-Amyloid Drugs?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N / BIIB.O</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACI / BAC / DHI / DIS / INTC.O / KBH / LEN / LLY.N / NVR / PFE.N / RKT / TOL / AMD.O / MU.O / NFLX.O / BIIB.O / DISCA.O / CCS.N / STAG.K / ABBV.N / PFSI.K / OMF / INSP.K / FTCH.K / RAPT.O / HMPT.O / AOMR.N</td><td class="leftalignment">Albertsons Companies Inc / Bank of America Corp / D R Horton Inc / Walt Disney Co / Intel Corp / KB Home / Lennar Corp / Eli Lilly and Co / NVR Inc / Pfizer Inc / Rocket Companies Inc / Toll Brothers Inc / Advanced Micro Devices Inc / Micron Technology Inc / Netflix Inc / Biogen Inc / Discovery Inc / Century Communities Inc / STAG Industrial Inc / Abbvie Inc / PennyMac Financial Services Inc / OneMain Holdings Inc / Inspire Medical Systems Inc / Farfetch Ltd / Rapt Therapeutics Inc / Home Point Capital Inc / Angel Oak Mortgage Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0028241000 / US0576652004 / US5324571083 / US7170811035 / US75886F1075 / US6402681083 / US7665596034 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US03209R1032 / US14167L1035 / US1488061029 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US45781M1018 / US44842L1035 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / CA05156X8843 / US7291391057 / US12233L1070 / US4131971040 / US04683R1068 / KYG7307E1070 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Abbott Laboratories / Balchem Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Catalent Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Innoviva Inc / HUTCHMED (China) Ltd / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Aurora Cannabis Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Qilian International Holding Group Ltd / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB NCD TMRW—When to Look, Where to Look, and What to Look For?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / BIIB.O</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">NCD scenarios and potential stock movements; 2H2022 lecanemab data most important, in our view.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / AN=US / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / MCD=US / WEN=US / AGL=US / BLDP=US / AMZN=US / BLD=US / INCY=US / RUN=US / GILD=US / PLUG=US / NOVA=US / LOW=US / THC=US / TTWO=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / MLM=US / UNH=US / KFY=US / AMED=US / AMN=US / SWIM=US / ARRY=US / BMRN=US / CBRL=US / KIDS=US / DRI=US / EXEL=US / FCN=US / GFF=US / ABG=US / IBP=US / MAS=US / MHK=US / ASGN=US / REGI=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / CCRN=US / CNC=US / R=US / CNM=US / JAZZ=US / BE=US / DIN=US / ACVA=US / BCO=US / MOH=US / BIIB=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / SPWR=US / CMG=US / REX=US / PGTI=US / GPRE=US / ICFI=US / AWI=US / OC=US / CPRX=US / TAST=US / QSR=US / PRPL=US / LULU=US / IAA=US / ATSG=US / JACK=US / RCUS=US / TREX=US / GNRC=US / FBHS=US / ZNGA=US / ENPH=US / TILE=US / NDLS=US / PTCT=US / FATE=US / CNCE=US / 00770K202 / LOCO=US / OSH=US / UPLD=US / ANTM=US / SHAK=US / GDDY=US / SEDG=US / WING=US / SPNE=US / NVCR=US / 82982L103 / GXO=US / IRTC=US / CRSP=US / ANAB=US / JELD=US / DCPH=US / ALLO=US / FERG=US / AHCO=US / AZEK=US / SHLS=US / PRVA=US / SNPO=US / ROIV=US</td><td class="leftalignment">Cars.com Inc / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / Ballard Power Systems Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Plug Power Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Martin Marietta Materials Inc / UnitedHealth Group Inc / Korn Ferry / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Array Technologies Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Darden Restaurants Inc / Exelixis Inc / FTI Consulting Inc / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Cross Country Healthcare Inc / Centene Corp / Ryder System Inc / Core & Main Inc / Jazz Pharmaceuticals PLC / Bloom Energy Corp / Dine Brands Global Inc / ACV Auctions Inc / Brinks Co / Molina Healthcare Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / SunPower Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / IAA Inc / Air Transport Services Group Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / Zynga Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Upland Software Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Solaredge Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Novocure Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / JELD-WEN Holding Inc / Deciphera Pharmaceuticals Inc / Allogene Therapeutics Inc / Ferguson PLC / Adapthealth Corp / Azek Company Inc / Shoals Technologies Group Inc / Privia Health Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FDA Acceptance Of BI's Spesolimab BLA Sets A Rather Low Bar For Imsidolimab. Reitate BUY</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ANAB=US / LLY=US / PFE=US / CNCE=US</td><td class="leftalignment">AnaptysBio Inc / Eli Lilly and Co / Pfizer Inc / Concert Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2002305 / 2050832 / 2219224 / 2270726 / 2542049 / 2576941 / 2670519 / 2100920 / 2455965 / 2471950 / 2645409 / 2689560 / 2684703 / 7103065 / B00FWN1 / B19FQ48 / 2713317 / 2969637 / B3D7K31 / B23FN39 / B1XGNW4 / B0796X4 / B7TL820 / B7254K9 / B7VD3F2 / B85KFY9 / B8DPDT7 / BFLR866 / BS7K7C9 / BYZLV46 / BFZNYB7 / BK0VHF6 / BD9GVY0 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BDD1B07 / BMXXBD9 / BNKGXX2 / BJ62Z18 / BL53KF5 / BK6L288 / BMBSNX0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Biogen Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / DICK'S Sporting Goods Inc / Discovery Inc / Lululemon Athletica Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Five Below Inc / Sarepta Therapeutics Inc / Twitter Inc / Nevro Corp / InflaRx NV / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Evergy Inc / Fox Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Rubius Therapeutics Inc / Figs Inc / Verve Therapeutics Inc / Ultragenyx Pharmaceutical Inc / F45 Training Holdings Inc / Beam Therapeutics Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PAHC-US -  Dividend Quality Analysis, for the period ended September 22,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PAHC.O / ADM / LLY / MRK / ICCC.O / HSKA.O / ZTS</td><td class="leftalignment">Phibro Animal Health Corp / Archer-Daniels-Midland Co / Eli Lilly and Co / Merck & Co Inc / ImmuCell Corp / Heska Corp / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Company Profile Eli Lilly and Company - 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY.N / LLY=US</td><td class="leftalignment">Eli Lilly and Co / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / North America</td><td class="leftalignment">COMPANY UPDATE / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, January 10 – Sunday, January 16</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pipeline Pulse - Total Number Of Drugs Up 3% YoY; PIII Assets At Historic High</td><td class="leftalignment">English</td><td class="rightalignment">140</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 9.2% Above Pre-Pandemic Base- Week 90</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Equity Strategy: 4Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">A.N / ABT.N / AIG.N / BAC.N / BAX.N / BK.N / BMY.N / C.N / CRM.N / CVS.N / DAL.N / ECL.N / EOG.N / GPS.N / HLT.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / PFE.N / PM.N / PNC.N / SO.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / SPG.N / PG.N / DUK.N / DHR.N / DIS.N / UNH.N / DE.N / UNP.N / GS.N / MCD.N / HD.N / LOW.N / UPS.N / KR.N / XOM.N / AMT.N / LIN.N / TGT.N / VZ.N / COO.N / NRG.N / TJX.N / PSA.N / V.N / PLD.N / BLK.N / CVX.N / MCO.N / TDY.N / HPQ.N / INTC.OQ / ABMD.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / FRC.N / FISV.OQ / MSFT.OQ / ROST.OQ / SJM.N / SNPS.OQ / SBUX.OQ / QCOM.OQ / INTU.OQ / XRAY.OQ / DLTR.OQ / AMZN.OQ / NVDA.OQ / ISRG.OQ / ILMN.OQ / EQIX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / TFC.N / DXCM.OQ / CDNS.OQ / MS.N / FIS.N / CME.OQ / AVGO.OQ / SCHW.N / NEE.N / TSLA.OQ / ADI.OQ / ABBV.N / ZTS.N / MAR.OQ / GOOGL.OQ / KEYS.N / PYPL.OQ / HPE.N / CSX.OQ / IQV.N / PEP.OQ / BKNG.OQ / FB.PS / AEP.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / American International Group Inc / Bank of America Corp / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Citigroup Inc / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / EOG Resources Inc / Gap Inc / Hilton Worldwide Holdings Inc / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Pfizer Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Southern Co / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Target Corp / Verizon Communications Inc / Cooper Companies Inc / NRG Energy Inc / TJX Companies Inc / Public Storage / Visa Inc / Prologis Inc / BlackRock Inc / Chevron Corp / Moody's Corp / Teledyne Technologies Inc / HP Inc / Intel Corp / ABIOMED Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / First Republic Bank / Fiserv Inc / Microsoft Corp / Ross Stores Inc / J M Smucker Co / Synopsys Inc / Starbucks Corp / Qualcomm Inc / Intuit Inc / DENTSPLY SIRONA Inc / Dollar Tree Inc / Amazon.com Inc / NVIDIA Corp / Intuitive Surgical Inc / Illumina Inc / Equinix Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Dexcom Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / CME Group Inc / Broadcom Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / Analog Devices Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Alphabet Inc / Keysight Technologies Inc / PayPal Holdings Inc / Hewlett Packard Enterprise Co / CSX Corp / IQVIA Holdings Inc / PepsiCo Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / American Electric Power Company Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US -  Dividend Quality Analysis, for the period ended December 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 07,2022.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CYCC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CYCC.O / BAX / JNJ / LLY / ARRY.O / SPPI.O / ONTX.O / CASI.O</td><td class="leftalignment">Cyclacel Pharmaceuticals Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Array Technologies Inc / Spectrum Pharmaceuticals Inc / Onconova Therapeutics Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ONCY-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ONCY.O / BMY / LLY / HBP.TO / AEZS.O / AVEO.O / MRTX.O / TEVA.K / SPHS.PK</td><td class="leftalignment">Oncolytics Biotech Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Helix Biopharma Corp / Aeterna Zentaris Inc / Aveo Pharmaceuticals Inc / Mirati Therapeutics Inc / Teva Pharmaceutical Industries Ltd / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0028241000 / US00846U1016 / US00971T1016 / US0116591092 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0718131099 / US0758871091 / US1011371077 / US1101221083 / US1266501006 / US1727551004 / US22284P1057 / US28176E1082 / US3021301094 / US3156161024 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US5951121038 / US66987V1098 / US6701002056 / US6795801009 / US7140461093 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8168501018 / US8308791024 / US8447411088 / US8610121027 / US8740391003 / US8807701029 / US9029251066 / US91347P1057 / US92343V1044 / US9507551086 / US9581021055 / TW0002330008 / US87157D1090 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US20030N1019 / US6402681083 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US12541W2098 / US00206R1023 / ACOR.OQ / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US58933Y1055 / US34959E1091 / US1920051067 / US9100471096 / US03027X1000 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US81762P1021 / US8725901040 / US6974351057 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US22822V1017 / US74736K1016 / US29444U7000 / IE00BTN1Y115 / US00653A1079 / US12685J1051 / US02079K1079 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / CA87241L1094 / US78410G1040 / US83304A1060 / US91325V1089 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US87105L1044 / US57777K1060 / US11135F1012 / US5904791358 / US0197701065 / US0144421072 / US90353T1007 / US18915M1071 / US09203E1055 / CH0499880968 / KYG3902L1095 / US5502411037 / US35909R1086 / US25401T1088 / US20717M1036 / US1920031010 / US02080L1026 / US35909D1090 / US23284C1027 / US2935941078 / KYG393871085 / KYG4701H1092 / US86337R1032 / US10576N1028 / US4181001037 / AU0000185993</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Abbott Laboratories / Agilent Technologies Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Bristol-Myers Squibb Co / CVS Health Corp / Cirrus Logic Inc / Covenant Logistics Group Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PerkinElmer Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Semtech Corp / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Taiwan Semiconductor Manufacturing Co Ltd / Teradyne Inc / USA Truck Inc / Universal Display Corp / Verizon Communications Inc / Werner Enterprises Inc / Western Digital Corp / Taiwan Semiconductor Manufacturing Co Ltd / Synaptics Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Nektar Therapeutics / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Merck & Co Inc / Fortinet Inc / Codexis Inc / United Airlines Holdings Inc / American Tower Corp / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / ServiceNow Inc / T-Mobile US Inc / Palo Alto Networks Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Medtronic PLC / Adaptimmune Therapeutics PLC / Cable One Inc / Alphabet Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TFI International Inc / SBA Communications Corp / Snap Inc / Uniti Group Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Switch Inc / MaxCyte Inc / Broadcom Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Uber Technologies Inc / Cloudflare Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / GDS Holdings Ltd / Lumen Technologies Inc / Frontier Group Holdings Inc / DigitalBridge Group Inc / Confluent Inc / Codex DNA Inc / Alpha Teknova Inc / Frontier Communications Parent Inc / Cyxtera Technologies Inc / Enovix Corp / Globalfoundries Inc / IHS Holding Ltd / Stronghold Digital Mining Inc / Braze Inc / Hashicorp Inc / Iris Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / CARS / FISV=US / LLY=US / AMGN=US / BMY=US / TWTR=US / AMZN=US / EBAY=US / GILD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / HUM=US / CVS=US / W=US / STZ=US / DV=US / AIR=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CCK=US / CW=US / DRH=US / DCO=US / EEFT=US / HEI=US / HXL=US / TREE=US / MRCY=US / NRDS=US / REGN=US / ROLL=US / SHOP=US / SFT=US / SNAP=US / TRIP=US / TGI=US / TRUE=US / VSEC=US / VRTX=US / WIX=US / WEX=US / FOUR=US / GPN=US / PYPL=US / BKNG=US / PRI=US / FB=US / MTCH=US / SPR=US / EVOP=US / MQ / DKS=US / PTON=US / BIIB=US / FLT=US / MOG.A=US / APP=US / SHO=US / BLDR=US / FIS=US / TDG=US / HST=US / MA=US / WU=US / KTOS=US / WH=US / IAC=US / 45665G303 / HGV=US / GDOT=US / WWD=US / PCRX=US / RLJ=US / VAC=US / ANGI=US / RHP=US / SSTK=US / ABBV=US / GOOGL=US / BABA=US / AFMD=US / CMPR=US / BVH=US / WBA=US / GDDY=US / ETSY=US / AJRD=US / BWXT=US / ZG=US / SQ=US / IBEX=US / NTLA=US / TTD=US / CRSP=US / TRVG=US / PK=US / PLYA=US / AYX=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / MAXR=US / GSKY=US / FTDR=US / EB=US / AXNX=US / LYFT=US / UBER=US / LSPD=US / APLT=US / LHX=US / RPAY=US / ONEW=US / SPCE=US / AZEK=US / TSHA / PAYA=US / ABNB=US / DASH=US / AFRM=US / VMEO=US / MNTV=US / SQSP=US / 00152K101</td><td class="leftalignment">Albany International Corp / Cars.com Inc / Fiserv Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Twitter Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / CVS Health Corp / Wayfair Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Euronet Worldwide Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / Nerdwallet Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Shopify Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / TrueCar Inc / VSE Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / WEX Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / Marqeta Inc / DICK'S Sporting Goods Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Applovin Corp / Sunstone Hotel Investors Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Western Union Co / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Green Dot Corp / Woodward Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Shutterstock Inc / Abbvie Inc / Alphabet Inc / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / Walgreens Boots Alliance Inc / GoDaddy Inc / ETSY Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / Ibex Ltd / Intellia Therapeutics Inc / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Alteryx Inc / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Maxar Technologies Inc / GreenSky Inc / Frontdoor Inc / Eventbrite Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Applied Therapeutics Inc / L3harris Technologies Inc / Repay Holdings Corp / OneWater Marine Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Taysha Gene Therapies Inc / Paya Holdings Inc / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 Large-Cap Biotech Preview</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">AMGN=US / BIIB=US / LLY=US / BMY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / ABBV=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">LLY/BIIB: Expectations Into CMS's Draft NCD for Anti-a-Beta Antibodies for AD</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US5324571083 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / HD=US / MCD=US / WEN=US / AGL=US / BLD=US / DGX=US / BC=US / CRM=US / LOW=US / FMS=US / THC=US / BRO=US / LEG=US / HCA=US / MANH=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / SWIM=US / BMRN=US / CBRL=US / ELY=US / FUN=US / CYH=US / COR=US / DRI=US / DVA=US / AJG=US / HAS=US / LH=US / HZO=US / MAS=US / MAT=US / MHK=US / PII=US / REGI=US / SGMO=US / SMG=US / THO=US / WW=US / WEX=US / WGO=US / GOLF=US / CNC=US / MKL=US / NLS=US / ENSG=US / APPN=US / DIN=US / MD=US / JRVR=US / MOH=US / FLT=US / TPX=US / EXP=US / TXRH=US / PLAY=US / DENN=US / LHCG=US / XM=US / ESMT=US / CMG=US / SIX=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / SEAS=US / WRB=US / CWH=US / JACK=US / VRSK=US / TREX=US / INSE / KNSL=US / OLO=US / FBHS=US / TILE=US / NDLS=US / FOXF=US / MBUU=US / CNCE=US / QURE=US / FIVN=US / LOCO=US / OSH=US / NVRO=US / ANTM=US / WBA=US / WK=US / SHAK=US / ETSY=US / WING=US / MCFT=US / AXSM=US / EDIT=US / NTLA=US / CRSP=US / TVTY=US / 50189K103 / JELD=US / FNKO=US / LAZY=US / TCRR=US / PLMR=US / AHCO=US / PNTG=US / OPCH=US / ONEM=US / ONEW=US / ZI=US / AZEK=US / NCNO=US / HYFM=US / PRVA=US / AVAH=US / HLLY=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / TopBuild Corp / Quest Diagnostics Inc / Brunswick Corp / Salesforce.Com Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Tenet Healthcare Corp / Brown & Brown Inc / Leggett & Platt Inc / HCA Healthcare Inc / Manhattan Associates Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Cedar Fair LP / Community Health Systems Inc / RespireRx Pharmaceuticals Inc / Darden Restaurants Inc / DaVita Inc / Arthur J Gallagher & Co / Hasbro Inc / Laboratory Corporation of America Holdings / MarineMax Inc / Masco Corp / Mattel Inc / Mohawk Industries Inc / Polaris Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Thor Industries Inc / WW International Inc / WEX Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Centene Corp / Markel Corp / Nautilus Inc / Ensign Group Inc / Appian Corp / Dine Brands Global Inc / MEDNAX Inc / James River Group Holdings Ltd / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / Eagle Materials Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Qualtrics International Inc / EngageSmart Inc / Chipotle Mexican Grill Inc / Six Flags Entertainment Corp / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / SeaWorld Entertainment Inc / W R Berkley Corp / Camping World Holdings Inc / Jack in the Box Inc / Verisk Analytics Inc / Trex Company Inc / Inspired Entertainment Inc / Kinsale Capital Group Inc / Olo Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Fox Factory Holding Corp / Malibu Boats Inc / Concert Pharmaceuticals Inc / Uniqure NV / Five9 Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Nevro Corp / Anthem Inc / Walgreens Boots Alliance Inc / Workiva Inc / Shake Shack Inc / ETSY Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Tivity Health Inc / LCI Industries / JELD-WEN Holding Inc / Funko Inc / Lazydays Holdings Inc / TCR2 Therapeutics Inc / Palomar Holdings Inc / Adapthealth Corp / Pennant Group Inc / Option Care Health Inc / 1Life Healthcare Inc / OneWater Marine Inc / ZoomInfo Technologies Inc / Azek Company Inc / nCino Inc / Hydrofarm Holdings Group Inc / Privia Health Group Inc / Aveanna Healthcare Holdings Inc / Holley Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Locked And Loaded. Ph3 THRIVE-AA1 and -AA2 On Track To Deliver Topline Data 2Q22 And 3Q22</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">CNCE=US / LLY=US / PFE=US / AXSM=US</td><td class="leftalignment">Concert Pharmaceuticals Inc / Eli Lilly and Co / Pfizer Inc / Axsome Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Donanemab Is On Our Mind; How We Think About Next Week's NCD Initial Determination</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Additional price increases in 2022 for BMRN, LLY and PFE</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / BMRN.OQ / PFE.N / LLY=US / PFE=US / BMRN=US</td><td class="leftalignment">Eli Lilly and Co / Biomarin Pharmaceutical Inc / Pfizer Inc / Eli Lilly and Co / Pfizer Inc / Biomarin Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / BLD=US / CMA=US / MTN=US / LOW=US / PB=US / EWBC=US / SPOT=US / UMPQ=US / LEG=US / VMC=US / MLM=US / SWIM=US / BLL=US / CCK=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / CNM=US / SSB=US / RF=US / CATY=US / PNFP=US / OGN / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / TXRH=US / BLDR=US / GMS=US / CMG=US / XPO=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / PRPL=US / TREX=US / FBHS=US / TILE=US / NDLS=US / SHAK=US / WING=US / LOB=US / 82982L103 / JELD=US / MBIN=US / HWC=US / OZK=US / APLT=US / FERG=US / AZEK=US / VTRS=US / DASH=US / SNPO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / TopBuild Corp / Comerica Inc / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Spotify Technology SA / Umpqua Holdings Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Ball Corp / Crown Holdings Inc / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Core & Main Inc / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / Pinnacle Financial Partners Inc / Organon & Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / XPO Logistics Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Purple Innovation Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Applied Therapeutics Inc / Ferguson PLC / Azek Company Inc / Viatris Inc / DoorDash Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2206657 / 2270726 / 2684703 / 7103065 / B067BM3 / 2857817 / B02R1L6 / B7TL820 / B7254K9 / BHC8X90 / BD8DJ71 / BJ2Z0H2 / BDT5KT5 / BYSGPK2 / BYXR425 / BGDQ8B3 / BMYRFV6 / BPH0546 / BMHRMK1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Coca-Cola Co / Walt Disney Co / Pfizer Inc / Novartis AG / Molson Coors Beverage Co / Netflix Inc / ALLETE Inc / Meta Platforms Inc / AxoGen Inc / Novo Nordisk A/S / Snap Inc / Pinterest Inc / Inspire Medical Systems Inc / ViewRay Inc / RH / Axonics Inc / Procept Biorobotics Corp / Life Time Group Holdings Inc / Vita Coco Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AGR / AIG / AJG / ALL / AME / AON / APO / AXP / AZO / BAC / CB / CCO / CMS / COF / DFS / DIS / DOW / DVN / FNB / FRC / GPS / HIG / IPG / JNJ / KKR / LLY.N / LNC / MA / MET / MMC / NSC / NTB / OLN / OMC / PGR / PNC / PNM / PRU / RE / RNR / SNV / SO / STZ / SYY / T / TFC / TRV / USB / V / WAL / AMZN.O / AUD.N / CMCSA.O / WWE / ASB / BRO / AAPL.O / CSCO.O / SBGI.O / GTN / SIRI.O / PACW.O / SYF / SNPS.O / CHTR.O / EXPE.O / CBSH.O / AXS / WBS / FBP.N / OFG.N / PBCT.O / SIVB.O / UMBF.O / BPOP.O / BOKF.O / ACGL.O / UMPQ.O / EWBC.O / PNFP.O / NFLX.O / BIIB.O / NXST.O / FHN / SBNY.O / VIAC.O / DISCA.O / ISBC.O / CNK.N / WRB.N / FTNT.O / IMAX.N / NXPI.O / FIBK.O / CZR.O / BKU / STAG.K / AMCX.O / FB.O / UIHC.O / ABBV.N / VOYA.K / FOXA.O / HMTV.O / MAR.O / GOOGL.O / ARES.K / BANC.K / TBK.O / QRVO.O / CABO.N / ZBH / TGNA.K / WLTW.O / FHB.O / LGFb.N / ATUS.N / BHF.O / BOMN.O / ROKU.O / EQH / SPOT.K / SSP.O / OZK.O / UBER.K / IHRT.O / AVTR.K / BRP.O / ROOT.O / VZIO.N / RYAN.N</td><td class="leftalignment">Avangrid Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / AMETEK Inc / Aon PLC / Apollo Global Management Inc / American Express Co / Autozone Inc / Bank of America Corp / Chubb Ltd / Clear Channel Outdoor Holdings Inc / CMS Energy Corp / Capital One Financial Corp / Discover Financial Services / Walt Disney Co / Dow Inc / Devon Energy Corp / FNB Corp / First Republic Bank / Gap Inc / Hartford Financial Services Group Inc / Interpublic Group of Companies Inc / Johnson & Johnson / KKR & Co Inc / Eli Lilly and Co / Lincoln National Corp / Mastercard Inc / MetLife Inc / Marsh & McLennan Companies Inc / Norfolk Southern Corp / Bank of N T Butterfield & Son Ltd / Olin Corp / Omnicom Group Inc / Progressive Corp / PNC Financial Services Group Inc / PNM Resources Inc / Prudential Financial Inc / Everest Re Group Ltd / Renaissancere Holdings Ltd / Synovus Financial Corp / Southern Co / Constellation Brands Inc / Sysco Corp / AT&T Inc / Truist Financial Corp / Travelers Companies Inc / US Bancorp / Visa Inc / Western Alliance Bancorp / Amazon.com Inc / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Associated Banc-Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Sinclair Broadcast Group Inc / Gray Television Inc / Sirius XM Holdings Inc / PacWest Bancorp / Synchrony Financial / Synopsys Inc / Charter Communications Inc / Expedia Group Inc / Commerce Bancshares Inc / AXIS Capital Holdings Ltd / Webster Financial Corp / First Bancorp / OFG Bancorp / People's United Financial Inc / SVB Financial Group / UMB Financial Corp / Popular Inc / BOK Financial Corp / Arch Capital Group Ltd / Umpqua Holdings Corp / East West Bancorp Inc / Pinnacle Financial Partners Inc / Netflix Inc / Biogen Inc / Nexstar Media Group Inc / First Horizon Corp / Signature Bank / ViacomCBS Inc / Discovery Inc / Investors Bancorp Inc / Cinemark Holdings Inc / W R Berkley Corp / Fortinet Inc / Imax Corp / NXP Semiconductors NV / First Interstate BancSystem Inc / Caesars Entertainment Inc / BankUnited Inc / STAG Industrial Inc / AMC Networks Inc / Meta Platforms Inc / United Insurance Holdings Corp / Abbvie Inc / Voya Financial Inc / Fox Corp / Hemisphere Media Group Inc / Marriott International Inc / Alphabet Inc / Ares Management Corp / Banc of California Inc / Triumph Bancorp Inc / Qorvo Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Tegna Inc / Willis Towers Watson PLC / First Hawaiian Inc / Lions Gate Entertainment Corp / Altice USA Inc / Brighthouse Financial Inc / Boston Omaha Corp / Roku Inc / Equitable Holdings Inc / Spotify Technology SA / E W Scripps Co / Bank Ozk / Uber Technologies Inc / iHeartMedia Inc / Avantor Inc / BRP Group Inc / Root Inc / Vizio Holding Corp / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Luxembourg / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2022 Global Pharmaceuticals Outlook: Relative P/E Valuation Attractive to Value Investors, but Slowing Growth, 2026+ Patent Cliff, & Limited 2022 Catalysts Likely Caps Upside</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Jan. 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / BA.N / BAC.N / C.N / CCL.N / CF.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / JPM.N / LLY.N / LUV.N / MDT.N / PFE.N / RHI.N / T.N / TMO.N / WFC.N / DRE.N / SPG.N / PG.N / NUE.N / DIS.N / UNH.N / TFX.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / IT.N / GWW.N / VZ.N / V.N / ACN.N / PLD.N / TWTR.N / MAA.N / HPQ.N / COP.N / AOS.N / AAPL.OQ / AMAT.OQ / CERN.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / COST.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / CZR.OQ / AMD.OQ / FANG.OQ / ABBV.N / LEGN.DE / NCLH.N / GOOGL.OQ / PAYC.N / ANET.N / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Abbott Laboratories / Boeing Co / Bank of America Corp / Citigroup Inc / Carnival Corp / CF Industries Holdings Inc / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / JPMorgan Chase & Co / Eli Lilly and Co / Southwest Airlines Co / Medtronic PLC / Pfizer Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Duke Realty Corp / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / Visa Inc / Accenture PLC / Prologis Inc / Twitter Inc / Mid-America Apartment Communities Inc / HP Inc / Conocophillips / A O Smith Corp / Apple Inc / Applied Materials Inc / Cerner Corp / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Costco Wholesale Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Caesars Entertainment Inc / Advanced Micro Devices Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Germany / Ireland / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Eq Strat: Signature Picks—December Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SBNY.OQ / AME / AZO / BAC / CB / CMS / DIS / DOW / DVN / GPS / JNJ / LLY.N / MA / NSC / OLN / SO / STZ / SYY / AMZN.O / AAPL.O / CSCO.O / SNPS.O / EXPE.O / ACGL.O / SBNY.O / FTNT.O / NXPI.O / CZR.O / STAG.K / FB.O / ABBV.N / MAR.O / GOOGL.O / QRVO.O / ZBH / UBER.K / AVTR.K</td><td class="leftalignment">Signature Bank / AMETEK Inc / Autozone Inc / Bank of America Corp / Chubb Ltd / CMS Energy Corp / Walt Disney Co / Dow Inc / Devon Energy Corp / Gap Inc / Johnson & Johnson / Eli Lilly and Co / Mastercard Inc / Norfolk Southern Corp / Olin Corp / Southern Co / Constellation Brands Inc / Sysco Corp / Amazon.com Inc / Apple Inc / Cisco Systems Inc / Synopsys Inc / Expedia Group Inc / Arch Capital Group Ltd / Signature Bank / Fortinet Inc / NXP Semiconductors NV / Caesars Entertainment Inc / STAG Industrial Inc / Meta Platforms Inc / Abbvie Inc / Marriott International Inc / Alphabet Inc / Qorvo Inc / Zimmer Biomet Holdings Inc / Uber Technologies Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Christopher P. Harvey / Gary S. Liebowitz, CFA / Anna Han / Mr. Steven Cahall</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB/LLY—Recasting Our Alz Scenarios for Aduhelm Price Cut</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">LLY.N / BIIB.O</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">20 Events In 2022 That Could Change Practice, Alter Companies, Move Stocks</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US6402681083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 4 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000120271 / GB0007980591 / US00971T1016 / US0116591092 / US0463531089 / US0556221044 / US1101221083 / US30231G1022 / US37733W1053 / US4062161017 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US91913Y1001 / US92343V1044 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US80105N1054 / US20030N1019 / LU0156801721 / US6402681083 / US88031M1099 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / US2538681030 / US19239V3024 / RDSa.AS / US2090341072 / US00206R1023 / US1314761032 / PAP310761054 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US00507V1098 / US58933Y1055 / US88160R1014 / US9100471096 / US0995021062 / US4361061082 / US56585A1025 / US03027X1000 / US7185461040 / US69318G1067 / US00287Y1091 / US98978V1035 / US81762P1021 / US8725901040 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US69888T2078 / US0465131078 / CA0089118776 / US22822V1017 / US29444U7000 / US00653A1079 / US12685J1051 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / GB00BDSFG982 / US78410G1040 / US91325V1089 / US05722G1004 / US24665A1034 / US02156K1034 / US87105L1044 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / US15872M1045 / KYG3902L1095 / US62955J1034 / US5502411037 / US25401T1088 / US20717M1036 / US35909D1090 / KYG4701H1092 / US10576N1028 / US4181001037</td><td class="leftalignment">TotalEnergies SE / BP PLC / Akamai Technologies Inc / Alaska Air Group Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Exxon Mobil Corp / GlaxoSmithKline PLC / Halliburton Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Valero Energy Corp / Verizon Communications Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Tenaris SA / Nektar Therapeutics / Tenaris SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / AT&T Inc / Calumet Specialty Products Partners LP / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Activision Blizzard Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / HollyFrontier Corp / Marathon Petroleum Corp / American Tower Corp / Phillips 66 / PBF Energy Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / T-Mobile US Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TechnipFMC PLC / SBA Communications Corp / Uniti Group Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Switch Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / ChampionX Corp / GDS Holdings Ltd / Nov Inc / Lumen Technologies Inc / DigitalBridge Group Inc / Confluent Inc / Frontier Communications Parent Inc / IHS Holding Ltd / Braze Inc / Hashicorp Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, January 3 – Sunday, January 9</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eight-bagger Eli Lilly and Company soars 66% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company surges 21% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / RHHBY.PK / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Quick Thoughts, Who's Gonna Get The Love And Who Could Feel The Pain in 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / US02043Q1076 / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alnylam Pharmaceuticals Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">90</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">844</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended October 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2002305 / 2973821 / 2542049 / 2689560 / 2684703 / 7103065 / B125XQ6 / B1XGNW4 / B0796X4 / BTN1Y11 / BFNR303 / BF3W461</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / Alliant Energy Corp / Dominion Energy Inc / PG&E Corp / Pfizer Inc / Novartis AG / Portland General Electric Co / Insulet Corp / Dexcom Inc / Medtronic PLC / Northwest Natural Holding Co / Tandem Diabetes Care Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company top market value gainer in Primecap Management Co [ranked 1 out of 168] since Sep 30</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Model update post CMD. Major catalyst of COVID data due early 22. CSe 60% POS $1b , NPV SFr 6.5/shr</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MOLN.S / JNJ.N / LLY.N / PFE.N / AZN.L / ROG.S / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / ABBV.N / ARGX.OQ</td><td class="leftalignment">Molecular Partners AG / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, LLY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BSX=US / NKE=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / MDT=US / BLD=US / PEB=US / H=US / CRM=US / MTN=US / LOW=US / IART=US / MAR=US / LEG=US / TNL=US / VMC=US / HLT=US / MANH=US / MLM=US / PATH=US / SWIM=US / CBRL=US / CCL=US / KIDS=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / VRTX=US / PYPL=US / CNM=US / APPN=US / DIN=US / BDSI=US / DKS=US / OGN / BIIB=US / TPX=US / EXP=US / NUVA=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / HST=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / OLO=US / HGV=US / RLJ=US / VAC=US / FBHS=US / GMED=US / RHP=US / TILE=US / NDLS=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / ZBH=US / WING=US / SPNE=US / PEN=US / 82982L103 / EVBG=US / IRTC=US / CRSP=US / PK=US / JELD=US / PLYA=US / SMAR=US / AXNX=US / LYFT=US / UBER=US / FERG=US / AZEK=US / AZYO=US / VTRS=US / DASH=US / DNUT=US / SNPO=US / ROIV=US</td><td class="leftalignment">Boston Scientific Corp / Nike Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / UiPath Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Carnival Corp / OrthoPediatrics Corp / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Vertex Pharmaceuticals Inc / PayPal Holdings Inc / Core & Main Inc / Appian Corp / Dine Brands Global Inc / BioDelivery Sciences International Inc / DICK'S Sporting Goods Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / NuVasive Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Olo Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Zimmer Biomet Holdings Inc / Wingstop Inc / SeaSpine Holdings Corp / Penumbra Inc / SiteOne Landscape Supply Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Smartsheet Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Azek Company Inc / Aziyo Biologics Inc / Viatris Inc / DoorDash Inc / Krispy Kreme Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2640147 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2455965 / 2689560 / 2684703 / 7103065 / 2713317 / 2857817 / B125XQ6 / BHC8X90 / BJJMGL2 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Novo Nordisk A/S / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Eli Lilly and Co Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Eli Lilly and Company (LLY) - Counting big from Donanemab - Alzheimer’s disease</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - Model update after investor day - donanemab lower, tirzepatide higher</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Lower Aducanumab Price Step in the Right Direction, Paves Way for a Smooth NCD in January</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N / BIIB.O</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">12/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.8% Above Pre-Pandemic Base- Week 89</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1380</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/18/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">ELI LILLY sees an upgrade to Positive due to a better fundamental star rating</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 10 to 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US00724F1012 / US0236081024 / US0311621009 / US0351282068 / US0383361039 / US0394831020 / US0536111091 / US0584981064 / US1101221083 / US1264081035 / US1564311082 / US2017231034 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4227041062 / US5324571083 / US5463471053 / US6516391066 / US65473P1057 / US6703461052 / US7170811035 / US7445731067 / US7802871084 / US8581191009 / US92276F1003 / US9746371007 / US98389B1008 / CA13321L1085 / CA6979001089 / CA8787422044 / CA2918434077 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA1349211054 / CA0636711016 / CA0641491075 / CA8765111064 / CA3359341052 / US20825C1045 / US35671D8570 / AU000000FMG4 / US09062X1037 / CA98462Y1007 / US02043Q1076 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / CA39138C1068 / CA4436281022 / CA1360691010 / US3546131018 / US74144T1088 / US09247X1019 / US44107P1049 / CA95083R1001 / US40637H1095 / CA1375761048 / US74460D1090 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / US30225T1025 / CA0966311064 / CA29258Y1034 / CA1999101001 / CA2271071094 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA46071W2058 / BMG491BT1088 / CA3518581051 / GB00B2QPKJ12 / GB0004300496 / US26884L1098 / US91912E1055 / US1921085049 / IE00B4BNMY34 / CA69946Q1046 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US2296631094 / CA54928Q1081 / AU000000EVN4 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09739D1000 / JE00B5TT1872 / US09609G1004 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3874371147 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0158571053 / CA0213611001 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA8661201167 / CA38045Y1025 / US16208T1025 / CA5054401073 / US45845P1084 / CA0266951064 / CA33812R1091 / CA17039A1066 / CA46579R1047 / US45378A1060 / CA65340P1062 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / CA45868C1095 / CA26153P1045 / CA1264621006 / CA7397211086 / US14174T1079 / CA68827L1013 / US78667J1088 / CA30606C1086 / IE00BQPVQZ61 / CA5503711080 / US30040W1080 / CA74273V1067 / US6378701063 / AU000000S320 / US4278255009 / CA0115321089 / CA05329M1041 / US95040Q1040 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / US53223X1072 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / US43300A2033 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US23355L1061 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / US03753U1060 / CA2960061091 / CA7766521099 / CA8585221051 / US92645B1035 / US3843135084 / US03168L1052 / US2997341035 / CA05585D1033 / US03836N1037 / CA0717341071 / US03843E1047 / CA4039254079 / US04335A1051 / CA38119T8077 / CA13000C2058 / US03990B1017 / CA72765Q8829 / US1255231003 / CA2849025093 / CA45075E1043 / US63253R2013 / AU0000018236 / CA7426943006 / CA57776F4050 / US09260D1072 / CA5625684025 / CA48086P1009 / US30205M1018 / CA29446Y5020 / US03768E1055 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / CA31890B1031 / US14316J1088 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA67079A1021 / US12529R1077 / US3773201062 / CA9004352071 / US3680361090 / CA64782A1075 / CA00288U1066 / CA36261G1028 / US15202L1070 / US24343R1068 / CA65401N1078 / US90364P1057 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA50202P1053 / CA65343M2094 / US1374041093 / CA0156581070 / CA24477T1003 / CA22289D1078 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Adobe Inc / Ameren Corp / Amgen Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Ball Corp / Bristol-Myers Squibb Co / CSX Corp / Century Aluminum Co / Commercial Metals Co / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hecla Mining Co / Eli Lilly and Co / Louisiana-Pacific Corp / Newmont Corporation / NiSource Inc / Nucor Corp / Pfizer Inc / Public Service Enterprise Group Inc / Royal Gold Inc / Steel Dynamics Inc / Ventas Inc / Winnebago Industries Inc / Xcel Energy Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Empire Company Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Canadian Apartment Properties Real Estate Investment Trust / Bank of Montreal / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Host Hotels & Resorts Inc / Wesdome Gold Mines Ltd / Halozyme Therapeutics Inc / Canfor Corp / Public Storage / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Extra Space Storage Inc / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Cominar Real Estate Investment Trust / Crombie Real Estate Investment Trust / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / InterRent Real Estate Investment Trust / Invesco Ltd / Franco-Nevada Corp / Fresnillo PLC / Pan African Resources PLC / EQT Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Parex Resources Inc / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / CubeSmart / Lucara Diamond Corp / Evolution Mining Ltd / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Centamin PLC / bluebird bio Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Algonquin Power & Utilities Corp / AltaGas Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / Summit Industrial Income REIT / GoGold Resources Inc / Chatham Lodging Trust / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Fission Uranium Corp / Choice Properties Real Estate Investment Trust / Ivanhoe Mines Ltd / Independence Realty Trust Inc / Nexgen Energy Ltd / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Prairiesky Royalty Ltd / CareTrust REIT Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Falco Resources Ltd / Horizon Therapeutics PLC / Lundin Gold Inc / Eversource Energy / Probe Metals Inc / National Storage Affiliates Trust / South32 Ltd / Hersha Hospitality Trust / Alamos Gold Inc / Automotive Properties Real Estate Investment Trust / Welltower Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Life Storage Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Hilton Worldwide Holdings Inc / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / DXC Technology Co / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Apellis Pharmaceuticals Inc / Ero Copper Corp / Roots Corp / Stelco Holdings Inc / Victory Capital Holdings Inc / GrafTech International Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Aptinyx Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Golden Star Resources Ltd / Calibre Mining Corp / Ares Management Corp / Platinum Group Metals Ltd / Cigna Corp / Eldorado Gold Corp / iA Financial Corporation Inc / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / Maverix Metals Inc / Blackstone Inc / Mandalay Resources Corp / Josemaria Resources Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / First Capital Real Estate Investment Trust / Carlyle Group Inc / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Abcellera Biologics Inc / G Mining Ventures Corp / Centerspace / Decibel Therapeutics Inc / Nickel 28 Capital Corp / UiPath Inc / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / Li-Cycle Holdings Corp / NextSource Materials Inc / Candel Therapeutics Inc / Algoma Steel Group Inc / Definity Financial Corp / Coveo Solutions Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CARS / LLY=US / OXY=US / TWTR=US / IP=US / AGL=US / AMZN=US / BLD=US / EBAY=US / CPE=US / MGY=US / SWN=US / VRM=US / MRO=US / EXPE=US / TTWO=US / ATVI=US / VMC=US / MGM=US / AKR=US / W=US / MLM=US / DV=US / KFY=US / HEI=US / IBP=US / TREE=US / NRDS=US / SFT=US / SNAP=US / TRIP=US / TRUE=US / WIX=US / BKNG=US / FB=US / FRT=US / KIM=US / MTCH=US / REG=US / APPN=US / BRX=US / ATRS=US / PTON=US / APP=US / BLDR=US / AAWW=US / CPRX=US / WRK=US / ATSG=US / IAC=US / ANGI=US / EA=US / SSTK=US / QURE=US / GOOGL=US / MTNB=US / BABA=US / CMPR=US / GDDY=US / ETSY=US / ZG=US / TTD=US / TRVG=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / FTDR=US / EB=US / SITC=US / LYFT=US / UBER=US / DKNG=US / BALY=US / ABNB=US / DASH=US / ROCC=US / VMEO=US / MNTV=US / SQSP=US / PKG=U / 00152K101</td><td class="leftalignment">Cars.com Inc / Eli Lilly and Co / Occidental Petroleum Corp / Twitter Inc / International Paper Co / agilon health Inc / Amazon.com Inc / TopBuild Corp / eBay Inc / Callon Petroleum Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Vroom Inc / Marathon Oil Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / Vulcan Materials Co / MGM Resorts International / Acadia Realty Trust / Wayfair Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Korn Ferry / HEICO Corp / Installed Building Products Inc / Lendingtree Inc / Nerdwallet Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Wix.Com Ltd / Booking Holdings Inc / Meta Platforms Inc / Federal Realty Investment Trust / Kimco Realty Corp / Match Group Inc / Regency Centers Corp / Appian Corp / Brixmor Property Group Inc / Antares Pharma Inc / Peloton Interactive Inc / Applovin Corp / Builders FirstSource Inc / Atlas Air Worldwide Holdings Inc / Catalyst Pharmaceuticals Inc / Westrock Co / Air Transport Services Group Inc / IAC/Interactivecorp / Angi Inc / Electronic Arts Inc / Shutterstock Inc / Uniqure NV / Alphabet Inc / Matinas BioPharma Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / ETSY Inc / Zillow Group Inc / Trade Desk Inc / Trivago NV / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Frontdoor Inc / Eventbrite Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / DraftKings Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / Ranger Oil Corp / Vimeo Inc / Momentive Global Inc / Squarespace Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAP / AR / AZO / BBY / BIO / CCO / CLR / CNX / CPE / DIS / DVN / EOG / EQT / FDX / FND / HD / IPG / LLY.N / LOW / MGY / MRO / OI / OMC / PXD / RH / RRC / SM / SWN / TFC / USB / W / WLL / WSM / AUD.N / CMCSA.O / RF / WWE / SBGI.O / ADBE.O / BBBY.O / SIRI.O / CHTR.O / LPI / CRK.N / TSCO.O / NDSN.O / ORLY.O / WOOF.O / NFLX.O / NXST.O / VIAC.O / DISCA.O / CNK.N / NOG.A / IMAX.N / CZR.O / AMCX.O / ESTE.K / MTDR.K / ARCT.O / PDCE.O / FANG.O / FOXA.O / HMTV.O / CIVI.K / CABO.N / TGNA.K / LGFb.N / CDEV.O / CVNA.K / ATUS.N / BOMN.O / ROKU.O / EYE.O / SPOT.K / SSP.O / BRY.O / FLTRF.L / IHRT.O / FTCH.K / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / SFT.O / CHK.O / VZIO.N / JOAN.O / GPOR.N / RIVN.O</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bio Rad Laboratories Inc / Clear Channel Outdoor Holdings Inc / Continental Resources Inc / CNX Resources Corp / Callon Petroleum Co / Walt Disney Co / Devon Energy Corp / EOG Resources Inc / EQT Corp / FedEx Corp / Floor & Decor Holdings Inc / Home Depot Inc / Interpublic Group of Companies Inc / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Marathon Oil Corp / O-I Glass Inc / Omnicom Group Inc / Pioneer Natural Resources Co / RH / Range Resources Corp / SM Energy Co / Southwestern Energy Co / Truist Financial Corp / US Bancorp / Wayfair Inc / Whiting Petroleum Corp / Williams-Sonoma Inc / Audacy Inc / Comcast Corp / Regions Financial Corp / World Wrestling Entertainment Inc / Sinclair Broadcast Group Inc / Adobe Inc / Bed Bath & Beyond Inc / Sirius XM Holdings Inc / Charter Communications Inc / Laredo Petroleum Inc / Comstock Resources Inc / Tractor Supply Co / Nordson Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Cinemark Holdings Inc / Northern Oil and Gas Inc / Imax Corp / Caesars Entertainment Inc / AMC Networks Inc / Earthstone Energy Inc / Matador Resources Co / Arcturus Therapeutics Holdings Inc / PDC Energy Inc / Diamondback Energy Inc / Fox Corp / Hemisphere Media Group Inc / Civitas Resources Inc / Cable One Inc / Tegna Inc / Lions Gate Entertainment Corp / Centennial Resource Development Inc / Carvana Co / Altice USA Inc / Boston Omaha Corp / Roku Inc / National Vision Holdings Inc / Spotify Technology SA / E W Scripps Co / Berry Corporation (Bry) / Flutter Entertainment PLC / iHeartMedia Inc / Farfetch Ltd / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / Shift Technologies Inc / Chesapeake Energy Corp / Vizio Holding Corp / Joann Inc / Gulfport Energy Corp / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2516152 / 2000019 / 2008154 / 2190750 / 2216850 / 2270726 / 2328915 / 2100920 / 2689560 / 2684703 / 2857817 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / B95N910 / BFLR866 / BD8DJ71 / BWTN5N1 / BJ2Z0H2 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BFNR303 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BKC9SX3 / BDD1B07 / BMPRZV5 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / PTC Inc / Twitter Inc / Snap Inc / ETSY Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / Northwest Natural Holding Co / Spire Inc / ViacomCBS Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - Read-across on FDA approvability of Chinese of PD-(L)1s</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / ROG.S / BMY.N / LLY.N / MRK.N / SASY.PA / GSK.L / BGNE.OQ</td><td class="leftalignment">AstraZeneca PLC / Roche Holding AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Sanofi SA / GlaxoSmithKline PLC / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Innovent: Recent FDA and Lilly events add more questions for PD-1 sintilimab's US approvability. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / 1801.HK / BGNE.OQ / 1877.HK</td><td class="leftalignment">Eli Lilly and Co / Innovent Biologics Inc / Beigene Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Healthcare: Key takeaways from our Pharma & Medtech virtual bus trip</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVN.S / FMEG.DE / FREG.DE / GSK.L / UCB.BR / COLOB.CO / STMN.S / BIIB.OQ / YPSN.S / IPN.PA / DEMANT.CO</td><td class="leftalignment">Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novartis AG / Fresenius Medical Care AG & Co KGaA / Fresenius SE & Co KGaA / GlaxoSmithKline PLC / Ucb SA / Coloplast A/S / Straumann Holding AG / Biogen Inc / Ypsomed Holding AG / Ipsen SA / Demant A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">LLY: Updating Our Model for 2022 Guidance</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIT / APO / BX / CE / DHI / DIS / F.N / FOR / GM.N / HEP / KBH / KKR / LLY.N / MDT / OKE / SUN / TOL / TPH / VFC / WMB / AMZN.O / ET / AAPL.O / BWA.N / LEA.N / MGA.N / DIOD.O / NFLX.O / DISCA.O / CCS.N / JNPR.K / IMAX.N / KEY.TO / LNG.N / TRGP.K / PSXP.K / QURE.O / ARES.K / LGFb.N / HLNE.O / AXNX.O / ETRN.K / CRNC.O / OMP.O / WKME.O / BRDG.N</td><td class="leftalignment">Applied Industrial Technologies Inc / Apollo Global Management Inc / Blackstone Inc / Celanese Corp / D R Horton Inc / Walt Disney Co / Ford Motor Co / Forestar Group Inc / General Motors Co / Holly Energy Partners LP / KB Home / KKR & Co Inc / Eli Lilly and Co / Medtronic PLC / ONEOK Inc / Sunoco LP / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / VF Corp / Williams Companies Inc / Amazon.com Inc / Energy Transfer LP / Apple Inc / Borgwarner Inc / Lear Corp / Magna International Inc / Diodes Inc / Netflix Inc / Discovery Inc / Century Communities Inc / Juniper Networks Inc / Imax Corp / Keyera Corp / Cheniere Energy Inc / Targa Resources Corp / Phillips 66 Partners LP / Uniqure NV / Ares Management Corp / Lions Gate Entertainment Corp / Hamilton Lane Inc / Axonics Inc / Equitrans Midstream Corp / Cerence Inc / Oasis Midstream Partners LP / Walkme Ltd / Bridge Investment Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">R&D Day highlights across neuroscience diabetes/obesity, immunology and oncology pipeline</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Revenue & Gross Margin Guidance Surprise, New Launches, & Robust Pipeline Further Validates Our Favorite Biopharma Growth Stock; PT to $300/shr</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Robust Pipeline Showcased; '22 Guidance Above Expectations, Confident Thru 2030</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">LLY: Strong Guidance, Pipeline Progress and Less Alzheimer's Discussion Paints a Better Picture</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">NKE=US / LLY=US / HD=US / TJX=US / MDT=US / CMA=US / PEB=US / APA=US / EOG=US / BC=US / H=US / MTN=US / LOW=US / PB=US / MUR=US / EWBC=US / MAR=US / VFC=US / ADS=US / TNL=US / HLT=US / PVH=US / AMK=US / CTRA=US / CHH=US / DRH=US / HEI=US / RL=US / ROST=US / CFB=US / CFR=US / ABCB=US / BOKF=US / MKL=US / FFIN=US / COP=US / DKS=US / TCBI=US / SHO=US / HST=US / LULU=US / WH=US / NOG=US / WRB=US / KNSL=US / OAS=US / HGV=US / LPLA=US / RLJ=US / VAC=US / RHP=US / IBTX=US / BURL=US / MBUU=US / BVH=US / UAA=US / PK=US / PLYA=US / OZK=US / TENB=US / FOCS=US / AMTB=US / OVV=US / ONEW=US / RBLX=US</td><td class="leftalignment">Nike Inc / Eli Lilly and Co / Home Depot Inc / TJX Companies Inc / Medtronic PLC / Comerica Inc / Pebblebrook Hotel Trust / APA Corp (US) / EOG Resources Inc / Brunswick Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Murphy Oil Corp / East West Bancorp Inc / Marriott International Inc / VF Corp / Alliance Data Systems Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / PVH Corp / AssetMark Financial Holdings Inc / Coterra Energy Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / HEICO Corp / Ralph Lauren Corp / Ross Stores Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / Ameris Bancorp / BOK Financial Corp / Markel Corp / First Financial Bankshares Inc / Conocophillips / DICK'S Sporting Goods Inc / Texas Capital Bancshares Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Lululemon Athletica Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / W R Berkley Corp / Kinsale Capital Group Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Independent Bank Group Inc / Burlington Stores Inc / Malibu Boats Inc / Bluegreen Vacations Holding Corp / Under Armour Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Bank Ozk / Tenable Holdings Inc / Focus Financial Partners Inc / Amerant Bancorp Inc / Ovintiv Inc / OneWater Marine Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US0341641035 / US0351282068 / US0394831020 / US1101221083 / US1564311082 / US2017231034 / US2372661015 / US3755581036 / US38059T1060 / US4227041062 / US4404521001 / US5324571083 / US6516391066 / US6703461052 / US75886F1075 / US7802871084 / US8000131040 / US8581191009 / US9024941034 / US9746371007 / CA13321L1085 / CA6979001089 / CA8787422044 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / CA8765111064 / CA3359341052 / US35671D8570 / AU000000FMG4 / BMG169621056 / CA98462Y1007 / CA5503721063 / CA8911605092 / CA4436281022 / CA1360691010 / CA95083R1001 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA29258Y1034 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / US3932221043 / GB00B2QPKJ12 / GB0004300496 / US91912E1055 / US1921085049 / CA69946Q1046 / US72147K1088 / CA66510M2040 / JE00B4T3BW64 / CA54928Q1081 / US4571871023 / AU000000EVN4 / JE00B5TT1872 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0213611001 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA5054401073 / CA33812R1091 / CA46579R1047 / CA65340P1062 / CA7397211086 / CA68827L1013 / CA30606C1086 / CA5503711080 / CA74273V1067 / AU000000S320 / CA0115321089 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / CA2960061091 / CA8585221051 / US3843135084 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA57776F4050 / CA5625684025 / CA48086P1009 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA9004352071 / US3680361090 / CA64782A1075 / CA36261G1028 / CA65401N1078 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA65343M2094 / CA0156581070 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Andersons Inc / AngloGold Ashanti Ltd / Archer-Daniels-Midland Co / Bristol-Myers Squibb Co / Century Aluminum Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Hormel Foods Corp / Eli Lilly and Co / Newmont Corporation / Nucor Corp / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Sanderson Farms Inc / Steel Dynamics Inc / Tyson Foods Inc / Winnebago Industries Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Taseko Mines Ltd / First Quantum Minerals Ltd / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Bunge Ltd / Yamana Gold Inc / Lundin Mining Corp / Toronto-Dominion Bank / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Wesdome Gold Mines Ltd / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Endeavour Silver Corp / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Green Plains Inc / Fresnillo PLC / Pan African Resources PLC / Vale SA / Coeur Mining Inc / Parex Resources Inc / Pilgrims Pride Corp / Northern Dynasty Minerals Ltd / Glencore PLC / Lucara Diamond Corp / Ingredion Inc / Evolution Mining Ltd / Centamin PLC / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / AltaGas Ltd / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / Labrador Iron Ore Royalty Corp / Fission Uranium Corp / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Prairiesky Royalty Ltd / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Probe Metals Inc / South32 Ltd / Alamos Gold Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / GrafTech International Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / Maverix Metals Inc / Mandalay Resources Corp / Josemaria Resources Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / NextSource Materials Inc / Algoma Steel Group Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2516152 / 2000019 / 2536763 / 2270726 / 2328915 / 2689560 / 2048804 / 2138158 / 2951452 / B7TL820 / BBGVT40 / B95N910 / BFLR866 / BD9GVY0 / BJ2Z0H2 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BFY7DC4 / 021513106 / BNTB3N8 / BF0QTY9 / BNC1BX1</td><td class="leftalignment">Eli Lilly and Co / Amazon.com Inc / Lowe's Companies Inc / Walt Disney Co / Nextera Energy Inc / PG&E Corp / Pinnacle West Capital Corp / Sempra Energy / J M Smucker Co / Meta Platforms Inc / News Corp / PTC Inc / Twitter Inc / Zai Lab Ltd / Pinterest Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Alphabet Inc / Altimmune Inc / Alto Ingredients Inc / Vizio Holding Corp / Chicken Soup for The Soul Entertainment Inc / Taysha Gene Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Biotechnology - ASH 2021: potential winners start to emerge</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">FR0000120578 / GB0009252882 / DK0010272202 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Genmab A/S / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Analyst Day Highlights Increasing Differentiated Growth Profile</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Innovent: A good clue on PD-1 sintilimab's US approval expected on 10 Feb 2022 . Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1801.HK / LLY.N / BGNE.OQ / 1877.HK</td><td class="leftalignment">Innovent Biologics Inc / Eli Lilly and Co / Beigene Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Investor Day Wrap-Up: Increasing TP to $320 on Longer-Term Margin Expansion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Pipeline Review and Guidance Event Supports Positive Momentum For the Stock in 2022+, Increasing PT to $335 From $315</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Investor Day: Morning Session Highlights and Q&A</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Initial Thoughts On 2022 Guidance - Top Line Ahead Of Expectations, Opex Step Up More Manageable Than Anticipated</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Dec. 15, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Consensus in-line with bottom end of LLY 2022 sales guidance range, guidance beat on EPS</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Investor Day First Take: 2022 EPS Guidance Above Consensus on Margin Expansion</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">LLY: Strong Guidance—Alzheimer's, GLP-1 in Focus</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">A Dash Of Sugar And Spice This Morning, First Look At 2022 Financial Guidance That Beat Expectations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">US0236081024 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US5463471053 / US75886F1075 / US9621661043 / CA9528451052 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / CA8911605092 / CA1360691010 / US7376301039 / CA1375761048 / US00287Y1091 / US09739D1000 / CA0158571053 / CA04016A1012 / CA45868C1095 / US78667J1088 / US23355L1061 / CA7766521099 / US90364P1057 / CA50202P1053</td><td class="leftalignment">Ameren Corp / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Regeneron Pharmaceuticals Inc / Weyerhaeuser Co / West Fraser Timber Co Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Potlatchdeltic Corp / Canfor Corp / Abbvie Inc / Boise Cascade Co / Algonquin Power & Utilities Corp / Argonaut Gold Inc / Interfor Corp / SAGE Therapeutics Inc / DXC Technology Co / Roots Corp / UiPath Inc / Li-Cycle Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2000019 / 2008154 / 2050832 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2048804 / 2707677 / 2730190 / 2440637 / 4595739 / 2857817 / B3D7K31 / 2949758 / B7TL820 / BCZS820 / BFDV8K0 / BBGVT40 / BP4GNK9 / BFZ1K46 / BMYML02 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BYY88Y7 / BNTB3N8 / BM8NHS1</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Genmab A/S / Netflix Inc / Discovery Inc / Nexstar Media Group Inc / Meta Platforms Inc / Fate Therapeutics Inc / MacroGenics Inc / News Corp / SAGE Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Alphabet Inc / Vizio Holding Corp / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / India / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended September 13,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Doc Call Follow-Up: Focus on CAR-T in DLBCL After Practice Changing Data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US00287Y1091</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Analyst Meeting Should Feature Positive Product News; 2022 EPS Guide Less Clear</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / INTC=US / MCD=US / ADI=US / AMD=US / GBT=US / PG=US / WEN=US / BLD=US / TXN=US / NVDA=US / MPWR=US / LOW=US / CHKP=US / DIOD=US / XLNX=US / LEG=US / TTMI=US / SEIC=US / VMC=US / BKI=US / CVS=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / DOC=US / MCHP=US / MHK=US / STRA=US / FORG=US / NET=US / FAF=US / CNM=US / FB=US / AUTL=US / DIN=US / OGN / RPD=US / TPX=US / EXP=US / BDC=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / TDG=US / PGTI=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / IAC=US / JACK=US / TREX=US / NXPI=US / LPLA=US / FBHS=US / ANGI=US / PANW=US / QLYS=US / BERY=US / TILE=US / NDLS=US / FATE=US / VRNS=US / LOCO=US / SHAK=US / ON=US / WING=US / ZS=US / MIME=US / 82982L103 / JELD=US / OKTA=US / SAIL=US / TENB=US / CRWD=US / FERG=US / AZEK=US / VTRS=US / RBLX=US / KNBE=US / VMEO=US / REPX=US / SNPO=US / MNDT=US / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / Intel Corp / McDonald's Corp / Analog Devices Inc / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Procter & Gamble Co / Wendys Co / TopBuild Corp / Texas Instruments Inc / NVIDIA Corp / Monolithic Power Systems Inc / Lowe's Companies Inc / Check Point Software Technologies Ltd / Diodes Inc / Xilinx Inc / Leggett & Platt Inc / TTM Technologies Inc / SEI Investments Co / Vulcan Materials Co / Black Knight Inc / CVS Health Corp / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Physicians Realty Trust / Microchip Technology Inc / Mohawk Industries Inc / Strategic Education Inc / ForgeRock Inc / Cloudflare Inc / First American Financial Corp / Core & Main Inc / Meta Platforms Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / PGT Innovations Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Fortune Brands Home & Security Inc / Angi Inc / Palo Alto Networks Inc / Qualys Inc / Berry Global Group Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Zscaler Inc / Mimecast Ltd / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Okta Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc / Roblox Corp / Knowbe4 Inc / Vimeo Inc / Riley Exploration Permian Inc / Snap One Holdings Corp / Mandiant Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US1264081035 / US3755581036 / US45337C1027 / US5324571083 / US6745991058 / US7170811035 / US75886F1075 / US20825C1045 / CA56501R1064 / CA8667961053 / CA39138C1068 / US26884L1098 / US58933Y1055 / US69327R1014 / CA21750U1012 / US31189P1021 / US86771W1053 / US03753U1060 / US03843E1047 / CA45075E1043 / US86745K1043 / US30205M1018</td><td class="leftalignment">CSX Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Occidental Petroleum Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Conocophillips / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / EQT Corp / Merck & Co Inc / PDC Energy Inc / Copper Mountain Mining Corp / Fate Therapeutics Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Aquestive Therapeutics Inc / iA Financial Corporation Inc / Sunnova Energy International Inc / Exicure Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2008154 / 2778844 / 2050832 / 2270726 / 2829515 / 2689560 / 2684703 / 2048804 / 7103065 / 2857817 / B3D7K31 / BCZS820 / BBGVT40 / BFLR866 / BFZNYB7 / BKVDFF7 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BZ05388 / BJVR9Y9 / BYY88Y7 / BG0Q4Y1 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Merck & Co Inc / Ameren Corp / Walt Disney Co / Edison International / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / News Corp / Twitter Inc / Allogene Therapeutics Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Alphabet Inc / Exicure Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">A / ABT / AIT / BAX / BDX / BIO / CRL / DGX / DHR / GWW / LH / LLY.N / MSM / MTD / PKI / SON / TMO / WAT / WCC / MGM.N / ICLR.O / ILMN.O / TECH.O / FAST.O / HOLX.O / BLUE.O / EXAS.O / BRKR.O / MPLX.K / MEIP.O / FATE.O / NVTA.N / UNVR.K / NTRA.O / OLLI.O / GBT.O / IQV / QGEN.K / GH.O / AVTR.K / KREF.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / Applied Industrial Technologies Inc / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / W W Grainger Inc / Laboratory Corporation of America Holdings / Eli Lilly and Co / MSC Industrial Direct Co Inc / Mettler-Toledo International Inc / PerkinElmer Inc / Sonoco Products Co / Thermo Fisher Scientific Inc / Waters Corp / Wesco International Inc / MGM Resorts International / ICON PLC / Illumina Inc / Bio-Techne Corp / Fastenal Co / Hologic Inc / bluebird bio Inc / Exact Sciences Corp / Bruker Corp / MPLX LP / MEI Pharma Inc / Fate Therapeutics Inc / Invitae Corp / Univar Solutions Inc / Natera Inc / Ollie's Bargain Outlet Holdings Inc / Global Blood Therapeutics Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / KKR Real Estate Finance Trust Inc / Stevanato Group SpA</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - 2022: Let's hope it's a good one</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended December 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">LLY: Thoughts Ahead of LLY Investor Event — Guidance, Alzheimer’s and More</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC - BUY - Preclinical Data Highlight ORIC-533 (CD73i) Potential in Multiple Myeloma; Pipeline Advancing with 3 New Trials to Commence by Early 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 0989529 / 2126335 / 2516152 / 2023607 / 7103065</td><td class="leftalignment">Oric Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 3: Wrap Up and Regeneron Investor Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US58933Y1055 / US31189P1021 / US03753U1060</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0576652004 / US45168D1046 / US5324571083 / US67018T1051 / US7170811035 / US75886F1075 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US14167L1035 / US1488061029 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US45781M1018 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US54142F1021 / US4158581094 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / US14147L1089 / US7291391057 / US12233L1070 / US04537Y1091 / US4131971040 / US04683R1068 / US66988N2053 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Balchem Corp / IDEXX Laboratories Inc / Eli Lilly and Co / NU Skin Enterprises Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / CareDx Inc / Catalent Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Innoviva Inc / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / LogicBio Therapeutics Inc / Harrow Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Cardiff Oncology Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Aspira Women's Health Inc / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Novan Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2516152 / 2000019 / 2094670 / 2008154 / 2065159 / 2280220 / 2270726 / 2542049 / 2829515 / 2457864 / 2689560 / 2680905 / 2684703 / 2857817 / B3D7K31 / BBGVT40 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BKS3SM8 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BYNQ369 / BDZ30Q0 / BN2R582 / BMDCDP2 / BN7K304 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BMXXBD9 / BNLYJ60</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Adobe Inc / Autodesk Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / ImmunoGen Inc / PG&E Corp / PPL Corp / Pfizer Inc / Netflix Inc / Discovery Inc / News Corp / Twitter Inc / Wix.Com Ltd / Shopify Inc / Chewy Inc / Snap Inc / IGM Biosciences Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Albertsons Companies Inc / Arvinas Inc / Relay Therapeutics Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Valneva SE / Squarespace Inc / Figs Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Thoughts Into 2022 Guidance</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 2: More Data Updates With GILD's Yescarta/ZUMA-7 in the Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US09609G1004 / US03753U1060 / US4718711033</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Next Two Weeks In Pharmaceuticals - Monday, December 13 – Sunday, December 26</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0311621009 / US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 88</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 3 to 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AU000000CIA2 / US0079031078 / US0091581068 / US0311621009 / US0383361039 / US1101221083 / US1264081035 / US1266501006 / US1270971039 / US1475281036 / US1844961078 / US2017231034 / US22160K1051 / US2372661015 / US25179M1036 / US26875P1012 / US30231G1022 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4404521001 / US4433201062 / US4456581077 / US45337C1027 / US4581401001 / US4601461035 / US5324571083 / US56418H1005 / US5962781010 / US6267171022 / US64125C1099 / US6558441084 / US6703461052 / US6745991058 / US6819191064 / US68389X1054 / US7170811035 / US7237871071 / US75281A1097 / US8454671095 / US8851601018 / US9024941034 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA29250N1050 / CA0977512007 / CA4530384086 / CA8787422044 / CA1247651088 / CA2918434077 / CA1469001053 / CA0679011084 / CA1363851017 / CA0099051009 / CA7029251088 / CA8959451037 / US1667641005 / CA13645T1003 / US5658491064 / CA13677F1018 / US0017441017 / US20825C1045 / US2274831047 / US09062X1037 / CA8676EP1086 / CA2052491057 / US14040H1059 / BMG169621056 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US02043Q1076 / CA4969024047 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA8935781044 / CA2935701078 / US12008R1077 / CA6993202069 / US8288061091 / US1252691001 / US12541W2098 / CA1125851040 / CA0906971035 / US42809H1077 / US57636Q1040 / CA30041N1078 / US59522J1034 / BMG383271050 / US9026531049 / CA2945051027 / CA6179141065 / CA14068G1046 / US5500211090 / US3932221043 / US3886891015 / US2120151012 / US38500T1016 / US26884L1098 / CA6252841045 / CA89154B1022 / CA9838911027 / CA22576C1014 / CA8672241079 / CA25675T1075 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / US98986T1088 / CA00829Q1019 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / US00287Y1091 / CA89156V1067 / US1091941005 / JE00B5TT1872 / US09609G1004 / US69327R1014 / CA04364G1063 / CA02215R1073 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA8204391079 / CA0805581091 / CA0213611001 / CA3565001086 / CA69338U1012 / CA74061A1084 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA38045Y1025 / CA81373C1023 / CA04682R1073 / CA29269R1055 / CA3748252069 / US5764852050 / US25278X1090 / CA4882951060 / CA46579R1047 / US31189P1021 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / US2383371091 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / CA83179X1087 / US95040Q1040 / US4622221004 / CA17040T3001 / US2057683029 / BMG162341090 / US13462K1097 / US15136A1025 / CA87241L1094 / CA46016U1084 / CA85859H1055 / CA6632782083 / CA15713J1049 / US12653C1080 / US8608971078 / CA35905B1076 / US03753U1060 / CA2960061091 / US00191U1025 / US11135F1012 / US87484T1088 / US76029N1063 / US34417P1003 / US08579X1019 / US04335A1051 / VGG1890L1076 / CA7241121077 / CA14179V5036 / US22052L1044 / CA6744822033 / US03768E1055 / US70614W1009 / US91734M1036 / CA31890B1031 / US69047Q1022 / US80810D1037 / MHY0436Q1098 / CA36168Q1046 / CA4220961078 / US03940R1077 / CA84678A1021 / US5168062058 / US05478C1053 / CA2674881040 / US13123X5086 / CA67079A1021 / CA89055A2039 / US23821D1000 / CA74022D4075 / US03750L1098 / US86333M1080 / US15202L1070 / CA83615X4075 / CA1295844056 / US78440X8048 / US1651677353 / US03743Q1085 / US90364P1057 / CA5362211040 / US44891N2080 / US92719V1008 / CA65532M6062 / CA00791P1071 / CA24874B1085 / US60646V1052 / CA03253E1079 / IE0003LFZ4U7 / CA53229C1077 / US98955K1043 / US4718711033 / US1374041093 / CA23344V1085 / CA0156581070</td><td class="leftalignment">Champion Iron Ltd / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / CSX Corp / CVS Health Corp / Coterra Energy Inc / Caseys General Stores Inc / Clean Harbors Inc / Commercial Metals Co / Costco Wholesale Corp / Darling Ingredients Inc / Devon Energy Corp / EOG Resources Inc / Exxon Mobil Corp / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hormel Foods Corp / Hub Group Inc / J B Hunt Transport Services Inc / Incyte Corp / Intel Corp / International Paper Co / Eli Lilly and Co / ManpowerGroup Inc / Middleby Corp / Murphy Oil Corp / Neurocrine Biosciences Inc / Norfolk Southern Corp / Nucor Corp / Occidental Petroleum Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Thor Industries Inc / Tyson Foods Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Enbridge Inc / Bombardier Inc / Imperial Oil Ltd / Teck Resources Ltd / CAE Inc / Empire Company Ltd / Cascades Inc / Barrick Gold Corp / Canadian Natural Resources Ltd / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Chevron Corp / Canadian Pacific Railway Ltd / Marathon Oil Corp / Canadian Western Bank / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Biogen Inc / Sunopta Inc / Computer Modelling Group Ltd / Capital One Financial Corp / Bunge Ltd / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Kinross Gold Corp / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Transcontinental Inc / Ensign Energy Services Inc / Builders FirstSource Inc / Paramount Resources Ltd / Simon Property Group Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Birchcliff Energy Ltd / Hess Corp / Mastercard Inc / Evertz Technologies Ltd / Mid-America Apartment Communities Inc / GeoPark Ltd / UDR Inc / Equitable Group Inc / Morguard Real Estate Investment Trust / Capstone Mining Corp / Lululemon Athletica Inc / Green Plains Inc / Graphic Packaging Holding Co / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Mullen Group Ltd / Total Energy Services Inc / Xebec Adsorption Inc / Crescent Point Energy Corp / Suncor Energy Inc / Dollarama Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Zynga Inc / Africa Oil Corp / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / bluebird bio Inc / PDC Energy Inc / Ascot Resources Ltd / Altus Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Shawcor Ltd / Belo Sun Mining Corp / AltaGas Ltd / Freehold Royalties Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / GoGold Resources Inc / Secure Energy Services Inc / Athabasca Oil Corp / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Kelt Exploration Ltd / Ivanhoe Mines Ltd / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / SmartCentres Real Estate Investment Trust / Welltower Inc / Ionis Pharmaceuticals Inc / Chorus Aviation Inc / Comstock Resources Inc / Brookfield Business Partners LP / Camping World Holdings Inc / Centennial Resource Development Inc / TFI International Inc / International Petroleum Corp / Step Energy Services Ltd / North West Company Inc / CES Energy Solutions Corp / CNX Resources Corp / Stitch Fix Inc / Frontera Energy Corp / Apellis Pharmaceuticals Inc / Ero Copper Corp / ASGN Inc / Broadcom Inc / Talos Energy Inc / Replimune Group Inc / Focus Financial Partners Inc / Berry Corporation (Bry) / Arvinas Inc / Capri Holdings Ltd / Pipestone Energy Corp / Cargojet Inc / Corteva Inc / Obsidian Energy Ltd / Apollo Global Management Inc / Peloton Interactive Inc / US Ecology Inc / First Capital Real Estate Investment Trust / Ovintiv Inc / Schrodinger Inc / Atlas Corp / GFL Environmental Inc / Headwater Exploration Inc / Arch Resources Inc / Spartan Delta Corp / Laredo Petroleum Inc / Azek Company Inc / Dye & Durham Ltd / Callon Petroleum Co / Nuvei Corp / Topaz Energy Corp / Datto Holding Corp / Precision Drilling Corp / Apartment Income REIT Corp / Stride Inc / Centerspace / Source Energy Services Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Chesapeake Energy Corp / APA Corp (US) / UiPath Inc / Lion Electric Co / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Mister Car Wash Inc / Anaergia Inc / Dole PLC / Lightspeed Commerce Inc / Zevia PBC / Jasper Therapeutics Inc / Candel Therapeutics Inc / D2L Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US0079031078 / US1844961078 / US22160K1051 / US4404521001 / US4581401001 / US5324571083 / US5951121038 / US67066G1040 / US68389X1054 / US8825081040 / US9024941034 / US94106L1098 / CA2918434077 / US0534841012 / CA8935781044 / US1252691001 / US5500211090 / US38500T1016 / CA02215R1073 / CA46579R1047 / US2267181046 / US1630921096 / US74736K1016 / US4622221004 / CA94106B1013 / US11135F1012 / US34417P1003 / US70614W1009 / US91734M1036 / CA36168Q1046 / US23821D1000 / US86333M1080 / US15202L1070 / US60646V1052 / CA23344V1085</td><td class="leftalignment">Advanced Micro Devices Inc / Clean Harbors Inc / Costco Wholesale Corp / Hormel Foods Corp / Intel Corp / Eli Lilly and Co / Micron Technology Inc / NVIDIA Corp / Oracle Corp / Texas Instruments Inc / Tyson Foods Inc / Waste Management Inc / Empire Company Ltd / Avalonbay Communities Inc / Transcontinental Inc / CF Industries Holdings Inc / Lululemon Athletica Inc / Gran Tierra Energy Inc / Altus Group Ltd / Ivanhoe Mines Ltd / Criteo SA / Chegg Inc / Qorvo Inc / Ionis Pharmaceuticals Inc / Waste Connections Inc / Broadcom Inc / Focus Financial Partners Inc / Peloton Interactive Inc / US Ecology Inc / GFL Environmental Inc / Datto Holding Corp / Stride Inc / Centerspace / Mister Car Wash Inc / D2L Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Investor Day Preview: Consensus for 2022 in Line, Focus on Answering What's Next</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ / LLY / MRK / PFE / ARAV</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Institutional ownership of LLY at Sep 30: 418 (22%) exits from Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AGR / AIG / AJG / ALL / AMAT.O / AME / AON / AR / AZO / BAC / CB / CMS / CNX / CPE / DOW / DVN / EOG / EQT / GPS / HIG / JNJ / KLAC.O / KNX / KO / LLY.N / LNC / LRCX.O / MA / MDT / MET / MGY / MMC / MRO / NSC / OLN / PGR / PNM / PRU / PXD / RE / RH / RNR / RRC / SM / SO / STZ / SWN / SYY / TRV / WLK / WLL / WMT / AMZN.O / EW / BRO / AAPL.O / CSCO.O / JBHT.O / HUBG.O / SNPS.O / EXPE.O / AXS / LPI / LYB / RENT.O / ACGL.O / SBNY.O / XPO / SAIA.O / NOG.A / WRB.N / FTNT.O / NXPI.O / CZR.O / STAG.K / ESTE.K / MTDR.K / FB.O / PDCE.O / FANG.O / UIHC.O / ABBV.N / VOYA.K / MAR.O / GOOGL.O / QRVO.O / CIVI.K / ZBH / WLTW.O / CDEV.O / ZYME.K / BHF.O / EQH / BRY.O / UNFI.K / UBER.K / AVTR.K / BRP.O / OAS.O / OVV.N / CTRA.K / ROOT.O / CHK.O / VZIO.N / PATH.N / RYAN.N / GXO.N / WEBR.N</td><td class="leftalignment">Avangrid Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Applied Materials Inc / AMETEK Inc / Aon PLC / Antero Resources Corp / Autozone Inc / Bank of America Corp / Chubb Ltd / CMS Energy Corp / CNX Resources Corp / Callon Petroleum Co / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Gap Inc / Hartford Financial Services Group Inc / Johnson & Johnson / KLA Corp / Knight-Swift Transportation Holdings Inc / Coca-Cola Co / Eli Lilly and Co / Lincoln National Corp / Lam Research Corp / Mastercard Inc / Medtronic PLC / MetLife Inc / Magnolia Oil & Gas Corp / Marsh & McLennan Companies Inc / Marathon Oil Corp / Norfolk Southern Corp / Olin Corp / Progressive Corp / PNM Resources Inc / Prudential Financial Inc / Pioneer Natural Resources Co / Everest Re Group Ltd / RH / Renaissancere Holdings Ltd / Range Resources Corp / SM Energy Co / Southern Co / Constellation Brands Inc / Southwestern Energy Co / Sysco Corp / Travelers Companies Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Walmart Inc / Amazon.com Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / J B Hunt Transport Services Inc / Hub Group Inc / Synopsys Inc / Expedia Group Inc / AXIS Capital Holdings Ltd / Laredo Petroleum Inc / LyondellBasell Industries NV / Rent the Runway Inc / Arch Capital Group Ltd / Signature Bank / XPO Logistics Inc / Saia Inc / Northern Oil and Gas Inc / W R Berkley Corp / Fortinet Inc / NXP Semiconductors NV / Caesars Entertainment Inc / STAG Industrial Inc / Earthstone Energy Inc / Matador Resources Co / Meta Platforms Inc / PDC Energy Inc / Diamondback Energy Inc / United Insurance Holdings Corp / Abbvie Inc / Voya Financial Inc / Marriott International Inc / Alphabet Inc / Qorvo Inc / Civitas Resources Inc / Zimmer Biomet Holdings Inc / Willis Towers Watson PLC / Centennial Resource Development Inc / Zymeworks Inc / Brighthouse Financial Inc / Equitable Holdings Inc / Berry Corporation (Bry) / United Natural Foods Inc / Uber Technologies Inc / Avantor Inc / BRP Group Inc / Oasis Petroleum Inc / Ovintiv Inc / Coterra Energy Inc / Root Inc / Chesapeake Energy Corp / Vizio Holding Corp / UiPath Inc / Ryan Specialty Group Holdings Inc / GXO Logistics Inc / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Eq Strat: Signature Picks—November Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SBNY.OQ / AME / AZO / BAC / CB / CMS / DOW / DVN / GPS / JNJ / LLY.N / MA / MDT / NSC / OLN / SO / STZ / SYY / AMZN.O / AAPL.O / CSCO.O / SNPS.O / EXPE.O / ACGL.O / SBNY.O / FTNT.O / NXPI.O / CZR.O / STAG.K / FB.O / ABBV.N / MAR.O / GOOGL.O / QRVO.O / ZBH / UBER.K / AVTR.K</td><td class="leftalignment">Signature Bank / AMETEK Inc / Autozone Inc / Bank of America Corp / Chubb Ltd / CMS Energy Corp / Dow Inc / Devon Energy Corp / Gap Inc / Johnson & Johnson / Eli Lilly and Co / Mastercard Inc / Medtronic PLC / Norfolk Southern Corp / Olin Corp / Southern Co / Constellation Brands Inc / Sysco Corp / Amazon.com Inc / Apple Inc / Cisco Systems Inc / Synopsys Inc / Expedia Group Inc / Arch Capital Group Ltd / Signature Bank / Fortinet Inc / NXP Semiconductors NV / Caesars Entertainment Inc / STAG Industrial Inc / Meta Platforms Inc / Abbvie Inc / Marriott International Inc / Alphabet Inc / Qorvo Inc / Zimmer Biomet Holdings Inc / Uber Technologies Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Christopher P. Harvey / Gary S. Liebowitz, CFA / Anna Han / Mr. Mohit Bansal</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">LLY: Initiating Equal Weight—Firing on All Cylinders, but Alzheimer's and Valuation Keep Us on Sidelines</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0576652004 / US45168D1046 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US1488061029 / CA68620P1018 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US4622221004 / US45781M1018 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US54142F1021 / US4158581094 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / US14147L1089 / CA05156X8843 / US7291391057 / US12233L1070 / US04537Y1091 / US4131971040 / US04683R1068 / US66988N2053 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Balchem Corp / IDEXX Laboratories Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Catalent Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Innoviva Inc / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / LogicBio Therapeutics Inc / Harrow Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Cardiff Oncology Inc / Aurora Cannabis Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Aspira Women's Health Inc / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Novan Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Early studies confirming vaccine induced immunity against Omicron is dropping, but conflicting data on by how much</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / GSK.L / PFIZ.NS / REGN.OQ</td><td class="leftalignment">Eli Lilly and Co / GlaxoSmithKline PLC / Pfizer Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Let LLY Be Your Sunshine; Still Like The Stock Heading Into Pipeline and Guidance Review Next Week</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 06,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended December 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / AMD=US / IP=US / WEN=US / BLD=US / KMI=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / RCL=US / MLM=US / UNH=US / AMED=US / SWIM=US / CBRL=US / ELY=US / CCL=US / FUN=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / WGO=US / SGMS=US / SIVB=US / CNM=US / NLS=US / COP=US / AUTL=US / VICI=US / DIN=US / MGP=US / OGN / BCO=US / MRNS=US / RRR=US / PRG=US / TPX=US / EXP=US / CZR=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / AWI=US / OC=US / SAIC=US / AMRX=US / TAST=US / QSR=US / WRK=US / PRPL=US / WH=US / JACK=US / AGS=US / TREX=US / HGV=US / LPLA=US / VAC=US / FBHS=US / RHP=US / FANG=US / TILE=US / NCLH=US / NDLS=US / FOXF=US / FATE=US / GLPI=US / COUP=US / LOCO=US / AFMD=US / BVH=US / SHAK=US / WING=US / EVRI=US / 82982L103 / 50189K103 / JELD=US / IOVA=US / ALLO=US / HARP=US / FERG=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / BALY=US / VTRS=US / CELU=US / ROCC=US / SNPO=US / HLLY=US / PKG=U / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / International Paper Co / Wendys Co / TopBuild Corp / Kinder Morgan Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Carnival Corp / Cedar Fair LP / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Winnebago Industries Inc / Scientific Games Corp / SVB Financial Group / Core & Main Inc / Nautilus Inc / Conocophillips / Autolus Therapeutics PLC / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / Organon & Co / Brinks Co / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / PROG Holdings Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Westrock Co / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / PlayAGS Inc / Trex Company Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Fox Factory Holding Corp / Fate Therapeutics Inc / Gaming and Leisure Properties Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / LCI Industries / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Ferguson PLC / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Celularity Inc / Ranger Oil Corp / Snap One Holdings Corp / Holley Inc / Packaging Corp of America / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US02553E1064 / US1101221083 / US2017231034 / US3647601083 / US3755581036 / US45337C1027 / US5324571083 / US6541061031 / US6556641008 / US6703461052 / US6819191064 / US68389X1054 / US7170811035 / US75886F1075 / US7782961038 / US8581191009 / US8725401090 / US8851601018 / US9170471026 / US9182041080 / CA8787422044 / CA87971M1032 / US9129091081 / US02043Q1076 / US9043111072 / US5500211090 / US90384S3031 / CA22576C1014 / US58933Y1055 / US6936561009 / US7512121010 / US98986T1088 / US00287Y1091 / US09609G1004 / CA1348082035 / CA96467A2002 / IE00B4Q5ZN47 / CA3748252069 / US31189P1021 / US1220171060 / US14174T1079 / US72703H1014 / US8760301072 / US8608971078 / US03753U1060 / US63845R1077 / CA8585221051 / US76029N1063 / VGG1890L1076 / US76156B1070 / US88339P1012 / US70614W1009 / US80810D1037 / CA2674881040 / US78440X8048 / US44891N2080 / CA00791P1071 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US4718711033 / US53190C1027 / CA0156581070</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Gap Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Nucor Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Steel Dynamics Inc / TJX Companies Inc / Thor Industries Inc / Urban Outfitters Inc / VF Corp / Teck Resources Ltd / Telus Corp / United States Steel Corp / Alnylam Pharmaceuticals Inc / Under Armour Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Crescent Point Energy Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Zynga Inc / Abbvie Inc / bluebird bio Inc / Canacol Energy Ltd / Whitecap Resources Inc / Jazz Pharmaceuticals PLC / Gibson Energy Inc / Fate Therapeutics Inc / Burlington Stores Inc / CareTrust REIT Inc / Planet Fitness Inc / Tapestry Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / National Vision Holdings Inc / Stelco Holdings Inc / Replimune Group Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Peloton Interactive Inc / Schrodinger Inc / Dye & Durham Ltd / SL Green Realty Corp / IAC/Interactivecorp / Advantage Energy Ltd / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Jasper Therapeutics Inc / Life Time Group Holdings Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2868165 / 2126335 / 2516152 / 2778844 / 2219224 / 2216850 / 2270726 / 2542049 / 2272476 / 2317087 / 2670519 / 2328915 / 2684703 / 2440637 / 7103065 / 2713317 / 2857817 / B125XQ6 / B3D7K31 / B1XGNW4 / 2855930 / B3P93Y7 / B0796X4 / BYVFC94 / BZBY005 / BJ2Z0H2 / BFZ1K46 / BYXJQG9 / BZ1LFG7 / BYY88Y7 / BF3W461 / BMC5RV6 / BMDJ397 / BF0QTY9 / BMDW0R3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Sysco Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Dollar Tree Inc / Entergy Corp / Exelon Corp / Nextera Energy Inc / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Insulet Corp / Overstock.com Inc / Anheuser Busch Inbev SA / Dexcom Inc / US Foods Holding Corp / Merus NV / Pinterest Inc / Spotify Technology SA / Spire Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / Adicet Bio Inc / Bolt Biotherapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Weave Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Anticipating Below-Consensus 2022 Guidance but December 15 Investor Day a Clearing Event, in Our View</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, December 6 – Sunday, December 12</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 ASH Preview and Itinerary Planner</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US31189P1021 / US03753U1060 / US80810D1037 / US4718711033</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc / Schrodinger Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Georgia / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini / Evan Hua</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Dec. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / ALK.N / BA.N / BAC.N / BMY.N / C.N / CCL.N / CL.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / OXY.N / PFE.N / PM.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / NUE.N / DIS.N / UNH.N / TFX.N / UNP.N / RCL.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / NKE.N / IT.N / GWW.N / VZ.N / DVA.N / V.N / ACN.N / TWTR.N / HPQ.N / COP.N / INTC.OQ / AOS.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / ADSK.OQ / FISV.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / AMD.OQ / ENPH.OQ / FANG.OQ / PTC.OQ / NCLH.N / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / Alaska Air Group Inc / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Citigroup Inc / Carnival Corp / Colgate-Palmolive Co / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Union Pacific Corp / Royal Caribbean Cruises Ltd / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / DaVita Inc / Visa Inc / Accenture PLC / Twitter Inc / HP Inc / Conocophillips / Intel Corp / A O Smith Corp / Adobe Inc / Amgen Inc / Apple Inc / Autodesk Inc / Fiserv Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Pool Corp / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Diamondback Energy Inc / PTC Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Ireland / Liberia / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">12/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 87</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 26 to December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US02553E1064 / US0383361039 / US0536111091 / US0584981064 / US1264081035 / US2017231034 / US2441991054 / US25179M1036 / US2788651006 / US30231G1022 / US31428X1063 / US3154051003 / US3647601083 / US4180561072 / US4282911084 / US4433201062 / US4456581077 / US4523081093 / US5010441013 / US5324571083 / US56418H1005 / US5770811025 / US5949181045 / US64125C1099 / US6516391066 / US6541061031 / US6556641008 / US6558441084 / US6703461052 / US6935061076 / US7170811035 / US7496851038 / US75886F1075 / US7703231032 / US7782961038 / US7802871084 / US81211K1007 / US8243481061 / US8581191009 / US8725401090 / US9078181081 / US9113121068 / US91324P1021 / US9170471026 / US9182041080 / US92532F1003 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA29250N1050 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA2908761018 / CA5592224011 / CA0084741085 / CA0679011084 / CA1363851017 / CA2499061083 / US1667641005 / CA13645T1003 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA5734591046 / US09062X1037 / NO0010208051 / US49446R1095 / CA98462Y1007 / US79466L3024 / US9604131022 / CA5503721063 / US29476L1070 / US7588491032 / US1508701034 / CA8911605092 / CA1360691010 / CA8935781044 / US8288061091 / US44107P1049 / US12541W2098 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / CA32076V1031 / GB00B1FW5029 / US5021751020 / US63633D1046 / CA14068G1046 / US5500211090 / US89785X1019 / US90384S3031 / CA3518581051 / US91912E1055 / CA8672241079 / US58933Y1055 / CA25675T1075 / CA15135U1093 / US2566771059 / CA14042M1023 / NL0009434992 / CA9237251058 / CA07317Q1054 / US18538R1032 / CA00208D4084 / CA2927661025 / US61945C1036 / JE00B4T3BW64 / US6936561009 / US7512121010 / US71922G2093 / CA7063271034 / CA4932711001 / CA89156V1067 / CA55903Q1046 / CA96145A2002 / US70509V1008 / CA04682R1073 / US78573L1061 / US8486371045 / CA87262K1057 / US08579W1036 / US23283R1005 / CA05577W2004 / US1220171060 / US11120U1051 / CA68827L1013 / US78667J1088 / CA0089118776 / BMG0750C1082 / US1638511089 / US92939U1060 / CA8485101031 / US86771W1053 / US72703H1014 / US4622221004 / US45688C1071 / US0441861046 / US7005171050 / CA87241L1094 / US6792951054 / CA9628791027 / GB00BF3ZNS54 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / CA67077M1086 / US98980G1022 / US00191U1025 / US83200N1037 / IE00BZ12WP82 / VGG1890L1076 / US28618M1062 / US2605571031 / GB00BJT16S69 / CA87807B1076 / CA14179V5036 / US26614N1028 / US76156B1070 / JE00BJ1F3079 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / MHY0436Q1098 / US03750L1098 / JE00BMVMZ478 / US1651677353 / US24343R1068 / CA00076T1057 / US90364P1057 / US11135E2037 / US5738741041 / US60646V1052 / US0708301041 / US9264001028 / US27923Q1094 / US89269P1030 / US94770D1028 / US53190C1027 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / American Eagle Outfitters Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / CSX Corp / Commercial Metals Co / Deere & Co / Devon Energy Corp / Ecolab Inc / Exxon Mobil Corp / FedEx Corp / Ferro Corp / Gap Inc / Hasbro Inc / Hexcel Corp / Hub Group Inc / J B Hunt Transport Services Inc / Illinois Tool Works Inc / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Mattel Inc / Microsoft Corp / Neurocrine Biosciences Inc / Newmont Corporation / Nike Inc / Nordstrom Inc / Norfolk Southern Corp / Nucor Corp / PPG Industries Inc / Pfizer Inc / RPM International Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Ross Stores Inc / Royal Gold Inc / Sealed Air Corp / Sherwin-Williams Co / Steel Dynamics Inc / TJX Companies Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Urban Outfitters Inc / VF Corp / Vertex Pharmaceuticals Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Enbridge Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Emera Inc / Magna International Inc / Agnico Eagle Mines Ltd / Barrick Gold Corp / Canadian Natural Resources Ltd / Descartes Systems Group Inc / Chevron Corp / Canadian Pacific Railway Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Martinrea International Inc / Biogen Inc / Yara International ASA / Kimco Realty Corp / Yamana Gold Inc / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Equity Residential / Regency Centers Corp / Celanese Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / Simon Property Group Inc / Host Hotels & Resorts Inc / CH Robinson Worldwide Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / First Majestic Silver Corp / Hochschild Mining PLC / LTC Properties Inc / National Health Investors Inc / Capstone Mining Corp / Lululemon Athletica Inc / TrueBlue Inc / Ulta Beauty Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Merck & Co Inc / Dollarama Inc / Cenovus Energy Inc / Dollar General Corp / Capital Power Corp / LyondellBasell Industries NV / Vermilion Energy Inc / Baytex Energy Corp / Clearwater Paper Corp / ARC Resources Ltd / Enerplus Corp / Mosaic Co / Glencore PLC / PVH Corp / Ralph Lauren Corp / PhosAgro PAO / Pembina Pipeline Corp / Keyera Corp / Tourmaline Oil Corp / MAG Silver Corp / Westshore Terminals Investment Corp / Pebblebrook Hotel Trust / Athabasca Oil Corp / Sabra Health Care REIT Inc / Splunk Inc / TMX Group Ltd / Berry Global Group Inc / CyrusOne Inc / BRP Inc / Burlington Stores Inc / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Air Canada / Axalta Coating Systems Ltd / Chemours Co / WEC Energy Group Inc / Spin Master Corp / Sunrun Inc / Planet Fitness Inc / Ionis Pharmaceuticals Inc / Ingevity Corp / Ashland Global Holdings Inc / Park Hotels & Resorts Inc / TFI International Inc / Okta Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Nutrien Ltd / Zscaler Inc / ASGN Inc / Smartsheet Inc / Linde PLC / Capri Holdings Ltd / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / TC Energy Corp / Cargojet Inc / Dupont De Nemours Inc / Revolve Group Inc / Amcor PLC / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Atlas Corp / Apartment Income REIT Corp / Atotech Ltd / Chesapeake Energy Corp / Decibel Therapeutics Inc / Abc Technologies Holdings Inc / UiPath Inc / Broadstone Net Lease Inc / Marvell Technology Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Ecovyst Inc / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Virgin Islands, British / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US0584981064 / US1264081035 / US31428X1063 / US4433201062 / US4456581077 / US5010441013 / US5324571083 / US6516391066 / US6558441084 / US7170811035 / US7802871084 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA5592224011 / CA0679011084 / CA13645T1003 / CA5734591046 / US09062X1037 / CA5503721063 / CA8911605092 / CA1360691010 / CA8935781044 / US12541W2098 / CA32076V1031 / US90384S3031 / US2566771059 / CA14042M1023 / JE00B4T3BW64 / CA96145A2002 / CA0089118776 / US4622221004 / CA87241L1094 / CA9628791027 / US83200N1037 / CA14179V5036 / MHY0436Q1098 / CA00076T1057 / US5738741041</td><td class="leftalignment">Ball Corp / CSX Corp / FedEx Corp / Hub Group Inc / J B Hunt Transport Services Inc / Kroger Co / Eli Lilly and Co / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Royal Gold Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Magna International Inc / Barrick Gold Corp / Canadian Pacific Railway Ltd / Martinrea International Inc / Biogen Inc / Lundin Mining Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / CH Robinson Worldwide Inc / First Majestic Silver Corp / Ulta Beauty Inc / Dollar General Corp / Capital Power Corp / Glencore PLC / Westshore Terminals Investment Corp / Air Canada / Ionis Pharmaceuticals Inc / TFI International Inc / Wheaton Precious Metals Corp / Smartsheet Inc / Cargojet Inc / Atlas Corp / Abc Technologies Holdings Inc / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Transcript: Expert Call on Alzheimer's Disease</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US5324571083 / US7170811035 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US30231G1022 / US4523081093 / US5324571083 / US91324P1021 / US92532F1003 / CA2908761018 / CA0084741085 / CA2499061083 / US1667641005 / CA6330671034 / CA7800871021 / US09062X1037 / CA98462Y1007 / GB00B1FW5029 / CA25675T1075 / CA07317Q1054 / US18538R1032 / CA04682R1073 / US8486371045 / CA05577W2004 / US78667J1088 / US6792951054 / CA87807B1076</td><td class="leftalignment">Exxon Mobil Corp / Illinois Tool Works Inc / Eli Lilly and Co / UnitedHealth Group Inc / Vertex Pharmaceuticals Inc / Emera Inc / Agnico Eagle Mines Ltd / Descartes Systems Group Inc / Chevron Corp / National Bank of Canada / Royal Bank of Canada / Biogen Inc / Yamana Gold Inc / Hochschild Mining PLC / Dollarama Inc / Baytex Energy Corp / Clearwater Paper Corp / Athabasca Oil Corp / Splunk Inc / BRP Inc / SAGE Therapeutics Inc / Okta Inc / TC Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 業績予想修正、目標株価引き下げ、アデュヘルムの高薬価の波紋は広がるのか？</td><td class="leftalignment">Japanese</td><td class="rightalignment">11</td><td class="leftalignment">4523.T / 4519.T / LLY.N / ROG.S</td><td class="leftalignment">Eisai Co Ltd / Chugai Pharmaceutical Co Ltd / Eli Lilly and Co / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Revising forecasts, lower target price: Will we see more repercussions from Aduhelm's high price?</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4523.T / 4519.T / LLY.N / ROG.S</td><td class="leftalignment">Eisai Co Ltd / Chugai Pharmaceutical Co Ltd / Eli Lilly and Co / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Alzheimer's Call Bullish for Positive CMS Decision & A-beta Antibodies Uptake</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US5324571083 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended December 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US -  Dividend Quality Analysis, for the period ended August 25,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US0536111091 / US2788651006 / US3154051003 / US4282911084 / US5324571083 / US5949181045 / US64125C1099 / US6935061076 / US7496851038 / US8243481061 / CA0641491075 / US09062X1037 / NO0010208051 / US79466L3024 / US9604131022 / CA5503721063 / US7588491032 / US1508701034 / US3137472060 / CA14068G1046 / NL0009434992 / US61945C1036 / US71922G2093 / US11120U1051 / CA68827L1013 / BMG0750C1082 / US1638511089 / US45688C1071 / US0441861046 / GB00BF3ZNS54 / CA67077M1086 / US98980G1022 / IE00BZ12WP82 / US28618M1062 / US2605571031 / GB00BJT16S69 / US26614N1028 / JE00BMVMZ478 / US90364P1057 / US27923Q1094 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / Avery Dennison Corp / Ecolab Inc / Ferro Corp / Hexcel Corp / Eli Lilly and Co / Microsoft Corp / Neurocrine Biosciences Inc / PPG Industries Inc / RPM International Inc / Sherwin-Williams Co / Bank of Nova Scotia / Biogen Inc / Yara International ASA / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Regency Centers Corp / Celanese Corp / Federal Realty Investment Trust / Capstone Mining Corp / LyondellBasell Industries NV / Mosaic Co / PhosAgro PAO / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / Axalta Coating Systems Ltd / Chemours Co / Ingevity Corp / Ashland Global Holdings Inc / Venator Materials PLC / Nutrien Ltd / Zscaler Inc / Linde PLC / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / Dupont De Nemours Inc / Atotech Ltd / UiPath Inc / Ecovyst Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Alzheimer’s Survey Supports A-beta Thesis: Slow Launch to Increase Over Time</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US5324571083 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company sinks 8.4% from 2 week high</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Nov. 30, 2021 / 12:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">REGN Confirms COVID Ab Cocktail May Be Less Effective Against Omicron</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / US5324571083 / US7170811035 / US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / TWTR=US / PG=US / WEN=US / BLD=US / LOW=US / SWN=US / EXPE=US / LEG=US / VMC=US / MLM=US / SWIM=US / BLL=US / CBRL=US / CHD=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / OI=US / REGI=US / SGMO=US / SEE=US / TRIP=US / BKNG=US / SIVB=US / CNM=US / FB=US / DIN=US / MGNI=US / PNFP=US / RGF=US / OGN / MNST=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / BERY=US / TILE=US / NDLS=US / FATE=US / 00770K202 / LOCO=US / AFMD=US / SHAK=US / WING=US / 82982L103 / IRTC=US / TRVG=US / JELD=US / YEXT=US / FERG=US / BRBR=US / AZEK=US / VTRS=US / ABNB=US / 67421J108 / DNUT=US / SNPO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Twitter Inc / Procter & Gamble Co / Wendys Co / TopBuild Corp / Lowe's Companies Inc / Southwestern Energy Co / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Ball Corp / Cracker Barrel Old Country Store Inc / Church & Dwight Co Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / O-I Glass Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Sealed Air Corp / Tripadvisor Inc / Booking Holdings Inc / SVB Financial Group / Core & Main Inc / Meta Platforms Inc / Dine Brands Global Inc / Magnite Inc / Pinnacle Financial Partners Inc / Real Good Food Company Inc / Organon & Co / Monster Beverage Corp / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Berry Global Group Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / Trivago NV / JELD-WEN Holding Inc / Yext Inc / Ferguson PLC / Bellring Brands Inc / Azek Company Inc / Viatris Inc / Airbnb Inc / Oatly Group AB / Krispy Kreme Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2936921 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2190750 / 2216850 / 2270726 / 2317087 / 2670519 / 2328915 / 2415204 / 2684703 / 7103065 / 2857817 / B3D7K31 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BVVN4Q8 / BXDZ9Z0 / BMYML02 / BFMXGR0 / BKTNTR9 / BWY52P3 / BYY88Y7 / BD6JX35 / BM8MM05 / BYQCZ35 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Pfizer Inc / Novartis AG / Netflix Inc / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Eversource Energy / Shopify Inc / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Blueprint Medicines Corp / Alphabet Inc / Krystal Biotech Inc / Madison Square Garden Entertainment Corp / Madison Square Garden Sports Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - Key Questions for management ahead of R&D day</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVN.S / BMY.N / LLY.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / REGN.OQ / GILD.OQ / BAYGN.DE / MOLN.S</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Bayer AG / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US02553E1064 / US2441991054 / US25179M1036 / US3647601083 / US5324571083 / US6541061031 / US6556641008 / US7170811035 / US75886F1075 / US7782961038 / US8725401090 / US9170471026 / US9182041080 / CA1363851017 / US20825C1045 / US49446R1095 / US29476L1070 / US7588491032 / US8288061091 / US44107P1049 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / US63633D1046 / US5500211090 / US90384S3031 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA00208D4084 / CA2927661025 / US6936561009 / US7512121010 / CA89156V1067 / US70509V1008 / US78573L1061 / US23283R1005 / CA0266951064 / US1220171060 / US86771W1053 / US72703H1014 / US7005171050 / US8760301072 / US8608971078 / US63845R1077 / VGG1890L1076 / US76156B1070 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / US03750L1098 / US1651677353 / US24343R1068 / US11135E2037 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027</td><td class="leftalignment">American Eagle Outfitters Inc / Deere & Co / Devon Energy Corp / Gap Inc / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Canadian Natural Resources Ltd / Conocophillips / Kimco Realty Corp / Equity Residential / Regency Centers Corp / Simon Property Group Inc / Host Hotels & Resorts Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / National Health Investors Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / ARC Resources Ltd / Enerplus Corp / PVH Corp / Ralph Lauren Corp / Tourmaline Oil Corp / Pebblebrook Hotel Trust / Sabra Health Care REIT Inc / CyrusOne Inc / American Hotel Income Properties REIT LP / Burlington Stores Inc / Sunrun Inc / Planet Fitness Inc / Park Hotels & Resorts Inc / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Apartment Income REIT Corp / Chesapeake Energy Corp / Decibel Therapeutics Inc / Broadstone Net Lease Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Though insulin GPO price cut milder than prior GPO, most players expected sales loss due to lower pricing</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">3933.HK / 600867.SS / LLY.N / NOVOB.CO / 2196.HK</td><td class="leftalignment">United Laboratories International Holdings Ltd / Tonghua Dongbao Pharmaceutical Co Ltd / Eli Lilly and Co / Novo Nordisk A/S / Shanghai Fosun Pharmaceutical Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen / European Pharma Team / Ms Jo Walton</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Eli Lilly and Company. in Global Cardiometabolic Diseases Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, November 29 - Sunday, December 5</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 86</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Omicron Variant: What We Know, What We Don’t, and the Impact on Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US5324571083 / US7170811035 / US75886F1075 / US58933Y1055</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for LLY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Initial thoughts on new variant B.1.1.529; Delta displacement concerning</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / ADI=US / MDT=US / NVDA=US / MPWR=US / DIOD=US / AIR=US / ATRO=US / AVGO=US / B=US / CBRL=US / ELY=US / CW=US / DCO=US / HEI=US / HXL=US / MRCY=US / MCHP=US / PLAN=US / ROLL=US / TGI=US / VSEC=US / GOLF=US / BKNG=US / SPR=US / MOG.A=US / TDG=US / KTOS=US / JACK=US / NXPI=US / WWD=US / ABBV=US / FATE=US / AFMD=US / ON=US / AJRD=US / BWXT=US / MAXR=US / LHX=US / SPCE=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Medtronic PLC / NVIDIA Corp / Monolithic Power Systems Inc / Diodes Inc / AAR Corp / Astronics Corp / Broadcom Inc / Barnes Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Curtiss-Wright Corp / Ducommun Inc / HEICO Corp / Hexcel Corp / Mercury Systems Inc / Microchip Technology Inc / Anaplan Inc / RBC Bearings Inc / Triumph Group Inc / VSE Corp / Acushnet Holdings Corp / Booking Holdings Inc / Spirit AeroSystems Holdings Inc / Moog Inc / TransDigm Group Inc / Kratos Defense and Security Solutions Inc / Jack in the Box Inc / NXP Semiconductors NV / Woodward Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Maxar Technologies Inc / L3harris Technologies Inc / Virgin Galactic Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Ireland / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mexico / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Philippines / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US0079031078 / US02553E1064 / US0326541051 / US5324571083 / US67066G1040 / CA9611485090 / CA0636711016 / CA0641491075 / CA7800871021 / US09062X1037 / CA8911605092 / CA1360691010 / US9285634021 / US2567461080 / CA45868C1095 / US00737L1035</td><td class="leftalignment">Advanced Micro Devices Inc / American Eagle Outfitters Inc / Analog Devices Inc / Eli Lilly and Co / NVIDIA Corp / George Weston Ltd / Bank of Montreal / Bank of Nova Scotia / Royal Bank of Canada / Biogen Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / VMware Inc / Dollar Tree Inc / Interfor Corp / Adtalem Global Education Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Philippines / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BioPharma Policy Call: Drug Pricing Boogeyman Stays Away With FY22 Budget Bill</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Model Update and raising price targets for ABBV, LLY, MRK, PFE</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / ABBV=US / MRK.N / PFE.N / MRK=US / PFE=US</td><td class="leftalignment">Eli Lilly and Co / Abbvie Inc / Merck & Co Inc / Pfizer Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Nov 23 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US00846U1016 / US0463531089 / US17275R1023 / US1924221039 / US2358511028 / US2829141009 / US34354P1057 / US37733W1053 / US4781601046 / US5324571083 / US5949181045 / US64125C1099 / US7711951043 / US7739031091 / US87612E1064 / US8793601050 / US8835561023 / US91307C1027 / US92532F1003 / US2948216088 / US0003752047 / US1314761032 / JE00B783TY65 / US98978V1035 / US41068X1000 / US76680R2067 / NL0010696654 / US83417M1045 / US87164F1057 / US74967X1037 / US87968A1043 / US5011471027 / US05351X1019 / US09354A1007 / US01671P1003 / US28414H1032 / US90184D1000 / US05352A1007 / US76156B1070 / US1567271093 / US4833791035 / US92537N1081 / US38246G1085 / US85209E1091 / US55406W1036 / US83444K1051 / 50066V107 / US8086441081 / KYG393871085 / US05153U1079 / US29384C1080</td><td class="leftalignment">Agilent Technologies Inc / AstraZeneca PLC / Cisco Systems Inc / Cognex Corp / Danaher Corp / 8x8 Inc / Flowserve Corp / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Microsoft Corp / Neurocrine Biosciences Inc / Roche Holding AG / Rockwell Automation Inc / Target Corp / Teledyne Technologies Inc / Thermo Fisher Scientific Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Telefonaktiebolaget LM Ericsson / Abb Ltd / Calumet Specialty Products Partners LP / Aptiv PLC / Zoetis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Uniqure NV / Solaredge Technologies Inc / Syndax Pharmaceuticals Inc / RH / Tellurian Inc / Krystal Biotech Inc / Avaya Holdings Corp / Blink Charging Co / Allakos Inc / Elanco Animal Health Inc / Twist Bioscience Corp / Avantor Inc / Revolve Group Inc / Cerence Inc / Kaleyra Inc / Vertiv Holdings Co / Goodrx Holdings Inc / Spruce Biosciences Inc / MYT Netherlands Parent BV / Somalogic Inc / KORE Group Holdings Inc / Science 37 Holdings Inc / Globalfoundries Inc / Aura Biosciences Inc / Entrada Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Korea, Republic of / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DNB / FISV=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / EFX=US / WEN=US / AMZN=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / TRU=US / V=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MRO=US / EXPE=US / LEG=US / VMC=US / BKI=US / MLM=US / UNH=US / PATH=US / SWIM=US / HRT=US / CBRL=US / CTRA=US / CENT=US / CNX=US / CSGP=US / DRI=US / EQT=US / EEFT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / PCTY=US / SSNC=US / TRIP=US / WEX=US / FOUR=US / CVX=US / GPN=US / PYPL=US / BKNG=US / CNM=US / FB=US / VNO=US / EVOP=US / COP=US / APPN=US / DIN=US / INST=US / MQ / OGN / FLT=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / XM=US / BLDR=US / GMS=US / CMG=US / FIS=US / MA=US / PGTI=US / WU=US / AWI=US / OC=US / AMRX=US / TAST=US / CENTA=US / QSR=US / CLR=US / PRPL=US / KTOS=US / NOG=US / JACK=US / VRSK=US / TREX=US / AR=US / OAS=US / GDOT=US / ESTE=US / FBHS=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / VNOM=US / COUP=US / LOCO=US / AFMD=US / CIVI=US / SHAK=US / AJRD=US / WING=US / SQ=US / IBEX=US / 82982L103 / CDEV=US / TRVG=US / JELD=US / SBOW=US / MAXR=US / UBER=US / LSPD=US / FERG=US / LHX=US / RPAY=US / OVV=US / SPCE=US / AZEK=US / PAYA=US / VTRS=US / ABNB=US / AFRM=US / ROCC=US / COUR=US / REPX=US / SNPO=US / UDMY=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Equifax Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / TransUnion / Visa Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Black Knight Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / UiPath Inc / Latham Group Inc / HireRight Holdings Corp / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Central Garden & Pet Co / CNX Resources Corp / CoStar Group Inc / Darden Restaurants Inc / EQT Corp / Euronet Worldwide Inc / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Paylocity Holding Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / WEX Inc / Shift4 Payments Inc / Chevron Corp / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Core & Main Inc / Meta Platforms Inc / Vornado Realty Trust / EVO Payments Inc / Conocophillips / Appian Corp / Dine Brands Global Inc / Instructure Holdings Inc / Marqeta Inc / Organon & Co / Fleetcor Technologies Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Mastercard Inc / PGT Innovations Inc / Western Union Co / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Verisk Analytics Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Green Dot Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Viper Energy Partners LP / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Civitas Resources Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Wingstop Inc / Block Inc / Ibex Ltd / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Maxar Technologies Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Ferguson PLC / L3harris Technologies Inc / Repay Holdings Corp / Ovintiv Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Paya Holdings Inc / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Ranger Oil Corp / Coursera Inc / Riley Exploration Permian Inc / Snap One Holdings Corp / Udemy Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2023607 / 2293819 / 2778844 / 2050832 / 2026242 / 2270726 / 2317087 / 2670519 / 2415204 / 2623911 / 2684703 / 2967589 / 7103065 / 2170473 / 2857817 / B3D7K31 / 2855930 / BBPK0J0 / BZ07BW4 / BZ1LFB2 / BJ1FD74 / BWTN5N1 / BFD20M9 / BFZ1K46 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BJMLSD2 / BD5GSZ4 / BM8NHS1 / BP2P6L0 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / eBay Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Hawaiian Electric Industries Inc / Neurocrine Biosciences Inc / Pfizer Inc / Williams-Sonoma Inc / Novartis AG / Constellation Brands Inc / Netflix Inc / Discovery Inc / Overstock.com Inc / Mirati Therapeutics Inc / Monster Beverage Corp / Deciphera Pharmaceuticals Inc / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Spotify Technology SA / Spire Inc / ViacomCBS Inc / Alphabet Inc / Karuna Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Adagio Therapeutics Inc / Tango Therapeutics Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NYMX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NYMX.O / ABT / DGX / JNJ / LLY / PFE / SPHS.PK</td><td class="leftalignment">Nymox Pharmaceutical Corp / Abbott Laboratories / Quest Diagnostics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Next Two Weeks In Pharmaceuticals - Monday, November 22 - Sunday, December 5</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Nov 12: Focus on Tagrisso</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: US government's additional purchase order of Lilly's COVID cocktail therapy indicates continued demand for array of COVID therapies . Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / PFE.N / MRCG.DE / 207940.KS</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Pfizer Inc / Merck KGaA / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Highlights From Recent Mgmt Meetings</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.6% Above Pre-Pandemic Base- Week 85</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">RNA Silencing Platform Firm Receives US$3.3 Billion Buyout Offer From Novo Nordisk</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">NOVOb.CO / LLY.N</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at OP: Leap-Frogging Peers With Strong Diabetes Supported by Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Nov. 18, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare: AstraZeneca- Most attractive valuation in HOLT in 5-years</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / PFE.N / SASY.PA / NOVOB.CO / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Novo Nordisk A/S / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Emilie Fung</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / DT=US / CMA=US / AMT=US / EOG=US / CONE=US / CCI=US / PB=US / UMPQ=US / ADS=US / TNL=US / WTFC=US / SWIM=US / CBRL=US / DRI=US / DRH=US / PDM=US / SBAC=US / WAL=US / HTH=US / HIW=US / ABCB=US / CUZ=US / FBK=US / DIN=US / OGN / TCBI=US / FHN=US / NUVA=US / TXRH=US / PLAY=US / WMG=US / DENN=US / CMG=US / MA=US / SIX=US / AMRX=US / TAST=US / QSR=US / NMTR=US / WH=US / JACK=US / HGV=US / LPLA=US / RLJ=US / VAC=US / SPLK=US / GMED=US / NDLS=US / FATE=US / LOCO=US / BVH=US / SHAK=US / WING=US / SPNE=US / SWCH=US / MBIN=US / BTAI=US / OSMT=US / VTRS=US / AVAH=US / 67421J108 / DBRG=US / SNPO=US / ROIV=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Dynatrace Inc / Comerica Inc / American Tower Corp / EOG Resources Inc / CyrusOne Inc / Crown Castle International Corp / Prosperity Bancshares Inc / Umpqua Holdings Corp / Alliance Data Systems Corp / Travel + Leisure Co / Wintrust Financial Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Piedmont Office Realty Trust Inc / SBA Communications Corp / Western Alliance Bancorp / Hilltop Holdings Inc / Highwoods Properties Inc / Ameris Bancorp / Cousins Properties Inc / FB Financial Corp / Dine Brands Global Inc / Organon & Co / Texas Capital Bancshares Inc / First Horizon Corp / NuVasive Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Warner Music Group Corp / Denny's Corp / Chipotle Mexican Grill Inc / Mastercard Inc / Six Flags Entertainment Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Splunk Inc / Globus Medical Inc / Noodles & Co / Fate Therapeutics Inc / El Pollo Loco Holdings Inc / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Switch Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Osmotica Pharmaceuticals PLC / Viatris Inc / Aveanna Healthcare Holdings Inc / Oatly Group AB / DigitalBridge Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2360326 / 2126335 / 2516152 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2345022 / 2100920 / 2630513 / 2657802 / 2689560 / 2684703 / 2707677 / 2825933 / 7103065 / B00FWN1 / 2822019 / 2857817 / B3D7K31 / 2390817 / B65LWX6 / B7TL820 / B7VD3F2 / BCZS820 / BVVN4Q8 / BTF8CF0 / BYZLV46 / BK0VHF6 / BD8DJ71 / BL2HYY7 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BJ9NFQ3 / BYY88Y7 / BDRW1L7 / BNGJQZ8 / BMHR7K6 / BNNTQY0 / BL98755 / BL53KF5 / BP0TJN7 / BPH0546 / BMV6Y64</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Gap Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Macy's Inc / FirstEnergy Corp / New Jersey Resources Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / South Jersey Industries Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Advance Auto Parts Inc / Netflix Inc / Discovery Inc / Gray Television Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / Fate Therapeutics Inc / Eversource Energy / Restaurant Brands International Inc / InflaRx NV / IDEAYA Biosciences Inc / Snap Inc / Casper Sleep Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Neoleukin Therapeutics Inc / Alphabet Inc / AnaptysBio Inc / Porch Group Inc / Impel Neuropharma Inc / Oatly Group AB / Beachbody Company Inc / F45 Training Holdings Inc / Xponential Fitness Inc / Life Time Group Holdings Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Next-Gen Interleukin Primer - Cranking Up the Thermostat as Winter Weather Approaches</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2457864 / 2471950 / 2730190 / 7103065 / 2982924 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BMC5RV6 / BF3NP05 / BMDJ397 / BN2RM92 / BLF0CW7 / BP7KZP7 / BMW5084 / BNLYJ60 / BNLYBF3 / BMVBZF5 / BP2P6L0 / BMV6Y64</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALM.MC: Almirall - 3Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ALM.MC / LLY.N / RECI.MI / AZN.L / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Almirall SA / Eli Lilly and Co / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Elizabeth Walton / Mr. Dominic Lunn / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Drug Pricing Reform Proposal: Is This The Long-Awaited Clearing Event?</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, November 15 - Sunday, November 21</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.9% Above Pre-Pandemic Base- Week 84</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / A.N / BDX.N / LLY.N / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / QGEN.N / ALM.MC / WAFGN.DE / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Eli Lilly and Co / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Qiagen NV / Almirall SA / Siltronic AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / LSI=US / AMGN=US / BMY=US / DIS=US / MCD=US / WEN=US / PLD=US / BLDP=US / AMZN=US / GILD=US / PEB=US / REI=US / PLUG=US / H=US / V=US / MTN=US / ENR=US / VRM=US / MAR=US / TNL=US / HLT=US / AKR=US / HUM=US / EQR=US / AMK=US / SWIM=US / CBRL=US / CHH=US / DRI=US / DRH=US / MAIN=US / NTST=US / PDM=US / SGMO=US / SHOP=US / FORG=US / VRTX=US / WIX=US / FOUR=US / AEL=US / GPN=US / HIW=US / SNV=US / ADC=US / FRT=US / INTA=US / OHI=US / SRC=US / REG=US / ENSG=US / BRX=US / DIN=US / ACVA=US / MQ / CRD.B=US / APP=US / SHO=US / PLAY=US / DENN=US / ESMT=US / SCPL=US / CMG=US / HST=US / MA=US / RPRX=US / GPRE=US / OC=US / CPRX=US / TAST=US / QSR=US / LUMN=US / WH=US / JACK=US / UTZ=US / BLND=US / HGV=US / SBRA=US / APTS=US / RLJ=US / VAC=US / ZNGA=US / SPLK=US / MEIP=US / RHP=US / NDLS=US / VRNS=US / 00770K202 / LOCO=US / AFMD=US / BVH=US / SHAK=US / CHCT=US / WING=US / MCFT=US / SQ=US / WVE=US / PK=US / PLYA=US / OKTA=US / ROOT=US / BTAI=US / AMTB=US / LSPD=US / ARQT=US / TSHA / DASH=US / AFRM=US / SHLS=US / HLLY=US / OLPX=US / GTLB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / McDonald's Corp / Wendys Co / Prologis Inc / Ballard Power Systems Inc / Amazon.com Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Plug Power Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Vroom Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Humana Inc / Equity Residential / AssetMark Financial Holdings Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Netstreit Corp / Piedmont Office Realty Trust Inc / Sangamo Therapeutics Inc / Shopify Inc / ForgeRock Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Shift4 Payments Inc / American Equity Investment Life Holding Co / Global Payments Inc / Highwoods Properties Inc / Synovus Financial Corp / Agree Realty Corp / Federal Realty Investment Trust / Intapp Inc / Omega Healthcare Investors Inc / Spirit Realty Capital Inc / Regency Centers Corp / Ensign Group Inc / Brixmor Property Group Inc / Dine Brands Global Inc / ACV Auctions Inc / Marqeta Inc / Crawford & Co / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / EngageSmart Inc / Sciplay Corp / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / Mastercard Inc / Royalty Pharma PLC / Green Plains Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / UTZ Brands Inc / Blend Labs Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Splunk Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Noodles & Co / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Community Healthcare Trust Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Block Inc / WAVE Life Sciences Ltd / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Root Inc / BioXcel Therapeutics Inc / Amerant Bancorp Inc / Lightspeed Commerce Inc / Arcutis Biotherapeutics Inc / Taysha Gene Therapies Inc / DoorDash Inc / Affirm Holdings Inc / Shoals Technologies Group Inc / Holley Inc / Olaplex Holdings Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 0989529 / 2516152 / 2000019 / 2023607 / 2640147 / 2778844 / 2222631 / 2270726 / 2542049 / 2684703 / 4595739 / 2857817 / 2982924 / B7TL820 / BCZS820 / BBPK0J0 / BDZCRX3 / BFLR866 / BFZCHN7 / BYVYD43 / BF4VBS8 / BFZNYB7 / BDHF4K6 / BJXBP41 / BMQ5T49 / BYY88Y7 / BL71K91 / BYP71H7 / BRJ3GY4 / BN2R582 / BYQCZ35 / BMPRZV5 / BMC5RV6 / BFY7DC4 / BNTB3N8 / BMFPJK6 / BN2RM92 / BMGGJK8 / BMF1LH5 / BMXXBD9 / BLF0CW7 / BP7KZP7 / BNLYJ60 / BNLYBF3 / BMDTR28</td><td class="leftalignment">Adidas AG / AstraZeneca PLC / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Pfizer Inc / Genmab A/S / Netflix Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Performance Food Group Co / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Alcon AG / Zentalis Pharmaceuticals Inc / Alphabet Inc / Revolution Medicines Inc / National Vision Holdings Inc / Xenon Pharmaceuticals Inc / Relay Therapeutics Inc / Madison Square Garden Sports Corp / Kymera Therapeutics Inc / Adicet Bio Inc / Altimmune Inc / Vizio Holding Corp / ACV Auctions Inc / Rain Therapeutics Inc / Valneva SE / Honest Company Inc / Figs Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / Imago BioSciences Inc / Erasca Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 3Q21 Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE / LLY.N / GSK.L</td><td class="leftalignment">Merck KGaA / Eli Lilly and Co / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MEDX.S: Medmix - Mixing growth and repositioning opportunities: initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">MEDX.S / ABT.N / BDX.N / EL.N / LLY.N / LVMH.PA / MDT.N / OREP.PA / PG.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MMM.N / MRCG.DE / WST.N / GSK.L / ATR.N / UCB.BR / AMGN.OQ / NDSN.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / SUN.S / FIN.S / DAE.S / YPSN.S / GXIG.DE / CLTN.S / ABBV.N / COTY.N / SFSN.S / SENSI.S / AVTR.N / NVST.N</td><td class="leftalignment">Medmix Ltd / Abbott Laboratories / Becton Dickinson and Co / Estee Lauder Companies Inc / Eli Lilly and Co / LVMH Moet Hennessy Louis Vuitton SE / Medtronic PLC / L'Oreal SA / Procter & Gamble Co / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / 3M Co / Merck KGaA / West Pharmaceutical Services Inc / GlaxoSmithKline PLC / Aptargroup Inc / Ucb SA / Amgen Inc / Nordson Corp / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Sulzer AG / Georg Fischer AG / Daetwyler Holding AG / Ypsomed Holding AG / Gerresheimer AG / Coltene Holding AG / Abbvie Inc / Coty Inc / SFS Group AG / Sensirion Holding AG / Avantor Inc / Envista Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler / Herr Patrick Laager</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - HUTCHMED (China) Limited: New report: Three targeted oncology drugs present bright globalisation prospect; Initiate with OUTPERFORM. Initiating Coverage with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0013.HK / HCM.OQ / LLY.N / AZN.L / BGNE.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / HUTCHMED (China) Ltd / Eli Lilly and Co / AstraZeneca PLC / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HCM: HUTCHMED (China) Limited - Three targeted oncology drugs present bright globalisation prospect; initiate with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">0013.HK / HCM.OQ / 1093.HK / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / 1177.HK / MRCG.DE / NVS.N / AMGN.OQ / INCY.OQ / RIGL.OQ / RO.S / BSLN.S / 600276.SS / 4568.T / 002422.SZ / ABBV.N / EPZM.OQ / BGNE.OQ / TPB.N / 300558.SZ / 6160.HK / 1801.HK / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / HUTCHMED (China) Ltd / CSPC Pharmaceutical Group Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Sino Biopharmaceutical Ltd / Merck KGaA / Novartis AG / Amgen Inc / Incyte Corp / Rigel Pharmaceuticals Inc / Roche Holding AG / Basilea Pharmaceutica AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Abbvie Inc / Epizyme Inc / Beigene Ltd / Turning Point Brands Inc / Betta Pharmaceuticals Co Ltd / Beigene Ltd / Innovent Biologics Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL - BUY - 3Q21 Recap; R&D Day on Dec.16; Continued Clinical Execution on ZN-c3; Frequent Data Readouts in 2022; PT to $97</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMQ5T49 / 0989529 / 0925288 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Solid Trajectory For Gvoke; Recorlev FDA Action Looming</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">532457108 / 03209R103</td><td class="leftalignment">Eli Lilly and Co / Amphastar Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Common threads from investor feedback on Treg competitive landscape</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / AMGN=US / MRK=US / BMY=US / GILD=US / SGMO=US</td><td class="leftalignment">Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / BMY=US / OXY=US / AMD=US / RRC=US / IP=US / MDT=US / DVN=US / INCY=US / GILD=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / PLUG=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / IGT=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / ESS=US / CLI=US / DV=US / AVGO=US / BLL=US / BNL=US / ENV=US / ELY=US / CTRA=US / CNX=US / CCK=US / EQT=US / GPOR=US / DOC=US / HOOK=US / REGI=US / TRIP=US / TGI=US / CVX=US / CGEN=US / SGMS=US / BDN=US / OFC=US / CUZ=US / PRI=US / DCP=US / EGP=US / FR=US / JAZZ=US / KIM=US / NHI=US / PRA=US / DRE=US / NLS=US / COP=US / MRNS=US / PTON=US / MMP=US / BIIB=US / RNG=US / APTX=US / NUVA=US / EXR=US / WRK=US / CLR=US / PRPL=US / SEAS=US / TIL=US / NOG=US / RCUS=US / HTA=US / OLO=US / AR=US / OAS=US / HGV=US / ESTE=US / CUBE=US / MTDR=US / PDCE=US / FANG=US / MODN=US / CNCE=US / VNOM=US / CIVI=US / OSH=US / VCEL=US / GSBD=US / NSA=US / EVBG=US / CDEV=US / VRNA=US / SBOW=US / IOVA=US / CARG=US / SAIL=US / COLD=US / FSK=US / RPAY=US / GMAB=US / GOCO=US / PNTG=US / OVV=US / CRMD.US / AZYO=US / ABNB=US / DASH=US / SHLS=US / ROCC=US / DHT.UN=CA / REPX=US / MNTV=US / DNUT=US / PYCR=US / PKG=U / 00152K101</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Medtronic PLC / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / DoubleVerify Holdings Inc / Broadcom Inc / Ball Corp / Bunzl plc / Envestnet Inc / Callaway Golf Co / Coterra Energy Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / Physicians Realty Trust / HOOKIPA Pharma Inc / Renewable Energy Group Inc / Tripadvisor Inc / Triumph Group Inc / Chevron Corp / Compugen Ltd / Scientific Games Corp / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / DCP Midstream LP / Eastgroup Properties Inc / First Industrial Realty Trust Inc / Jazz Pharmaceuticals PLC / Kimco Realty Corp / National Health Investors Inc / ProAssurance Corp / Duke Realty Corp / Nautilus Inc / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Biogen Inc / RingCentral Inc / Aptinyx Inc / NuVasive Inc / Extra Space Storage Inc / Westrock Co / Continental Resources Inc / Purple Innovation Inc / SeaWorld Entertainment Inc / Instil Bio Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Healthcare Trust Of America Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / CubeSmart / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Model N Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Civitas Resources Inc / Oak Street Health Inc / Vericel Corp / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Everbridge Inc / Centennial Resource Development Inc / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / CarGurus Inc / SailPoint Technologies Holdings Inc / Americold Realty Trust / FS KKR Capital Corp / Repay Holdings Corp / Genmab A/S / Gohealth Inc / Pennant Group Inc / Ovintiv Inc / CorMedix Inc / Aziyo Biologics Inc / Airbnb Inc / DoorDash Inc / Shoals Technologies Group Inc / Ranger Oil Corp / Dri Healthcare Trust / Riley Exploration Permian Inc / Momentive Global Inc / Krispy Kreme Inc / Paycor HCM Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SUPN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SUPN.O / ABT / BMY / JNJ / LLY / UTHR.O / ZGNX.O</td><td class="leftalignment">Supernus Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / United Therapeutics Corp / Zogenix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HALO-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HALO.O / BAX / JNJ / LLY / PFE / MNKD.O / SNY.O</td><td class="leftalignment">Halozyme Therapeutics Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / MannKind Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">It's difficult to compare cognition off-treatment across trials despite sustained plaque reduction</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2732635 / 2229126 / 2270726 / 2345022 / 2121352 / 2459202 / 2613990 / 2515030 / 2630085 / 2684703 / 2862532 / 2943523 / 2931034 / 7103065 / B0X7DZ3 / 2713317 / 2857817 / 2951452 / 2598246 / B44C366 / B7TL820 / B8L2798 / BBPK0J0 / BDZCRX3 / B95WG16 / BS7K7C9 / BYVFC94 / BYQHP96 / BF5L3T2 / BJLT387 / BJLKVS6 / BZB1XF2 / BYZR4X4 / BJ5FZ74 / BGCYWN8 / BZ8FPH3 / BKVDFF7 / BFXC911 / BHZSB82 / BDH65C8 / BP3YM85 / BL95N25 / BYY88Y7 / BKC9SX3 / BD6JX35 / BKS3RS7 / BYTJZL1 / BDD1B07 / BFY7DC4 / BKPGJQ1 / BFYVZ75 / BF0QTY9 / BMW15J8 / BYYGK12</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / AutoNation Inc / Columbia Sportswear Co / Walt Disney Co / Macy's Inc / Group 1 Automotive Inc / IDEXX Laboratories Inc / Illumina Inc / Lithia Motors Inc / Neogen Corp / Pfizer Inc / E W Scripps Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Novartis AG / Chipotle Mexican Grill Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / J M Smucker Co / Neogenomics Inc / Heska Corp / Meta Platforms Inc / Hemisphere Media Group Inc / Mirati Therapeutics Inc / RingCentral Inc / Zoetis Inc / Nevro Corp / US Foods Holding Corp / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Avantor Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Axsome Therapeutics Inc / Adaptive Biotechnologies Corp / Xencor Inc / Editas Medicine Inc / Oric Pharmaceuticals Inc / Guardant Health Inc / Covetrus Inc / PetIQ Inc / Trupanion Inc / Phibro Animal Health Corp / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / 10X Genomics Inc / Zogenix Inc / Rubius Therapeutics Inc / Altimmune Inc / Squarespace Inc / Seelos Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Renalytix PLC / TPI Composites Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RNA: 3Q21 Earnings - Pipeline Progress with 2022 Catalysts On-Track</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RNA.OQ / LLY.N</td><td class="leftalignment">Avidity Biosciences Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: Credit Suisse Healthcare Conference: Fireside Chat Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABOS.OQ / LLY.N / BIIB.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, November 8 - Sunday, November 14</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Insulin GPO rules appearing more lenient than before; human insulin tender could be more competitive than insulin analog</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / SASY.PA / NOVOB.CO / 600867.SS / 3933.HK / 1558.HK</td><td class="leftalignment">Eli Lilly and Co / Sanofi SA / Novo Nordisk A/S / Tonghua Dongbao Pharmaceutical Co Ltd / United Laboratories International Holdings Ltd / YiChang HEC ChangJiang Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Denmark / France / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Readacross from Pfizer's oral COVID Ph-2/3 data; what additional data should we expect in near future</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / PFE.N / LLY.N / MRK.N / GSK.L / REGN.OQ / 006280.KS</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Pfizer Inc / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Green Cross Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 83</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/06/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Eli Lilly & Company: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/06/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">LLY: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GB0009252882 / US0463531089 / US22284P1057 / US2310211063 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US5150981018 / US5324571083 / US6795801009 / US6937181088 / US7711951043 / US7782961038 / US8725401090 / US9029251066 / US9507551086 / US12541W2098 / US78709Y1055 / US75025X1000 / US9837931008 / US1220171060 / US03937C1053 / US6323071042 / CA87241L1094 / US23753F1075 / US80689H1023 / US4990491049 / US74766Q1013 / US57777K1060 / US2362721001 / US74623V1035 / US63909J1088 / US26916J1060 / US4650051067</td><td class="leftalignment">GlaxoSmithKline PLC / AstraZeneca PLC / Covenant Logistics Group Inc / Cummins Inc / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Landstar System Inc / Eli Lilly and Co / Old Dominion Freight Line Inc / Paccar Inc / Roche Holding AG / Ross Stores Inc / TJX Companies Inc / USA Truck Inc / Werner Enterprises Inc / CH Robinson Worldwide Inc / Saia Inc / Radiant Logistics Inc / XPO Logistics Inc / Burlington Stores Inc / ArcBest Corp / Natera Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / MaxCyte Inc / Danimer Scientific Inc / Purecycle Technologies Inc / Nautilus Biotechnology Inc / ESS Tech Inc / IsoPlexis Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS MORNING: KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: Friday at 11:00 am ET, We're Talking Obesity and the Untapped $20-30B TAM (NOVO.B, LLY, ALT... and More)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / ALT.OQ / 2516152 / BHC8X90 / BFY7DC4</td><td class="leftalignment">Eli Lilly and Co / Altimmune Inc / Eli Lilly and Co / Novo Nordisk A/S / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Hospital procurement data released for China insulin VBP in line with expectations</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NOVOB.CO / LLY.N / SASY.PA</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Nov. 04, 2021 / 12:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Feedback from London post 3Q management meeting</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">NOVOB.CO / LLY.N</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Stocks/Sectors that Benefit from Inflation</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">A.N / AAP.N / AEE.N / AES.N / AIG.N / ALB.N / ALK.N / ALL.N / APD.N / AXP.N / BA.N / BAX.N / BBY.N / BEN.AX / BMY.N / BSX.N / C.N / CCI.N / CCL.N / CI.N / CL.N / ECL.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / FMC.N / HLT.N / IP.N / IR.N / KMB.N / LLY.N / LMT.N / MDT.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PNC.N / PNW.N / RHI.N / RL.N / SEE.N / SLB.N / SO.N / SWK.N / TAP.N / TMO.N / TRV.N / TXT.N / WFC.N / PG.N / WY.N / NUE.N / ROK.N / CPB.N / ETR.N / AAL.L / ADML.L / ETN.N / DHR.N / DIS.N / UNH.N / TFX.N / CMI.N / D.N / URI.N / AIZ.N / DE.N / IEX.N / PH.N / PGR.N / IPG.N / UNP.N / CLX.N / CAG.N / VNO.N / LOW.N / GLW.N / LH.N / UPS.N / KR.N / MMM.N / GIS.N / NI.N / XOM.N / AMT.N / WHR.N / RMD.N / DTEGN.F / IT.N / TGT.N / AVY.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / WST.N / REG.N / COO.N / STZ.N / VFC.N / LNC.N / APH.N / AZO.N / EFX.N / PSA.N / EW.N / OKE.N / BXP.N / ACN.N / ARE.N / RSG.N / SNA.N / CHD.N / TWTR.N / ESS.N / FRT.N / HRL.N / PVH.N / BLK.N / AJG.N / ABC.N / CVX.N / MCO.N / JNPR.N / IRM.N / COP.N / CNP.N / INTC.OQ / CTSH.OQ / AOS.N / ABMD.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CINF.OQ / CTAS.OQ / CSCO.OQ / FAST.OQ / JKHY.OQ / JBHT.OQ / LRCX.OQ / ATVI.OQ / NTRS.OQ / PCAR.OQ / PAYX.OQ / PBCT.OQ / TROW.OQ / ROST.OQ / SJM.N / TECH.OQ / ZION.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / ODFL.OQ / INTU.OQ / COST.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / NTAP.OQ / TPR.N / ANSS.OQ / GL.N / AMZN.OQ / TTWO.OQ / VRSN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / ILMN.OQ / EQIX.OQ / GPN.N / MNST.OQ / TXN.OQ / CMCSA.OQ / TFC.N / DPZ.N / MOS.N / MKTX.OQ / MPWR.OQ / VIAC.OQ / NDAQ.OQ / ICE.N / LYV.N / MS.N / CMG.N / FIS.N / ADP.PA / HBI.N / WU.N / AON.N / ULTA.OQ / WRB.N / CME.OQ / NWSA.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / LYB.N / MSI.N / NLSN.N / MPC.N / FBHS.N / XYL.N / ENPH.OQ / FANG.OQ / LEGN.DE / CDW.OQ / FOXA.O / LDOS.N / ALLE.N / PTC.OQ / SYF.N / CTLT.N / KEYS.N / ANTM.N / QRVO.OQ / ETSY.OQ / ZBH.N / WRK.N / CSX.OQ / SPGI.K / FTV.N / LW.N / XEL.OQ / BKNG.OQ / CBRE.N / CDAY.N / EVRG.N / TER.OQ / NWL.OQ / LNT.OQ / LHX.N / EXC.OQ / NLOK.OQ / RTX.N / OTIS.N / APA.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Ameren Corp / AES Corp / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Allstate Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Best Buy Co Inc / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Crown Castle International Corp / Carnival Corp / Cigna Corp / Colgate-Palmolive Co / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / FMC Corp / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Schlumberger NV / Southern Co / Stanley Black & Decker Inc / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Textron Inc / Wells Fargo & Co / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Entergy Corp / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Cummins Inc / Dominion Energy Inc / United Rentals Inc / Assurant Inc / Deere & Co / IDEX Corp / Parker-Hannifin Corp / Progressive Corp / Interpublic Group of Companies Inc / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Lowe's Companies Inc / Corning Inc / Laboratory Corporation of America Holdings / United Parcel Service Inc / Kroger Co / 3M Co / General Mills Inc / NiSource Inc / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Resmed Inc / Deutsche Telekom AG / Gartner Inc / Target Corp / Avery Dennison Corp / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / West Pharmaceutical Services Inc / Regency Centers Corp / Cooper Companies Inc / Constellation Brands Inc / VF Corp / Lincoln National Corp / Amphenol Corp / Autozone Inc / Equifax Inc / Public Storage / Edwards Lifesciences Corp / ONEOK Inc / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / Twitter Inc / Essex Property Trust Inc / Federal Realty Investment Trust / Hormel Foods Corp / PVH Corp / BlackRock Inc / Arthur J Gallagher & Co / Amerisourcebergen Corp / Chevron Corp / Moody's Corp / Juniper Networks Inc / Iron Mountain Inc / Conocophillips / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / A O Smith Corp / ABIOMED Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Cincinnati Financial Corp / Cintas Corp / Cisco Systems Inc / Fastenal Co / Jack Henry & Associates Inc / J B Hunt Transport Services Inc / Lam Research Corp / Activision Blizzard Inc / Northern Trust Corp / Paccar Inc / Paychex Inc / People's United Financial Inc / T Rowe Price Group Inc / Ross Stores Inc / J M Smucker Co / Bio-Techne Corp / Zions Bancorporation NA / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Old Dominion Freight Line Inc / Intuit Inc / Costco Wholesale Corp / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / NetApp Inc / Tapestry Inc / ANSYS Inc / Globe Life Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Illumina Inc / Equinix Inc / Global Payments Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Domino's Pizza Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / ViacomCBS Inc / Nasdaq Inc / Intercontinental Exchange Inc / Live Nation Entertainment Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / HanesBrands Inc / Western Union Co / Aon PLC / Ulta Beauty Inc / W R Berkley Corp / CME Group Inc / News Corp / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Nielsen Holdings PLC / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / Enphase Energy Inc / Diamondback Energy Inc / LEG Immobilien SE / CDW Corp / Fox Corp / Leidos Holdings Inc / Allegion PLC / PTC Inc / Synchrony Financial / Catalent Inc / Keysight Technologies Inc / Anthem Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / Westrock Co / CSX Corp / S&P Global Inc / Fortive Corp / Lamb Weston Holdings Inc / Xcel Energy Inc / Booking Holdings Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Evergy Inc / Teradyne Inc / Newell Brands Inc / Alliant Energy Corp / L3harris Technologies Inc / Exelon Corp / NortonLifeLock Inc / Raytheon Technologies Corp / Otis Worldwide Corp / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / France / United Kingdom / Ireland / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended November 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">5671735 / 2868165 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2973821 / 2544960 / 2437071 / 2219224 / 2206657 / 2208073 / 2829515 / 2037170 / 2317087 / 2576941 / 2328915 / 2100920 / 2459202 / 2471950 / 2645409 / 2689560 / 2684703 / 2048804 / 2707677 / 2931034 / B0PZN11 / B02R1L6 / B570P91 / B5B2106 / B4Y1MH7 / B6197Q2 / 2949758 / B3SWPT2 / B7TL820 / B4V9661 / B8CKK03 / BJ0KXV4 / BYY8XK8 / BYVYD43 / BYVFC94 / BP4GNK9 / BJF8Q81 / BZ1LFB2 / BD8DJ71 / BJ2Z0H2 / BYWMQJ2 / BL95N25 / BZ1LFG7 / BYY88Y7 / BDT5KT5 / BFWGXQ7 / BP84RX0 / BD72R64 / BFY7DC4 / BMZ9Z11 / BNTB3N8 / BMFPJK6 / BJ62Z18</td><td class="leftalignment">Sanofi SA / Sysco Corp / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Alliant Energy Corp / Beasley Broadcast Group Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Coca-Cola Co / Copart Inc / Edison International / 8x8 Inc / Entergy Corp / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / IDEXX Laboratories Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Vertex Pharmaceuticals Inc / Under Armour Inc / ALLETE Inc / Lear Corp / Fortinet Inc / KAR Auction Services Inc / Generac Holdings Inc / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / Ralph Lauren Corp / Mondelez International Inc / ONE Gas Inc / WEC Energy Group Inc / Performance Food Group Co / US Foods Holding Corp / SAGE Therapeutics Inc / IAA Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Pinterest Inc / Alteryx Inc / Phibro Animal Health Corp / Roku Inc / Alphabet Inc / Inspire Medical Systems Inc / Container Store Group Inc / Townsquare Media Inc / Liberty Media Corp / Altimmune Inc / Prometheus Biosciences Inc / Vizio Holding Corp / ACV Auctions Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">1801.HK: Innovent - 2021 CIC Live takeaways</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1801.HK / LLY.N / 600276.SS</td><td class="leftalignment">Innovent Biologics Inc / Eli Lilly and Co / Jiangsu Hengrui Pharmaceuticals Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2045623 / 2206657 / 2270726 / 2829515 / 2317087 / 2670519 / 2100920 / 2623911 / 2689560 / 2684703 / 2048804 / 7103065 / B125XQ6 / B2R3PV1 / B5B2106 / B3SWPT2 / B7TL820 / BBGVT40 / B95N910 / BVVN4Q8 / BD3W133 / BJLT387 / BK7Y2V9 / BD8DJ71 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BD6D4Y5 / BYY88Y7 / BZ0P3Z5 / BMG75B4 / BN0XTW4 / BFY7DC4 / BNTB3N8 / BMW15J8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / Coca-Cola Co / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / FirstEnergy Corp / Neurocrine Biosciences Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Portland General Electric Co / American Water Works Company Inc / Fortinet Inc / Ameresco Inc / Meta Platforms Inc / News Corp / PTC Inc / Eversource Energy / Keurig Dr Pepper Inc / Avantor Inc / Akero Therapeutics Inc / Snap Inc / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / Altair Engineering Inc / Alphabet Inc / Tegna Inc / Inventiva SA / Orphazyme A/S / Altimmune Inc / Vizio Holding Corp / Renalytix PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Nov. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / BAC.N / BMY.N / CL.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / JPM.N / LLY.N / LMT.N / NEM.N / OXY.N / PNW.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / PXD.N / NUE.N / CPB.N / DIS.N / UNH.N / D.N / MGM.N / CLX.N / HD.N / MRO.N / WEC.N / XOM.N / DVN.N / IT.N / VZ.N / V.N / MKC.N / HRL.N / CVX.N / COP.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / INCY.OQ / PENN.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / ISRG.OQ / GPN.N / VRTX.OQ / NFLX.OQ / WYNN.OQ / EXR.N / MOS.N / MKTX.OQ / LVS.N / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / FTNT.OQ / TSLA.OQ / MPC.N / FANG.OQ / GOOGL.OQ / TMUS.OQ / LW.N / XEL.OQ / FB.PS / AEP.OQ / VTRS.OQ / BBWI.N</td><td class="leftalignment">Albemarle Corp / Bank of America Corp / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Pioneer Natural Resources Co / Nucor Corp / Campbell Soup Co / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / MGM Resorts International / Clorox Co / Home Depot Inc / Marathon Oil Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / Verizon Communications Inc / Visa Inc / McCormick & Company Inc / Hormel Foods Corp / Chevron Corp / Conocophillips / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Incyte Corp / Penn National Gaming Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Intuitive Surgical Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Wynn Resorts Ltd / Extra Space Storage Inc / Mosaic Co / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Fortinet Inc / Tesla Inc / Marathon Petroleum Corp / Diamondback Energy Inc / Alphabet Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / Xcel Energy Inc / San Miguel Food and Beverage Inc / American Electric Power Company Inc / Viatris Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for LLY</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 22</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">1877.HK: Shanghai Junshi Biosciences Co., Ltd - 2021 CIC Live takeaways</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / 1801.HK</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 3Q21 results preview</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE / LLY.N / ROG.S / GSK.L</td><td class="leftalignment">Merck KGaA / Eli Lilly and Co / Roche Holding AG / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Mgmt set PD-1 2022 domestic sales target at Rmb1.5 bn; No AdCom expected for PD-1's FDA review. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / 1801.HK</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, November 1 - Sunday, November 7</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q3 2021: Eli Lilly and Company EPS drops 20%</td><td class="leftalignment">English</td><td class="rightalignment">86</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Primer Ahead Of Today's KOL Call On Discounted Pricing Strategies For Anti-PD-(L)1s; What To Know</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY / MRK / CKPT / US3755581036 / US45337C1027 / US75886F1075 / US88322Q1085 / US03969F1093</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Checkpoint Therapeutics Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / CACI=US / LLY=US / PFE=US / ADI=US / AMD=US / IP=US / AGL=US / AMZN=US / INCY=US / TXN=US / GILD=US / AMT=US / PEB=US / BC=US / MPWR=US / CONE=US / V=US / NOVA=US / CHKP=US / IART=US / XLNX=US / TRMK=US / TNL=US / CMCSA=US / CI=US / W=US / WTFC=US / APH=US / AVT=US / CNX=US / CPRT=US / DVA=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MHK=US / TEAM=US / NTST=US / ASGN=US / REGN=US / SLGN=US / VSEC=US / WEX=US / FOUR=US / CFR=US / CPT=US / OFC=US / CUZ=US / MAA=US / WRE=US / AMSF=US / VICI=US / ACVA=US / MD=US / MOH=US / FLT=US / TPX=US / KAR=US / TXRH=US / BAH=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / TEL=US / TAST=US / EIG=US / PRPL=US / EHC=US / IAA=US / WH=US / RCUS=US / KNSL=US / AR=US / NXPI=US / NLSN=US / LKQ=US / PTCT=US / 00770K202 / CMPR=US / GDDY=US / ETSY=US / SPNE=US / ARGX=US / NVCR=US / WLTW=US / KDP=US / FTDR=US / EB=US / ARQT=US / AIRC=US / HYFM=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Advanced Micro Devices Inc / International Paper Co / agilon health Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / Monolithic Power Systems Inc / CyrusOne Inc / Visa Inc / Sunnova Energy International Inc / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Xilinx Inc / Trustmark Corp / Travel + Leisure Co / Comcast Corp / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Amphenol Corp / Avnet Inc / CNX Resources Corp / Copart Inc / DaVita Inc / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ASGN Inc / Regeneron Pharmaceuticals Inc / Silgan Holdings Inc / VSE Corp / WEX Inc / Shift4 Payments Inc / Cullen/Frost Bankers Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Amerisafe Inc / VICI Properties Inc / ACV Auctions Inc / MEDNAX Inc / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Texas Roadhouse Inc / Booz Allen Hamilton Holding Corp / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / TE Connectivity Ltd / Carrols Restaurant Group Inc / Employers Holdings Inc / Purple Innovation Inc / Encompass Health Corp / IAA Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / NXP Semiconductors NV / Nielsen Holdings PLC / LKQ Corp / PTC Therapeutics Inc / Aemetis Inc / Cimpress PLC / GoDaddy Inc / ETSY Inc / SeaSpine Holdings Corp / argenx SE / Novocure Ltd / Willis Towers Watson PLC / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arcutis Biotherapeutics Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">5671735 / 2516152 / 2681511 / 2000019 / 2550707 / 2778844 / 2002305 / 2003698 / 2026242 / 2219224 / 2206657 / 2229126 / 2270726 / 2317087 / 2328915 / 2345022 / 2048804 / 2730190 / 2440637 / 2829601 / 2842255 / 2853688 / 2098876 / 2503529 / 2181334 / 2971029 / B00FWN1 / B067BM3 / 2212922 / 2216991 / 2857817 / B3P93Y7 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BFLR866 / BFH3N85 / BVVN4Q8 / BD3W133 / BXDZ9Z0 / BJLT387 / BD8DJ71 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BJJMGL2 / BYXJQG9 / BWY52P3 / BYY88Y7 / BMH0MR7 / BDVLM39 / BMG75B4 / BQXZP64 / BJRFSB7 / BD5GSZ4 / BNGJQZ8 / BJ9N563</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / McDonald's Corp / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / American Electric Power Company Inc / CMS Energy Corp / Coca-Cola Co / Columbia Sportswear Co / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Macy's Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Starbucks Corp / Stryker Corp / Yum! Brands Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / LKQ Corp / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / NRG Energy Inc / Tempur Sealy International Inc / Netflix Inc / Anheuser Busch Inbev SA / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Twitter Inc / Veeva Systems Inc / Eversource Energy / Keurig Dr Pepper Inc / Shopify Inc / Avantor Inc / Snap Inc / Pinterest Inc / Spotify Technology SA / DraftKings Inc / Fox Corp / Spire Inc / Blueprint Medicines Corp / Alphabet Inc / Zendesk Inc / argenx SE / Inventiva SA / Wayfair Inc / Immunovant Inc / Infrastructure and Energy Alternatives Inc / Porch Group Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / France / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Biotech Sector - Can China PD-1 be approved in the US? Knowing the history could help tell the future</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / NOVN.S / BGNE.OQ / ATNX.OQ / 1801.HK / 1877.HK</td><td class="leftalignment">Eli Lilly and Co / Novartis AG / Beigene Ltd / Athenex Inc / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CYCC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CYCC.O / BAX / JNJ / LLY / ARRY.O / SPPI.O / ONTX.O / CASI.O</td><td class="leftalignment">Cyclacel Pharmaceuticals Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Array Technologies Inc / Spectrum Pharmaceuticals Inc / Onconova Therapeutics Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ONCY-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ONCY.O / BMY / LLY / HBP.TO / AEZS.O / AVEO.O / MRTX.O / TEVA.K / SPHS.PK</td><td class="leftalignment">Oncolytics Biotech Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Helix Biopharma Corp / Aeterna Zentaris Inc / Aveo Pharmaceuticals Inc / Mirati Therapeutics Inc / Teva Pharmaceutical Industries Ltd / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company climbs 15.1% from 4 week low</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Rux cream MAA validation for vitiligo a key step for derm franchise expansion, in our view</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">INCY=US / LLY=US / PFE=US / ARQT=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Pfizer Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Eli Lilly (LLY US) - Q3 second opinion: trailblazing</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IMAB: I-Mab Biopharma - Global innovation with differentiated product portfolio to drive upside</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">IMAB.OQ / 4502.T / BMY.N / LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / GILD.OQ / 000661.SZ / 095700.KQ / 300009.SZ / ABBV.N / TGTX.OQ / MGNX.OQ / BGNE.OQ / CRVS.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / ALXO.OQ</td><td class="leftalignment">I-Mab / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Changchun High & New Technology Industries Group Inc / Genexine Inc / Anhui Anke Biotechnology Group Co Ltd / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Beigene Ltd / Corvus Pharmaceuticals Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 3Q21 Earnings (BMY, BSX, LLY, TMO) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / BMY.N / BSX.N / TMO.N</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Thermo Fisher Scientific Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2H 2022 is now a key timeframe around how the Alzheimer's competitive and treatment landscape shapes up: Lowering PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037 / LLY</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, LLY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">礼来 Eli Lilly-Tirzepatide 有望推动未来收入增长-10/27/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">2</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chloe Kim</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / LLY=US / PFE=US / TWTR=US / AMD=US / RRC=US / EFX=US / BXP=US / TXN=US / GILD=US / GPK=US / APA=US / MPWR=US / TRU=US / V=US / DIOD=US / XLNX=US / BRO=US / BYD=US / MAR=US / SPOT=US / ADS=US / TTWO=US / ATVI=US / ESS=US / MANH=US / AKR=US / EQR=US / AIR=US / ARCC=US / ATRO=US / CSGP=US / DCO=US / ABG=US / HAS=US / HEI=US / HXL=US / MAIN=US / HZO=US / MRCY=US / MCHP=US / ORCC=US / OI=US / PII=US / ST=US / SGMO=US / STRA=US / TGI=US / VSEC=US / BXS=US / HIW=US / PYPL=US / CNC=US / BDN=US / EGP=US / SPR=US / UDR=US / CATY=US / ECPG=US / PRAA=US / JRVR=US / BIIB=US / AINV=US / DLR=US / XM=US / SCPL=US / TDG=US / HST=US / MA=US / AWI=US / CADE=US / CLR=US / PNNT=US / KTOS=US / NMTR=US / APEI=US / RCUS=US / AAN=US / 45665G303 / OAS=US / NXPI=US / RLJ=US / FBHS=US / ZNGA=US / EA=US / MTDR=US / ENPH=US / MEIP=US / SSTK=US / IBTX=US / CEQP=US / GOOGL=US / TSLX=US / 70806A106 / AFMD=US / ON=US / AJRD=US / GSBD=US / BWXT=US / SQ=US / TENB=US / FSK=US / LHX=US / HYFM=US / RBLX=US / SSBK=US / PKG=U / ROIV=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Twitter Inc / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Boston Properties Inc / Texas Instruments Inc / Gilead Sciences Inc / Graphic Packaging Holding Co / APA Corp (US) / Monolithic Power Systems Inc / TransUnion / Visa Inc / Diodes Inc / Xilinx Inc / Brown & Brown Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Activision Blizzard Inc / Essex Property Trust Inc / Manhattan Associates Inc / Acadia Realty Trust / Equity Residential / AAR Corp / Ares Capital Corp / Astronics Corp / CoStar Group Inc / Ducommun Inc / Asbury Automotive Group Inc / Hasbro Inc / HEICO Corp / Hexcel Corp / Main Street Capital Corp / MarineMax Inc / Mercury Systems Inc / Microchip Technology Inc / Owl Rock Capital Corp / O-I Glass Inc / Polaris Inc / Sensata Technologies Holding PLC / Sangamo Therapeutics Inc / Strategic Education Inc / Triumph Group Inc / VSE Corp / Cadence Bank / Highwoods Properties Inc / PayPal Holdings Inc / Centene Corp / Brandywine Realty Trust / Eastgroup Properties Inc / Spirit AeroSystems Holdings Inc / UDR Inc / Cathay General Bancorp / Encore Capital Group Inc / PRA Group Inc / James River Group Holdings Ltd / Biogen Inc / Apollo Investment Corp / Digital Realty Trust Inc / Qualtrics International Inc / Sciplay Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Armstrong World Industries Inc / Cadence Bank / Continental Resources Inc / Pennantpark Investment Corp / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / American Public Education Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Oasis Petroleum Inc / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Matador Resources Co / Enphase Energy Inc / MEI Pharma Inc / Shutterstock Inc / Independent Bank Group Inc / Crestwood Equity Partners LP / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / BWX Technologies Inc / Block Inc / Tenable Holdings Inc / FS KKR Capital Corp / L3harris Technologies Inc / Hydrofarm Holdings Group Inc / Roblox Corp / Southern States Bancshares Inc / Packaging Corp of America / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2516152 / 2026242 / 2270726 / 2317087 / 2455965 / 2689560 / 2680905 / 2048804 / 2138158 / 7103065 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B65SQW4 / BFLR866 / BFH3N85 / BVVN4Q8 / BJXBP41 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BKTNTR9 / BYY88Y7</td><td class="leftalignment">Eli Lilly and Co / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Biogen Inc / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Sempra Energy / Novartis AG / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Enphase Energy Inc / Twitter Inc / Veeva Systems Inc / Eversource Energy / Alcon AG / Snap Inc / Pinterest Inc / Warner Music Group Corp / ViacomCBS Inc / Alphabet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Model Update Post 3Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Eli Lilly and Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 3Q Takeaways – Solid Core Performance; 2022 Opex Investments As Expected with Several Major Launches on the Horizon</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended October 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended September 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: 3Q21: They said what?! Highlights from conference call that just ended... and our impressions</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Alzheimer's color from LLY 3Q21 call and additional BIIB commentary</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / BIIB.OQ / LLY=US / SGMO=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Eli Lilly and Co / Sangamo Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Sunshine And Flowers, Liking LLY Ahead Of Important Launches And Data Readouts In 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">alzheimers head to head: LLY vs BIIB</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 EPS Light But Sales Beat; 2021 Revenue And EPS Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">thoughts on Q</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 3Q First Impressions: Core Business on Track; Several Major Approvals on the Horizon in 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GOOGL.OQ / BP.L / CIT.N / CNC.N / COF.N / ECL.N / GE.N / IBM.N / LLY.N / LMT.N / PHM.N / SLB.N / EQR.N / HAL.N / ADM.N / GLW.N / UPS.N / WM.N / XOM.N / SHW.N / AMP.N / V.N / BXP.N / TWTR.N / BYD.N / UDR.N / HUBb.N / GPK.N / AAPL.OQ / MSFT.OQ / PCAR.OQ / ST.N / SBUX.OQ / WRLD.OQ / AMZN.OQ / CHRW.OQ / FFIV.OQ / JBLU.OQ / TXN.OQ / 0700.HK / NOV.N / RDSa.L / AWI.N / 9999.HK / IVZ.N / MSCI.N / HAS.OQ / BKR.N / FBHS.N / AMD.OQ / ENPH.OQ / NVSJ.J / SPGI.N / TPB.N / TRTN.N / PFG.OQ / TER.OQ / LYFT.OQ / CB.BN / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / RTX.N / 9618.HK / ABNB.OQ / PNT.DE</td><td class="leftalignment">Alphabet Inc / BP PLC / First-Citizens Bank & Trust Co / Centene Corp / Capital One Financial Corp / Ecolab Inc / General Electric Co / International Business Machines Corp / Eli Lilly and Co / Lockheed Martin Corp / Pultegroup Inc / Schlumberger NV / Equity Residential / Halliburton Co / Archer-Daniels-Midland Co / Corning Inc / United Parcel Service Inc / Waste Management Inc / Exxon Mobil Corp / Sherwin-Williams Co / Ameriprise Financial Inc / Visa Inc / Boston Properties Inc / Twitter Inc / Boyd Gaming Corp / UDR Inc / Hubbell Inc / Graphic Packaging Holding Co / Apple Inc / Microsoft Corp / Paccar Inc / Sensata Technologies Holding PLC / Starbucks Corp / World Acceptance Corp / Amazon.com Inc / CH Robinson Worldwide Inc / F5 Inc / JetBlue Airways Corp / Texas Instruments Inc / Tencent Holdings Ltd / Nov Inc / Royal Dutch Shell PLC / Armstrong World Industries Inc / NetEase Inc / Invesco Ltd / MSCI Inc / Hasbro Inc / Baker Hughes Co / Fortune Brands Home & Security Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Novus Holdings Ltd / S&P Global Inc / Turning Point Brands Inc / Triton International Ltd / Principal Financial Group Inc / Teradyne Inc / Lyft Inc / Chubb Ltd / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / Raytheon Technologies Corp / JD.Com Inc / Airbnb Inc / Pentair PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / United States / South Africa / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Brief of Eli Lilly and Co conference call, Oct. 26, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Oct. 26, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: 3Q Beat/Meet and Raise Bolstered by Olumiant COVID Sales; Donanemab Rolling Submission Initiated & Tirzepatide Filing with PRV Sets 1H22 PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">LLY plans head-to-head comparing donanemab to aducanumab; could take time in our view</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / BIIB=US / LLY=US / BIIB.OQ</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Mixed But FY Guidance Raised, Tirzepatide Filed, Donanemab Rolling Filing</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Look At 3Q21 Sales Beat And EPS Miss For LLY</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2100920 / 2455965 / 2684703 / 2799351 / 2503529 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BYY88Y7 / BFYVZ75 / BP96C52 / BMDTR28</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Sinclair Broadcast Group Inc / World Wrestling Entertainment Inc / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Snap Inc / Uniqure NV / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Alphabet Inc / Seelos Therapeutics Inc / Surrozen Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRTX: GAIN Trial for Atuzaginstat (COR388) Misses Primary Endpoints, Lower TP</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRTX.OQ / 4523.T / LLY.N / BIIB.OQ</td><td class="leftalignment">Cortexyme Inc / Eisai Co Ltd / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for LLY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended October 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Eli Lilly and Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">SEC Investigation Updates:  HFFG, HOPE, LADR, LLY, MGNX, LUG, and TBBK</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US40417F1093 / TBBK.OQ / LLY.N / PLUG.OQ / MGNX.OQ / LADR.N / HOPE.OQ</td><td class="leftalignment">Hf Foods Group Inc / Bancorp Inc / Eli Lilly and Co / Plug Power Inc / MacroGenics Inc / Ladder Capital Corp / Hope Bancorp Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Banks / Biotechnology / Electrical / Pharmaceuticals / Real Estate / Retailing</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">John Gavin</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China PD-(L)1 on the move: Picking long-term winners in a competitive race</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">BGNE.OQ / 1877.HK / BMY.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / INCY.OQ / AGEN.OQ / 600276.SS / 0950.HK / 002437.SZ / 300003.SZ / MRTX.OQ / ZLAB.OQ / 6160.HK / 1801.HK</td><td class="leftalignment">Beigene Ltd / Shanghai Junshi Biosciences Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / Agenus Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Lee's Pharmaceutical Holdings Ltd / Harbin Gloria Pharmaceuticals Co Ltd / Lepu Medical Technology Beijing Co Ltd / Mirati Therapeutics Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, October 25 - Sunday, October 31</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.3% Above Pre-Pandemic Base- Week 81</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED: Please Join Our KOL Video Call to Discuss SITC 2021 and ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2434209 / 2936921 / 2516152 / 2000019 / 2536763 / 2002305 / 2050832 / 2219224 / 2280220 / 2317087 / 2328915 / 2100920 / 2415204 / 2455965 / 2515030 / 2825933 / 4595739 / 7103065 / 2857817 / B03PGL4 / 2949758 / B7TL820 / B4MG4Z6 / BNGY4Q0 / BJFSR88 / BR4T3B3 / BJ2Z0H2 / BMQ5T49 / BFZ1K46 / BLGJ610 / BJVR9Y9 / BYY88Y7 / BDZ30Q0 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Home Depot Inc / Walmart Inc / Eli Lilly and Co / Amazon.com Inc / Lowe's Companies Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / DTE Energy Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Biogen Inc / Lithia Motors Inc / South Jersey Industries Inc / Genmab A/S / Novartis AG / Netflix Inc / NorthWestern Corp / Nexstar Media Group Inc / Meta Platforms Inc / AMC Networks Inc / Nextera Energy Partners LP / Uniqure NV / HubSpot Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / iHeartMedia Inc / Alphabet Inc / Arvinas Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / ECL.N / EL.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / SLB.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / NUE.N / ROK.N / UHS.N / MET.N / ETN.N / DHR.N / GD.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / SYY.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / IQV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / General Dynamics Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Sysco Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN, ZNTL (Both BUY) - Positive Read-Through From Successful RDUS EMERALD Trial to SERDs/ER-degraders</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARVN.OQ / ZNTL.OQ / 5671735 / 0989529 / 2516152 / 7103065 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Arvinas Inc / Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Novartis AG / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN - BUY - Previewing Upcoming Trial Updates on ARV-471 (ER Degrader) and ARV-110 (AR Degrader) at SABCS and ASCO-GU, Respectively</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BDZ30Q0 / 5671735 / 0989529 / 2516152 / 2684703 / 7103065 / B6RS2B3 / BMQ5T49</td><td class="leftalignment">Arvinas Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc / Novartis AG / Clovis Oncology Inc / Zentalis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / PPG.N / SLB.N / T.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / ROK.N / UHS.N / ETN.N / DHR.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / CHTR.OQ / MTCH.OQ / ALGN.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / ANTM.N / TMUS.OQ / CSX.OQ / IQV.N / FB.PS / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Match Group Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Anthem Inc / T-Mobile US Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MOGa / HEI.N / FR0000054470 / BE0165385973 / US0079031078 / US0123481089 / US01741R1023 / US0311621009 / US0382221051 / US0463531089 / US0970231058 / US0997241064 / US1101221083 / US1442851036 / US2358511028 / US2855121099 / US3695501086 / US37733W1053 / US4228061093 / US4282911084 / US4385161066 / US4523271090 / US4781601046 / US5128071082 / US5324571083 / US5398301094 / US55306N1046 / US5949181045 / US6668071029 / US66987V1098 / US6701002056 / US7170811035 / US7475251036 / US7711951043 / US8356993076 / US8740541094 / US8835561023 / US8968181011 / US91307C1027 / US9807451037 / CA0977512007 / IL0010824113 / JP3435000009 / US92343X1000 / US80105N1054 / US1167941087 / US6098391054 / US8936411003 / US8485741099 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US34959E1091 / US1920051067 / US88160R1014 / US69404D1081 / US29082A1079 / US92839U2069 / US4464131063 / JE00B783TY65 / US03027X1000 / US98986T1088 / US29414B1044 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US6974351057 / US63009R1095 / US29664W1053 / US60468T1051 / NL0010696654 / US9222801022 / US09062W2044 / US98936J1016 / US04523Y1055 / US22822V1017 / US30050B1017 / GB00BZ09BD16 / US98138J2069 / US07725L1026 / US90138F1021 / US78410G1040 / US23355L1061 / US03236M2008 / US98980G1022 / US92336X1090 / US2575541055 / US01671P1003 / US28414H1032 / US90184D1000 / IL0011571556 / US03828A1016 / US22788C1053 / US5024311095 / US88025U1097 / US18915M1071 / US85205L1070 / US1567271093 / US4432011082 / US75513E1010 / US6541101050 / GB00BMVP7Y09 / US75943R1023 / US8334451098 / US03044L1052 / US22041X1028 / US38246G1085 / US33813J1060 / US81578P1066 / US00810F1066 / US72815L1070 / US67080N1019 / LU2314763264 / US49926T1043 / US90089L1089 / US90364P1057 / US68622V1061 / US23954D1090 / US81730H1095 / US28489L1044 / US30049H1023 / IL0011786154 / US3696043013 / US75340L1044 / US00091E1091 / CA50202P1053 / US45254E1073 / IL0011794802 / US34631B1017 / US90240B1061 / IL0011796625 / US00152K1016 / US8852601090 / US1095041000 / US2297901009</td><td class="leftalignment">Moog Inc / HEICO Corp / Ubisoft Entertainment SA / Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Allegheny Technologies Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / Boeing Co / Borgwarner Inc / Bristol-Myers Squibb Co / Carpenter Technology Corp / Danaher Corp / Electronic Arts Inc / General Dynamics Corp / GlaxoSmithKline PLC / HEICO Corp / Hexcel Corp / Honeywell International Inc / Illumina Inc / Johnson & Johnson / Lam Research Corp / Eli Lilly and Co / Lockheed Martin Corp / MKS Instruments Inc / Microsoft Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Sony Group Corp / Take-Two Interactive Software Inc / Thermo Fisher Scientific Inc / Triumph Group Inc / United Therapeutics Corp / Woodward Inc / Bombardier Inc / Check Point Software Technologies Ltd / Sony Group Corp / Verint Systems Inc / Sanofi SA / Bruker Corp / Monolithic Power Systems Inc / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Fortinet Inc / Codexis Inc / Tesla Inc / Pacific Biosciences of California Inc / Embraer SA / Visteon Corp / Huntington Ingalls Industries Inc / Aptiv PLC / American Tower Corp / Zynga Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / Palo Alto Networks Inc / NanoString Technologies Inc / Esperion Therapeutics Inc / Mirati Therapeutics Inc / Uniqure NV / Varonis Systems Inc / BioLife Solutions Inc / Zendesk Inc / Aspen Aerogels Inc / Crown Castle International Corp / Evolent Health Inc / Atlassian Corporation PLC / Workhorse Group Inc / Beigene Ltd / Twilio Inc / SBA Communications Corp / DXC Technology Co / Amyris Inc / Zscaler Inc / Veoneer Inc / Domo Inc / Allakos Inc / Elanco Animal Health Inc / Twist Bioscience Corp / Tufin Software Technologies Ltd / Applied Therapeutics Inc / CrowdStrike Holdings Inc / L3harris Technologies Inc / 10X Genomics Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Cerence Inc / Howmet Aerospace Inc / Raytheon Technologies Corp / Nikola Corp / Royalty Pharma PLC / Relay Therapeutics Inc / Snowflake Inc. / American Well Corp / Corsair Gaming Inc / Goodrx Holdings Inc / Fisker Inc / Seer Inc / AerSale Corp / Playtika Holding Corp / Nuvation Bio Inc / Arrival SA / Knowbe4 Inc / TuSimple Holdings Inc / UiPath Inc / Organon & Co / Day One Biopharmaceuticals Inc / SentinelOne Inc / Electric Last Mile Solutions Inc / Evolv Technologies Holdings Inc / REE Automotive Ltd / General Electric Co / Rapid Micro Biosystems Inc / Absci Corp / Li-Cycle Holdings Corp / Immuneering Corp / Cellebrite DI Ltd / ForgeRock Inc / Tyra Biosciences Inc / Arbe Robotics Ltd / AKA Brands Holding Corp / Thorne Healthtech Inc / Brilliant Earth Group Inc / Cue Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Japan / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2550707 / 2486813 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2366799 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2842255 / 2931034 / 7103065 / B01SD70 / 2857817 / B125XQ6 / B3D7K31 / B4N0JJ6 / B7TL820 / B783TY6 / BFLR866 / BNGY4Q0 / BD8DJ71 / BJLKVS6 / BKTHM05 / BYZR4X4 / BMYML02 / BJJMGL2 / BYXJQG9 / BYY88Y7 / BYNQ369 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / McDonald's Corp / Kellogg Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Starbucks Corp / Vertex Pharmaceuticals Inc / Novartis AG / Domino's Pizza Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Twitter Inc / Nextera Energy Partners LP / Snap Inc / Phathom Pharmaceuticals Inc / Passage Bio Inc / Axsome Therapeutics Inc / DraftKings Inc / Fox Corp / Spire Inc / Alphabet Inc / Albertsons Companies Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BK.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / OMC.N / PM.N / PPG.N / SLB.N / T.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / UHS.N / HAL.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / SYF.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, October 18 - Sunday, October 24</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BK.N / BMY.N / BR.N / BSX.N / CB.N / CCI.N / CE.N / CL.N / CNC.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / SLB.N / T.N / TEL.PS / TRV.N / PG.N / DGX.N / WY.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / GD.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / RCL.N / MCD.N / YUM.N / VLO.N / SYK.N / GLW.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / GPC.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / ORLY.OQ / GILD.OQ / DFS.N / TSCO.OQ / POOL.OQ / AMZN.OQ / EBAY.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / LYB.N / MSI.N / KEY.TO / BKR.N / PSX.N / NOW.N / ABBV.N / GOOGL.OQ / SYF.N / CFG.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Broadridge Financial Solutions Inc / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / Procter & Gamble Co / Quest Diagnostics Inc / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Yum! Brands Inc / Valero Energy Corp / Stryker Corp / Corning Inc / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / Amazon.com Inc / eBay Inc / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Baker Hughes Co / Phillips 66 / ServiceNow Inc / Abbvie Inc / Alphabet Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Small/Mid Cap 3Q21 Earnings Preview Conference Call THIS FRIDAY, October 22 at 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">COLL / GRAY / JAZZ / JNJ / LLY / PFE / BDSI / ARDX / ARDS / MNKD / ZTS</td><td class="leftalignment">Collegium Pharmaceutical Inc / Graybug Vision Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / BioDelivery Sciences International Inc / Ardelyx Inc / Aridis Pharmaceuticals Inc / MannKind Corp / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.1% Above Pre-Pandemic Base- Week 80</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large Cap 3Q21 Earnings Preview Conference Call TODAY, October 15 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ZTS / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2437071 / 2280220 / 2270726 / 2317087 / 2576941 / 2455965 / 2471950 / 2623911 / 2632003 / 2048804 / 2730190 / 2825933 / 2931034 / 4595739 / B00FWN1 / B1F76F9 / B19FQ48 / 2713317 / B01SD70 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BXDZ9Z0 / BZ1LFB2 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BDFZSP1 / BK6N347 / BFWK4R7 / BYYWPW6 / BWY52P3 / BYY88Y7 / BDZ30Q0 / BYTJZL1 / BNRQM83 / BJ62Z18</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / New York Times Co / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Genmab A/S / Alnylam Pharmaceuticals Inc / Western Union Co / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Domino's Pizza Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Shopify Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Okta Inc / Uber Technologies Inc / PagSeguro Digital Ltd / Beigene Ltd / Blueprint Medicines Corp / Alphabet Inc / Arvinas Inc / Zogenix Inc / Petco Health and Wellness Company Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech: RNA-Targeting Small Molecule Drugs? Non-Canonical Roles of Estrogen Receptor (ER) as an RNA Binding Protein</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2576941 / 2455965 / 2684703 / 2931034 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Exelixis Inc / Biogen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Debjit Chattopadhyay, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">3Q21 Global Biopharma Preview: Lackluster 3Q Results Won’t Shake Deteriorating Investor Sentiment, but There’s Value Here</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TRV.N / PG.N / NUE.N / UHS.N / HAL.N / DHR.N / UNH.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / MCD.N / VLO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / MCO.N / TDY.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / SIVB.OQ / ZION.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / TFC.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / NOW.N / SYF.N / ANTM.N / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Procter & Gamble Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Moody's Corp / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Truist Financial Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / ServiceNow Inc / Synchrony Financial / Anthem Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / CE.N / CNC.N / COF.N / DAL.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TEL.PS / TRV.N / USB.N / WFC.N / PG.N / DGX.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / UNH.N / GD.N / DOV.N / ROP.N / IPG.N / UNP.N / GS.N / MCD.N / VLO.N / UPS.N / WM.N / MMM.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / WST.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / GPC.N / BLK.N / TDY.N / RF.N / INTC.OQ / FRC.N / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / SIVB.OQ / ZION.OQ / ORLY.OQ / DFS.N / TSCO.OQ / POOL.OQ / EBAY.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / BIIB.OQ / TFC.N / DPZ.N / DLR.N / NDAQ.OQ / CDNS.OQ / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / BKR.N / NOW.N / SYF.N / CFG.N / ANTM.N / WBA.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / TER.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Centene Corp / Capital One Financial Corp / Delta Air Lines Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / US Bancorp / Wells Fargo & Co / Procter & Gamble Co / Quest Diagnostics Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / UnitedHealth Group Inc / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / West Pharmaceutical Services Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / BlackRock Inc / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / First Republic Bank / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / O'Reilly Automotive Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / eBay Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Biogen Inc / Truist Financial Corp / Domino's Pizza Inc / Digital Realty Trust Inc / Nasdaq Inc / Cadence Design Systems Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Walgreens Boots Alliance Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Teradyne Inc / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Ending The Year On A High Note, Label Expansion For Verzenio Includes Adjuvant Use For Ki-67 Population</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2050832 / 2206657 / 2317087 / 2684703 / 2799351 / 2825933 / 2900335 / 7103065 / 2712013 / B121557 / 2857817 / 2598246 / B3SWPT2 / B7TL820 / BCZS820 / B7577T2 / BVVN4Q8 / BFZNYB7 / BDHF4K6 / BZ1LFB2 / BR4T3B3 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BN4RD42 / BNTB3N8 / BMVBZF5 / 120483382</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Ameren Corp / Coca-Cola Co / Entergy Corp / Pfizer Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Tractor Supply Co / Novartis AG / Global Payments Inc / Mastercard Inc / Netflix Inc / Neogenomics Inc / Ameresco Inc / Meta Platforms Inc / Fate Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / HubSpot Inc / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / CureVac NV / Vizio Holding Corp / Immuneering Corp / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 01</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - D2021 10 12</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AMD.OQ / LPLA.OQ / CB.N / CF.N / LLY.N / MCD.N / HD.N / KFY.N / PWR.N / CVX.N / CSCO.OQ / SJM.N / ELY.N / EEFT.OQ / MRVL.OQ / LHCG.OQ / WIX.OQ / NVRO.N / U.BK / PYPL.OQ / VRM.OQ</td><td class="leftalignment">Advanced Micro Devices Inc / LPL Financial Holdings Inc / Chubb Ltd / CF Industries Holdings Inc / Eli Lilly and Co / McDonald's Corp / Home Depot Inc / Korn Ferry / Quanta Services Inc / Chevron Corp / Cisco Systems Inc / J M Smucker Co / Callaway Golf Co / Euronet Worldwide Inc / Marvell Technology Inc / LHC Group Inc / Wix.Com Ltd / Nevro Corp / U City PCL / PayPal Holdings Inc / Vroom Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / Thailand / United States</td><td class="leftalignment">Chemicals / Engineering & Construction / Financial Services / Food / Healthcare / Insurance / Leisure & Entertainment / Lodging & Restaurants / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Oil & Gas / Internet</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 and ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY / HRTX / TBPH / HGEN / AZYO</td><td class="leftalignment">Eli Lilly and Co / Heron Therapeutics Inc / Theravance Biopharma Inc / Humanigen Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company sixty-eighth best performer of S&P 500 Index in 2021</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts on Friday, November 5 at 11:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED: Please Join Our KOL Video Call to Discuss PDUFA VII & BsUFA III on Wednesday, October 13 at 1:00 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">COLL / JAZZ / JNJ / LLY / MRK / ACRS / ACRX / ARDS</td><td class="leftalignment">Collegium Pharmaceutical Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, October 11 - Sunday, October 17</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Eli Lilly (LLY US) - RORIng ahead; up to Buy</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DH: Attractive Growth Prospects & Financial Profile, Initiate with a Neutral</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">DH.OQ / BSX.N / CRM.N / GE.N / IBM.N / JNJ.N / LLY.N / ZEN.N / PG.N / SIEGN.DE / HCA.N / ACN.N / ADBE.OQ / CERN.OQ / MSFT.OQ / TRU.N / AMZN.OQ / MDRX.OQ / NOW.N / VEEV.N / SNOW.N / HUBS.N / SHOP.N / TDOC.N / TWLO.N / COUP.OQ / WDAY.OQ / IQV.N / ZS.OQ / BCSF.N / ZM.OQ / CRWD.OQ / DDOG.OQ / ACCD.OQ / ZI.OQ / GDRX.OQ / AMWL.N / CERT.OQ / HIMS.N</td><td class="leftalignment">Definitive Healthcare Corp / Boston Scientific Corp / Salesforce.Com Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Eli Lilly and Co / Zendesk Inc / Procter & Gamble Co / Siemens AG / HCA Healthcare Inc / Accenture PLC / Adobe Inc / Cerner Corp / Microsoft Corp / TransUnion / Amazon.com Inc / Allscripts Healthcare Solutions Inc / ServiceNow Inc / Veeva Systems Inc / Snowflake Inc. / HubSpot Inc / Shopify Inc / Teladoc Health Inc / Twilio Inc / Coupa Software Inc / Workday Inc / IQVIA Holdings Inc / Zscaler Inc / Bain Capital Specialty Finance Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Datadog Inc / Accolade Inc / ZoomInfo Technologies Inc / Goodrx Holdings Inc / American Well Corp / Certara Inc / Hims & Hers Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra / Jialin (Jay) Jin</td></tr>
<tr class="even"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.0% Above Pre-Pandemic Base- Week 79</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large Cap 3Q21 Earnings Preview Conference Call on Friday, October 15 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ZTS / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Small/Mid Cap 3Q21 Earnings Preview Conference Call on Friday, October 22 at 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALKS / GRAY / JAZZ / JNJ / LLY / MRK / ACRS / ACRX / MNKD / AERI</td><td class="leftalignment">Alkermes Plc / Graybug Vision Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / MannKind Corp / Aerie Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Global BioPharma : SERDs Deep Dive</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">LLY.N / AZN.L / SASY.PA / ROG.S / RDUS.O / OLMA.O</td><td class="leftalignment">Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Radius Health Inc / Olema Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Richard B. Vosser / Christopher T. Schott, CFA / Ms. Jessica Fye / Anupam Rama / Ms. Laerke Engkilde / James D. Gordon / Zain Ebrahim</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 3Q Earnings And Beyond – Inline Results But Several Major Launches On The Horizon</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2026242 / 2732635 / 2222631 / 2270726 / 2542049 / 2317087 / 2121352 / 2415204 / 2515030 / 2684703 / 2048804 / 2730190 / 2825933 / 2943523 / 2503529 / 2181334 / 2170473 / B00FWN1 / 2769796 / 2857817 / B5B2106 / B7TL820 / B7VD3F2 / B8DPDT7 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BQT3XY6 / BZ1HM42 / BNFWR44 / BR4T3B3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BNTB3N8 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / AutoNation Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Group 1 Automotive Inc / Hawaiian Electric Industries Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Constellation Brands Inc / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Netflix Inc / Fortinet Inc / Meta Platforms Inc / Duke Energy Corp / Sarepta Therapeutics Inc / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Cyberark Software Ltd / Adyen NV / Worldline SA / HubSpot Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Vizio Holding Corp / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">LLY - Embedded Expectations Analysis - 2021 10 05</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / MDT=US / PATH=US / CBRL=US / DRI=US / MHK=US / REGI=US / SAGE=US / OPT=US / CGEN=US / KRT=US / APPN=US / DIN=US / OGN / BIIB=US / NUVA=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AWI=US / AMRX=US / TAST=US / QSR=US / JACK=US / PCRX=US / ESTE=US / TILE=US / NDLS=US / FEYE=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / WING=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Medtronic PLC / UiPath Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Mohawk Industries Inc / Renewable Energy Group Inc / SAGE Therapeutics Inc / Opthea Ltd / Compugen Ltd / Karat Packaging Inc / Appian Corp / Dine Brands Global Inc / Organon & Co / Biogen Inc / NuVasive Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Armstrong World Industries Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Pacira Biosciences Inc / Earthstone Energy Inc / Interface Inc / Noodles & Co / Mandiant Inc / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2280220 / 2270726 / 2542049 / 2317087 / 2630085 / 2657802 / 2684703 / 2048804 / 2730190 / 7103065 / B121557 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / B7577T2 / BFLR866 / BVVN4Q8 / BD8DJ71 / BJ2Z0H2 / BGCYWN8 / BYZM6C2 / BJJMGL2 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BD72R64 / BNTB3N8 / BMW5LX6</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Neogen Corp / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Mastercard Inc / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Snap Inc / Pinterest Inc / Xencor Inc / Intellia Therapeutics Inc / Fox Corp / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Liberty Media Corp / Vizio Holding Corp / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Merck's molnupiravir data and read-across to Celltrion stocks</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / MRCG.DE / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / NVAX.OQ / INO.OQ / MRNA.OQ / CVAC.OQ / ABCL.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Merck KGaA / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / CureVac NV / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, October 4 - Sunday, October 10</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Growth Driven By New Products, Margin Expansion</td><td class="leftalignment">English</td><td class="rightalignment">107</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Industrials Calendar : October-December 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.L / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / MT.AS / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / EVKn.DE / CSTM.N / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O / HON.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / ArcelorMittal SA / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Evonik Industries AG / Constellium SE / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OXY=US / RRC=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / HSII=US / MGY=US / SWN=US / MUR=US / MRO=US / KFRC=US / MANH=US / STZ=US / KFY=US / AMN=US / PATH=US / BLL=US / ENV=US / COLL=US / CNX=US / CCK=US / EQT=US / GPOR=US / MAN=US / ASGN=US / RHI=US / CVX=US / CCRN=US / FB=US / COP=US / BDSI=US / RNG=US / MIC=US / FRPT=US / XM=US / NSP=US / CLR=US / NOG=US / AR=US / OAS=US / BLND=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / FATE=US / CNCE=US / QTWO=US / VNOM=US / GSBD=US / CDEV=US / PVAC=US / ANAB=US / OKTA=US / SBOW=US / DCPH=US / OVV=US / ARQT=US / NCNO=US / BIGC=US / REPX=US / 67421J108 / DBRG=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Occidental Petroleum Corp / Range Resources Corp / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Kforce Inc / Manhattan Associates Inc / Constellation Brands Inc / Korn Ferry / AMN Healthcare Services Inc / UiPath Inc / Ball Corp / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / ManpowerGroup Inc / ASGN Inc / Robert Half International Inc / Chevron Corp / Cross Country Healthcare Inc / Meta Platforms Inc / Conocophillips / BioDelivery Sciences International Inc / RingCentral Inc / Macquarie Infrastructure Holdings LLC / Freshpet Inc / Qualtrics International Inc / Insperity Inc / Continental Resources Inc / Northern Oil and Gas Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Q2 Holdings Inc / Viper Energy Partners LP / Goldman Sachs BDC Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / Okta Inc / SilverBow Resources Inc / Deciphera Pharmaceuticals Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / nCino Inc / Bigcommerce Holdings Inc / Riley Exploration Permian Inc / Oatly Group AB / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">91390310 / 75991610 / 91324P10 / 71708110 / 44485910 / 88355610 / 94184810 / 04635310 / 75886F10 / 53245710 / 02343610 / 50187A10 / 58933Y10 / 88033G40 / 87918A10 / 03675210 / 40412C10 / 67181A10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / G3910J11 / 05370A10 / F5548N10 / 00288U10 / 00404A10 / 12552310 / 04683R10</td><td class="leftalignment">Universal Health Services Inc / Repligen Corp / UnitedHealth Group Inc / Pfizer Inc / Humana Inc / Thermo Fisher Scientific Inc / Waters Corp / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Amedisys Inc / LHC Group Inc / Merck & Co Inc / Tenet Healthcare Corp / Teladoc Health Inc / Anthem Inc / HCA Healthcare Inc / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC / Avidity Biosciences Inc / Sanofi SA / Abcellera Biologics Inc / Acadia Healthcare Company Inc / Cigna Corp / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mr. Whit Mayo / Stephanie Davis, CFA / Mr. Puneet Souda / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Sep 24</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Vitiligo data robust, further support INCY derm franchise. Maintain Buy, new PT $95/sh (vs. $120/sh)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">INCY=US / LLY=US / PFE=US / ARQT=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Pfizer Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.6% Above Pre-Pandemic Base- Week 78</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2516152 / 2778844 / 2732635 / 2270726 / 2317087 / 2328915 / 2345022 / 2100920 / 2457864 / 2459020 / 2515030 / 2048804 / 2440637 / 2857817 / 2983563 / B3D7K31 / B7TL820 / B7JYSG3 / B7577T2 / BVVN4Q8 / BYW36M8 / BK0VHF6 / BZ1LFB2 / BJ5FZ74 / BFZ1K46 / BLGJ610 / BKTNTR9 / BGSP7M9 / BJXBP30 / BZ1LFG7 / BKS3RS7 / BZ0P3Z5 / BN2R582 / BFY7DC4 / BNTB3N8 / BLF0CW7 / BF0QTY9</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Merck & Co Inc / AutoNation Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Macy's Inc / FirstEnergy Corp / ImmunoGen Inc / Intuit Inc / Lithia Motors Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Netflix Inc / Carmax Inc / Discovery Inc / Meta Platforms Inc / Guidewire Software Inc / Renewable Energy Group Inc / Eversource Energy / PayPal Holdings Inc / IDEAYA Biosciences Inc / Deciphera Pharmaceuticals Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / Warner Music Group Corp / ViacomCBS Inc / Zoom Video Communications Inc / Turning Point Therapeutics Inc / Roku Inc / 10X Genomics Inc / Tegna Inc / Relay Therapeutics Inc / Altimmune Inc / Vizio Holding Corp / Repare Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker - Wegovy launch insights: For The Week Ended Sep 17</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Eli Lilly and Company SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Innovent: Investor day takeaways: Commercialisation/early-stage pipeline are near-/long-term market focus. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1801.HK / LLY.N / NOVOB.CO</td><td class="leftalignment">Innovent Biologics Inc / Eli Lilly and Co / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Updates on global vaccine rollouts, variants, boosters and waning immunity</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / LONN.S / GSK.L / NVAX.OQ / 1099.HK</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Sep. 28, 2021 / 1:20PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2094670 / 2778844 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2657802 / 2689560 / 2684703 / 2707677 / 2730190 / 2862532 / 2138158 / 2799351 / 2829601 / 7103065 / 2857817 / 2390817 / B7TL820 / B7JYSG3 / B8L2798 / B7577T2 / B8DPDT7 / BFLR866 / BVVN4Q8 / BK0VHF6 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BGKG6M3 / BF3N4P3 / BMV31Q4 / BNNTQY0 / BJ62Z18</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Novartis AG / Netflix Inc / Gray Television Inc / Meta Platforms Inc / Guidewire Software Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / IDEAYA Biosciences Inc / Snap Inc / Xencor Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / StoneCo Ltd / Arena Pharmaceuticals Inc / Audacy Inc / Oatly Group AB / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 27 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / BE0165385973 / CH0012032048 / CH0012005267 / US0116591092 / US0234361089 / US0463531089 / US0997241064 / US1101221083 / US1264081035 / US22284P1057 / US23918K1088 / US3021301094 / US31428X1063 / US37733W1053 / US4433201062 / US4448591028 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8356993076 / US8447411088 / US9029251066 / US9078181081 / US9113121068 / US91324P1021 / US9139031002 / US9507551086 / CA1363751027 / JP3435000009 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US60855R1005 / US15135B1017 / US50187A1079 / US0491642056 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / NL0000687663 / US01748X1028 / US2473617023 / US00922R1059 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / US40412C1018 / JE00B783TY65 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US72919P2020 / US00912X3026 / US00404A1097 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / US03937C1053 / CA0089118776 / US0367521038 / US86881A1007 / US98138J2069 / CA87241L1094 / US74967X1037 / US23753F1075 / US80689H1023 / US4990491049 / US92336X1090 / US5904791358 / US28414H1032 / US1255231003 / US1567271093 / US26142R1041 / US6541101050 / US67181A1079 / US33813J1060 / US18914F1030 / US55406W1036 / US6877931096 / US82671G1004 / US45784A1043 / LU2314763264 / US90089L1089 / US01625V1044 / US74276R1023 / US00857U1079 / US92337R1014 / US68622V1061 / US53228F1012 / US28489L1044 / US10920V1070 / US13781Y1038 / US28623U1016 / IL0011786154 / CA50202P1053 / US14171W1036</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Melexis NV / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amedisys Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / DaVita Inc / Expeditors International of Washington Inc / FedEx Corp / GlaxoSmithKline PLC / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Sony Group Corp / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Universal Health Services Inc / Werner Enterprises Inc / Canadian National Railway Co / Sony Group Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Molina Healthcare Inc / Centene Corp / LHC Group Inc / Atlas Air Worldwide Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Air Transport Services Group Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / HCA Healthcare Inc / Aptiv PLC / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Plug Power Inc / Air Lease Corp / Acadia Healthcare Company Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / ArcBest Corp / Air Canada / Anthem Inc / Surgery Partners Inc / Workhorse Group Inc / TFI International Inc / RH / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Veoneer Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Cerence Inc / DraftKings Inc / Nikola Corp / Oak Street Health Inc / Fisker Inc / Clover Health Investments Corp / MYT Netherlands Parent BV / Oscar Health Inc / Signify Health Inc / InnovAge Holding Corp / Arrival SA / TuSimple Holdings Inc / Alignment Healthcare Inc / Privia Health Group Inc / agilon health Inc / Vera Therapeutics Inc / Organon & Co / Lifestance Health Group Inc / Electric Last Mile Solutions Inc / Bright Health Group Inc / Cano Health Inc / Elevation Oncology Inc / REE Automotive Ltd / Li-Cycle Holdings Corp / CareMax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Japan / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Sunday, September 26 - Sunday, October 3</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.2% Above Pre-Pandemic Base- Week 77</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Revisiting Our Core Thesis: Tirzepatide And Donanemab Position LLY For Sustained Outperformance</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Third BD deal in 2H21: Multi-target collaboration with AbCellera to discover new antibodies. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / LLY.N / SASY.PA / NOVN.S / GSK.L / PFIZ.NS / GILD.OQ / 1877.HK / ABCL.OQ / 2142.HK</td><td class="leftalignment">Everest Medicines Ltd / Eli Lilly and Co / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Pfizer Ltd / Gilead Sciences Inc / Shanghai Junshi Biosciences Co Ltd / Abcellera Biologics Inc / Hbm Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / France / United Kingdom / India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Key takeaways from our ESMO breast cancer expert call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / AZN.L / SASY.PA / ROG.S / PFIZ.NS / 4568.T</td><td class="leftalignment">Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Pfizer Ltd / Daiichi Sankyo Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / India / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Eli Lilly and Company (LLY) - Counting big from Donanemab - Alzheimer’s disease</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BSX=US / LLY=US / AMZN=US / BLD=US / INCY=US / PB=US / EWBC=US / UMPQ=US / VMC=US / MGM=US / RCL=US / MLM=US / CBRL=US / CCL=US / EXEL=US / IBP=US / PACW=US / TRIP=US / WAL=US / BXS=US / FMBI=US / SNV=US / SSB=US / WRE=US / CATY=US / BDSI=US / BCO=US / STRO=US / BIIB=US / TCBI=US / FNB=US / FHN=US / KAR=US / PLAY=US / BLDR=US / NCLH=US / FOXF=US / VCEL=US / PEN=US / SFIX=US / COLD=US / HWC=US / OZK=US / UBER=US / XAIR=US / GMAB=US / DKNG=US</td><td class="leftalignment">Boston Scientific Corp / Eli Lilly and Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Prosperity Bancshares Inc / East West Bancorp Inc / Umpqua Holdings Corp / Vulcan Materials Co / MGM Resorts International / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Carnival Corp / Exelixis Inc / Installed Building Products Inc / PacWest Bancorp / Tripadvisor Inc / Western Alliance Bancorp / Cadence Bank / First Midwest Bancorp Inc / Synovus Financial Corp / SouthState Corp / Washington Real Estate Investment Trust / Cathay General Bancorp / BioDelivery Sciences International Inc / Brinks Co / Sutro Biopharma Inc / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Dave & Buster's Entertainment Inc / Builders FirstSource Inc / Norwegian Cruise Line Holdings Ltd / Fox Factory Holding Corp / Vericel Corp / Penumbra Inc / Stitch Fix Inc / Americold Realty Trust / Hancock Whitney Corp / Bank Ozk / Uber Technologies Inc / Beyond Air Inc / Genmab A/S / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Feedback from London small group meeting</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">NOVOB.CO / LLY.N</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Rux cream approved w/ label; we expect drug to be used. Stock likely down on sentiment.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">INCY=US / LLY=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2684703 / 2730190 / 2842255 / 2098876 / 7103065 / B121557 / 2769796 / 2857817 / B7TL820 / B4MG4Z6 / BBPK0J0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BHC8X90 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Yum! Brands Inc / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Novo Nordisk A/S / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1235</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Mid-Quarter Model & Valuation Updates: GSK-LON, LLY, NOVN-SWX, NOVO.B-CSE</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">2516152 / 0925288 / NOVOb.CO / GSK.L / 7103065 / BHC8X90</td><td class="leftalignment">Eli Lilly and Co / GlaxoSmithKline PLC / Novo Nordisk A/S / GlaxoSmithKline PLC / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Eli Lilly and Co Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's Getting Hot In Here, Key Questions For Our Fireside Chats at the Cantor Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AMRN / GRAY / JNJ / LLY / PFE / ACRS / ARAV / SPRO / TXMD / FBIO / EYPT / PCVX / VYNE / EFTR</td><td class="leftalignment">Amarin Corporation PLC / Graybug Vision Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Aclaris Therapeutics Inc / Aravive Inc / Spero Therapeutics Inc / TherapeuticsMD Inc / Fortress Biotech Inc / EyePoint Pharmaceuticals Inc / Vaxcyte Inc / Vyne Therapeutics Inc / eFFECTOR Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Sunday, September 19 - Sunday, September 26</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: EUA of Lilly/Junshi's COVID-19 NAb expanded to include prophylaxis use. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / REGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">JNJ / AMRN / CDTX / GRAY / HCM / LLY / MRK / MSB / PFE / ACRS / CKPT / SPRO / ZTS / OMER / AERI / SCYX / LPCN / FBIO / AYTU / EYPT / PDSB / ARQT / IMAB / VYNE</td><td class="leftalignment">Johnson & Johnson / Amarin Corporation PLC / Cidara Therapeutics Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Pfizer Inc / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Lipocine Inc / Fortress Biotech Inc / Aytu Biopharma Inc / EyePoint Pharmaceuticals Inc / PDS Biotechnology Corp / Arcutis Biotherapeutics Inc / I-Mab / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Remain Stable Amidst Delta - Week 76</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US -  Dividend Quality Analysis, for the period ended September 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended September 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SUPN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SUPN.O / ABT / BMY / JNJ / LLY / UTHR.O / ZGNX.O</td><td class="leftalignment">Supernus Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / United Therapeutics Corp / Zogenix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALGM=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Allegro Microsystems Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00846U1016 / US0463531089 / US1101221083 / US2435371073 / US5324571083 / US6541061031 / US66987V1098 / US7170811035 / US7711951043 / US9418481035 / US3448491049 / US80105N1054 / US2533931026 / FI0009013296 / US9043111072 / US58933Y1055 / US5560991094 / US64104Y1064 / US30057T1051 / US89377M1099 / US0843101017</td><td class="leftalignment">Agilent Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Deckers Outdoor Corp / Eli Lilly and Co / Nike Inc / Novartis AG / Pfizer Inc / Roche Holding AG / Waters Corp / Foot Locker Inc / Sanofi SA / DICK'S Sporting Goods Inc / Neste Oyj / Under Armour Inc / Merck & Co Inc / MacroGenics Inc / Neste Oyj / Evoqua Water Technologies Corp / Transmedics Group Inc / Berkeley Lights Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Finland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Our Take On Data In ESMO Abstracts Ahead Of The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 2516152 / 2681511 / 2000019 / 2023607 / 2008154 / 2497406 / 2778844 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2689560 / 2707677 / 2730190 / 2212922 / 2857817 / B3D7K31 / B5B2106 / B7TL820 / BBPK0J0 / B87ZMX0 / B7577T2 / B424494 / BFLR866 / BVVN4Q8 / BYW36M8 / BF4VBS8 / BXDZ9Z0 / BF5L3T2 / BYNZGK1 / BZ00V34 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BM8NHS1</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Adobe Inc / Kroger Co / Merck & Co Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PG&E Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / NRG Energy Inc / Netflix Inc / Discovery Inc / Fortinet Inc / Meta Platforms Inc / Mirati Therapeutics Inc / Palo Alto Networks Inc / Renewable Energy Group Inc / Splunk Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / BioXcel Therapeutics Inc / Shopify Inc / Elanco Animal Health Inc / Block Inc / Zscaler Inc / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / AMGN=US / BMY=US / HD=US / MDT=US / GILD=US / PEB=US / H=US / MTN=US / LOW=US / IGT=US / MAR=US / ADS=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CLI=US / CHH=US / DRH=US / EXEL=US / MHK=US / HOOK=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / CNM=US / MTCH=US / IGMS=US / STRO=US / APP=US / SHO=US / HST=US / WH=US / TIL=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / RHP=US / TILE=US / AERI=US / BWXT=US / PEN=US / IBEX=US / TTD=US / PK=US / PLYA=US / CVNA=US / NCNA=US / DCPH=US / GSKY=US / BTAI=US / TCRR=US / GMAB=US / RBLX=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Medtronic PLC / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Veris Residential Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Exelixis Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Core & Main Inc / Match Group Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Aerie Pharmaceuticals Inc / BWX Technologies Inc / Penumbra Inc / Ibex Ltd / Trade Desk Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Deciphera Pharmaceuticals Inc / GreenSky Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S / Roblox Corp / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: New US government order for COVID NAb is a positive surprise. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / GSK.L / REGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ESMO Planner Highlights 130+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / LLY=US / AMGN=US / BMY=US / GILD=US / EXEL=US / HOOK=US / REGN=US / IGMS=US / STRO=US / TIL=US / NCNA=US / DCPH=US / BTAI=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Billal Jahangiri / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Sep. 14, 2021 / 1:15PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2670519 / 2328915 / 2459020 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2212922 / 2857817 / 2982924 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B95N910 / BVVN4Q8 / BYW36M8 / BZ1LFB2 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BJDX8Y8 / BWY4XV3 / BGT0PL8 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Spectrum Pharmaceuticals Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / Eversource Energy / PayPal Holdings Inc / Deciphera Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Mirum Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / DiaMedica Therapeutics Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, September 13 - Sunday, September 19</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China insulin VBP moves forward: Tendering expected Oct/Nov for early 2022 implementation</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / FMEG.DE / MRCG.DE / GSK.L / BAYGN.DE</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 75</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALGM=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Allegro Microsystems Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / OPTN / PFE / RMTI / SIBN / ACRS / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / ARDS / CUTR / BSLN / MNKD / RANI / ARAV / AVTX / SPRO / ZTS / RDHL / OMER / AXGN / TXMD / HRTX / TRVN / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / OptiNose Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Aclaris Therapeutics Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Rani Therapeutics Holdings Inc / Aravive Inc / Avalo Therapeutics Inc / Spero Therapeutics Inc / Zoetis Inc / Redhill Biopharma Ltd / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next In Biotech? Protein Degraders Now Have a Guide - Ligand-PROTAC/MGD Conjugates to Selectively Target Cancer Cells</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152 / 2457864 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Eli Lilly and Co / ImmunoGen Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Sep. 09, 2021 / 9:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2732635 / 2437071 / 2208073 / 2270726 / 2317087 / 2670519 / 2328915 / 2457864 / 2515030 / 2689560 / 2684703 / B121557 / 2857817 / 2983563 / B3D7K31 / B23FN39 / B7TL820 / B7VD3F2 / BBGVT40 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYZLV46 / BJF8Q81 / BD8DJ71 / BJLKVS6 / BZB1XF2 / BYXJQG9 / BYY88Y7 / BMG75B4 / BYXR425 / BZ4CHH2 / BMDJ397 / BLR6S36 / BMFPJK6 / BNLYBF3</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / AutoNation Inc / Biomarin Pharmaceutical Inc / Copart Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / ImmunoGen Inc / Lithia Motors Inc / PG&E Corp / Pfizer Inc / Mastercard Inc / Netflix Inc / Carmax Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Duke Energy Corp / News Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / InflaRx NV / IAA Inc / Snap Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Spire Inc / Alphabet Inc / Inventiva SA / RH / Soleno Therapeutics Inc / Bolt Biotherapeutics Inc / Longboard Pharmaceuticals Inc / ACV Auctions Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / HCM / JNJ / LLY / PFE / BSLN / IMAB</td><td class="leftalignment">Merck & Co Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Basilea Pharmaceutica AG / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended September 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2367026 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2270726 / 2317087 / 2670519 / 2328915 / 2689560 / 2684703 / 2048804 / 2829601 / 7103065 / B1F76F9 / 2857817 / B3D7K31 / BCZS820 / BFDV8K0 / BVVN4Q8 / BYW36M8 / BJLT387 / BD8DJ71 / BJ5FZ74 / BFZ1K46 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BWY4XV3 / BMG5660 / BMHR7K6 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / General Mills Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Novartis AG / Western Union Co / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / MacroGenics Inc / Eversource Energy / PayPal Holdings Inc / Avantor Inc / Snap Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / ViacomCBS Inc / Roku Inc / Alphabet Inc / Adaptimmune Therapeutics PLC / Joann Inc / Impel Neuropharma Inc / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Highlights; What We'll Be Watching At ESMO Next Week</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / HCM / JNJ / LLY / PFE / BSLN / IMAB</td><td class="leftalignment">Merck & Co Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Basilea Pharmaceutica AG / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 74</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ALGM=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Allegro Microsystems Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: Poll x-reads on the EMPEROR (AZN/NOVN): influence could be extensive?</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AZN.L / NOVN.S / LLY.N</td><td class="leftalignment">AstraZeneca PLC / Novartis AG / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIRP.PA / ALB.N / AXP.N / BA.N / BAC.N / BAX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / IBM.N / JNJ.N / JPM.N / LLY.N / LMT.N / MDT.N / OXY.N / PFE.N / PM.N / PPCJ.J / RHI.N / SC.N / SLB.N / T.N / TMO.N / U.N / WAT.N / WFC.N / WMT.N / ACI.N / SPG.N / PG.N / HUM.N / NUE.N / CPB.N / HAL.N / DHR.N / UNH.N / IPG.N / SPOT.N / GS.N / CLX.N / VLO.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / KR.N / PCG.N / XOM.N / DVN.N / AMT.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / JCI.N / ORCL.N / VFC.N / V.N / ACN.N / WSM.N / PLD.N / JLL.N / HAE.N / SAM.N / BLK.N / CRL.N / CVX.N / IRM.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / REGN.OQ / RGEN.OQ / QDEL.OQ / SNPS.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / STLD.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / ERIE.OQ / NVDA.OQ / PLUG.OQ / MTCH.OQ / ISRG.OQ / BLUE.OQ / GRMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / SBNY.OQ / ACAD.OQ / EXR.N / MKTX.OQ / MPWR.OQ / LVS.N / NOV.N / DXCM.OQ / MS.N / CMG.N / FIS.N / STX.AX / HES.N / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / JAZZ.OQ / TDC.N / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / EPAM.N / PSX.N / NOW.N / SRPT.OQ / FANG.OQ / ABBV.N / BLDR.N / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / ARES.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / NVCR.OQ / PSTG.N / IONS.OQ / TWLO.N / COUP.OQ / LW.N / AYX.N / IOVA.OQ / ROKU.OQ / ZS.OQ / FB.PS / STNE.OQ / NFE.OQ / LYFT.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / MRVI.OQ / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Humana Inc / Nucor Corp / Campbell Soup Co / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / Kroger Co / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Johnson Controls International PLC / Oracle Corp / VF Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Prologis Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Iron Mountain Inc / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Repligen Corp / Quidel Corp / Synopsys Inc / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / Erie Indemnity Co / NVIDIA Corp / Plug Power Inc / Match Group Inc / Intuitive Surgical Inc / bluebird bio Inc / Garmin Ltd / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Nov Inc / Dexcom Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Hess Corp / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Jazz Pharmaceuticals PLC / Teradata Corp / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Epam Systems Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / Builders FirstSource Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / Ares Management Corp / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Novocure Ltd / Pure Storage Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Roku Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Maravai LifeSciences Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2000019 / 2065159 / 2270726 / 2317087 / 2670519 / 2328915 / 2471950 / 2689560 / 2684703 / 2048804 / 2730190 / 7103065 / 2857817 / B0T7YX2 / B7VD3F2 / B85KFY9 / BFH3N85 / BVVN4Q8 / BZ1HM42 / BNFWR44 / BLGJ610 / BJJMGL2 / BKTNTR9 / BDFZSP1</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Autodesk Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Incyte Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Netflix Inc / Live Nation Entertainment Inc / Duke Energy Corp / Five Below Inc / Veeva Systems Inc / Eversource Energy / Adyen NV / Worldline SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Okta Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Eli Lilly (LLY US) - Priced for perfection</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Toripalimab US approval expected in 1H22; resumption of JS016 US distribution adding possibility of further order. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / AZN.L / CHRS.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Coherus BioSciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company down 5.4% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2778844 / 2002305 / 2026242 / 2113434 / 2216850 / 2270726 / 2829515 / 2317087 / 2670519 / 2328915 / 2100920 / 2689560 / 2684703 / 2048804 / 2138158 / 2799351 / 2829601 / 2503529 / 7103065 / 2212922 / 2857817 / BDZCRX3 / BFH3N85 / BVVN4Q8 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BGKG6M3 / BNTB3N8 / BP8GHT2 / BLF0CW7 / BM8NHS1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Boston Scientific Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / NRG Energy Inc / Netflix Inc / RingCentral Inc / Veeva Systems Inc / Eversource Energy / Fox Corp / ViacomCBS Inc / Roku Inc / StoneCo Ltd / Vizio Holding Corp / Vascular Biogenics Ltd / Repare Therapeutics Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY / SAVA / BCYC</td><td class="leftalignment">Eli Lilly and Co / Cassava Sciences Inc / Bicycle Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US0079731008 / US0116591092 / US0126531013 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US00287Y1091 / NL0010273215 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / CA0089118776 / KYG4740B1059 / CA53680Q2071 / SE0009414576 / US5904791358 / US53814L1089 / US5533681012 / US58406B1035 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Albemarle Corp / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Ichor Holdings Ltd / Lithium Americas Corp / Oncopeptides AB / Mesa Air Group Inc / Livent Corp / Mp Materials Corp / MedAvail Holdings Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Next Two Weeks In Pharmaceuticals - Monday, August 30 - Sunday, September 12</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Jardiance HFpEF ESC Data Solid; Model Updated; Estimates & Price Target Raised</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 73</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The SGLT2is Race Continues; Key Takeaways From Detailed EMPEROR-Preserved Data At ESC 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">No Cooling Down This Summer With Significant Progress Across Subsidiary Companies</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company in top 3% performers of S&P 500 Index in past quarter; Institutional Ownership steady</td><td class="leftalignment">English</td><td class="rightalignment">78</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 2516152 / 2023607 / 2486813 / 2065159 / 2942605 / 2280220 / 2270726 / 2542049 / 2317087 / 2576941 / 2670519 / 2328915 / 2342034 / 2459020 / 2689560 / 2048804 / 2503529 / 2822019 / B125XQ6 / B0T7YX2 / B28TS42 / B03PGL4 / 2982924 / B4N0JJ6 / B7TL820 / B7VD3F2 / BBPK0J0 / BVVN4Q8 / BFZ1K46 / BMYML02 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BYQHPK7 / BYYWPW6 / BL95N25 / BZ1LFG7 / BDZ30Q0 / BMPRZV5 / BD72R64 / BNTB3N8 / BP7KZP7</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / Amgen Inc / Kellogg Co / Autodesk Inc / Avista Corp / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Intuit Inc / PG&E Corp / Pinnacle West Capital Corp / World Wrestling Entertainment Inc / Advance Auto Parts Inc / Portland General Electric Co / Live Nation Entertainment Inc / Ulta Beauty Inc / NorthWestern Corp / Spectrum Pharmaceuticals Inc / Visteon Corp / Meta Platforms Inc / Duke Energy Corp / Mirati Therapeutics Inc / Eversource Energy / Spotify Technology SA / DraftKings Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Zymeworks Inc / Beigene Ltd / Phibro Animal Health Corp / Roku Inc / Arvinas Inc / Kymera Therapeutics Inc / Liberty Media Corp / Vizio Holding Corp / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY), GLUE (BUY), KYMR (BUY) - LLY + Lycia Therapeutics Collaboration Highlights Continued Strategic Interest in TPD Category</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / ARVN.OQ / GLUE.OQ / KYMR.OQ / 2516152 / BDZ30Q0 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Eli Lilly and Co / Arvinas Inc / Monte Rosa Therapeutics Inc / Kymera Therapeutics Inc / Eli Lilly and Co / Arvinas Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EGRX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EGRX.O / BMY / JNJ / LLY / NVS / AMGN.O / GSK / TEVA.K</td><td class="leftalignment">Eagle Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ATRS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ATRS.O / BDX / JNJ / LLY / PFE / WST / RVP / ANIP.O / TEVA.K</td><td class="leftalignment">Antares Pharma Inc / Becton Dickinson and Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / West Pharmaceutical Services Inc / Retractable Technologies Inc / ANI Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NYMX-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NYMX.O / ABT / DGX / JNJ / LLY / PFE / SPHS.PK</td><td class="leftalignment">Nymox Pharmaceutical Corp / Abbott Laboratories / Quest Diagnostics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2973821 / 2216850 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2459020 / 2680905 / 2684703 / 2048804 / 2503529 / 7103065 / B125XQ6 / B0T7YX2 / 2949758 / B7577T2 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BYZR4X4 / BMYML02 / BKTNTR9 / BD72R64 / 021513106 / BN4NJG4 / BKPGJQ1 / BMVBZF5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / World Wrestling Entertainment Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / Nexstar Media Group Inc / Renewable Energy Group Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Axsome Therapeutics Inc / DraftKings Inc / ViacomCBS Inc / Liberty Media Corp / Alto Ingredients Inc / Freeline Therapeutics Holdings PLC / Squarespace Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CD47 still remains one of the hot targets in IO combos - reads to GILD and ALX from PFE deal</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US3755581036 / PFE.N / LLY / PFE / ALXO</td><td class="leftalignment">Gilead Sciences Inc / Pfizer Inc / Eli Lilly and Co / Pfizer Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Ms. Emma K. Nealon, III / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Revisiting modelling assumptions and raising target price from DKK 470 to DKK 625</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">NOVOB.CO / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / BAYGN.DE</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.3% Above Pre-Pandemic Base- Week 72</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2516152 / 2486813 / 2270726 / 2317087 / 2670519 / 2328915 / 2342034 / 2369174 / 2689560 / 2048804 / 2989301 / 2503529 / 2857817 / B0T7YX2 / B4N0JJ6 / B7TL820 / BCZS820 / BVVN4Q8 / BYVYD43 / BYW36M8 / BZ1HM42 / BMYML02 / BKTNTR9 / BYQCZ35 / BD72R64 / BNLYJ60</td><td class="leftalignment">Eli Lilly and Co / Kellogg Co / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / PG&E Corp / Pinnacle West Capital Corp / TJX Companies Inc / World Wrestling Entertainment Inc / Netflix Inc / Live Nation Entertainment Inc / Visteon Corp / Meta Platforms Inc / Fate Therapeutics Inc / Eversource Energy / Performance Food Group Co / PayPal Holdings Inc / Adyen NV / DraftKings Inc / ViacomCBS Inc / Madison Square Garden Sports Corp / Liberty Media Corp / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Highlights from Our Virtual Indy Investor Visit with Management</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US -  Dividend Quality Analysis, for the period ended June 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Insulin GPO expected in two months; rules similar to Wuhan program and could benefit large players</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / SASY.PA / NOVOB.CO / 600867.SS / 3933.HK</td><td class="leftalignment">Eli Lilly and Co / Sanofi SA / Novo Nordisk A/S / Tonghua Dongbao Pharmaceutical Co Ltd / United Laboratories International Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Denmark / France / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Pipeline Advancements Exceeding Our Expectations; Raising PT to $315 From $300</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LGND-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LGND.O / BAX / BMY / JNJ / LLY / MRK / PFE / AMGN.O / GSK / SPPI.O</td><td class="leftalignment">Ligand Pharmaceuticals Inc / Baxter International Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Spectrum Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HALO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HALO.O / BAX / JNJ / LLY / PFE / MNKD.O / SNY.O</td><td class="leftalignment">Halozyme Therapeutics Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / MannKind Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / HD=US / MCD=US / WEN=US / MDT=US / PEB=US / H=US / CRM=US / HLT=US / CBRL=US / CHH=US / DRI=US / DRH=US / MRCY=US / PCTY=US / REGI=US / CNM=US / KIM=US / DIN=US / INST=US / STRO=US / RNG=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / GPRE=US / TAST=US / QSR=US / KTOS=US / NMTR=US / JACK=US / BLND=US / RLJ=US / GMED=US / RHP=US / NDLS=US / FATE=US / FIVN=US / 00770K202 / LOCO=US / NVRO=US / WK=US / SHAK=US / AJRD=US / BWXT=US / WING=US / SPNE=US / 82982L103 / CRSP=US / PK=US / PLYA=US / MAXR=US / ALLO=US / OSMT=US / FERG=US / LHX=US / SPCE=US / DKNG=US / TSHA / RBLX=US / REPX=US / 67421J108 / PYCR=US / GAMB=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Home Depot Inc / McDonald's Corp / Wendys Co / Medtronic PLC / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Hilton Worldwide Holdings Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Mercury Systems Inc / Paylocity Holding Corp / Renewable Energy Group Inc / Core & Main Inc / Kimco Realty Corp / Dine Brands Global Inc / Instructure Holdings Inc / Sutro Biopharma Inc / RingCentral Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / Jack in the Box Inc / Blend Labs Inc / RLJ Lodging Trust / Globus Medical Inc / Ryman Hospitality Properties Inc / Noodles & Co / Fate Therapeutics Inc / Five9 Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Nevro Corp / Workiva Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Maxar Technologies Inc / Allogene Therapeutics Inc / Osmotica Pharmaceuticals PLC / Ferguson PLC / L3harris Technologies Inc / Virgin Galactic Holdings Inc / DraftKings Inc / Taysha Gene Therapies Inc / Roblox Corp / Riley Exploration Permian Inc / Oatly Group AB / Paycor HCM Inc / Gambling.com Group Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2270726 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B17HG57 / B0T7YX2 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BK1KWF7 / BMYML02 / BLGJ610 / BYXJQG9 / BKTNTR9 / BD72R64 / BP8GHT2 / BMHR7K6 / BNNTQY0 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Live Nation Entertainment Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Grocery Outlet Holding Corp / DraftKings Inc / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / Liberty Media Corp / Vascular Biogenics Ltd / Impel Neuropharma Inc / Oatly Group AB / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SOPH: SOPHiA Genetics - Tests Positive with Data-Driven Precision Medicine; Initiate with an Outperform Rating</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">SOPH.OQ / 4503.T / A.N / GE.N / LLY.N / MRK.N / PHG.AS / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / NOVN.S / PKI.N / ADPT.OQ / MYGN.OQ / BLUE.OQ / ILMN.OQ / EXAS.OQ / FINA.PA / QGEN.N / SLP.OQ / BAYGN.DE / SHLG.DE / PACB.OQ / VEEV.N / VCYT.OQ / SEER3.SA / NSTG.OQ / PINFRAL.MX / NVTA.N / NTRA.OQ / TPB.N / TWLO.N / IQV.N / CNTG.OQ / ABCL.OQ / CERT.OQ</td><td class="leftalignment">Sophia Genetics SA / Astellas Pharma Inc / Agilent Technologies Inc / General Electric Co / Eli Lilly and Co / Merck & Co Inc / Koninklijke Philips NV / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Novartis AG / PerkinElmer Inc / Adaptive Biotechnologies Corp / Myriad Genetics Inc / bluebird bio Inc / Illumina Inc / Exact Sciences Corp / Immobiliere Dassault SA / Qiagen NV / Simulations Plus Inc / Bayer AG / Siemens Healthineers AG / Pacific Biosciences of California Inc / Veeva Systems Inc / Veracyte Inc / Ser Educacional SA / NanoString Technologies Inc / Promotora y Operadora de Infraestructura SAB de CV / Invitae Corp / Natera Inc / Turning Point Brands Inc / Twilio Inc / IQVIA Holdings Inc / Centogene NV / Abcellera Biologics Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Germany / France / United Kingdom / Japan / Mexico / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">We Continue to Believe Lebrikizumab Will Be A Meaningful "AD"-ition To The Market, More Detailed Data to Come</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lebrikizumab in AD met endpoints; awaiting full data to understand competitive advantage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Lebri Delivers Another Mega-Market with Positive Ph 3 Data in Atopic Derm; Dose and Tolerability Differentiation TBD</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Yatin Suneja</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Next Two Weeks In Pharmaceuticals - Monday, August 16 - Sunday, August 29</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: 2Q21 review: Profitability hit despite ongoing US biosimilar share gains; all about Regkirona sales in 2H21. Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">091990.KQ / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / 068270.KS</td><td class="leftalignment">Celltrion Healthcare Co Ltd / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 71</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Summer May Be Ending, but Things Are Heating Up for Innate Immunity Drug Development: Featuring Top 10 Hot Targets in Neuro/Immunology</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">0925288 / 2126335 / 2516152 / 2778844 / 2369174 / 2455965 / 7103065 / BGCYWN8 / BMPRZV5 / BJLV8T9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Novartis AG / Xencor Inc / Kymera Therapeutics Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">YPSN.S: Ypsomed - In advanced stage of heavy investment phase. Upgrade to Neutral</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">YPSN.S / LLY.N / GXIG.DE / MEDA.S / MOVE.S</td><td class="leftalignment">Ypsomed Holding AG / Eli Lilly and Co / Gerresheimer AG / Medartis Holding AG / Medacta Group SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - 2Q21 Recap; Pipeline On Track With Continued Execution on Clinical Trial Initiations</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMQ5T49 / 0925288 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From Virtual Company Visits - Day 2</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0463531089 / US37733W1053 / US5324571083 / US6701002056 / US7711951043</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Novo Nordisk A/S / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NBIX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NBIX.O / LLY / PFE / PTN / RGEN.O / RPRX.O / ATHX.O / ANIP.O / ABBV.K / CASI.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Eli Lilly and Co / Pfizer Inc / Palatin Technologies Inc / Repligen Corp / Royalty Pharma PLC / Athersys Inc / ANI Pharmaceuticals Inc / Abbvie Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / SCOR=US / MUR=US / SPOT=US / MRO=US / LEG=US / VMC=US / EQR=US / MLM=US / DISH=US / SWIM=US / CBRL=US / ELY=US / CNX=US / DRI=US / EQT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / SGMS=US / BKNG=US / DCP=US / NHI=US / PRA=US / NLS=US / COP=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / APEI=US / NOG=US / JACK=US / TREX=US / AR=US / OAS=US / BLND=US / APTS=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / MODN=US / NDLS=US / HTRG=US / VNOM=US / 70806A106 / LOCO=US / OSH=US / SHAK=US / GSBD=US / WING=US / CABO=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / CDEV=US / PVAC=US / ANAB=US / JELD=US / SBOW=US / SAIL=US / RTLR=US / FERG=US / RPAY=US / PNTG=US / OVV=US / DKNG=US / AZEK=US / PAYA=US / AZYO=US / BALY=US / VTRS=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Vulcan Materials Co / Equity Residential / Martin Marietta Materials Inc / DISH Network Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Scientific Games Corp / Booking Holdings Inc / DCP Midstream LP / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Conocophillips / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / American Public Education Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Model N Inc / Noodles & Co / Heritage Insurance Holdings Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Oak Street Health Inc / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Cable One Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / SilverBow Resources Inc / SailPoint Technologies Holdings Inc / Rattler Midstream LP / Ferguson PLC / Repay Holdings Corp / Pennant Group Inc / Ovintiv Inc / DraftKings Inc / Azek Company Inc / Paya Holdings Inc / Aziyo Biologics Inc / Bally's Corp / Viatris Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2973821 / 2050832 / 2280220 / 2542049 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B0T7YX2 / B570P91 / BBFL7S1 / B7VD3F2 / B8L2798 / BFDV8K0 / BBPK0J0 / BQPVQZ6 / BYVY8G0 / BYW36M8 / BYQHP96 / BF5L3T2 / BYNZGK1 / BD9GVY0 / BKS3SM8 / BYZR4X4 / BYQNYR5 / BMYML02 / BLGJ610 / BYXJQG9 / BJXBP30 / BZ1LFG7 / BKC9SX3 / BD6JX35 / BDVLM39 / BZ0P3Z5 / BYSFJV8 / BYTJZL1 / BWY4XV3 / BDD1B07 / BDRW1L7 / BF3N4P3 / BJRFSB7 / BD72R64 / BLR6S36 / BNTB3N8 / BMV31Q4 / BKPGJQ1 / BFYVZ75 / BNLYJ60 / BNLYBF3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Ameren Corp / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Live Nation Entertainment Inc / Lear Corp / bluebird bio Inc / Duke Energy Corp / Hemisphere Media Group Inc / MacroGenics Inc / Mirati Therapeutics Inc / Horizon Therapeutics PLC / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Block Inc / Zai Lab Ltd / IGM Biosciences Inc / Axsome Therapeutics Inc / Senseonics Holdings Inc / DraftKings Inc / Warner Music Group Corp / Spire Inc / Turning Point Therapeutics Inc / Roku Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Tegna Inc / Planet Fitness Inc / Zogenix Inc / Adaptimmune Therapeutics PLC / Rubius Therapeutics Inc / AnaptysBio Inc / Arena Pharmaceuticals Inc / Immunovant Inc / Liberty Media Corp / Longboard Pharmaceuticals Inc / Vizio Holding Corp / Audacy Inc / Squarespace Inc / Seelos Therapeutics Inc / Imago BioSciences Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report LLY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 2516152 / 2496113 / 2486813 / 2640147 / 2973821 / 2050832 / 2113393 / 2216850 / 2270726 / 2542049 / 2328915 / 2342034 / 2100920 / 2369174 / 2471950 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2503529 / B121557 / 2212922 / 2769796 / 2857817 / B0T7YX2 / B570P91 / 2598246 / 2982924 / B4MG4Z6 / B7VD3F2 / B83YYY6 / BBGVT40 / B7577T2 / BCGCR79 / BTN1Y11 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BD8DJ71 / BP7RS48 / BWFKZT2 / BMYML02 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BFWK4R7 / BD6D4Y5 / BMH0MR7 / BMDCDP2 / BMPRZV5 / BD72R64 / BNGJQZ8 / BMHR7K6 / BKPGJQ1 / BMBP1Q0 / BL53KF5</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Kohls Corp / Kellogg Co / Nike Inc / Alliant Energy Corp / Ameren Corp / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Gilead Sciences Inc / Incyte Corp / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / Lear Corp / Neogenomics Inc / Spectrum Pharmaceuticals Inc / AMC Networks Inc / Duke Energy Corp / ICAD Inc / News Corp / Renewable Energy Group Inc / Sprouts Farmers Market Inc / Medtronic PLC / PayPal Holdings Inc / Shopify Inc / Block Inc / Snap Inc / Intersect Ent Inc / Cellectis SA / DraftKings Inc / Evergy Inc / Spire Inc / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / PagSeguro Digital Ltd / Altair Engineering Inc / Zendesk Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / Liberty Media Corp / Porch Group Inc / Impel Neuropharma Inc / Squarespace Inc / Flywire Corp / F45 Training Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, August 9 - Sunday, August 15</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 70</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INCY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / LLY / NVS / PFE / AMGN.O / CTIC.O / LGND.O / GERN.O / AVEO.O / ARDX.O</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / CTI Biopharma Corp / Ligand Pharmaceuticals Inc / Geron Corp / Aveo Pharmaceuticals Inc / Ardelyx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended August 02,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">2Q21 Update: Gvoke Trending Well; Tidbits On The Strongbridge Assets</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">98422L107 / 532457108 / 03209R103</td><td class="leftalignment">Xeris Biopharma Holdings Inc / Eli Lilly and Co / Amphastar Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Eli Lilly and Company reports 2.6% sequential rise in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">78</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company climbs 8.4% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: SMID-Cap Oncology Take-Aways From Big-Cap 2Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / GILD=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DNB / WMB=US / CACI=US / LLY=US / LSI=US / AMGN=US / OXY=US / GBT=US / AMZN=US / BLD=US / DVN=US / INCY=US / PEB=US / AKAM=US / H=US / V=US / CRK=US / PXD=US / PAA=US / IGT=US / MAR=US / LEG=US / ATVI=US / KFRC=US / HLT=US / BKI=US / CVS=US / AIZ=US / BNL=US / CSGP=US / DVA=US / AJG=US / MRCY=US / MCHP=US / OKE=US / SAGE=US / PSA=US / BXS=US / MANT=US / MTCH=US / SRC=US / COP=US / MRNS=US / BIIB=US / RNG=US / CZR=US / KAR=US / SHO=US / BAH=US / DENN=US / SPWR=US / FIS=US / HST=US / MA=US / GPRE=US / ICFI=US / SAIC=US / CADE=US / CLR=US / LUMN=US / PAGP=US / IAA=US / KTOS=US / CWH=US / PSN=US / HTA=US / TREX=US / OAS=US / NXPI=US / GDOT=US / PCRX=US / RLJ=US / VAC=US / RHP=US / FANG=US / NDLS=US / LDOS=US / NMIH=US / VNOM=US / BABA=US / NEWR=US / WBA=US / WK=US / DEA=US / NSA=US / CHCT=US / ZBH=US / SQ=US / MIME=US / WLTW=US / 82982L103 / CDEV=US / PVAC=US / 50189K103 / AYX=US / SWCH=US / LYFT=US / LHX=US / OPCH=US / ZI=US / COUR-US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Williams Companies Inc / CACI International Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Occidental Petroleum Corp / Global Blood Therapeutics Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / Visa Inc / Comstock Resources Inc / Pioneer Natural Resources Co / Plains All American Pipeline LP / International Game Technology PLC / Marriott International Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Hilton Worldwide Holdings Inc / Black Knight Inc / CVS Health Corp / Assurant Inc / Bunzl plc / CoStar Group Inc / DaVita Inc / Arthur J Gallagher & Co / Mercury Systems Inc / Microchip Technology Inc / ONEOK Inc / SAGE Therapeutics Inc / Public Storage / Cadence Bank / ManTech International Corp / Match Group Inc / Spirit Realty Capital Inc / Conocophillips / Marinus Pharmaceuticals Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / KAR Auction Services Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Denny's Corp / SunPower Corp / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / ICF International Inc / Science Applications International Corp / Cadence Bank / Continental Resources Inc / Lumen Technologies Inc / Plains GP Holdings LP / IAA Inc / Kratos Defense and Security Solutions Inc / Camping World Holdings Inc / Parsons Corp / Healthcare Trust Of America Inc / Trex Company Inc / Oasis Petroleum Inc / NXP Semiconductors NV / Green Dot Corp / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Noodles & Co / Leidos Holdings Inc / NMI Holdings Inc / Viper Energy Partners LP / Alibaba Group Holding Ltd / New Relic Inc / Walgreens Boots Alliance Inc / Workiva Inc / Easterly Government Properties Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zimmer Biomet Holdings Inc / Block Inc / Mimecast Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / LCI Industries / Alteryx Inc / Switch Inc / Lyft Inc / L3harris Technologies Inc / Option Care Health Inc / ZoomInfo Technologies Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2778844 / 2229126 / 2208073 / 2270726 / 2829515 / 2670519 / 2328915 / 2100920 / 2471950 / 2623911 / 2657802 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2829601 / 2853688 / 7103065 / 2783815 / 2712013 / B00FWN1 / B0PZN11 / B121557 / 2769796 / 2857817 / B0T7YX2 / B2R3PV1 / B3D7K31 / B4Y1MH7 / 2390817 / B44C366 / B3SWPT2 / B4V9661 / BJ0KXV4 / BDZCRX3 / BFLR866 / BFZCHN7 / BYY8XK8 / BYVY8G0 / BTF8CF0 / BP4GNK9 / BYW36M8 / BYNZGK1 / BJT1RW7 / BD9GVY0 / BJF8Q81 / BZ1LFB2 / BR4T3B3 / BJ2Z0H2 / BLGJ610 / BJJMGL2 / BZ05388 / BDT5KT5 / BKC9SX3 / BFWGXQ7 / BP84RX0 / 021513106 / BNTB3N8</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Columbia Sportswear Co / Copart Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Incyte Corp / Neurocrine Biosciences Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Southern Co / Stryker Corp / Novartis AG / Zimmer Biomet Holdings Inc / Global Payments Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Discovery Inc / KAR Auction Services Inc / Gray Television Inc / Heska Corp / Ameresco Inc / Ralph Lauren Corp / ONE Gas Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / WEC Energy Group Inc / Alphabet Inc / Restaurant Brands International Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Block Inc / Lyft Inc / Zai Lab Ltd / IAA Inc / Deciphera Pharmaceuticals Inc / HubSpot Inc / Pinterest Inc / Warner Music Group Corp / Fox Corp / Global Blood Therapeutics Inc / Inspire Medical Systems Inc / Arcturus Therapeutics Holdings Inc / Container Store Group Inc / Townsquare Media Inc / Alto Ingredients Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Several Positive Pipeline Updates Reinforce Best In Class Growth Profile – Updating Estimates</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Notes from 2Q21 management call</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">NOVOB.CO / LLY.N</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: August 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CVS.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / STE.N / WMT.N / MET.N / DUK.N / DIS.N / D.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / RMD.N / BLL.N / VTR.N / AMGN.OQ / REGN.OQ / TT.N / DISH.OQ / ANSS.OQ / EBAY.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / TDG.N / MSI.N / MPC.N / EA.OQ / ZTS.N / PRGO.N / CDW.OQ / NCLH.N / ETSY.OQ / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / STERIS plc / Walmart Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Resmed Inc / Ball Corp / Ventas Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / DISH Network Corp / ANSYS Inc / eBay Inc / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / TransDigm Group Inc / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / CDW Corp / Norwegian Cruise Line Holdings Ltd / ETSY Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 2Q21 Earnings (AMGN, LLY, ZBH) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N / AMGN.O</td><td class="leftalignment">Eli Lilly and Co / Amgen Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY 2Q21 Full Postview – okay quarter, big catalyst path, durable high-growth name</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 2Q Takeaways - Pipeline Progress Continues; Donanemab On Track For YE21 Filing</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: 2Q21 - They Said What?! Highlights from Conf Call…and our perspective</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">very positive body language on key R&D programs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Takeaways on LLY's Donanemab on 2Q21 EPS call and read to BIIB's Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS Miss, Sales Beat; 2021 Guidance Mostly Intact</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It Always Is, And It Always Is Not, All About Alzheimer's; Liking LLY Ahead of Pipeline Advancements and Drugs Approvals in 2H21+</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 2Q First Impressions: Core Business on Track; All Eyes Remain on Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Brief of Eli Lilly and Co conference call, Aug. 03, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Aug. 03, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on August 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LYFT.OQ / BP.L / DD.N / FMC.N / IBM.N / LLY.N / OXY.N / PEG.N / RL.N / SEE.N / SLB.N / WAT.N / BEN.N / HAL.N / ETN.N / CMI.N / AIZ.N / PGR.N / CLX.N / UNM.N / WEC.N / XOM.N / DVN.N / IT.N / DVA.N / PSA.N / OKE.N / AME.N / DNB.N / PRU.N / COP.N / AMGN.OQ / AAPL.OQ / EXPD.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / MCHP.OQ / INCY.OQ / HSIC.OQ / AMZN.OQ / ZBRA.OQ / AKAM.OQ / 0700.HK / RDSa.L / LYV.N / FIS.N / IPGP.OQ / 9999.HK / VRSK.OQ / CZR.OQ / BKR.N / XYL.N / PSXP.N / LDOS.N / MAR.OQ / TSLX.N / PAYC.N / ZBH.N / PINS.N / BYND.OQ / UBER.N / ZM.OQ / LHX.N / PEAK.N / 9988.HK / J.N / 9618.HK / HST.OQ / ABNB.OQ / WTY.F</td><td class="leftalignment">Lyft Inc / BP PLC / Dupont De Nemours Inc / FMC Corp / International Business Machines Corp / Eli Lilly and Co / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Ralph Lauren Corp / Sealed Air Corp / Schlumberger NV / Waters Corp / Franklin Resources Inc / Halliburton Co / Eaton Corporation PLC / Cummins Inc / Assurant Inc / Progressive Corp / Clorox Co / Unum Group / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / DaVita Inc / Public Storage / ONEOK Inc / AMETEK Inc / Dun & Bradstreet Holdings Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Apple Inc / Expeditors International of Washington Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / Microchip Technology Inc / Incyte Corp / Henry Schein Inc / Amazon.com Inc / Zebra Technologies Corp / Akamai Technologies Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Live Nation Entertainment Inc / Fidelity National Information Services Inc / IPG Photonics Corp / NetEase Inc / Verisk Analytics Inc / Caesars Entertainment Inc / Baker Hughes Co / Xylem Inc / Phillips 66 Partners LP / Leidos Holdings Inc / Marriott International Inc / Sixth Street Specialty Lending Inc / Paycom Software Inc / Zimmer Biomet Holdings Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / L3harris Technologies Inc / Healthpeak Properties Inc / Alibaba Group Holding Ltd / Jacobs Engineering Group Inc / JD.Com Inc / Host Hotels & Resorts Inc / Airbnb Inc / Willis Towers Watson PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: 2Q Sales & EPS Bolstered by Cialis China Sale, Guidance Narrowed; Op Margin Guidance Reduced on COVID Antibody Challenges</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS Miss, Sales Beat; 2021 Guidance Largely Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Partly Cloudy, First Look At Mixed 2Q21 Results; LLY Reaffirms 2021 EPS Guidance Range</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2270726 / 2542049 / 2829515 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 7103065 / 2712013 / B1HMF22 / B125XQ6 / B3SWPT2 / BCZS820 / BDZCRX3 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BYNZGK1 / BJLT387 / BZB1XF2 / BR4T3B3 / BYXJQG9 / BGSP7M9 / BZ1LFG7 / BDVLM39 / BG0Q4Y1 / BJRFSB7 / BMZ9Z11 / BNTB3N8 / BWC52Q6 / BJ62Z18</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Global Payments Inc / First Solar Inc / Portland General Electric Co / Ameresco Inc / Fate Therapeutics Inc / RingCentral Inc / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Block Inc / Avantor Inc / Tactile Systems Technology Inc / HubSpot Inc / Spire Inc / Zoom Video Communications Inc / Roku Inc / argenx SE / Exicure Inc / Immunovant Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Solaredge Technologies Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: August 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / STE.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / TSN.N / SYY.N / IFF.N / EMR.N / RMD.N / BLL.N / PSA.N / AME.N / VTR.N / PRU.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / MCHP.OQ / DISH.OQ / ANSS.OQ / EBAY.OQ / SBAC.OQ / EXPE.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / FIS.N / TDG.N / NXPI.OQ / MSI.N / MPC.N / EA.OQ / PSX.N / ZTS.N / PRGO.N / CDW.OQ / MAR.OQ / NCLH.N / ETSY.OQ / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / STERIS plc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Resmed Inc / Ball Corp / Public Storage / AMETEK Inc / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Microchip Technology Inc / DISH Network Corp / ANSYS Inc / eBay Inc / SBA Communications Corp / Expedia Group Inc / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Zoetis Inc / Perrigo Company PLC / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / ETSY Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for LLY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ROKU=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Roku Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 2Q21 results preview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE / LLY.N</td><td class="leftalignment">Merck KGaA / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: August 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AEE.N / AES.N / AIG.N / APD.N / BDX.N / BR.N / CAH.N / CF.N / CI.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GM.N / LLY.N / MCK.N / PEG.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / TSN.N / SYY.N / IFF.N / VNO.N / EMR.N / VMC.N / WEC.N / XOM.N / RMD.N / BLL.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / TTWO.OQ / EBAY.OQ / ZBRA.OQ / SBAC.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / PPL.TO / VRSK.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / FANG.OQ / ZTS.N / PRGO.N / CDW.OQ / MAR.OQ / NCLH.N / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / KHC.OQ / WLTW.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / Cardinal Health Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Public Service Enterprise Group Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / Resmed Inc / Ball Corp / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Take-Two Interactive Software Inc / eBay Inc / Zebra Technologies Corp / SBA Communications Corp / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Pembina Pipeline Corp / Verisk Analytics Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / Diamondback Energy Inc / Zoetis Inc / Perrigo Company PLC / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Willis Towers Watson PLC / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Perception is Reality – Spate of FDA Surprises Eroding Physician Confidence</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">0989529 / 717081103 / 375558103 / 532457108 / 09062X103 / 09061G101 / 45337C102 / 00287Y109 / 039697107 / 00972D105</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Eli Lilly and Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Abbvie Inc / Ardelyx Inc / Akebia Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Yasmeen Rahimi, Ph.D. / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, August 2 - Sunday, August 8</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 69</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ROKU=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Roku Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company jumps 20.6% from 7 week low</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Exploratory Analyses Of TRAILBLAZER Support Donanemab's Outlook</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">NL0000226223 / FR0000120578 / GB0009895292 / DE0006231004 / GB0009252882 / CH0012032048 / CH0012005267 / US0079031078 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1985161066 / US2435371073 / US2546871060 / US37733W1053 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US5951121038 / US6541061031 / US6549022043 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8610121027 / US8807701029 / US9282981086 / US9581021055 / US83088M1027 / US80105N1054 / US1572101053 / US6098391054 / US9043111072 / US82706C1080 / US5500211090 / US25470F1049 / US58933Y1055 / US4485791028 / US25470F3029 / US00164V1035 / US30212P3038 / US8969452015 / US00287Y1091 / NL0010273215 / US55405Y1001 / KYG037AX1015 / DK0060534915 / US74736K1016 / KYG4740B1059 / LGFb / US89686D1054 / US43300A2033 / LGFa / VGG273581030 / US09857L1089 / US11135F1012 / US98585X1046 / US35137L1052 / US70614W1009 / US89677Q1076 / US92556H2067 / GB00BMVP7Y09 / US0090661010 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US68622V1061 / US81730H1095 / US89142B1070 / US69120X1072 / US30049H1023</td><td class="leftalignment">STMicroelectronics NV / Sanofi SA / AstraZeneca PLC / Infineon Technologies AG / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Micro Devices Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / GlaxoSmithKline PLC / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Micron Technology Inc / Nike Inc / Nokia Oyj / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / STMicroelectronics NV / Teradyne Inc / Vishay Intertechnology Inc / Western Digital Corp / Skyworks Solutions Inc / Sanofi SA / CEVA Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / Lululemon Athletica Inc / Discovery Inc / Merck & Co Inc / Hyatt Hotels Corp / Discovery Inc / AMC Networks Inc / Expedia Group Inc / Tripadvisor Inc / Abbvie Inc / ASML Holding NV / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Novo Nordisk A/S / Qorvo Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Trivago NV / Hilton Worldwide Holdings Inc / Lions Gate Entertainment Corp / Despegar.com Corp / Booking Holdings Inc / Broadcom Inc / Yeti Holdings Inc / Fox Corp / Peloton Interactive Inc / Trip.com Group Ltd / ViacomCBS Inc / Royalty Pharma PLC / Airbnb Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / Organon & Co / SentinelOne Inc / Torrid Holdings Inc / Owlet Inc / Evolv Technologies Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ALT: Building The Case For Our "Best Idea" as ALT-801's 12-Week Results Approach & Mgmt Gears Up for Phase 2's in Obesity & NASH; $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">BFY7DC4 / 5671735 / 0989529 / 2516152 / BHC8X90</td><td class="leftalignment">Altimmune Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MRK.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / CAT.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / CMCSA.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Its Clearer Than Ever Now, New Donanemab Data Supports Its Best-In-Class Potential</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / MRK</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / PFE.N / SO.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / KLAC.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Pfizer Inc / Southern Co / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / KLA Corp / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BE0165385973 / US0079031078 / US0123481089 / US0311621009 / US0323325045 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1265011056 / US1985161066 / US2435371073 / US37733W1053 / US45167R1041 / US4657411066 / US48203R1041 / US5128071082 / US5324571083 / US5370081045 / US55306N1046 / US5949181045 / US6541061031 / US66987V1098 / US6745991058 / US7170811035 / US7237871071 / US7711951043 / US8552441094 / US8636671013 / US8807701029 / US9113121068 / US9282981086 / US98956P1021 / US00508Y1029 / US4198791018 / US80105N1054 / US6098391054 / US6866881021 / US12541W2098 / US9043111072 / US42330P1075 / US3364331070 / US5500211090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US13100M5094 / US88160R1014 / US92839U2069 / US8676524064 / JE00B783TY65 / US00287Y1091 / US72919P2020 / US5764852050 / US29355A1079 / US41068X1000 / IE00BLS09M33 / US83417M1045 / US89400J1079 / US87918A1051 / US02079K1079 / US98138J2069 / US87266J1043 / CH0371153492 / US92336X1090 / US0937121079 / US04206A1016 / KY30744W1070 / US98585X1046 / US35952H6018 / US76156B1070 / US86150R1077 / US88339P1012 / US70614W1009 / US1567271093 / US69047Q1022 / US75513E1010 / US6541101050 / US04271T1007 / US33813J1060 / US74767V1098 / US62955J1034 / US73739W1045 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036 / US83089J1088 / US30260D1037</td><td class="leftalignment">Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Amgen Inc / Amtech Systems Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CTS Corp / Columbia Sportswear Co / Deckers Outdoor Corp / GlaxoSmithKline PLC / IDEX Corp / Itron Inc / Juniper Networks Inc / Lam Research Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microsoft Corp / Nike Inc / Novartis AG / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Starbucks Corp / Stryker Corp / Teradyne Inc / United Parcel Service Inc / Vishay Intertechnology Inc / Zimmer Biomet Holdings Inc / Acuity Brands Inc / Hawaiian Holdings Inc / Sanofi SA / Monolithic Power Systems Inc / Ormat Technologies Inc / CH Robinson Worldwide Inc / Under Armour Inc / Helix Energy Solutions Group Inc / First Solar Inc / Lululemon Athletica Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Calix Inc / Tesla Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Abbvie Inc / Plug Power Inc / Matador Resources Co / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Pentair PLC / Solaredge Technologies Inc / TransUnion / Teladoc Health Inc / Alphabet Inc / Workhorse Group Inc / TPI Composites Inc / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Arlo Technologies Inc / Farfetch Ltd / Yeti Holdings Inc / Fuelcell Energy Inc / Revolve Group Inc / Stoke Therapeutics Inc / RealReal Inc / Peloton Interactive Inc / Cerence Inc / Ovintiv Inc / Raytheon Technologies Corp / Nikola Corp / Array Technologies Inc / Fisker Inc / Quantumscape Corp / Nov Inc / Poshmark Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc / Skywater Technology Inc / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharma Pipelines: Number of Pharma Pipeline Candidates Up 15% YoY</td><td class="leftalignment">English</td><td class="rightalignment">129</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: Alzheimer's expert call: key takes (ROG/MOR) - Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Cantor Healthcare Small/Mid Cap 2Q21 Earnings Preview Conference Call On Friday, July 30 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / OPTN / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / OptiNose Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS / JNJ / LLY / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / ARQT / VYNE</td><td class="leftalignment">Aclaris Therapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Arcutis Biotherapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / INTC=US / MCD=US / AMD=US / RRC=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / TEVA=US / NVDA=US / PEB=US / LOW=US / CHKP=US / HSII=US / CHRS=US / BRO=US / SPOT=US / LEG=US / VMC=US / HLT=US / MLM=US / KFY=US / SWIM=US / BNL=US / CBRL=US / DRI=US / ENDP=US / AJG=US / GFF=US / HAS=US / HXL=US / IBP=US / TREE=US / NOW=US / MAS=US / MEDP=US / MHK=US / TEAM=US / NTST=US / PRGO=US / REGI=US / ROLL=US / SNOW=US / BXS=US / CFB=US / LCI=US / ADC=US / BDN=US / FB=US / SSB=US / CATY=US / GBCI=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / LUMN=US / APEI=US / TIL=US / EPRT=US / JACK=US / ZTS=US / TREX=US / AR=US / RLJ=US / FBHS=US / SPLK=US / ABBV=US / TILE=US / NDLS=US / QURE=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ACBI=US / WLTW=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / AYX=US / IOVA=US / ARVN=US / ESTC=US / FERG=US / DDOG=US / AZEK=US / BALY=US / DBRG=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / Pebblebrook Hotel Trust / Lowe's Companies Inc / Check Point Software Technologies Ltd / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Brown & Brown Inc / Spotify Technology SA / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Korn Ferry / Latham Group Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Endo International PLC / Arthur J Gallagher & Co / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / Lendingtree Inc / ServiceNow Inc / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / Perrigo Company PLC / Renewable Energy Group Inc / RBC Bearings Inc / Snowflake Inc. / Cadence Bank / Crossfirst Bankshares Inc / Lannett Company Inc / Agree Realty Corp / Brandywine Realty Trust / Meta Platforms Inc / SouthState Corp / Cathay General Bancorp / Glacier Bancorp Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lumen Technologies Inc / American Public Education Inc / Instil Bio Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Zoetis Inc / Trex Company Inc / Antero Resources Corp / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Splunk Inc / Abbvie Inc / Interface Inc / Noodles & Co / Uniqure NV / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Atlantic Capital Bancshares Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Arvinas Inc / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc / Bally's Corp / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2681511 / 2550707 / 2778844 / 2973821 / 2026242 / 2270726 / 2829515 / 2328915 / 2100920 / 2344922 / 2689560 / 2684703 / 2829601 / 2842255 / 2098876 / 2181334 / 7103065 / 7123870 / B0X7DZ3 / B01SD70 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / BFLR866 / B3NXMJ9 / BNGY4Q0 / BYVY8G0 / BTF8CF0 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BJFSR88 / BYXJQG9 / BKTNTR9 / BDH65C8 / BMH0MR7 / BYSFJV8 / BMBP1Q0 / BL98755</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / McDonald's Corp / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / Walt Disney Co / Edison International / Nextera Energy Inc / FirstEnergy Corp / Jack in the Box Inc / PG&E Corp / Pfizer Inc / Southern Co / Starbucks Corp / Yum! Brands Inc / Check Point Software Technologies Ltd / Novartis AG / Nestle SA / Chipotle Mexican Grill Inc / Domino's Pizza Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Twitter Inc / Wendys Co / Nextera Energy Partners LP / Alphabet Inc / Restaurant Brands International Inc / Shopify Inc / Chewy Inc / Snap Inc / Uniqure NV / Spire Inc / ViacomCBS Inc / PetIQ Inc / Zendesk Inc / Planet Fitness Inc / Flywire Corp / Beachbody Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / PFE / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assuming coverage of ABBV, BMY, LLY, MRK, and PFE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N / ABBV=US / BMY=US / MRK.N / PFE.N / MRK=US / LLY=US / PFE=US</td><td class="leftalignment">Eli Lilly and Co / Abbvie Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Expert Call Invite: Alzheimer's double-header: TODAY 15:00 UK (ROG/MOR) reminder*</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Pentathlon: Which Pharma's R&D Is Faster, Higher, Stronger?- Ahead of Curve</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / GB0009895292 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Event Analysis (2): Development status and event outlook for Alzheimer's disease drug development programs</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">4519.T / 4523.T / LLY.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Eli Lilly and Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: A Differentiated A  Approach; Initiate with an Outperform Rating, $26 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ABOS.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / BIIB.OQ / PRTA.OQ / ACIU.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Biogen Inc / Prothena Corporation PLC / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: イベントアナリシス②：アルツハイマー病治療薬の開発状況とイベント予測</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4519.T / 4523.T / LLY.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Eli Lilly and Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALM.MC: Almirall - 1H21 Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ALM.MC / LLY.N</td><td class="leftalignment">Almirall SA / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Spain / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, July 26 - Sunday, August 1</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.7% Above Pre-Pandemic Base- Week 68</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">FINAM</td><td class="leftalignment">Eli Lilly: большие, но дорогие надежды</td><td class="leftalignment">Russian</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Alexander Kovalev</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / JNJ / LLY / ACRS / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / VYNE</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Aclaris Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2308.TW / 4502.T / AKZO.AS / ATCOA.ST / BA.N / BARC.L / CPG.L / CSL.AX / DNB.OL / EDP.LS / ELUXB.ST / ERICB.ST / HEIN.AS / HSBA.L / III.L / JNJ.N / LGEN.L / LLOY.L / LLY.N / PFE.N / RR.L / RYA.I / SAN.MC / SAPJ.J / SCHN.PA / SHBA.ST / SN.L / SOGN.PA / STAN.L / TW.L / ULVR.L / WLSNC.AS / WTB.L / AIR.PA / AZN.L / SASY.PA / TKAG.DE / ROG.S / LUN.CO / NOVN.S / ENEI.MI / MRCG.DE / DTEGN.F / UHR.S / NZYMB.CO / GSK.L / NEXS.PA / NKT.CO / UCB.BR / AMA.MC / ALFA.ST / AER.N / TOP.CO / NWG.L / MAERSKB.CO / KNIN.S / RIEN.S / LOGN.S / BEAN.S / IFCN.S / STMN.S / INGA.AS / YAR.OL / ASOS.L / PGHN.S / RMG.L / WCHG.DE / AKE.PA / TEVA.N / HOLN.S / KCOGN.DE / ERIC.OQ / MBTN.S / SKG.I / PRY.MI / ALM.MC / GRLS.MC / ZO1G.DE / BKGH.L / BNRGN.DE / AGES.BR / BASFN.DE / SHLG.DE / DKSH.S / ABBV.N / OCI.AS / FDEV.L / FBK.MI / UBSG.S / COTNE.S / ENPLQ.L / MEDA.S / SFOR.L / DEMANT.CO / MOVE.S / NWG.N</td><td class="leftalignment">Delta Electronics Inc / Takeda Pharmaceutical Co Ltd / Akzo Nobel NV / Atlas Copco AB / Boeing Co / Barclays PLC / Compass Group PLC / CSL Ltd / DNB Bank ASA / EDP Energias de Portugal SA / Electrolux AB / Telefonaktiebolaget LM Ericsson / Heineken NV / HSBC Holdings PLC / 3i Group PLC / Johnson & Johnson / Legal & General Group PLC / Lloyds Banking Group PLC / Eli Lilly and Co / Pfizer Inc / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Banco Santander SA / Sappi Ltd / Schneider Electric SE / Svenska Handelsbanken AB / Smith & Nephew PLC / Societe Generale SA / Standard Chartered PLC / Taylor Wimpey PLC / Unilever PLC / Wolters Kluwer NV / Whitbread PLC / Airbus SE / AstraZeneca PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / H Lundbeck A/S / Novartis AG / Enel SpA / Merck KGaA / Deutsche Telekom AG / Swatch Group AG / Novozymes A/S / GlaxoSmithKline PLC / Nexans SA / Nkt A/S / Ucb SA / Amadeus IT Group SA / Alfa Laval AB / AerCap Holdings NV / Topdanmark A/S / Natwest Group PLC / AP Moeller - Maersk A/S / Kuehne und Nagel International AG / Rieter Holding AG / Logitech International SA / Belimo Holding AG / Inficon Holding AG / Straumann Holding AG / ING Groep NV / Yara International ASA / ASOS PLC / Partners Group Holding AG / Royal Mail PLC / Wacker Chemie AG / Arkema SA / Teva Pharmaceutical Industries Ltd / Holcim AG / Kloeckner & Co SE / Telefonaktiebolaget LM Ericsson / Meyer Burger Technology AG / Smurfit Kappa Group PLC / Prysmian SpA / Almirall SA / Grifols SA / Zooplus AG / Berkeley Group Holdings PLC / Brenntag SE / Ageas SA / BASF SE / Siemens Healthineers AG / DKSH Holding AG / Abbvie Inc / OCI NV / Frontier Developments PLC / FinecoBank Banca Fineco SpA / UBS Group AG / Comet Holding AG / En+ Group MKPAO / Medartis Holding AG / S4 Capital PLC / Demant A/S / Medacta Group SA / Natwest Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / Norway / Portugal / Russian Federation / Sweden / Taiwan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Expert Call Invite: Alzheimer's double-header: Mon 26 July 15:00 UK (ROG/MOR) reminder*</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL THIS MORNING To Discuss Where The Pandemic Is Headed And the Future of COVID-19 Vaccines/ Treatments at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / PFE / CERC / AYTU / HGEN / IMAB</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Avalo Therapeutics Inc / Aytu Biopharma Inc / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - BeiGene: Novartis unveiling a rich BLA filing plan for PD-1, further supporting BeiGene globalisation progress. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / 6160.HK / NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / ROG.S / UTHR.OQ / 1801.HK / 1877.HK</td><td class="leftalignment">Beigene Ltd / Beigene Ltd / Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Roche Holding AG / United Therapeutics Corp / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Expert Call Invite: Alzheimer's double-header: Mon 26 July 15:00 UK/10:00 ET (ROG/MOR)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Commercial stage biotech Q Biomed reports progress F2Q21 - Reiterate Buy and lower PT to $6 from $7</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">QBIO.PK / LLY.N / ESALY.PK / ALC.N / OMER.OQ / CLVS.OQ / NAVB.A / AERI.OQ / AKBA.OQ / OCUL.OQ / LNTH.OQ / APLS.OQ / DE000BAY0199 / TVTX.OQ</td><td class="leftalignment">Q BioMed Inc / Eli Lilly and Co / Eisai Co Ltd / Alcon AG / Omeros Corp / Clovis Oncology Inc / Navidea Biopharmaceuticals Inc / Aerie Pharmaceuticals Inc / Akebia Therapeutics Inc / Ocular Therapeutix Inc / Lantheus Holdings Inc / Apellis Pharmaceuticals Inc / Bayer AG / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Japan / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">NL0000226223 / DE0006231004 / DE0007164600 / US00724F1012 / US0079031078 / US0231351067 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1265011056 / US1266501006 / US14149Y1082 / US1727551004 / US17275R1023 / US1924461023 / US22160K1051 / US2545431015 / US2910111044 / US30226D1063 / US3156161024 / US3647601083 / US37733W1053 / US4456581077 / US45167R1041 / US4567881085 / US4581401001 / US48203R1041 / US4824801009 / US5002551043 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US58155Q1031 / US5949181045 / US5950171042 / US5951121038 / US6556641008 / US66987V1098 / US6701002056 / US67066G1040 / US6821891057 / US68389X1054 / US7170811035 / US7274931085 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8030542042 / US8168501018 / US8269191024 / US8610121027 / US8725401090 / US87612E1064 / US9282981086 / US9311421039 / US9581021055 / US9839191015 / IL0010824113 / US03073E1055 / US83088M1027 / US80105N1054 / US21036P1084 / US1572101053 / US79466L3024 / US6098391054 / US82706C1080 / US55616P1049 / US88076W1036 / US90384S3031 / IE00B4BNMY34 / US58933Y1055 / US4485791028 / US34959E1091 / NL0009538784 / US03027X1000 / US30212P3038 / US8969452015 / US29414B1044 / US00287Y1091 / US98978V1035 / US5017971046 / US81762P1021 / US98138H1014 / US55405Y1001 / US8486371045 / US6974351057 / KYG037AX1015 / US9222801022 / US98936J1016 / US0404131064 / US0396971071 / LU0974299876 / IL0011334468 / US4435731009 / US0994061002 / US64829B1008 / US22822V1017 / US74736K1016 / US74624M1027 / GB00BZ09BD16 / US90138F1021 / IE00BY7QL619 / US89686D1054 / US43300A2033 / US78410G1040 / US02156B1035 / US23355L1061 / US6792951054 / US03782L1017 / US8760301072 / US76674Q1076 / VGG273581030 / US09354A1007 / US09857L1089 / US98980G1022 / US11135F1012 / US2575541055 / US29260V1052 / US28414H1032 / CA64079L1058 / KY30744W1070 / US69553P1003 / IL0011571556 / US22788C1053 / US39874R1014 / US18915M1071 / US89677Q1076 / IE00BK9ZQ967 / US39813G1094 / US14448C1045 / GB00BMVP7Y09 / US8334451098 / US07373B1098 / US86646P1030 / US74767V1098 / US0090661010 / US7761531083 / US55406W1036 / US15961R1059 / US49926T1043 / US90364P1057 / US5738741041 / US68622V1061 / IL0011762130 / US20717M1036 / US02080L1026 / IE000GID8VI0 / US28623U1016 / US38870X1046</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / SAP SE / Adobe Inc / Advanced Micro Devices Inc / Amazon.com Inc / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CTS Corp / CVS Health Corp / Cardinal Health Inc / Cirrus Logic Inc / Cisco Systems Inc / Cognizant Technology Solutions Corp / Costco Wholesale Corp / Diodes Inc / Emerson Electric Co / Extreme Networks Inc / F5 Inc / Gap Inc / GlaxoSmithKline PLC / J B Hunt Transport Services Inc / IDEX Corp / Infosys Ltd / Intel Corp / Juniper Networks Inc / KLA Corp / Kohls Corp / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Mckesson Corp / Microsoft Corp / Microchip Technology Inc / Micron Technology Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / ON Semiconductor Corp / Oracle Corp / Pfizer Inc / Plantronics Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SAP SE / Semtech Corp / Silicon Laboratories Inc / STMicroelectronics NV / TJX Companies Inc / Target Corp / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Xilinx Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / Skyworks Solutions Inc / Sanofi SA / Constellation Brands Inc / CEVA Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Macy's Inc / Teradata Corp / Ulta Beauty Inc / Accenture PLC / Merck & Co Inc / Hyatt Hotels Corp / Fortinet Inc / NXP Semiconductors NV / American Tower Corp / Expedia Group Inc / Tripadvisor Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / Bath & Body Works Inc / ServiceNow Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Palo Alto Networks Inc / Ambarella Inc / Varonis Systems Inc / Zendesk Inc / Arista Networks Inc / Ardelyx Inc / Globant SA / Cyberark Software Ltd / HubSpot Inc / Boot Barn Holdings Inc / New Relic Inc / Crown Castle International Corp / Qorvo Inc / Pure Storage Inc / Atlassian Corporation PLC / Twilio Inc / Johnson Controls International PLC / Trivago NV / Hilton Worldwide Holdings Inc / SBA Communications Corp / Alteryx Inc / DXC Technology Co / Okta Inc / Appian Corp / Tapestry Inc / Rimini Street Inc / Despegar.com Corp / Blink Charging Co / Booking Holdings Inc / Zscaler Inc / Broadcom Inc / Domo Inc / Endava PLC / Elanco Animal Health Inc / Neptune Wellness Solutions Inc / Farfetch Ltd / PagerDuty Inc / Tufin Software Technologies Ltd / CrowdStrike Holdings Inc / Grocery Outlet Holding Corp / Cloudflare Inc / Trip.com Group Ltd / Trane Technologies PLC / Grid Dynamics Holdings Inc / Carrier Global Corp / Royalty Pharma PLC / Snowflake Inc. / Beam Global / Sumo Logic Inc / Quantumscape Corp / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / UiPath Inc / Marvell Technology Inc / Organon & Co / Monday.Com Ltd / Confluent Inc / Alpha Teknova Inc / GH Research PLC / Elevation Oncology Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIN / AN=US / MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / CAG=US / HD=US / KO=US / MCD=US / TWTR=US / CL=US / PG=US / WEN=US / PLD=US / T=US / BLD=US / INCY=US / TEVA=US / APA=US / LOW=US / ENR=US / CHRS=US / BRO=US / LEG=US / ATVI=US / VMC=US / NWL=US / MLM=US / FLO=US / STZ=US / DISH=US / WTFC=US / AIR=US / SWIM=US / ATRO=US / B=US / BMRN=US / CBRL=US / CENT=US / CHD=US / CW=US / DRI=US / DCO=US / EPC=US / AJG=US / GFF=US / HAIN=US / HEI=US / HXL=US / IBP=US / MAS=US / MRCY=US / MHK=US / PACW=US / REGI=US / ROLL=US / SMG=US / SNAP=US / TGI=US / VSEC=US / WIX=US / POST=US / ZION=US / FB=US / FBK=US / SPR=US / NTRA=US / DIN=US / MGP=US / MGPI=US / MNST=US / NOMD=US / RPD=US / RNG=US / TPX=US / MOG.A=US / EXP=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / TDG=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / KTOS=US / TIL=US / JACK=US / AAN=US / UTZ=US / TREX=US / WWD=US / FBHS=US / TILE=US / NDLS=US / FIVN=US / 00770K202 / LOCO=US / NVRO=US / SHAK=US / AJRD=US / BWXT=US / WING=US / WLTW=US / 82982L103 / JELD=US / IOVA=US / PETQ=US / MAXR=US / KDP=US / FERG=US / LHX=US / BRBR=US / REYN=US / SPCE=US / AZEK=US / VTRS=US / HYFM=US / 67421J108</td><td class="leftalignment">Albany International Corp / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Conagra Brands Inc / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Twitter Inc / Colgate-Palmolive Co / Procter & Gamble Co / Wendys Co / Prologis Inc / AT&T Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / APA Corp (US) / Lowe's Companies Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Brown & Brown Inc / Leggett & Platt Inc / Activision Blizzard Inc / Vulcan Materials Co / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / DISH Network Corp / Wintrust Financial Corp / AAR Corp / Latham Group Inc / Astronics Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Ducommun Inc / Edgewell Personal Care Co / Arthur J Gallagher & Co / Griffon Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / RBC Bearings Inc / Scotts Miracle-Gro Co / Snap Inc / Triumph Group Inc / VSE Corp / Wix.Com Ltd / Post Holdings Inc / Zions Bancorporation NA / Meta Platforms Inc / FB Financial Corp / Spirit AeroSystems Holdings Inc / Natera Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Rapid7 Inc / RingCentral Inc / Tempur Sealy International Inc / Moog Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / TransDigm Group Inc / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Instil Bio Inc / Jack in the Box Inc / Aaron's Company Inc / UTZ Brands Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Five9 Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Nevro Corp / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Wingstop Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Maxar Technologies Inc / Keurig Dr Pepper Inc / Ferguson PLC / L3harris Technologies Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Viatris Inc / Hydrofarm Holdings Group Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Luxembourg / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2732635 / 2942605 / 2219224 / 2270726 / 2829515 / 2328915 / 2684703 / 2829601 / 2900335 / 2980906 / 2503529 / 7103065 / B17HG57 / B121557 / 2857817 / B7TL820 / B4MG4Z6 / B7VD3F2 / BFLR866 / BYNZGK1 / BP7RS48 / BFMXGR0 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BDT5KT5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / AutoNation Inc / Avista Corp / CMS Energy Corp / Walt Disney Co / Edison International / Nextera Energy Inc / Pfizer Inc / Southern Co / Tractor Supply Co / Foot Locker Inc / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Mastercard Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Twitter Inc / Block Inc / Intersect Ent Inc / Evergy Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Inspire Medical Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma - 2Q21 Quarterly Prep Pack</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Eli Lilly and Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Growth Driven By New Products, Margin Expansion</td><td class="leftalignment">English</td><td class="rightalignment">100</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1205</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FR0000121014 / FR0000054470 / US0028241000 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1567821046 / US1925761066 / US22284P1057 / US2855121099 / US2944291051 / US3021301094 / US3377381088 / US37733W1053 / US4433201062 / US4456581077 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5763231090 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US74762E1029 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8807701029 / US9029251066 / US91347P1057 / US91913Y1001 / US92343V1044 / US9507551086 / US37940X1028 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US20030N1019 / US21036P1084 / US3463751087 / US90385V1070 / US12541W2098 / US00206R1023 / US31620M1062 / US1314761032 / US57636Q1040 / US78709Y1055 / PAP310761054 / US75025X1000 / US3364331070 / US01748X1028 / US2473617023 / US25470M1099 / US7181721090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US39304D1028 / US9100471096 / US3390411052 / US4361061082 / US56585A1025 / US8676524064 / US98986T1088 / US7185461040 / US9837931008 / US96208T1043 / US69318G1067 / US00287Y1091 / NL0010273215 / US98978V1035 / US8725901040 / US29355A1079 / PR30040P1032 / US69366J2006 / US00847X1046 / US8485771021 / US21240E1055 / CH0210483332 / US90184L1026 / US02376R1023 / US03937C1053 / KYG8807B1068 / US69888T2078 / US94419L1017 / CA0089118776 / US83417M1045 / US09627Y1091 / US12685J1051 / US89400J1079 / US70450Y1038 / CA1380351009 / US8522341036 / US16119P1084 / KYG4740B1059 / CA87241L1094 / GB00BDSFG982 / US83304A1060 / US23753F1075 / US80689H1023 / US05722G1004 / US24665A1034 / US02156K1034 / US4990491049 / US26927E1047 / US46571Y1073 / US74275G1076 / US5904791358 / CA39342L1085 / US28414H1032 / KY30744W1070 / US26142R1041 / US22041X1028 / CA67079A1021 / US04271T1007 / US11778X1046 / US72815L1070 / US55406W1036 / US82489W1071 / US30320C1036 / BMG6964L1072 / US20717M1036 / US61225M1027</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Ubisoft Entertainment SA / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerner Corp / Cohu Inc / Covenant Logistics Group Inc / Electronic Arts Inc / Equifax Inc / Expeditors International of Washington Inc / Fiserv Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / MasTec Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Quanta Services Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teradyne Inc / USA Truck Inc / Universal Display Corp / Valero Energy Corp / Verizon Communications Inc / Werner Enterprises Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / Comcast Corp / Constellation Brands Inc / FormFactor Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / Mastercard Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / DISH Network Corp / Philip Morris International Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / Green Dot Corp / United Airlines Holdings Inc / Fleetcor Technologies Inc / HollyFrontier Corp / Marathon Petroleum Corp / SunPower Corp / Zynga Inc / Phillips 66 / XPO Logistics Inc / WEX Inc / PBF Energy Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / T-Mobile US Inc / Enphase Energy Inc / Evertec Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / Twitter Inc / American Airlines Group Inc / ArcBest Corp / Theravance Biopharma Inc / Par Pacific Holdings Inc / Wayfair Inc / Air Canada / Solaredge Technologies Inc / Blueprint Medicines Corp / Cable One Inc / TransUnion / PayPal Holdings Inc / Canopy Growth Corp / Block Inc / Charter Communications Inc / Ichor Holdings Ltd / TFI International Inc / TechnipFMC PLC / Snap Inc / Daseke Inc / Schneider National Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / EVO Payments Inc / I3 Verticals Inc / Priority Technology Holdings Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Farfetch Ltd / DraftKings Inc / Corsair Gaming Inc / Nuvei Corp / Array Technologies Inc / BTRS Holdings Inc / Playtika Holding Corp / MYT Netherlands Parent BV / Shoals Technologies Group Inc / FTC Solar Inc / Paysafe Ltd / Confluent Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Puerto Rico / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2002305 / 2026242 / 2216850 / 2270726 / 2829515 / 2670519 / 2328915 / 2459020 / 2730190 / 2440637 / 2829601 / B067BM3 / 2857817 / B1XGNW4 / B0796X4 / B7TL820 / BTN1Y11 / BS7K7C9 / BYW36M8 / BZBY005 / BJ5FZ74 / BLGJ610 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BF3W461 / BDZ30Q0 / BMPRZV5 / BMC8SQ7 / BP7KZP7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Consolidated Edison Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / Intuit Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Molson Coors Beverage Co / Netflix Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Medtronic PLC / Nevro Corp / PayPal Holdings Inc / Merus NV / Adaptive Biotechnologies Corp / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Tandem Diabetes Care Inc / Arvinas Inc / Kymera Therapeutics Inc / BTRS Holdings Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, July 19 - Sunday, July 25</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / PFE / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 67</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2Q21 Global Biopharma Preview: Group Fundamentals Solid & Valuations Improving but Don't Look for Big 2Q Beats</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Call to Discuss New Alzheimer's Drugs and How They Will Be Reimbursed, July 23 at 11 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS MORNING: Please Join Our Large-Cap 2Q21 Earnings Preview Conference Call On July 16 At 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE / HCM / JNJ / LLY / MRK / ZTS / IMAB</td><td class="leftalignment">Pfizer Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Innovent: Creative collaboration deal benefiting both Innovent and Ascentage. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1801.HK / LLY.N / 2196.HK / AMGN.OQ / BGNE.OQ</td><td class="leftalignment">Innovent Biologics Inc / Eli Lilly and Co / Shanghai Fosun Pharmaceutical Group Co Ltd / Amgen Inc / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 0989529 / 2516152 / 2000019 / 2026242 / 2219224 / 2206657 / 2270726 / 2542049 / 2829515 / 2328915 / 2100920 / 2366799 / 2455965 / 2707677 / 2138158 / 2829601 / 2712013 / B121557 / 2769796 / 2857817 / B3D7K31 / B4N0JJ6 / B7TL820 / B783TY6 / B7VD3F2 / BYVY8G0 / BP4GNK9 / BXDZ9Z0 / BYNZGK1 / BD8DJ71 / BZ1HM42 / BFZ1K46 / BLGJ610 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BKS3RS7 / BKPGJQ1 / BJ62Z18</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Coca-Cola Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Biogen Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Global Payments Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Discovery Inc / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / Alphabet Inc / SAGE Therapeutics Inc / Shopify Inc / Block Inc / Snap Inc / Adyen NV / Spotify Technology SA / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / Roku Inc / 10X Genomics Inc / Squarespace Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss the Future of COVID-19 Vaccines & Treatments on Thursday, July 22 at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / CERC / AYTU / HGEN / IMAB</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Avalo Therapeutics Inc / Aytu Biopharma Inc / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Clarification from BIIB and LLY on Comments Made by Our Expert with Regard to the NCD Process and CED Studies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / BIIB.OQ / 2516152 / 2455965</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 07 13</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BLKB.OQ / CVS.N / BMY.N / CAH.N / GE.N / LLY.N / WMT.N / CPB.N / LOW.N / AMT.N / AMGN.OQ / AMAT.OQ / CASY.OQ / CGNX.OQ / SJM.N / INTU.OQ / AMZN.OQ / MTCH.OQ / SIX.N / VRSK.OQ / ZM.OQ</td><td class="leftalignment">Blackbaud Inc / CVS Health Corp / Bristol-Myers Squibb Co / Cardinal Health Inc / General Electric Co / Eli Lilly and Co / Walmart Inc / Campbell Soup Co / Lowe's Companies Inc / American Tower Corp / Amgen Inc / Applied Materials Inc / Caseys General Stores Inc / Cognex Corp / J M Smucker Co / Intuit Inc / Amazon.com Inc / Match Group Inc / Six Flags Entertainment Corp / Verisk Analytics Inc / Zoom Video Communications Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Conglomerates / Electronics / Food / Healthcare / Info. Tech./Software / Leisure & Entertainment / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / OXY=US / ADI=US / AMD=US / RRC=US / WEN=US / AMZN=US / BLD=US / DVN=US / TXN=US / TEVA=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / DIOD=US / MGY=US / SWN=US / XLNX=US / MUR=US / CHRS=US / BRO=US / UMPQ=US / MRO=US / LEG=US / TTMI=US / VMC=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / CERN=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAN=US / MAS=US / MCHP=US / MHK=US / PACW=US / REGI=US / ST=US / WAL=US / CVX=US / BXS=US / SNV=US / FB=US / CATY=US / COP=US / DIN=US / BIIB=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BDC=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / JACK=US / TREX=US / AR=US / OAS=US / NXPI=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / WING=US / WLTW=US / EDIT=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / MPWR-US / HWC=US / OZK=US / RTLR=US / FERG=US / GMAB=US / OVV=US / AZEK=US / VTRS=US / VMEO=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Xilinx Inc / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / TTM Technologies Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Cerner Corp / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Western Alliance Bancorp / Chevron Corp / Cadence Bank / Synovus Financial Corp / Meta Platforms Inc / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Willis Towers Watson PLC / Editas Medicine Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Monolithic Power Systems Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Azek Company Inc / Viatris Inc / Vimeo Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2270726 / 2542049 / 2829515 / 2100920 / 2455965 / 2684703 / 2048804 / 2707677 / 2138158 / 2825933 / 2829601 / 2503529 / 7103065 / B121557 / 2857817 / B125XQ6 / B02R1L6 / B7TL820 / BFLR866 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BNFWR44 / BFZ1K46 / BKTNTR9 / BRJ3GY4 / BJ9N563 / BNKGXX2</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Edison International / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Mastercard Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / Meta Platforms Inc / Twitter Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Worldline SA / Spotify Technology SA / ViacomCBS Inc / Xenon Pharmaceuticals Inc / Sunnova Energy International Inc / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2Q Earnings Preview - Easy Comps and Receding COVID-19 Headwinds</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Increasing Price Targets For CUTR, IMAB, ZTS, and HCM</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">HCM.L / CUTR.O / LLY / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Cutera Inc / Eli Lilly and Co / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / CUTR.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / LPCN.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / CERC.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Lipocine Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / Avalo Therapeutics Inc / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, July 12 - Sunday, July 18</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 66</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">央行全面降准，宽松流动性有望延续-07/09/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">9</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB, LLY, ROG: Including Alzheimer's revenues for the first time EVER!</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">532457108 / 09062X103 / ROG.S / 7110388</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended June 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended July 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Large-Cap 2Q21 Earnings Preview Conference Call On July 16 At 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE / ZTS / HCM.L / JNJ / LLY / MRK / IMAB.O</td><td class="leftalignment">Pfizer Inc / Zoetis Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">LLY - Embedded Expectations Analysis - 2021 07 07</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2497406 / 2026242 / 2219224 / 2280220 / 2270726 / 2670519 / 2342034 / 2100920 / 2684703 / 2707677 / 2138158 / 2829601 / 7103065 / 2857817 / B3D7K31 / B6197Q2 / B7TL820 / BFLR866 / BYVY8G0 / BG31GH0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BZ4CHH2 / BKPGJQ1 / BFYVZ75</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kroger Co / American Electric Power Company Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Exelon Corp / Fiserv Inc / FirstEnergy Corp / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Novartis AG / Netflix Inc / Discovery Inc / Generac Holdings Inc / Meta Platforms Inc / Twitter Inc / Alphabet Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Soleno Therapeutics Inc / Squarespace Inc / Seelos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: July 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / AL.N / ALK.N / AXP.N / BA.N / BAC.N / BDX.N / C.N / CL.N / COF.N / CRM.N / CVS.N / DAL.N / ECL.N / EIX.N / EOG.N / F.N / GPS.N / IBM.N / JPM.N / KO.N / LLY.N / LUV.N / MO.N / OXY.N / PFE.N / PM.N / SC.N / SEE.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / CPB.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / DE.N / CAT.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / BLL.N / VZ.N / NYT.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / NEU.N / EFX.N / EQT.N / V.N / ACN.N / WSM.N / ESI.N / HAE.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / FISV.OQ / HOLX.OQ / HBAN.OQ / LRCX.OQ / MSFT.OQ / ROL.N / THO.N / ALKS.OQ / QDEL.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / COST.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / CSGP.OQ / ERIE.OQ / NVDA.OQ / FFIV.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / GPN.N / VRTX.OQ / JBLU.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / TFC.N / SBNY.OQ / ACAD.OQ / CG.TO / DPZ.N / MKTX.OQ / LVS.N / DISCA.OQ / MS.N / STX.AX / RPRX.OQ / HES.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / LOPE.OQ / MSCI.N / VRSK.OQ / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / APO.N / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / ADT.N / FANG.OQ / BFAM.N / RNG.N / COMM.OQ / MAR.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / BWXT.K / PEN.N / NVCR.OQ / TMUS.OQ / IONS.OQ / IAC.OQ / NTNX.OQ / RETA.OQ / COUP.OQ / AYX.N / DXC.N / IOVA.OQ / WDAY.OQ / ROKU.OQ / SWCH.N / IQV.N / BKNG.OQ / FB.PS / UAL.OQ / STNE.OQ / FSLY.N / CRWD.OQ / PTON.OQ / NLOK.OQ / RTX.N / AMWL.N / VTRS.OQ / PLTK.OQ</td><td class="leftalignment">Abbott Laboratories / Air Lease Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Becton Dickinson and Co / Citigroup Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Southwest Airlines Co / Altria Group Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Sealed Air Corp / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / New York Times Co / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / NewMarket Corp / Equifax Inc / EQT Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Element Solutions Inc / Haemonetics Corp / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Fiserv Inc / Hologic Inc / Huntington Bancshares Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Thor Industries Inc / Alkermes Plc / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Costco Wholesale Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / CoStar Group Inc / Erie Indemnity Co / NVIDIA Corp / F5 Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Grand Canyon Education Inc / MSCI Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Apollo Global Management Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / ADT Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / RingCentral Inc / CommScope Holding Company Inc / Marriott International Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / BWX Technologies Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Nutanix Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Alteryx Inc / DXC Technology Co / Iovance Biotherapeutics Inc / Workday Inc / Roku Inc / Switch Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / StoneCo Ltd / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / American Well Corp / Viatris Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Luxembourg / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Don't Break My Heart, Positive EMPEROR-Preserved Data Supports Blockbuster Opportunity For LLY</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / LLY=US / OXY=US / RRC=US / T=US / DVN=US / TXN=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / BYD=US / MRO=US / MGM=US / MANH=US / PENN=US / W=US / STZ=US / AMED=US / ENV=US / COLL=US / CNX=US / DRH=US / EQT=US / HZO=US / MCRI=US / ASGN=US / PLAN=US / PCTY=US / REGN=US / SGMO=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / CGEN=US / SGMS=US / SIVB=US / FRT=US / COP=US / MGNI=US / BDSI=US / PTON=US / BIIB=US / CZR=US / TXRH=US / SHO=US / XM=US / BLDR=US / SCPL=US / HST=US / CLR=US / PRPL=US / NOG=US / JACK=US / AR=US / OAS=US / RLJ=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / GTT=US / GOOGL=US / VNOM=US / HUBS=US / VCEL=US / UPLD=US / PRAH=US / WBA=US / SHAK=US / BWXT=US / WING=US / NVCR=US / TTD=US / CDEV=US / PK=US / PVAC=US / SBOW=US / IOVA=US / BTAI=US / UBER=US / CRWD=US / OVV=US / SPCE=US / ZI=US / TSHA / 96758W101 / BALY=US / REPX=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Occidental Petroleum Corp / Range Resources Corp / AT&T Inc / Devon Energy Corp / Texas Instruments Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Boyd Gaming Corp / Marathon Oil Corp / MGM Resorts International / Manhattan Associates Inc / Penn National Gaming Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / MarineMax Inc / Monarch Casino & Resort Inc / ASGN Inc / Anaplan Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Compugen Ltd / Scientific Games Corp / SVB Financial Group / Federal Realty Investment Trust / Conocophillips / Magnite Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Caesars Entertainment Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Qualtrics International Inc / Builders FirstSource Inc / Sciplay Corp / Host Hotels & Resorts Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Antero Resources Corp / Oasis Petroleum Inc / RLJ Lodging Trust / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / GTT Communications Inc / Alphabet Inc / Viper Energy Partners LP / HubSpot Inc / Vericel Corp / Upland Software Inc / Prahova Estival 2002 SA / Walgreens Boots Alliance Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Novocure Ltd / Trade Desk Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / SilverBow Resources Inc / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Ovintiv Inc / Virgin Galactic Holdings Inc / ZoomInfo Technologies Inc / Taysha Gene Therapies Inc / WideOpenWest Inc / Bally's Corp / Riley Exploration Permian Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Israel / Romania / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: LLY - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="odd"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Biologics Sector - Looking ahead into upcoming updated Regkirona data release this week; revisiting select COVID antibody and vaccine plays in Korea</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / 006280.KS / 068270.KS / 128940.KS / 091990.KQ</td><td class="leftalignment">Eli Lilly and Co / Green Cross Corp / Celltrion Inc / Hanmi Pharm Co Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">07/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 65</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / ICLR=US / AMZN=US / HSII=US / VRM=US / EXPE=US / KFRC=US / MGM=US / W=US / KFY=US / AMN=US / MAN=US / HZO=US / ASGN=US / RHI=US / SNAP=US / TRIP=US / WAL=US / WIX=US / WGO=US / CCRN=US / BKNG=US / SIVB=US / FB=US / FRT=US / MGNI=US / PTON=US / BIIB=US / CZR=US / APP=US / NSP=US / MA=US / ANGI=US / GOOGL=US / BABA=US / CMPR=US / PRAH=US / WBA=US / GDDY=US / BWXT=US / MCFT=US / NVCR=US / CVNA=US / SFIX=US / FTDR=US / LYFT=US / UBER=US / OPCH=US / VMEO=US / 100017125</td><td class="leftalignment">Eli Lilly and Co / ICON PLC / Amazon.com Inc / Heidrick & Struggles International Inc / Vroom Inc / Expedia Group Inc / Kforce Inc / MGM Resorts International / Wayfair Inc / Korn Ferry / AMN Healthcare Services Inc / ManpowerGroup Inc / MarineMax Inc / ASGN Inc / Robert Half International Inc / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Winnebago Industries Inc / Cross Country Healthcare Inc / Booking Holdings Inc / SVB Financial Group / Meta Platforms Inc / Federal Realty Investment Trust / Magnite Inc / Peloton Interactive Inc / Biogen Inc / Caesars Entertainment Inc / Applovin Corp / Insperity Inc / Mastercard Inc / Angi Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Prahova Estival 2002 SA / Walgreens Boots Alliance Inc / GoDaddy Inc / BWX Technologies Inc / Mastercraft Boat Holdings Inc / Novocure Ltd / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Lyft Inc / Uber Technologies Inc / Option Care Health Inc / Vimeo Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Romania / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY / JNJ / ARCT</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">0989529 / 0925288 / 2516152 / 2000019 / 2026242 / 2270726 / 2100920 / 2630513 / 2689560 / 2707677 / 2138158 / 2825933 / 2829601 / B121557 / 2857817 / B7TL820 / BFLR866 / BTN1Y44 / BYVY8G0 / BYW36M8 / BJ2Z0H2 / BFZ1K46 / BKTNTR9 / BZ1LFG7 / BKX9VD3 / BN4RD42</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / Walt Disney Co / FirstEnergy Corp / New Jersey Resources Corp / PG&E Corp / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Mastercard Inc / Netflix Inc / Meta Platforms Inc / Twitter Inc / Walgreens Boots Alliance Inc / Alphabet Inc / PayPal Holdings Inc / Pinterest Inc / Spotify Technology SA / ViacomCBS Inc / Roku Inc / Arcutis Biotherapeutics Inc / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Donanemab: not first, but perhaps better AND cheaper; raising est’s and PT to $262</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Sugar, Don't Quit on Me; Takeaways from Diabetes Update Underscore Best-in-Class Portfolio</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">LLY event highlighted tirzepatide’s compelling profile, intriguing early-stage programs</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : ADA Conf Call Takeaways - No Major Surprises, Best-in-Class Tirzepatide Profile Confirmed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: After SURPASSing T2D Benchmarks, Tirzepatide Marching to SURMOUNT Obesity in 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Jul. 01, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company in top 5% performers of S&P 500 Index in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company surges 24% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TODAY @ 11 AM ET: Please Join Our Virtual Call to Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / US3755581036 / HTBX.OQ / US62818Q1040 / MRKR.OQ / IMAB.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Heat Biologics Inc / Mustang Bio Inc / Marker Therapeutics Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2367026 / 2516152 / 2000019 / 2496113 / 2486813 / 2973821 / 2216850 / 2280220 / 2270726 / 2542049 / 2317087 / 2328915 / 2369174 / 2707677 / 2730190 / 2138158 / 2829601 / 7123870 / B121557 / B1Y9TB3 / 2857817 / 2951452 / B7TL820 / B7VD3F2 / B8CKK03 / B3V9F12 / BDZCRX3 / BYRY499 / BYY8XK8 / BYVY8G0 / BYW36M8 / BYQHP96 / BXDZ9Z0 / BYNZGK1 / BK7Y2V9 / BJ1N1M9 / BD8DJ71 / BJJMGL2 / BGSP7M9 / BJDX8Y8 / BJMLSD2 / BMG75B4 / BGT0PL8 / BD8QGD5 / BD72R64 / BFY7DC4 / BMCC9R7 / BMC8SQ7</td><td class="leftalignment">General Mills Inc / Eli Lilly and Co / Amazon.com Inc / Kohls Corp / Kellogg Co / Alliant Energy Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Gilead Sciences Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Nestle SA / Mastercard Inc / Danone SA / Netflix Inc / J M Smucker Co / Meta Platforms Inc / Duke Energy Corp / Mondelez International Inc / PVH Corp / RingCentral Inc / Kraft Heinz Co / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Shopify Inc / Block Inc / Akero Therapeutics Inc / Capri Holdings Ltd / Snap Inc / Fox Corp / Zoom Video Communications Inc / Mirum Pharmaceuticals Inc / Karuna Therapeutics Inc / Inventiva SA / DiaMedica Therapeutics Inc / Liberty Media Corp / Liberty Media Corp / Altimmune Inc / SCYNEXIS Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Eli Lilly and Company JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: ADA Panel Comfortable With Tirzepatide's Safety Profile; SURPASS 3 & 5 Data Robust... Focus Shifting to Obesity/NASH</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIN / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / LOW=US / LEG=US / LSTR=US / VMC=US / HUM=US / MLM=US / AMED=US / SWIM=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HXL=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / SPR=US / DIN=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / LHCG=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / JACK=US / TREX=US / WWD=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / RLMD=US / ETSY=US / WING=US / EDIT=US / NTLA=US / 82982L103 / CRSP=US / JELD=US / FERG=US / PNTG=US / ARQT=US / AZEK=US / AVAH=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Leggett & Platt Inc / Landstar System Inc / Vulcan Materials Co / Humana Inc / Martin Marietta Materials Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Spirit AeroSystems Holdings Inc / Dine Brands Global Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / Jack in the Box Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / ETSY Inc / Wingstop Inc / Editas Medicine Inc / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Ferguson PLC / Pennant Group Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2113393 / 2280220 / 2270726 / 2576941 / 2670519 / 2100920 / 2369174 / 2455965 / 2471950 / 2689560 / 2672689 / 2684703 / 2707677 / 2138158 / 2825933 / 2829601 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / BCZS820 / BDZCRX3 / BYVY8G0 / BYW36M8 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BHC8X90 / BD8DJ71 / BMQ5T49 / BWFKZT2 / BJJMGL2 / BKTNTR9 / BGSP7M9</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / Biogen Inc / Incyte Corp / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Fate Therapeutics Inc / RingCentral Inc / Alphabet Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / JNJ / PDSB</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / PDS Biotechnology Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PAHC-US -  Dividend Quality Analysis, for the period ended June 23,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PAHC.O / ADM / LLY / MRK / ICCC.O / HSKA.O / ZTS</td><td class="leftalignment">Phibro Animal Health Corp / Archer-Daniels-Midland Co / Eli Lilly and Co / Merck & Co Inc / ImmuCell Corp / Heska Corp / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - Mid-Year Updates Include ZN-c5 New Data; ZN-c3 Pivotal Trial Initiated</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMQ5T49 / 5671735 / 0989529 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US1101221083 / US1924221039 / US3695501086 / US37733W1053 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US87612E1064 / US8832031012 / CA0977512007 / US4771431016 / US4198791018 / US80105N1054 / US31620M1062 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US29082A1079 / US00287Y1091 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US70450Y1038 / US5588681057 / US8760301072 / US5904791358 / US28414H1032 / US76156B1070 / US88339P1012 / US26142R1041 / US12769G1004 / CA67079A1021 / US05875B1061 / US73739W1045 / BMG6964L1072</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cognex Corp / General Dynamics Corp / GlaxoSmithKline PLC / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Target Corp / Textron Inc / Bombardier Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Embraer SA / Abbvie Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / PayPal Holdings Inc / Madrigal Pharmaceuticals Inc / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Revolve Group Inc / RealReal Inc / DraftKings Inc / Caesars Entertainment Inc / Nuvei Corp / Bally's Corp / Poshmark Inc / Paysafe Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2516152 / 2000019 / 2973821 / 2065159 / 2437071 / 2280220 / 2270726 / 2829515 / 2455965 / 2459020 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 2895163 / B00FWN1 / B125XQ6 / 2983563 / B6197Q2 / B87ZMX0 / B95N910 / B424494 / BFZCHN7 / BYVY8G0 / BS7K7C9 / BF4VBS8 / BXDZ9Z0 / BK0VHF6 / BD8DJ71 / BLGJ610 / BGSP7M9 / BZ1LFG7 / BMDCDP2 / BMC8SQ7 / BNTB3N8 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Alliant Energy Corp / Autodesk Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Edison International / Biogen Inc / Intuit Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / United Natural Foods Inc / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Carmax Inc / Generac Holdings Inc / Palo Alto Networks Inc / PTC Inc / Splunk Inc / Wix.Com Ltd / Alphabet Inc / Nevro Corp / BioXcel Therapeutics Inc / Shopify Inc / IDEAYA Biosciences Inc / Snap Inc / Warner Music Group Corp / Zoom Video Communications Inc / Roku Inc / Bigcommerce Holdings Inc / BTRS Holdings Inc / Vizio Holding Corp / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Learn your ADC</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, June 28 - Sunday, July 4</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX - Synthetic Lethal Targeting of DNA Damage "Repare"; Initiating Coverage with a BUY Rating and $46 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BLF0CW7 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2684703 / B6RS2B3 / BK0VHF6 / BMQ5T49 / BWY52P3</td><td class="leftalignment">Repare Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Clovis Oncology Inc / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's New, LLY Publishes More SURPASS Data That Supports Tirzepatide's Best-In-Class Potential</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 64</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ABBV Confident In Rinvoq New Indications Post Delay; KOLs Lean More Cautiously</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BSX=US / LLY=US / ADI=US / MDT=US / PD=US / AMZN=US / EBAY=US / INCY=US / CMA=US / BC=US / IART=US / PB=US / VRM=US / EWBC=US / TRMK=US / SPOT=US / UMPQ=US / EXPE=US / W=US / WTFC=US / ARCC=US / BNL=US / CCL=US / CSTR=US / DRI=US / AJG=US / MAIN=US / ORCC=US / PACW=US / SNAP=US / TRIP=US / WAL=US / WIX=US / HTH=US / BXS=US / BKNG=US / CFR=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / BOKF=US / FB=US / FBK=US / MKL=US / ASB=US / SSB=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / PTON=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / FHN=US / APP=US / AINV=US / TXRH=US / RNST=US / MA=US / CADE=US / TAST=US / PNNT=US / NMTR=US / UTZ=US / KNSL=US / OAS=US / RLJ=US / ANGI=US / IBTX=US / GOOGL=US / TSLX=US / BABA=US / CMPR=US / UPLD=US / GDDY=US / GSBD=US / LOB=US / ACBI=US / TTD=US / CVNA=US / MBIN=US / 100088732 / SFIX=US / HWC=US / OZK=US / FTDR=US / EB=US / FSK=US / LYFT=US / UBER=US / ABNB=US / VMEO=US</td><td class="leftalignment">Boston Scientific Corp / Eli Lilly and Co / Analog Devices Inc / Medtronic PLC / PagerDuty Inc / Amazon.com Inc / eBay Inc / Incyte Corp / Comerica Inc / Brunswick Corp / Integra Lifesciences Holdings Corp / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Spotify Technology SA / Umpqua Holdings Corp / Expedia Group Inc / Wayfair Inc / Wintrust Financial Corp / Ares Capital Corp / Bunzl plc / Carnival Corp / CapStar Financial Holdings Inc / Darden Restaurants Inc / Arthur J Gallagher & Co / Main Street Capital Corp / Owl Rock Capital Corp / PacWest Bancorp / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Hilltop Holdings Inc / Cadence Bank / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / Meta Platforms Inc / FB Financial Corp / Markel Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Peloton Interactive Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Applovin Corp / Apollo Investment Corp / Texas Roadhouse Inc / Renasant Corp / Mastercard Inc / Cadence Bank / Carrols Restaurant Group Inc / Pennantpark Investment Corp / 9 Meters Biopharma Inc / UTZ Brands Inc / Kinsale Capital Group Inc / Oasis Petroleum Inc / RLJ Lodging Trust / Angi Inc / Independent Bank Group Inc / Alphabet Inc / Sixth Street Specialty Lending Inc / Alibaba Group Holding Ltd / Cimpress PLC / Upland Software Inc / GoDaddy Inc / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Trade Desk Inc / Carvana Co / Merchants Bancorp / First Horizon Corp / Stitch Fix Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Eventbrite Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: TTD, MDCA, MGNI, CELC, EVC, LRN, SHAK, FSLR, CYBE, KLIC, BTU, CEIX, DEN, SM, LPI, HASI, JYNT, SMTI, AMEH, BEAM, EDIT, CRSP, CLDX, XOMA, LLY, GSM, RAIL, CHS, LIVE, WISH, MOXC, OPRX, APPS, SEMR, XAIR, BMBL, ESEA, ZIM, SBLK,</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">LLY.N / 4FAP.F / 120357732 / BEAM.OQ / BMBL.OQ / BTU.N / CELC.OQ / CLDX.OQ / CRSP.BN / CYBE.OQ / EDIT.OQ / ESEA.OQ / EVC.N / FSLR.OQ / HASI.N / JYNT.OQ / KLIC.OQ / LRN.N / MAXN.OQ / MGNI.OQ / OPRX.OQ / RAIL.OQ / SEMR.N / SHAK.N / SMTI.OQ / TTD.OQ / XAIR.OQ / SM.N / XOMA.OQ / LIVE.OQ / LPI.N / ZBH.N / CEIX.N / GSM.AX / DEN.N</td><td class="leftalignment">Eli Lilly and Co / Star Bulk Carriers Corp / Moxian (BVI) Inc / Beam Therapeutics Inc / Bumble Inc / Peabody Energy Corp / Celcuity Inc / Celldex Therapeutics Inc / CRISPR Therapeutics AG / CyberOptics Corp / Editas Medicine Inc / Euroseas Ltd / Entravision Communications Corp / First Solar Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Joint Corp / Kulicke and Soffa Industries Inc / Stride Inc / Maxeon Solar Technologies Ltd / Magnite Inc / OPTIMIZERx Corp / FreightCar America Inc / SEMrush Holdings Inc / Shake Shack Inc / Sanara Medtech Inc / Trade Desk Inc / Beyond Air Inc / SM Energy Co / XOMA Corp / Live Ventures Inc / Laredo Petroleum Inc / Zimmer Biomet Holdings Inc / CONSOL Energy Inc / Golden State Mining Ltd / Denbury Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Singapore / United States / Marshall Islands</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AXP / 0989529 / 0925288 / 2516152 / 2000019 / 2640147 / 2219224 / 2280220 / 2270726 / 2455965 / 2471950 / 2705198 / 2829601 / 7103065 / 2857817 / B3D7K31 / B7TL820 / B85KFY9 / BFDV8K0 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BZ1HM42 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BYSGPK2 / BMDCDP2 / BJNQGL0 / BYXB1Y8 / BN7K304 / BJ9N563</td><td class="leftalignment">American Express Co / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Amazon.com Inc / Nike Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Biogen Inc / Incyte Corp / Progress Software Corp / Southern Co / Novartis AG / Netflix Inc / Discovery Inc / Meta Platforms Inc / Five Below Inc / MacroGenics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Adyen NV / Fox Corp / ViacomCBS Inc / Roku Inc / ViewRay Inc / Bigcommerce Holdings Inc / Rite Aid Corp / Sunrun Inc / Academy Sports and Outdoors Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / CUTR.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / LPCN.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / CERC.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Avalo Therapeutics Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Our Check-in With LLY Post "TRAILBLAZing" Update from FDA</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Yatin Suneja / Tarun Soni / Mr. Evan B. Wang / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Eli Lilly Receives FDA Breakthrough Therapy Designation for Alzheimer's Treatment</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Early Donanemab Filing Update Represents a Clear Positive</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY, BIIB, ROG: Donanemab a market leading product because of its differentiation? Coming early</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">532457108 / 09062X103 / ROG.S / 7110388</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss Current and Developing Treatments in Atopic Dermatitis and Psoriasis on Thursday, July 15 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARQT.O / JNJ / LLY / PFE / AMGN.O / INCY.O / ARNA.O / REGN.O / ACRS.O / EVLO.O / RAPT.O / PHGE.K / VYNE.O</td><td class="leftalignment">Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Incyte Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Aclaris Therapeutics Inc / Evelo Biosciences Inc / Rapt Therapeutics Inc / Biomx Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Alzheimer’s Space Heating Up Faster than Expected</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10 / 53245710</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Focus on reimbursement; multiple players are expected, we model competition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">LLY pursuing accelerated approval of donanemab</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">FDA Opens the Flood Gates in Alzheimer's, Grants BTD to BIIB/Eisai's BAN2401 and LLY's Donanemab; LLY to File for Accelerated Approval by YE21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / BIIB.OQ / 2516152 / 2455965</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">KOL Checks Post Release Of FDA Memos Suggest Path For Donanemab; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">600276.SS: Jiangsu Hengrui Medicine Co. Ltd - Deep-dive for innovative drug pipeline supporting upside; reiterate OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">600276.SS / 1093.HK / 4503.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / 600267.SS / 0867.HK / 4568.T / 3933.HK / BAYGN.DE / 0460.HK / 601607.SS / 002422.SZ / 300003.SZ / 2607.HK / ABBV.N / 1513.HK / 2186.HK / 1530.HK / 1558.HK / BGNE.OQ / 300558.SZ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / CSPC Pharmaceutical Group Ltd / Astellas Pharma Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / Zhejiang Hisun Pharmaceutical Co Ltd / China Medical System Holdings Ltd / Daiichi Sankyo Co Ltd / United Laboratories International Holdings Ltd / Bayer AG / Sihuan Pharmaceutical Holdings Group Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Lepu Medical Technology Beijing Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Abbvie Inc / Livzon Pharmaceutical Group Inc / Luye Pharma Group Ltd / 3SBio Inc / YiChang HEC ChangJiang Pharmaceutical Co Ltd / Beigene Ltd / Betta Pharmaceuticals Co Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company climbs 9.7% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / GILD=US / LOW=US / LEG=US / VMC=US / MLM=US / SWIM=US / CBRL=US / CW=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / CRTO=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / RCUS=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / UPLD=US / SHAK=US / WING=US / EVRI=US / 82982L103 / JELD=US / FOCS=US / UBER=US / FERG=US / ARQT=US / AZEK=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Gilead Sciences Inc / Lowe's Companies Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Criteo SA / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Upland Software Inc / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Focus Financial Partners Inc / Uber Technologies Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2008154 / 2544960 / 2280220 / 2270726 / 2670519 / 2342034 / 2684703 / 2440637 / 2829601 / 7103065 / B121557 / 2769796 / B02R1L6 / B3D7K31 / B03PGL4 / B7VD3F2 / BYW36M8 / BXDZ9Z0 / BHC8X90 / BKDS4H5 / BMYML02 / BLGJ610 / BFNR303 / BKTNTR9 / BJVR9Y9 / BP3YM85 / BZ1LFG7 / BQXZP64 / BP8XZL1 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Adobe Inc / Beasley Broadcast Group Inc / DTE Energy Co / Walt Disney Co / Exelon Corp / Fiserv Inc / Pfizer Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / ALLETE Inc / Discovery Inc / NorthWestern Corp / Duke Energy Corp / PayPal Holdings Inc / Shopify Inc / Novo Nordisk A/S / Bill.com Holdings Inc / DraftKings Inc / Warner Music Group Corp / Northwest Natural Holding Co / ViacomCBS Inc / iHeartMedia Inc / Trupanion Inc / Roku Inc / Wayfair Inc / Healthequity Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Diabetes Drug/Device Expert Call : DXCM Leads in T1s, ABT Leads in T2s at Our Expert's Center; TNDM Leads in New Pumps; Indicates Preference for Trulicity vs. Ozempic</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT.N / DXCM.OQ / TNDM.OQ / LLY.N / MDT.N / NOVOB.CO / YPSN.S / PODD.OQ / SENSI.S</td><td class="leftalignment">Abbott Laboratories / Dexcom Inc / Tandem Diabetes Care Inc / Eli Lilly and Co / Medtronic PLC / Novo Nordisk A/S / Ypsomed Holding AG / Insulet Corp / Sensirion Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Matt S. Miksic / European Pharma Team / Vik Chopra / Herr. Christoph Gretler</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - CS forecasts 2.2% CAGR Rev Growth to 2030 range of 0% to 6.4% based on R&D success</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / CL.N / JNJ.N / LLY.N / MRK.N / OREP.PA / PFE.N / ULVR.L / PG.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BEIG.DE / ABBV.N / RKT.L</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / L'Oreal SA / Pfizer Inc / Unilever PLC / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Beiersdorf AG / Abbvie Inc / Reckitt Benckiser Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4523271090 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US34959E1091 / US9100471096 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US70438V1061 / CA0089118776 / US07725L1026 / KYG4740B1059 / US8760301072 / US5904791358 / US28414H1032 / US46583P1021 / US26142R1041 / US83089J1088 / US1241551027 / US30260D1037 / US82933R1005 / US23954D1090</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Fortinet Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paylocity Holding Corp / Air Canada / Beigene Ltd / Ichor Holdings Ltd / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Iveric Bio Inc / DraftKings Inc / Skywater Technology Inc / Butterfly Network Inc / Figs Inc / Singular Genomics Systems Inc / Day One Biopharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">V / 2516152 / 2000019 / 2008154 / 2026242 / 2113393 / 2280220 / 2270726 / 2317087 / 2670519 / 2328915 / 2342034 / 2100920 / 2689560 / 2048804 / 2829601 / B00FWN1 / B067BM3 / 2212922 / 2857817 / B125XQ6 / B02R1L6 / B03PGL4 / 2949758 / B7TL820 / B7VD3F2 / BYVY8G0 / BYVYD43 / BXDZ9Z0 / BMYML02 / BJJMGL2 / BZ1LFG7 / BGKG6M3 / BN0XTW4 / BMBP1Q0 / BMXXBD9</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / American Electric Power Company Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / PG&E Corp / Pinnacle West Capital Corp / Southern Co / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / NRG Energy Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / NorthWestern Corp / Nexstar Media Group Inc / Meta Platforms Inc / Duke Energy Corp / Alphabet Inc / Performance Food Group Co / Shopify Inc / DraftKings Inc / Fox Corp / Roku Inc / StoneCo Ltd / Orphazyme A/S / Flywire Corp / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: From LGBT 350 to LGBT 400:  Pride and corporate performance</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0005.HK / 4502.T / 4503.T / 6702.T / AIRP.PA / BARC.L / BNPP.PA / C.N / CAH.N / CAPP.PA / COF.N / CSGN.S / DOW.N / ECL.N / ERICB.ST / EXHO.PA / GM.N / HSBA.L / JNJ.N / JPM.N / LLY.N / MCK.N / NOC.N / PRTP.PA / PSON.L / PUBP.PA / RAND.AS / RR.L / SBRY.L / SCHN.PA / SOGN.PA / STAN.L / T.N / ULVR.L / USB.N / VOD.L / WFC.N / WMT.N / WPP.L / HUM.N / DELL.N / AZN.L / NOK.N / SASY.PA / ATOS.PA / DHR.N / SIEGN.DE / DBKGN.F / LOW.N / NOVN.S / LH.N / EMR.N / NOKIA.HE / NG.L / VZ.N / ACN.N / GSK.L / MTB.N / ABC.N / CVX.N / MCO.N / AV.L / AAPL.OQ / AMAT.OQ / LRCX.OQ / MSFT.OQ / INTU.OQ / DFS.N / CTXS.OQ / AMZN.OQ / NVDA.OQ / TXN.OQ / 005930.KS / CMCSA.OQ / NDAQ.OQ / TEVA.N / MA.N / ERIC.OQ / CRSL.NS / BAES.L / MQG.AX / ABI.BR / BASFN.F / SHLG.DE / MPC.N / VAC.N / CSTM.N / CDW.OQ / GOOGL.OQ / ANTM.N / UBSG.S / PAGE.L / EQH.N / EXC.OQ / J.N / PSFE.N</td><td class="leftalignment">HSBC Holdings PLC / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Fujitsu Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Barclays PLC / BNP Paribas SA / Citigroup Inc / Cardinal Health Inc / Capgemini SE / Capital One Financial Corp / Credit Suisse Group AG / Dow Inc / Ecolab Inc / Telefonaktiebolaget LM Ericsson / Sodexo SA / General Motors Co / HSBC Holdings PLC / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Mckesson Corp / Northrop Grumman Corp / Kering SA / Pearson PLC / Publicis Groupe SA / Randstad NV / Rolls-Royce Holdings PLC / J Sainsbury PLC / Schneider Electric SE / Societe Generale SA / Standard Chartered PLC / AT&T Inc / Unilever PLC / US Bancorp / Vodafone Group PLC / Wells Fargo & Co / Walmart Inc / WPP PLC / Humana Inc / Dell Technologies Inc / AstraZeneca PLC / Nokia Oyj / Sanofi SA / Atos SE / Danaher Corp / Siemens AG / Deutsche Bank AG / Lowe's Companies Inc / Novartis AG / Laboratory Corporation of America Holdings / Emerson Electric Co / Nokia Oyj / National Grid PLC / Verizon Communications Inc / Accenture PLC / GlaxoSmithKline PLC / M&T Bank Corp / Amerisourcebergen Corp / Chevron Corp / Moody's Corp / Aviva PLC / Apple Inc / Applied Materials Inc / Lam Research Corp / Microsoft Corp / Intuit Inc / Discover Financial Services / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Texas Instruments Inc / Samsung Electronics Co Ltd / Comcast Corp / Nasdaq Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Telefonaktiebolaget LM Ericsson / CRISIL Ltd / BAE Systems PLC / Macquarie Group Ltd / Anheuser Busch Inbev SA / BASF SE / Siemens Healthineers AG / Marathon Petroleum Corp / Marriott Vacations Worldwide Corp / Constellium SE / CDW Corp / Alphabet Inc / Anthem Inc / UBS Group AG / Pagegroup PLC / Equitable Holdings Inc / Exelon Corp / Jacobs Engineering Group Inc / Paysafe Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Switzerland / Germany / Finland / France / United Kingdom / India / Ireland / Israel / Japan / Korea, Republic of / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Environmental, Social, Governance</td><td class="leftalignment">Bahar Sezer Longworth / Eugene Klerk / Akanksha Kharbanda</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Highlights from Our Guggenheim BioPharma Strategy Series Discussion with CSO, Dr. Dan Skovronsky</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, June 21 - Sunday, June 27</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Eli Lilly and Company (LLY) - Revenue growth of 52% from core business in Q1FY21</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 63</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 6.18.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 00282410 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 58949210 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710 / 00288U10 / 90184D10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Abbott Laboratories / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc / Abcellera Biologics Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1171</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Jun. 18, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">礼来公司-管线药物显示出潜力-06/17/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">2</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chloe Kim</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2434209 / 2516152 / 2280220 / 2270726 / 2670519 / 2328915 / 2369174 / 2455965 / 2689560 / 2829601 / B1F76F9 / B02R1L6 / B03PGL4 / 2949758 / B7TL820 / B783TY6 / B7VD3F2 / BFDV8K0 / BFLR866 / BYVY8G0 / BXDZ9Z0 / BF5L3T2 / BD9GVY0 / BJFSR88 / BWY52P3 / BN4RD42 / BFY7DC4 / BN4NJG4 / BMF1LH5</td><td class="leftalignment">American Express Co / Home Depot Inc / Eli Lilly and Co / DTE Energy Co / Walt Disney Co / Exelon Corp / Nextera Energy Inc / Gilead Sciences Inc / Biogen Inc / PG&E Corp / Southern Co / Western Union Co / ALLETE Inc / NorthWestern Corp / Nexstar Media Group Inc / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / MacroGenics Inc / Twitter Inc / Alphabet Inc / Shopify Inc / Elanco Animal Health Inc / Zai Lab Ltd / Uniqure NV / Blueprint Medicines Corp / CureVac NV / Altimmune Inc / Freeline Therapeutics Holdings PLC / Honest Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / MCD=US / OXY=US / RRC=US / WEN=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / PB=US / IGT=US / MGY=US / SWN=US / MUR=US / EWBC=US / BRO=US / BYD=US / UMPQ=US / MRO=US / EXPE=US / MGM=US / PENN=US / CBRL=US / CNX=US / DRI=US / EQIX=US / EQT=US / AJG=US / MCRI=US / PACW=US / REGI=US / TRIP=US / WAL=US / CVX=US / SGMS=US / BXS=US / BKNG=US / SNV=US / FBK=US / MKL=US / PRA=US / CATY=US / COP=US / DIN=US / PNFP=US / RRR=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / CZR=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / GPRE=US / TAST=US / QSR=US / CLR=US / NMTR=US / NOG=US / JACK=US / KNSL=US / AR=US / ESTE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / ABBV=US / NDLS=US / FATE=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / DEA=US / WING=US / ARGX=US / WLTW=US / CDEV=US / TRVG=US / PVAC=US / SBOW=US / HWC=US / OZK=US / RTLR=US / AHCO=US / OVV=US / ARQT=US / DKNG=US / ZI=US / BALY=US / ABNB=US / VMEO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / East West Bancorp Inc / Brown & Brown Inc / Boyd Gaming Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / Equinix Inc / EQT Corp / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / Renewable Energy Group Inc / Tripadvisor Inc / Western Alliance Bancorp / Chevron Corp / Scientific Games Corp / Cadence Bank / Booking Holdings Inc / Synovus Financial Corp / FB Financial Corp / Markel Corp / ProAssurance Corp / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Red Rock Resorts Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / Caesars Entertainment Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Easterly Government Properties Inc / Wingstop Inc / argenx SE / Willis Towers Watson PLC / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / SilverBow Resources Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Adapthealth Corp / Ovintiv Inc / Arcutis Biotherapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Bally's Corp / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2008154 / 2050832 / 2026242 / 2216850 / 2280220 / 2270726 / 2328915 / 2100920 / 2680905 / 2684703 / 2707677 / 2829601 / 7103065 / B067BM3 / B125XQ6 / B02R1L6 / B3D7K31 / B03PGL4 / BVVN4Q8 / BJLFHW7 / BFZ1K46 / BMYML02 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BGKG6M3 / BN2S6Y8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Molson Coors Beverage Co / Portland General Electric Co / ALLETE Inc / Discovery Inc / NorthWestern Corp / Eversource Energy / Chewy Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / StoneCo Ltd / Talaris Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Pay for performance: CEO compensation</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : FAQs Post the Aducanumab Approval and Ahead of ADA - We Continue to See a Favorable Risk/Reward</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments, Wednesday June 30th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / BSLN.S / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: to Discuss European Hematology Association (EHA) Highlights at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / MRK.N / 0715.HK / LLY.N / PFE.N / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / China Oceanwide Holdings Ltd / Eli Lilly and Co / Pfizer Inc / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US09058V1035 / US1101221083 / US37733W1053 / US45337C1027 / US4663671091 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9699041011 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US90384S3031 / US58933Y1055 / US9100471096 / US00287Y1091 / US98978V1035 / IE00B4Q5ZN47 / US8485771021 / US21240E1055 / CA05156V1022 / US02376R1023 / IE00BQPVQZ61 / CA0089118776 / US07725L1026 / US74967X1037 / US5904791358 / US28414H1032 / US0144421072 / US98420X1037 / US26142R1041</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Incyte Corp / Jack in the Box Inc / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Williams-Sonoma Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / Zoetis Inc / Jazz Pharmaceuticals PLC / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Horizon Therapeutics PLC / Air Canada / Beigene Ltd / RH / Mesa Air Group Inc / Elanco Animal Health Inc / Alector Inc / X4 Pharmaceuticals Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 14 Jun): Sector roars back to life</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / LLY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 3626.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Eli Lilly and Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / TIS Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Biologics Sector - Regkirona Ph-3 topline data read; key findings from the confirmatory trial and read-through to share price direction - Initial take</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">068270.KS / 091990.KQ / LLY.N / GSK.L / REGN.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月14日～）: 息を吹き返したセクターパフォーマンス</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / LLY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 3626.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Eli Lilly and Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / TIS Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, June 14 - Sunday, June 20</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 62</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BMY ASCO Call Highlights; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US1101221083 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Upgrading to Outperform: Raise TP, upgrade on approval of Aduhelm for Alzheimer's disease</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4523.T / 4519.T / LLY.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Chugai Pharmaceutical Co Ltd / Eli Lilly and Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / CUTR.O / BSLN.S / MNKD.O / SIBN.MM / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / CERC.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Gazprom Neft' PAO / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / Avalo Therapeutics Inc / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Russian Federation / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">NVS ASCO Call Highlights; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US66987V1098 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Novartis AG / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Samsung Biologics (207940.KS, Not Covered) - 2021 Asia Healthcare Corporate Day takeaways</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">207940.KS / LLY.N / GSK.L / BIIB.OQ / MRNA.OQ</td><td class="leftalignment">Samsung Biologics Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / CUTR.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / CERC.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Avalo Therapeutics Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Jun. 09, 2021 / 8:50AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2065159 / 2216850 / 2270726 / 2542049 / 2829515 / 2576941 / 2328915 / 2455965 / 2457864 / 2689560 / 2684703 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / BBGVT40 / BYVY8G0 / BP4GNK9 / BYNZGK1 / BJ2Z0H2 / BMQ5T49 / BFMXGR0 / BFNR303 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDVLM39 / BP8XZL1 / BMG5660</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / News Corp / Alphabet Inc / SAGE Therapeutics Inc / Block Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Northwest Natural Holding Co / ViacomCBS Inc / Roku Inc / Alphabet Inc / argenx SE / Healthequity Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: BIIB's Broad Aduhelm Label a Positive Surprise for BIIB, and a Potentially Positive Development for LLY and Other Biotechs; PT Raised to $246/shr</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2516152 / BIIB.OQ / 2455965</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BAYRY-US -  Dividend Quality Analysis, for the period ended May 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BAYRY.PK / JNJ / LLY / MRK / NVS / PFE / GSK / REGN.O / NKTR.O / TEVA.K / SNY.O</td><td class="leftalignment">Bayer AG / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US -  Dividend Quality Analysis, for the period ended May 26,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended June 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : FDA Shift To Plaque Reduction Surrogate Represents A Clear Positive For Donanemab</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB, LLY, ROG: Aducanumab approved, BROAD ramifications – see our category forecasts here</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">532457108 / 09062X103 / ROG.S / 7110388</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Aducanumab approval bodes well for donanemab</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: KOL Video Call To Discuss ASCO Highlights at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM / JNJ / LLY / MRK / PFE / GILD.O / US75886F1075 / BSLN.S / HTBX.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Basilea Pharmaceutica AG / Heat Biologics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments, Wednesday June 30th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARAV.OQ / IMAB.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / BSLN.S / HGEN.OQ</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BE0165385973 / US0091581068 / US00971T1016 / US0116591092 / US0311621009 / US0323325045 / US0463531089 / US0997241064 / US1101221083 / US17275R1023 / US2310211063 / US34354P1057 / US37733W1053 / US45167R1041 / US4523271090 / US45337C1027 / US4657411066 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8835561023 / US92343V1044 / US9427491025 / CA8265161064 / US30063P1057 / US00508Y1029 / US4771431016 / US4198791018 / US80105N1054 / US64111Q1040 / US1281261099 / US79466L3024 / US6866881021 / US2538681030 / US00206R1023 / US6247581084 / PAP310761054 / US16115Q3083 / US3364331070 / US01748X1028 / US2473617023 / US53261M1045 / US90384S3031 / US1940141062 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US69404D1081 / US92839U2069 / US8676524064 / JE00B783TY65 / US98419M1009 / US00287Y1091 / US98978V1035 / US8725901040 / US72919P2020 / US64051T1007 / US29355A1079 / US23283R1005 / US41068X1000 / US8485771021 / US21240E1055 / US5560991094 / US02376R1023 / IE00BLS09M33 / US0404131064 / CA0089118776 / US29444U7000 / US46185L1035 / US83417M1045 / US6323071042 / US98138J2069 / US45073V1089 / US34959J1088 / US87266J1043 / US36165L1089 / US45782B1044 / NL0012169213 / US87105L1044 / US8760301072 / US30057T1051 / US4622601007 / US05351X1019 / CH0371153492 / US92336X1090 / US0937121079 / US5904791358 / US28414H1032 / KY30744W1070 / US40131M1099 / US35952H6018 / US71535D1063 / US1567271093 / US23725P2092 / US92537N1081 / US26142R1041 / US6541101050 / US12233L1070 / US04271T1007 / KYG3902L1095 / US5502411037 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036</td><td class="leftalignment">Melexis NV / Air Products and Chemicals Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Amtech Systems Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cisco Systems Inc / Cummins Inc / Flowserve Corp / GlaxoSmithKline PLC / IDEX Corp / Illumina Inc / Incyte Corp / Itron Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Thermo Fisher Scientific Inc / Verizon Communications Inc / Watts Water Technologies Inc / Sierra Wireless Inc / Exact Sciences Corp / Acuity Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / NETGEAR Inc / CalAmp Corp / Salesforce.Com Inc / Ormat Technologies Inc / Digital Realty Trust Inc / AT&T Inc / Mueller Water Products Inc / Copa Holdings SA / Chart Industries Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Ulta Beauty Inc / Colfax Corp / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Xylem Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / Plug Power Inc / NeoPhotonics Corp / Enphase Energy Inc / CyrusOne Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / Pentair PLC / Arista Networks Inc / Air Canada / Equinix Inc / Invitae Corp / Solaredge Technologies Inc / Natera Inc / Workhorse Group Inc / ITT Inc / Fortive Corp / TPI Composites Inc / GDS Holdings Ltd / Inseego Corp / Qiagen NV / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Iovance Biotherapeutics Inc / Avaya Holdings Corp / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Mesa Air Group Inc / Elanco Animal Health Inc / Farfetch Ltd / Guardant Health Inc / Fuelcell Energy Inc / Personalis Inc / Cerence Inc / DarioHealth Corp / Vertiv Holdings Co / DraftKings Inc / Nikola Corp / Burning Rock Biotech Ltd / Array Technologies Inc / GDS Holdings Ltd / Lumen Technologies Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / MRK=US / LLY=US / PEP=US / AMGN=US / CAG=US / KO=US / CL=US / PG=US / T=US / INCY=US / GILD=US / ENR=US / MANH=US / NWL=US / FLO=US / STZ=US / PATH=US / ENV=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / REGN=US / SMG=US / FOUR=US / POST=US / GPN=US / SNV=US / AUTL=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / FRPT=US / DENN=US / THS=US / FIS=US / ELF=US / TIL=US / AAN=US / UTZ=US / OLO=US / MEIP=US / ABBV=US / FATE=US / COUP=US / SQ=US / NTLA=US / IOVA=US / PETQ=US / EQH=US / KDP=US / BTAI=US / HARP=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Energizer Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / UiPath Inc / Envestnet Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shift4 Payments Inc / Post Holdings Inc / Global Payments Inc / Synovus Financial Corp / Autolus Therapeutics PLC / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Fidelity National Information Services Inc / elf Beauty Inc / Instil Bio Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / Coupa Software Inc / Block Inc / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Equitable Holdings Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Harpoon Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Equity Development</td><td class="leftalignment">Encouraging AGM and M3 updates</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">DEST=GB / LLY=US / GSK=GB</td><td class="leftalignment">Destiny Pharma PLC / Eli Lilly and Co / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andy Smith</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - ASCO 2021: Tecentriq in adjuvant lung cancer likely practice changing in a limited population</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - ASCO 2021 weekend takeaways</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - ASCO 2021 Weekend highlights</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, June 7 - Sunday, June 13</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 61</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Tafasitamab ASCO highlights - 3 year L-MIND & early first-MIND data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">INCY=US / LLY=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">FR0000120073 / DE0006231004 / US0079031078 / US0091581068 / US0530151036 / US0970231058 / US1005571070 / US1264081035 / US1727551004 / US1924461023 / US22284P1057 / US2310211063 / US2371941053 / US2545431015 / US3021301094 / US3377381088 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US5150981018 / US5324571083 / US5801351017 / US6558441084 / US67066G1040 / US6795801009 / US7043261079 / US8552441094 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US37940X1028 / US9884981013 / US21036P1084 / US09062X1037 / US1572101053 / US25754A2015 / US0042251084 / US02043Q1076 / US60871R2094 / US12541W2098 / US31620M1062 / US1696561059 / US78709Y1055 / US75025X1000 / US16115Q3083 / US3020811044 / US92932M1018 / US87874R1005 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US95058W1009 / US29414B1044 / US9837931008 / US98978V1035 / US72919P2020 / KYG037AX1015 / US70438V1061 / US70432V1026 / US03937C1053 / US98936J1016 / LU0974299876 / US0465131078 / US64829B1008 / CA76131D1033 / US8190471016 / US00653A1079 / US9741551033 / US70450Y1038 / US05464T1043 / US8522341036 / US00773U1088 / US90138F1021 / US2067871036 / CA87241L1094 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US03782L1017 / US4990491049 / US89854H1023 / US15677J1088 / US46571Y1073 / US2575541055 / US0937121079 / US29260V1052 / US28414H1032 / US0197701065 / IE00BZ12WP82 / US0144421072 / US09203E1055 / US39813G1094 / CH0499880968 / US90364P1057 / US92719V1008</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Infineon Technologies AG / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Automatic Data Processing Inc / Boeing Co / Boston Beer Company Inc / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Covenant Logistics Group Inc / Cummins Inc / Darden Restaurants Inc / Diodes Inc / Expeditors International of Washington Inc / Fiserv Inc / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / McDonald's Corp / Norfolk Southern Corp / NVIDIA Corp / Old Dominion Freight Line Inc / Paychex Inc / Starbucks Corp / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Yum! Brands Inc / Constellation Brands Inc / Biogen Inc / CEVA Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / CH Robinson Worldwide Inc / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Saia Inc / Radiant Logistics Inc / Chart Industries Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / TechTarget Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / Wendys Co / Epam Systems Inc / XPO Logistics Inc / Zoetis Inc / Plug Power Inc / Ambarella Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Zendesk Inc / Globant SA / Atara Biotherapeutics Inc / New Relic Inc / Restaurant Brands International Inc / Shake Shack Inc / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / Axsome Therapeutics Inc / Block Inc / Adverum Biotechnologies Inc / Twilio Inc / Conduent Inc / TFI International Inc / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Appian Corp / Knight-Swift Transportation Holdings Inc / TTEC Holdings Inc / Ceridian HCM Holding Inc / I3 Verticals Inc / Domo Inc / Bloom Energy Corp / Endava PLC / Elanco Animal Health Inc / Allogene Therapeutics Inc / Linde PLC / Alector Inc / Black Diamond Therapeutics Inc / Grid Dynamics Holdings Inc / ADC Therapeutics SA / UiPath Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2496113 / 2023607 / 2778844 / 2973821 / 2216850 / 2222631 / 2270726 / 2317087 / 2670519 / 2328915 / 2680905 / 2707677 / 2829601 / 7103065 / 2857817 / 2951452 / B0T7YX2 / B02R1L6 / B3D7K31 / B23FN39 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / BJ0KXV4 / B424494 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BKS3SM8 / BZ1HM42 / BFZ1K46 / BFMXGR0 / BJJMGL2 / BFWK4R7 / BL71K91 / BK71LY6 / BDRW1L7 / BKF9DQ8 / BNG3RZ7 / BMDJ085 / BMG5660 / BP8GHT2</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kohls Corp / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Cooper Companies Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PPL Corp / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Netflix Inc / J M Smucker Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / ONE Gas Inc / Splunk Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / IGM Biosciences Inc / Adyen NV / Spotify Technology SA / Evergy Inc / Fox Corp / PagSeguro Digital Ltd / Revolution Medicines Inc / WW International Inc / AnaptysBio Inc / Phreesia Inc / Leslie's Inc / Shoals Technologies Group Inc / Joann Inc / Vascular Biogenics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IGMS (BUY) - Mgmt Discussion Highlights Potential COVID-19 Prophylaxis Opportunity with IGM-6268, a New Pipeline Agent</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKS3SM8 / 0925288 / 2516152 / 2730190</td><td class="leftalignment">IGM Biosciences Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / KMI=US / V=US / LOW=US / HSII=US / LEG=US / KFRC=US / VMC=US / MLM=US / KFY=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAN=US / MAS=US / MRCY=US / MHK=US / ASGN=US / REGI=US / RHI=US / SMG=US / SHOP=US / TRIP=US / CGEN=US / CCRN=US / PYPL=US / AVTR=US / CRTO=US / NFLX=US / DIN=US / PTON=US / RNG=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / MA=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / KTOS=US / NXGN=US / JACK=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / PTCT=US / CEQP=US / FATE=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / BWXT=US / WING=US / 100095108 / 82982L103 / IRTC=US / JELD=US / ROKU=US / SYNH=US / MAXR=US / BTAI=US / FERG=US / LHX=US / IMVT=US / ARQT=US / SPCE=US / FBRX=US / AZEK=US / AFRM=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Kinder Morgan Inc / Visa Inc / Lowe's Companies Inc / Heidrick & Struggles International Inc / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Korn Ferry / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Robert Half International Inc / Scotts Miracle-Gro Co / Shopify Inc / Tripadvisor Inc / Compugen Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Avantor Inc / Criteo SA / Netflix Inc / Dine Brands Global Inc / Peloton Interactive Inc / RingCentral Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / NextGen Healthcare Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Bank of America Corp / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Roku Inc / Syneos Health Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Ferguson PLC / L3harris Technologies Inc / Immunovant Inc / Arcutis Biotherapeutics Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2701271 / 2126335 / 2516152 / 2000019 / 2486813 / 2002305 / 2973821 / 2050832 / 2216850 / 2270726 / 2670519 / 2684703 / 2048804 / 2707677 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / BFLR866 / BYRY499 / BTN1Y11 / BQPVQZ6 / BYVY8G0 / BNFWR44 / BWFKZT2 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BDVLM39 / BKWD3M9 / BGKG6M3 / BJRFSB7 / BMDJ085 / BMFPJK6</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / Costco Wholesale Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Abbott Laboratories / Alliant Energy Corp / Ameren Corp / Consolidated Edison Inc / Walt Disney Co / Exelon Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Twitter Inc / Kraft Heinz Co / Medtronic PLC / Horizon Therapeutics PLC / Alphabet Inc / Worldline SA / Cellectis SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Alphabet Inc / argenx SE / Progyny Inc / StoneCo Ltd / Immunovant Inc / Shoals Technologies Group Inc / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CAH.N / CC.N / CL.N / COF.N / CRM.N / ECL.N / EIX.N / EOG.N / F.N / FCX.N / FDX.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KMB.N / LLY.N / LMT.N / MRK.N / SC.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / AAL.L / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / NKE.N / LIN.N / OLN.N / IT.N / TGT.N / AVY.N / RKT.N / BLL.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / VFC.N / NRG.N / PWR.N / NEU.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / HAE.N / PVH.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / INTC.OQ / CTSH.OQ / ABMD.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / JKHY.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / SIVB.OQ / QDEL.OQ / QCOM.OQ / INTU.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / STLD.OQ / AMZN.OQ / LNG.A / MRCY.OQ / NVDA.OQ / SBAC.OQ / BMRN.OQ / PACW.OQ / TREE.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / TXN.OQ / CMCSA.OQ / BIIB.OQ / TPX.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / WAL.N / MS.N / FIS.N / STX.AX / RPRX.OQ / HES.N / MA.N / AWI.N / FSLR.OQ / CNK.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / NEE.N / TSLA.OQ / LPLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / LDOS.N / RNG.N / COMM.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / SQ.N / IONS.OQ / IAC.OQ / TTD.OQ / COUP.OQ / UAA.N / AYX.N / DXC.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / QRTEA.OQ / FB.PS / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / LMND.N / AMWL.N / VTRS.OQ / HON.OQ</td><td class="leftalignment">Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Cardinal Health Inc / Chemours Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Linde PLC / Olin Corp / Gartner Inc / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / VF Corp / NRG Energy Inc / Quanta Services Inc / NewMarket Corp / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Haemonetics Corp / PVH Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Jack Henry & Associates Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Quidel Corp / Qualcomm Inc / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Lendingtree Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Western Alliance Bancorp / Morgan Stanley / Fidelity National Information Services Inc / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Cinemark Holdings Inc / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / LPL Financial Holdings Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / Leidos Holdings Inc / RingCentral Inc / CommScope Holding Company Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Block Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Trade Desk Inc / Coupa Software Inc / Under Armour Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Lemonade Inc / American Well Corp / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0116591092 / US0970231058 / US5002551043 / US5324571083 / US6556641008 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US58933Y1055 / US9100471096 / US98419M1009 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Alaska Air Group Inc / Boeing Co / Kohls Corp / Eli Lilly and Co / Nordstrom Inc / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Merck & Co Inc / United Airlines Holdings Inc / Xylem Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Animal Health A Near $37B WW Market Poised For Continued +4-6% Growth</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US5324571083 / US58933Y1055 / US98978V1035 / US28414H1032</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Sanofi - Read across from Kyowa Kirin/Amgen collaboration for OX-40 in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SASY.PA / LLY.N / AZN.L / 4151.T / REGN.OQ / ALM.MC</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / AstraZeneca PLC / Kyowa Kirin Co Ltd / Regeneron Pharmaceuticals Inc / Almirall SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Spain / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Tuesday, June 1 - Sunday, June 6</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IMAB.O / JNJ / LLY / MRK / PFE / US3755581036 / BSLN / HCM.O / MBIO.O</td><td class="leftalignment">I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company climbs 12.3% from 4 week low</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.28.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, May 26, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company dips 1.8% in past quarter; Institutional Ownership up 2%</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / LSI=US / PFE=US / AMGN=US / BMY=US / MCD=US / WEN=US / INCY=US / CHKP=US / IART=US / MAC=US / BMRN=US / BNL=US / CBRL=US / CRL=US / DRI=US / EXEL=US / NOW=US / REGI=US / STOR=US / PSA=US / NET=US / OFC=US / SRC=US / NTRA=US / DIN=US / RPD=US / BIIB=US / EXR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / CMG=US / REX=US / GPRE=US / EHTH=US / OC=US / TAST=US / QSR=US / JACK=US / NEO=US / CUBE=US / PANW=US / ABBV=US / NDLS=US / FEYE=US / VRNS=US / 00770K202 / LOCO=US / SHAK=US / NSA=US / WING=US / LOB=US / ZS=US / LGF.B=US / OKTA=US / YEXT=US / SAIL=US / TENB=US / CRWD=US / ARQT=US / 96758W101 / VTRS=US / ABNB=US / HYFM=US / HIMS=US / KNBE=US</td><td class="leftalignment">Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Wendys Co / Incyte Corp / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Macerich Co / Biomarin Pharmaceutical Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Charles River Laboratories International Inc / Darden Restaurants Inc / Exelixis Inc / ServiceNow Inc / Renewable Energy Group Inc / STORE Capital Corp / Public Storage / Cloudflare Inc / Corporate Office Properties Trust / Spirit Realty Capital Inc / Natera Inc / Dine Brands Global Inc / Rapid7 Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / eHealth Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Neogenomics Inc / CubeSmart / Palo Alto Networks Inc / Abbvie Inc / Noodles & Co / Mandiant Inc / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / National Storage Affiliates Trust / Wingstop Inc / Live Oak Bancshares Inc / Zscaler Inc / Lions Gate Entertainment Corp / Okta Inc / Yext Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc / WideOpenWest Inc / Viatris Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Hims & Hers Health Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2973821 / 2942605 / 2317087 / 2576941 / 2100920 / 2459020 / 2657802 / 2684703 / 2048804 / 2440637 / 2138158 / 2829601 / 7103065 / B125XQ6 / B02R1L6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BK7Y2V9 / BD8DJ71 / BJ2Z0H2 / BFMXGR0 / BYY88Y7 / BK71LY6 / BMG75B4 / BKLCX50 / BMTVQT8 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Alliant Energy Corp / Avista Corp / Entergy Corp / Exelixis Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sempra Energy / Southern Co / Novartis AG / Portland General Electric Co / ALLETE Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Akero Therapeutics Inc / Snap Inc / Pinterest Inc / Evergy Inc / Alphabet Inc / WW International Inc / Inventiva SA / Health Catalyst Inc / Goodrx Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NBIX-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NBIX.O / LLY / PFE / PTN / RGEN.O / RPRX.O / ATHX.O / ANIP.O / ABBV.K / CASI.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Eli Lilly and Co / Pfizer Inc / Palatin Technologies Inc / Repligen Corp / Royalty Pharma PLC / Athersys Inc / ANI Pharmaceuticals Inc / Abbvie Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call on New and Emerging Heme Malignancy Treatments | 5/27 @ 11am ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US62818Q1040 / MRKR.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / BSLN.S / ARAV.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Mustang Bio Inc / Marker Therapeutics Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0079731008 / US0116591092 / US0311001004 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1925761066 / US37733W1053 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5951121038 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US91347P1057 / US9282981086 / US9581021055 / US9699041011 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US79466L3024 / US6098391054 / US82706C1080 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US0995021062 / US7512121010 / US00287Y1091 / NL0010273215 / US98978V1035 / US98138H1014 / US55405Y1001 / US8486371045 / KYG037AX1015 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / CA0089118776 / US74736K1016 / IE00BTN1Y115 / CA1380351009 / US40434L1052 / KYG4740B1059 / US74967X1037 / US11135F1012 / US2575541055 / US5904791358 / US28414H1032 / US24703L2025 / US85205L1070 / US75943R1023 / US8334451098 / US5738741041 / US30320C1036 / US83089J1088 / IE00BKVD2N49</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / AMETEK Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Cohu Inc / GlaxoSmithKline PLC / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vishay Intertechnology Inc / Western Digital Corp / Williams-Sonoma Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Abbvie Inc / ASML Holding NV / Zoetis Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Ambarella Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / Air Canada / Qorvo Inc / Medtronic PLC / Canopy Growth Corp / HP Inc / Ichor Holdings Ltd / RH / Broadcom Inc / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Dell Technologies Inc / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Snowflake Inc. / Marvell Technology Inc / FTC Solar Inc / Skywater Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2973821 / 2270726 / 2670519 / 2369174 / 2459020 / 2657802 / 2048804 / 2829601 / 2928683 / 2980906 / 7103065 / B125XQ6 / B0T7YX2 / B02R1L6 / B3D7K31 / 2949758 / B7TL820 / BCZS820 / B87ZMX0 / BYVY8G0 / BXDZ9Z0 / BYNZGK1 / BFZNYB7 / BDHF4K6 / BHC8X90 / BD8DJ71 / BWFKZT2 / BFMXGR0 / BKTNTR9 / BMDJ085</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Exelon Corp / Gilead Sciences Inc / Intuit Inc / OGE Energy Corp / Pinnacle West Capital Corp / Southern Co / VF Corp / Foot Locker Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Nexstar Media Group Inc / Meta Platforms Inc / Fate Therapeutics Inc / Palo Alto Networks Inc / Alphabet Inc / Shopify Inc / Block Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Cellectis SA / Evergy Inc / ViacomCBS Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Global Pharma Model Sweep: Reopening and Washington Headwinds Should Abate in 2H21 as Key Potential Catalysts Approach</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Pharma : Relative Valuation Finally Finding A Bottom?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N / LLY.N / ENDP.O / IDXX.O / HSKA.O / TEVA.N / HZNP.O / ABBV.N / ZTS.N / PRGO.N / AMRX.N / BHC.N / ELAN.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Endo International PLC / IDEXX Laboratories Inc / Heska Corp / Teva Pharmaceutical Industries Ltd / Horizon Therapeutics PLC / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova / Xiling Chen</td></tr>
<tr class="even"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, May 24 - Sunday, May 30</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : Updated Credit Views from the "USD HG Coverage and Rating Report"</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABC.N / AMGN.O / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CI.N / JNJ.N / LLY.N / MCK.N / MRK.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / BIIB.O / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amerisourcebergen Corp / Amgen Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Biogen Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / MRKR.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / Marker Therapeutics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Why LLY Keeps SURPASSing The Competition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstracts And Our Take On The Data</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Abstracts Review: Few Surprises Overall, but BMY's Relatlimab Looks Additive to Us</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Bristol-Myers Squibb Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Innovent: FDA acceptance of PD-1 BLA earlier than expected; more clinical catalysts in 2H21. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1801.HK / LLY.N / NOVN.S / CHRS.OQ / BGNE.OQ</td><td class="leftalignment">Innovent Biologics Inc / Eli Lilly and Co / Novartis AG / Coherus BioSciences Inc / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Where To Find Sun And Fun At ASCO This Year</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ARAV.O / PFE / JNJ / LLY / MRK / BSLN.S / HCM.O / HGEN.O / IMAB.O</td><td class="leftalignment">Aravive Inc / Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / HCM.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / HGEN.O / AZYO.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / HUTCHMED (China) Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Aziyo Biologics Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy Treatments, Thursday May 27th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / HCM.O / MRKR.O / MBIO.O / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Marker Therapeutics Inc / Mustang Bio Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY), ARVN (BUY) - Potential Read-Through from SAN-FP's AMEERA-3 Trial - Bellwether for Oral SERDs?</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ARVN.OQ / ZNTL.OQ / 5671735 / 0989529 / 2516152 / 2684703 / 7103065 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Arvinas Inc / Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc / Novartis AG / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RNA: Avidity Analyst Event Highlights Breadth of Platform</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RNA.OQ / LLY.N</td><td class="leftalignment">Avidity Biosciences Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - Our expectations for amcenestrant in breast cancer</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">SASY.PA / LLY.N / AZN.L / ROG.S / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ZNTL.OQ</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Zentalis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor KOL Call to Discuss New and Emerging Treatments for Diabetes and Cardiovascular Disease on May 27th at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / INCY=US / AMT=US / LOW=US / SCOR=US / LEG=US / VMC=US / MANH=US / MLM=US / UNH=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / CCRN=US / NFLX=US / DIN=US / MGNI=US / MRNS=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / OLO=US / NLSN=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / WING=US / 82982L103 / LGF.B=US / JELD=US / ROKU=US / FERG=US / ARQT=US / ZI=US / AZEK=US / HIMS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Incyte Corp / American Tower Corp / Lowe's Companies Inc / Comscore Inc / Leggett & Platt Inc / Vulcan Materials Co / Manhattan Associates Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Cross Country Healthcare Inc / Netflix Inc / Dine Brands Global Inc / Magnite Inc / Marinus Pharmaceuticals Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Olo Inc / Nielsen Holdings PLC / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Lions Gate Entertainment Corp / JELD-WEN Holding Inc / Roku Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2973821 / 2050832 / 2219224 / 2270726 / 2542049 / 2670519 / 2342034 / 2415204 / 2471950 / 2657802 / 2689560 / 2684703 / 2829601 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B125XQ6 / B02R1L6 / B3D7K31 / B7TL820 / B7254K9 / BFLR866 / B95WG16 / BVVN4Q8 / BNGY4Q0 / BYVY8G0 / BYNZGK1 / BD8DJ71 / BKTHM05 / BZ1HM42 / BMQ5T49 / BFZ1K46 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BKS3RS7 / BK71LV3 / BQXZP64 / BMC5RV6 / BGT0PL8 / BMCC9R7 / BMDJ085 / BNTB3N8 / BD9MK29 / BP8GHT2 / BMHR7K6 / BN2RM92</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Alliant Energy Corp / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Fiserv Inc / Hawaiian Electric Industries Inc / Incyte Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Meta Platforms Inc / AxoGen Inc / Twitter Inc / Zoetis Inc / Eversource Energy / Nextera Energy Partners LP / Alphabet Inc / Block Inc / Snap Inc / Passage Bio Inc / Adyen NV / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Evergy Inc / Vistra Corp / ViacomCBS Inc / Roku Inc / 10X Genomics Inc / Relmada Therapeutics Inc / Wayfair Inc / Adicet Bio Inc / DiaMedica Therapeutics Inc / SCYNEXIS Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Onconova Therapeutics Inc / Vascular Biogenics Ltd / Impel Neuropharma Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INCY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / LLY / NVS / PFE / AMGN.O / CTIC.O / LGND.O / GERN.O / AVEO.O / ARDX.O</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / CTI Biopharma Corp / Ligand Pharmaceuticals Inc / Geron Corp / Aveo Pharmaceuticals Inc / Ardelyx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, May 17 - Sunday, May 23</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1311931042 / US17275R1023 / US37733W1053 / US5324571083 / US5398301094 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US00206R1023 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US9100471096 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US70432V1026 / CA0089118776 / US23355L1061 / US81141R1005 / US5904791358 / US49926T1043 / US90364P1057 / US83089J1088 / US98985X1000</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cisco Systems Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Lockheed Martin Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / AT&T Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paycom Software Inc / Air Canada / DXC Technology Co / Sea Ltd / Mesa Air Group Inc / Knowbe4 Inc / UiPath Inc / Skywater Technology Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level- Week 59</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.14.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for LLY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABCL: Steady Progress on New Programs Under Contract</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABCL.OQ / LLY.N</td><td class="leftalignment">Abcellera Biologics Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 1Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / 4901.T / A.N / BDX.N / LLY.N / PFE.N / RECI.MI / STDM.PA / TMO.N / WAT.N / ROG.S / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / WST.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / MRNA.OQ / VIFN.S / 2269.HK / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Fujifilm Holdings Corp / Agilent Technologies Inc / Becton Dickinson and Co / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Roche Holding AG / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / West Pharmaceutical Services Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Moderna Inc / Vifor Pharma AG / WuXi Biologics (Cayman) Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, May 11, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / ICLR=US / WEN=US / BLD=US / INCY=US / TEVA=US / KMI=US / CMA=US / REI=US / PLUG=US / CRM=US / LOW=US / ENR=US / FMS=US / VRM=US / CHRS=US / MAR=US / LEG=US / VMC=US / MLM=US / CBRL=US / ELY=US / CHH=US / CSGP=US / DRI=US / GFF=US / IBP=US / NOW=US / MAS=US / MPLX=US / MHK=US / SHOP=US / GOLF=US / SAGE=US / SPG=US / EPD=US / SGMS=US / BKNG=US / NLS=US / DIN=US / MGNI=US / PTON=US / RNG=US / TCBI=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / APEI=US / WH=US / JACK=US / TREX=US / APTS=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / NDLS=US / LOCO=US / OSH=US / VCEL=US / SHAK=US / GSBD=US / WING=US / SQ=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / JELD=US / ATNX=US / SWCH=US / SAIL=US / EQH=US / BTAI=US / SVMK=US / PLMR=US / FERG=US / RPAY=US / ARQT=US / REYN=US / SPCE=US / FBRX=US / AZEK=US / BALY=US / VTRS=US / ABNB=US / AFRM=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / ICON PLC / Wendys Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / Comerica Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Lowe's Companies Inc / Energizer Holdings Inc / Fresenius Medical Care AG & Co KGaA / Vroom Inc / Coherus BioSciences Inc / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CoStar Group Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Shopify Inc / Acushnet Holdings Corp / SAGE Therapeutics Inc / Simon Property Group Inc / Enterprise Products Partners LP / Scientific Games Corp / Booking Holdings Inc / Nautilus Inc / Dine Brands Global Inc / Magnite Inc / Peloton Interactive Inc / RingCentral Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / American Public Education Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Preferred Apartment Communities Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Oak Street Health Inc / Vericel Corp / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Block Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / SailPoint Technologies Holdings Inc / Equitable Holdings Inc / BioXcel Therapeutics Inc / Momentive Global Inc / Palomar Holdings Inc / Ferguson PLC / Repay Holdings Corp / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2973821 / 2219224 / 2175672 / 2222631 / 2037170 / 2328915 / 2369174 / 2415204 / 2457864 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 4595739 / 7103065 / B1F76F9 / B121557 / B19FQ48 / B125XQ6 / B7TL820 / B4MG4Z6 / B7VD3F2 / BJ0XLZ3 / BDZCRX3 / BFH3N85 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYVFC94 / BF4VBS8 / BK0VHF6 / BD9GVY0 / BJXPS33 / BD8DJ71 / BJFSR88 / BYZR4X4 / BP7RS48 / BKVDFF7 / BYXJQG9 / BZ1LFG7 / BL71K91 / BD6JX35 / BZ0P3Z5 / BYTJZL1 / BDD1B07 / BKT6B38 / BF3N4P3 / BM8MM05 / BLBLMD5 / BNG3RZ7 / BMDJ085 / BLR6S36</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Cardinal Health Inc / Cooper Companies Inc / 8x8 Inc / Nextera Energy Inc / Gilead Sciences Inc / Hawaiian Electric Industries Inc / ImmunoGen Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Genmab A/S / Novartis AG / Western Union Co / Mastercard Inc / Amicus Therapeutics Inc / Portland General Electric Co / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Heron Therapeutics Inc / RingCentral Inc / Veeva Systems Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / US Foods Holding Corp / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / BELLUS Health Inc / Snap Inc / Uniqure NV / Axsome Therapeutics Inc / Intersect Ent Inc / Oric Pharmaceuticals Inc / Spire Inc / Roku Inc / Revolution Medicines Inc / Krystal Biotech Inc / Tegna Inc / Zogenix Inc / Rubius Therapeutics Inc / SmileDirectClub Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Array Technologies Inc / Leslie's Inc / Shoals Technologies Group Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, May 10 - Sunday, May 16</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call on Current and Emerging Cardiovascular Disease Treatments Thursday, May 20 at 11 AM EST</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMRN.O / JNJ / LLY / MRK / MSB / PFE</td><td class="leftalignment">Amarin Corporation PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 10 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US2371941053 / US37733W1053 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US5801351017 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8552441094 / US8807701029 / US91347P1057 / US9884981013 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / US25754A2015 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US95058W1009 / US00287Y1091 / NL0010273215 / LU0914713705 / US38046C1099 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / CA76131D1033 / US8190471016 / US9741551033 / US45782B1044 / KYG4740B1059 / CA35805P1071 / US05351X1019 / US68373M1071 / US5904791358 / IE00BZ12WP82 / US4833791035 / US92556H2067 / US92537N1081 / US26142R1041 / US38246G1085 / US90089L1089</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / GlaxoSmithKline PLC / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Teradyne Inc / Universal Display Corp / Yum! Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / Wendys Co / Abbvie Inc / ASML Holding NV / Intelsat SA / Gogo Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Restaurant Brands International Inc / Shake Shack Inc / Wingstop Inc / Inseego Corp / Ichor Holdings Ltd / Freshii Inc / Avaya Holdings Corp / Opera Ltd / Mesa Air Group Inc / Linde PLC / Kaleyra Inc / ViacomCBS Inc / Vertiv Holdings Co / DraftKings Inc / Goodrx Holdings Inc / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">DS-1062 Data Early, But Suggest Best-In-Class Potential; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Holding Steady - Week 58</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: The Weekly Observer</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2330.TW / 7974.T / AALI.JK / ASII.JK / GM.N / LLY.N / RIO.AX / RIO.L / TLS.AX / X.N / LNR.TO / XOM.N / CMC.N / BLK.N / CLF.N / CU.TO / NIO.N / 600900.SS / 600886.SS / 0700.HK / CLNE.OQ / BX.N / 0968.HK / GOOGL.OQ / ENGIE.PA / TME.N / PTON.OQ</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Nintendo Co Ltd / Astra Agro Lestari Tbk PT / Astra International Tbk PT / General Motors Co / Eli Lilly and Co / Rio Tinto Ltd / Rio Tinto PLC / Telstra Corporation Ltd / United States Steel Corp / Linamar Corp / Exxon Mobil Corp / Commercial Metals Co / BlackRock Inc / Cleveland-Cliffs Inc / Canadian Utilities Ltd / NIO Inc / China Yangtze Power Co Ltd / SDIC Power Holdings Co Ltd / Tencent Holdings Ltd / Clean Energy Fuels Corp / Blackstone Inc / Xinyi Solar Holdings Ltd / Alphabet Inc / Engie SA / Tencent Music Entertainment Group / Peloton Interactive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / China / Cayman Islands / France / United Kingdom / Indonesia / Japan / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity / Environmental, Social, Governance</td><td class="leftalignment">Global ESG Team</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.7.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AXP / 2516152 / 2486813 / 2778844 / 2973821 / 2045623 / 2219224 / 2175672 / 2216850 / 2576941 / 2670519 / 2345022 / 2459202 / 2459020 / 2378534 / 2630513 / 2645409 / 2657802 / 2680905 / 2684703 / 2048804 / 2707677 / 2730190 / 2440637 / 2416962 / 2138158 / 2799351 / 2825933 / 5531000 / 7103065 / 2212922 / 2769796 / 2857817 / B125XQ6 / B0T7YX2 / B02R1L6 / B3P93Y7 / B44C366 / B7TL820 / B783TY6 / BBPK0J0 / BBGVT40 / B95N910 / BDZCRX3 / B8DPDT7 / BFLR866 / B6WXT12 / B95WG16 / BZ07BW4 / BYVY8G0 / BYW36M8 / BF09HX3 / BYNZGK1 / BJT1RW7 / BZBY005 / BKS3SM8 / BQT3XY6 / BJ1FD74 / BJFSR88 / BKDS4H5 / BR4T3B3 / BWFKZT2 / BKVDFF7 / BFMXGR0 / BJJMGL2 / BFXC911 / BKTNTR9 / BK6N347 / BJVR9Y9 / BYWMQJ2 / BHZSB82 / BL95N25 / BD6D4Y5 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BJMLSD2 / BYQBFS7 / BYSFJV8 / BKWD3M9 / BYTJZL1 / BX7RSN3 / BYNPPC6 / BWY4XV3 / BJTJGC4 / BKLCX50 / BYQCZ35 / BQXZP64 / BGDW0N7 / BMPRZV5 / BGT0PL8 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / ANSYS Inc / CMS Energy Corp / Cardinal Health Inc / Consolidated Edison Inc / Exelixis Inc / Exelon Corp / Macy's Inc / IDEXX Laboratories Inc / Intuit Inc / Mckesson Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Henry Schein Inc / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / MorphoSys AG / Novartis AG / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Anheuser Busch Inbev SA / Heska Corp / Meta Platforms Inc / Aptiv PLC / Mirati Therapeutics Inc / News Corp / PTC Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / TherapeuticsMD Inc / Zoetis Inc / Monster Beverage Corp / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Block Inc / Lyft Inc / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Revolve Group Inc / Uniqure NV / Bill.com Holdings Inc / HubSpot Inc / Cellectis SA / Oric Pharmaceuticals Inc / Evergy Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Alteryx Inc / Covetrus Inc / Phibro Animal Health Corp / Altair Engineering Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Karuna Therapeutics Inc / Tabula Rasa HealthCare Inc / Planet Fitness Inc / Progyny Inc / Zogenix Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Adaptimmune Therapeutics PLC / Kontoor Brands Inc / Health Catalyst Inc / Madison Square Garden Sports Corp / Wayfair Inc / Trevena Inc / Kymera Therapeutics Inc / DiaMedica Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) - Mgmt Takeaways Post-Earnings Highlight Upcoming 2H 2021 Adagrasib Milestones; Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BBPK0J0 / 2516152 / 2778844 / 7103065</td><td class="leftalignment">Mirati Therapeutics Inc / Eli Lilly and Co / Merck & Co Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Balanced Fund Ups Stock Allocation After Defensive Turn to Fixed Income</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / LLY.N / NSRGY / PFE.N / PXD.N / UNH.N / CAT.N / UNP.N / VLO.N / RMD.N / RF.N / HELE.OQ / SIVB.OQ / AMZN.OQ / FITB.OQ / GOOG.OQ / SBGSY / ZTS.N / AZN.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Nestle SA / Pfizer Inc / Pioneer Natural Resources Co / UnitedHealth Group Inc / Caterpillar Inc / Union Pacific Corp / Valero Energy Corp / Resmed Inc / Regions Financial Corp / Helen of Troy Ltd / SVB Financial Group / Amazon.com Inc / Fifth Third Bancorp / Alphabet Inc / Schneider Electric SE / Zoetis Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended May 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Eli Lilly and Company - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">FISV=US / LLY=US / LSI=US / PFE=US / DIS=US / DVN=US / INCY=US / BR=US / AKAM=US / H=US / CRK=US / PXD=US / MGY=US / EXPE=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / VMC=US / CVS=US / MLM=US / AIR=US / AIZ=US / BMRN=US / BNL=US / CYH=US / DVA=US / DCO=US / EEFT=US / EXEL=US / MPLX=US / MRCY=US / ASGN=US / RARE=US / HOOK=US / TRIP=US / SAGE=US / GPN=US / MANT=US / BKNG=US / JAZZ=US / MTCH=US / COP=US / MRNS=US / RRR=US / IGMS=US / STRO=US / KAR=US / HURN=US / WMG=US / DENN=US / SCPL=US / FIS=US / HST=US / XPO=US / WU=US / ICFI=US / PAGP=US / IAA=US / CWH=US / 45665G303 / VRSK=US / ZNGA=US / BCEI=US / EA=US / GMED=US / FANG=US / TMUS=US / PTCT=US / LDOS=US / NMIH=US / MBUU=US / CNCE=US / ARCB=US / VNOM=US / DEA=US / RLMD=US / SEDG=US / NSA=US / CHCT=US / ZBH=US / BWXT=US / ZG=US / 82982L103 / CDEV=US / TRVG=US / PVAC=US / AYX=US / MPWR-US / DCPH=US / BHC=US / ARVN=US / LYFT=US / RTLR=US / ARQT=US / FBRX=US / 96758W101 / ABNB=US / RBLX=US</td><td class="leftalignment">Fiserv Inc / Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Walt Disney Co / Devon Energy Corp / Incyte Corp / Broadridge Financial Solutions Inc / Akamai Technologies Inc / Hyatt Hotels Corp / Comstock Resources Inc / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Vulcan Materials Co / CVS Health Corp / Martin Marietta Materials Inc / AAR Corp / Assurant Inc / Biomarin Pharmaceutical Inc / Bunzl plc / Community Health Systems Inc / DaVita Inc / Ducommun Inc / Euronet Worldwide Inc / Exelixis Inc / MPLX LP / Mercury Systems Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Tripadvisor Inc / SAGE Therapeutics Inc / Global Payments Inc / ManTech International Corp / Booking Holdings Inc / Jazz Pharmaceuticals PLC / Match Group Inc / Conocophillips / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Sutro Biopharma Inc / KAR Auction Services Inc / Huron Consulting Group Inc / Warner Music Group Corp / Denny's Corp / Sciplay Corp / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Western Union Co / ICF International Inc / Plains GP Holdings LP / IAA Inc / Camping World Holdings Inc / Infinity Pharmaceuticals Inc / Verisk Analytics Inc / Zynga Inc / Civitas Resources Inc / Electronic Arts Inc / Globus Medical Inc / Diamondback Energy Inc / T-Mobile US Inc / PTC Therapeutics Inc / Leidos Holdings Inc / NMI Holdings Inc / Malibu Boats Inc / Concert Pharmaceuticals Inc / ArcBest Corp / Viper Energy Partners LP / Easterly Government Properties Inc / Relmada Therapeutics Inc / Solaredge Technologies Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zimmer Biomet Holdings Inc / BWX Technologies Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / Alteryx Inc / Monolithic Power Systems Inc / Deciphera Pharmaceuticals Inc / Bausch Health Companies Inc / Arvinas Inc / Lyft Inc / Rattler Midstream LP / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / WideOpenWest Inc / Airbnb Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: 1Q EPS Drivers in Animal Health; Sustained Strength in Companion Animal; Positive on ZTS, ELAN into 1Q Prints</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">CVET.OQ / ELAN.N / ZTS.N / CL.N / LLY.N / MRK.N / TSCO.L / VIRB.PA / GIS.N / DPH.L / GNS.L / SJM.N / IDXX.OQ / PDCO.OQ / TSCO.OQ / NEOG.OQ / HSKA.OQ / WOOF.OQ / PETS.OQ / NESN.S / FRPT.OQ / CVSG.L / ZO1G.DE / BAYGN.DE / CENTA.OQ / PETSP.L / PAHC.OQ / KINO.JK / TRUP.OQ / CHWY.N</td><td class="leftalignment">Covetrus Inc / Elanco Animal Health Inc / Zoetis Inc / Colgate-Palmolive Co / Eli Lilly and Co / Merck & Co Inc / Tesco PLC / Virbac SA / General Mills Inc / Dechra Pharmaceuticals PLC / Genus PLC / J M Smucker Co / IDEXX Laboratories Inc / Patterson Companies Inc / Tractor Supply Co / Neogen Corp / Heska Corp / Petco Health and Wellness Company Inc / Petmed Express Inc / Nestle SA / Freshpet Inc / CVS Group PLC / Zooplus AG / Bayer AG / Central Garden & Pet Co / Pets at Home Group PLC / Phibro Animal Health Corp / Kino Indonesia Tbk PT / Trupanion Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Indonesia / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, LLY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung / Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Despite 1Q miss, reiteration of guidance implies a strong 2H2021; next up, derm catalysts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INCY=US / LLY=US / ARQT=US / FBRX=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Brief of Eli Lilly and Co conference call, May 04, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, May 04, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2045623 / 2437071 / 2219224 / 2542049 / 2670519 / 2613990 / 2501578 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 7103065 / B1F76F9 / B125XQ6 / 2679204 / 2390817 / B7TL820 / BDZCRX3 / B8DPDT7 / BFLR866 / B76LYJ2 / BYY8XK8 / BJLT387 / BZBY005 / BZB1XF2 / BR4T3B3 / BMQ5T49 / BFMXGR0 / BYQRFY1 / BKT6B38 / BMPRZV5 / BLBLMD5 / BNTB3N8 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / ANSYS Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Dominion Energy Inc / Exelon Corp / Illumina Inc / Ligand Pharmaceuticals Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Novartis AG / Western Union Co / Portland General Electric Co / Align Technology Inc / Gray Television Inc / Meta Platforms Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Vocera Communications Inc / WEC Energy Group Inc / Avantor Inc / Merus NV / Tactile Systems Technology Inc / HubSpot Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Teladoc Health Inc / SmileDirectClub Inc / Kymera Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABCL: Next-Gen COVID Antibody Enters Clinic</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABCL.OQ / LLY.N</td><td class="leftalignment">Abcellera Biologics Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALB.N / AN.N / AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CL.N / CNC.N / COF.N / CRM.N / ED.N / EIX.N / EOG.N / FCX.N / GE.N / GM.N / GPS.N / IBM.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / MRK.N / OXY.N / TXT.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / DHR.N / DIS.N / UNH.N / FE.N / URI.N / DE.N / CAT.N / SPOT.N / AMG.N / GS.N / CLX.N / HON.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / LIN.N / OLN.N / TGT.N / AVY.N / PKI.N / VZ.N / NYT.N / KSS.N / HRB.N / ORCL.N / KMX.N / PWR.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / AIV.N / HAE.N / LB.TO / BLK.N / CVX.N / MHK.N / NWS.AX / IRM.N / NCR.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / COHR.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / PII.N / REGN.OQ / SIVB.OQ / XLNX.OQ / QDEL.OQ / QCOM.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / VSAT.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / NVDA.OQ / BMRN.OQ / PACW.OQ / EXPE.OQ / TREE.OQ / MRVL.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / SGEN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / BIIB.OQ / SNX.N / TPX.N / SBNY.OQ / AGO.N / ACAD.OQ / MOS.N / MKTX.OQ / DXCM.OQ / WAL.N / MS.N / STX.AX / MA.N / AWI.N / FSLR.OQ / IVZ.N / CLR.N / QGEN.N / TDC.N / SATS.OQ / MRNA.OQ / NWSA.OQ / AGCO.N / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / NXPI.OQ / ADSGN.F / LPLA.OQ / AMD.OQ / XYL.N / SLM.OQ / ENPH.OQ / TRIP.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / RNG.N / MAR.OQ / PTC.OQ / GOOGL.OQ / PAYC.N / EQC.N / HUBS.N / ETSY.OQ / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / IONS.OQ / RETA.OQ / TWLO.N / COUP.OQ / CDEV.OQ / AYX.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / PEP.OQ / ZS.OQ / FB.PS / STNE.OQ / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / RTX.N / CARR.N / LMND.N / AMWL.N / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / AutoNation Inc / Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Occidental Petroleum Corp / Textron Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Linde PLC / Olin Corp / Target Corp / Avery Dennison Corp / PerkinElmer Inc / Verizon Communications Inc / New York Times Co / Kohls Corp / H & R Block Inc / Oracle Corp / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Haemonetics Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Mohawk Industries Inc / News Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Coherent Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / SVB Financial Group / Xilinx Inc / Quidel Corp / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / ViaSat Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Expedia Group Inc / Lendingtree Inc / Marvell Technology Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Seagen Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Biogen Inc / TD Synnex Corp / Tempur Sealy International Inc / Signature Bank / Assured Guaranty Ltd / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Dexcom Inc / Western Alliance Bancorp / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Invesco Ltd / Continental Resources Inc / Qiagen NV / Teradata Corp / EchoStar Corp / Moderna Inc / News Corp / AGCO Corp / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / Adidas AG / LPL Financial Holdings Inc / Advanced Micro Devices Inc / Xylem Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / RingCentral Inc / Marriott International Inc / PTC Inc / Alphabet Inc / Paycom Software Inc / Equity Commonwealth / HubSpot Inc / ETSY Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Centennial Resource Development Inc / Alteryx Inc / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / PepsiCo Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / American Well Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Ireland / Luxembourg / Netherlands / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, May 3 - Sunday, May 9</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MOGa / US0116591092 / US0231351067 / US0463531089 / US0758871091 / US1101221083 / US14149Y1082 / US37733W1053 / US4234521015 / US5324571083 / US58155Q1031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US03073E1055 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US5380341090 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US7185461040 / US69318G1067 / US00287Y1091 / US55345K1034 / US8485771021 / US21240E1055 / US02376R1023 / US94419L1017 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / GB00BDSFG982 / US7493971052 / US02156B1035 / US5904791358 / US0197701065 / US0144421072 / US5024311095 / US70614W1009 / US09203E1055 / US26142R1041 / CH0499880968 / US15872M1045 / US44891N1090 / US69353Y1038 / US62955J1034</td><td class="leftalignment">Moog Inc / Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Eli Lilly and Co / Mckesson Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Amerisourcebergen Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Live Nation Entertainment Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Phillips 66 / PBF Energy Inc / Abbvie Inc / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Wayfair Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TechnipFMC PLC / R1 RCM Inc / Alteryx Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / L3harris Technologies Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / ChampionX Corp / IAC/Interactivecorp / PMV Pharmaceuticals Inc / Nov Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner – Key Updates Across Our Global Pharma / Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : Thoughts As We Wrap Up A Difficult 1Q Earnings Season</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Activity Remains Positive - Week 57</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Eli Lilly and Company (LLY:$182.77) falls for a second consecutive month, a two-month fall of 11%</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Eli Lilly (LLY US) - Paying for the pipeline</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BPMC: 1Q21 Recap: Pipeline Shines, but Gavreto Stalls Early</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BPMC.OQ / LLY.N</td><td class="leftalignment">Blueprint Medicines Corp / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Feedback: Notes from Novartis CEO discussion</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">NOVN.S / LLY.N / APNJ.J / AMGN.OQ</td><td class="leftalignment">Novartis AG / Eli Lilly and Co / Aspen Pharmacare Holdings Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 1Q21 Earnings Highlights — What Mattered for Credit (AMGN, BSX, HUM, LLY)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N / AMGN.O / BSX.N / HUM.N</td><td class="leftalignment">Eli Lilly and Co / Amgen Inc / Boston Scientific Corp / Humana Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Getting Pumped About Cardiovascular Drugs</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRK.N / PFE.N / JNJ.N / LLY.N / AMRN.OQ / MSB.AX</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Amarin Corporation PLC / Mesoblast Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FISV=US / LLY=US / INTC=US / TWTR=US / ADI=US / AMD=US / RRC=US / EFX=US / BXP=US / PD=US / AMZN=US / DT=US / INCY=US / TXN=US / TEVA=US / NVDA=US / PEB=US / TRU=US / V=US / SYK=US / DIOD=US / XLNX=US / THC=US / BRO=US / BYD=US / ESS=US / MGM=US / MANH=US / HUM=US / PENN=US / EQR=US / CSGP=US / ENDP=US / ABG=US / HAS=US / NOW=US / MEDP=US / MCRI=US / TEAM=US / OKE=US / PII=US / REGI=US / ST=US / TRIP=US / WEX=US / FOUR=US / SAGE=US / SNOW=US / GPN=US / HIW=US / PYPL=US / CNC=US / LCI=US / EGP=US / FB=US / FBK=US / UDR=US / EVOP=US / VICI=US / MGP=US / RRR=US / FLT=US / CZR=US / NUVA=US / RNST=US / FIS=US / MA=US / GPRE=US / AWI=US / OC=US / AMRX=US / EHC=US / AAN=US / NXPI=US / ENPH=US / SPLK=US / SSTK=US / FEYE=US / CEQP=US / GLPI=US / GOOGL=US / NEWR=US / GDDY=US / NXRT=US / ARGX=US / SQ=US / CDEV=US / AYX=US / TENB=US / ESTC=US / LSPD=US / RPAY=US / XAIR=US / DDOG=US / IMVT=US / DKNG=US / BALY=US / VTRS=US / AIRC=US</td><td class="leftalignment">Fiserv Inc / Eli Lilly and Co / Intel Corp / Twitter Inc / Analog Devices Inc / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Boston Properties Inc / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / Incyte Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / Pebblebrook Hotel Trust / TransUnion / Visa Inc / Stryker Corp / Diodes Inc / Xilinx Inc / Tenet Healthcare Corp / Brown & Brown Inc / Boyd Gaming Corp / Essex Property Trust Inc / MGM Resorts International / Manhattan Associates Inc / Humana Inc / Penn National Gaming Inc / Equity Residential / CoStar Group Inc / Endo International PLC / Asbury Automotive Group Inc / Hasbro Inc / ServiceNow Inc / Medpace Holdings Inc / Monarch Casino & Resort Inc / Atlassian Corporation PLC / ONEOK Inc / Polaris Inc / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Tripadvisor Inc / WEX Inc / Shift4 Payments Inc / SAGE Therapeutics Inc / Snowflake Inc. / Global Payments Inc / Highwoods Properties Inc / PayPal Holdings Inc / Centene Corp / Lannett Company Inc / Eastgroup Properties Inc / Meta Platforms Inc / FB Financial Corp / UDR Inc / EVO Payments Inc / VICI Properties Inc / MGM Growth Properties LLC / Red Rock Resorts Inc / Fleetcor Technologies Inc / Caesars Entertainment Inc / NuVasive Inc / Renasant Corp / Fidelity National Information Services Inc / Mastercard Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Encompass Health Corp / Aaron's Company Inc / NXP Semiconductors NV / Enphase Energy Inc / Splunk Inc / Shutterstock Inc / Mandiant Inc / Crestwood Equity Partners LP / Gaming and Leisure Properties Inc / Alphabet Inc / New Relic Inc / GoDaddy Inc / NexPoint Residential Trust Inc / argenx SE / Block Inc / Centennial Resource Development Inc / Alteryx Inc / Tenable Holdings Inc / Elastic NV / Lightspeed Commerce Inc / Repay Holdings Corp / Beyond Air Inc / Datadog Inc / Immunovant Inc / DraftKings Inc / Bally's Corp / Viatris Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2516152 / 2023607 / 2219224 / 2280220 / 2270726 / 2829515 / 2670519 / 2342034 / 2613990 / 2689560 / 2707677 / 2440637 / 2853688 / 2931034 / 2503529 / 2181334 / 7103065 / B121557 / B125XQ6 / B4Y1MH7 / B8CKK03 / BYVY8G0 / BFZNYB7 / BDHF4K6 / BJ2Z0H2 / BWFKZT2 / BFZ1K46 / BZ8VJQ8 / BG31GH0 / BZ05388 / BYY88Y7 / BD6JX35 / BMH0MR7 / BLBLMD5 / BNG3RZ7</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / Amgen Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Edison International / Exelon Corp / Fiserv Inc / Illumina Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Stryker Corp / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Novartis AG / Mastercard Inc / Portland General Electric Co / KAR Auction Services Inc / Mondelez International Inc / Alphabet Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Pinterest Inc / Cellectis SA / Spotify Technology SA / Vistra Corp / Y-mAbs Therapeutics Inc / Global Blood Therapeutics Inc / Alphabet Inc / Krystal Biotech Inc / Zendesk Inc / Array Technologies Inc / Leslie's Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BA.N / CL.N / CVS.N / EL.N / GM.N / LLY.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / EMR.N / WEC.N / XOM.N / V.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / NOW.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Boeing Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / General Motors Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / ServiceNow Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Primary focus remains on Covid-19 partnership</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MOLN.S / LLY.N / ROG.S / NOVN.S / AMGN.OQ / REGN.OQ / ABBV.N</td><td class="leftalignment">Molecular Partners AG / Eli Lilly and Co / Roche Holding AG / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler / Ms Jo Walton</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Model Update Post 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY 1Q21 Full Postview – messy quarter, but LT growth still 2x peers – makes for a compelling story</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Trimming EPS on higher R&D investment</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 1Q Takeaways – Core Growth Thesis Intact As We Move Past A Noisy Qtr</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updating Estimates to Reflect COVID Ab Revenue and Lowered LLY Guidance</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N / 53245710</td><td class="leftalignment">Eli Lilly and Co / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Puneet Souda / Westley Dupray, CFA / Scott Mafale</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: 1Q21 - They Said What?! Highlights from Conf Call…and our perspective</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">tons of R&D updates today</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Powered By Purpose; Like LLY Despite Lumpy 1Q21</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 Sales, EPS Miss; 2021 Guidance Reduced On COVID Antibody Expectations</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q light, but 2Q-4Q EPS intact vs. our model; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 1Q First Impressions: Messy Qtr Appears Largely 1x In Nature; Core Business Remains On Track</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Brief of Eli Lilly and Co conference call, Apr. 27, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Apr. 27, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Apr 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / BP.L / CNC.N / COF.N / EIX.N / GE.N / LLY.N / MMC.N / PHM.N / EQR.N / IEX.N / ROP.N / DTE.N / ADM.N / SYK.N / GLW.N / UPS.N / WM.N / MMM.N / SHW.N / V.N / OKE.N / BXP.N / EGP.N / UDR.N / JNPR.N / AMGN.OQ / FISV.OQ / MSFT.OQ / PCAR.OQ / SBUX.OQ / CHRW.OQ / FFIV.OQ / ILMN.OQ / JBLU.OQ / TXN.OQ / NOV.N / IVZ.N / MSCI.N / HAS.OQ / AMD.OQ / ENPH.OQ / MDLZ.OQ / GOOGL.OQ / SYF.N / PFG.OQ / TER.OQ / CB.BN / RTX.N</td><td class="leftalignment">Pinterest Inc / BP PLC / Centene Corp / Capital One Financial Corp / Edison International / General Electric Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Pultegroup Inc / Equity Residential / IDEX Corp / Roper Technologies Inc / DTE Energy Co / Archer-Daniels-Midland Co / Stryker Corp / Corning Inc / United Parcel Service Inc / Waste Management Inc / 3M Co / Sherwin-Williams Co / Visa Inc / ONEOK Inc / Boston Properties Inc / Eastgroup Properties Inc / UDR Inc / Juniper Networks Inc / Amgen Inc / Fiserv Inc / Microsoft Corp / Paccar Inc / Starbucks Corp / CH Robinson Worldwide Inc / F5 Inc / Illumina Inc / JetBlue Airways Corp / Texas Instruments Inc / Nov Inc / Invesco Ltd / MSCI Inc / Hasbro Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Mondelez International Inc / Alphabet Inc / Synchrony Financial / Principal Financial Group Inc / Teradyne Inc / Chubb Ltd / Raytheon Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: 1Q EPS Missed Our Below Consensus Forecast; Low Quality 1Q and Covid Ab-Related Cut to Guidance Disappoint</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 EPS, Sales Miss; 2021 Guidance Lowered But Ex-COVID Dynamics Appear On Track</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / AMRN / EBS / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / HCM.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Amarin Corporation PLC / Emergent BioSolutions Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / HUTCHMED (China) Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Lumpy Oatmeal This Morning, First Look At 1Q21 Sales and EPS Miss</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / CL=US / WEN=US / PLD=US / AMZN=US / BLD=US / DVN=US / INCY=US / KMI=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / CHKP=US / PXD=US / ENR=US / HSII=US / MGY=US / SWN=US / MUR=US / BRO=US / BYD=US / MRO=US / LEG=US / HCA=US / VMC=US / MGM=US / PENN=US / NWL=US / MLM=US / FLO=US / KFY=US / ARCC=US / CBRL=US / CENT=US / CHD=US / CNX=US / DRI=US / EPC=US / EQT=US / GFF=US / HAIN=US / IBP=US / SAFE=US / TREE=US / MAIN=US / MAS=US / MEDP=US / MHK=US / MCRI=US / ORCC=US / PACW=US / REGN=US / REGI=US / SBAC=US / SMG=US / SSNC=US / SNAP=US / VRTX=US / CVX=US / POST=US / BXS=US / BKNG=US / FBK=US / FR=US / FFIN=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / MNST=US / RRR=US / NOMD=US / TPX=US / FNB=US / EXP=US / CZR=US / NUVA=US / AINV=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / NOG=US / JACK=US / AAN=US / TREX=US / AR=US / NXPI=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / NDLS=US / GLPI=US / TSLX=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / ANTM=US / SHAK=US / AJRD=US / GSBD=US / WING=US / ARGX=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / ROKU=US / CARG=US / COLD=US / EOLS=US / KDP=US / OZK=US / FSK=US / LYFT=US / RTLR=US / FERG=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DKNG=US / FSKR=US / AZEK=US / BALY=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Pioneer Natural Resources Co / Energizer Holdings Inc / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Brown & Brown Inc / Boyd Gaming Corp / Marathon Oil Corp / Leggett & Platt Inc / HCA Healthcare Inc / Vulcan Materials Co / MGM Resorts International / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Korn Ferry / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Hain Celestial Group Inc / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Main Street Capital Corp / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / Scotts Miracle-Gro Co / SS&C Technologies Holdings Inc / Snap Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Post Holdings Inc / Cadence Bank / Booking Holdings Inc / FB Financial Corp / First Industrial Realty Trust Inc / First Financial Bankshares Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Red Rock Resorts Inc / Nomad Foods Ltd / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Caesars Entertainment Inc / NuVasive Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Trex Company Inc / Antero Resources Corp / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Gaming and Leisure Properties Inc / Sixth Street Specialty Lending Inc / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / CarGurus Inc / Americold Realty Trust / Evolus Inc / Keurig Dr Pepper Inc / Bank Ozk / FS KKR Capital Corp / Lyft Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DraftKings Inc / FS KKR Capital Corp / Azek Company Inc / Bally's Corp / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2613990 / 2630513 / 2689560 / 2684703 / 2440637 / 2825933 / 2829601 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / BH65L93 / BYVY8G0 / BJFSR88 / BNFWR44 / BYZR4X4 / BFZ1K46 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BJ9NFQ3 / BYNQ369 / BMH0MR7 / BQXZP64 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Illumina Inc / New Jersey Resources Corp / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / South Jersey Industries Inc / Southern Co / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Seacoast Banking Corporation of Florida / Alphabet Inc / Uniqure NV / Worldline SA / Axsome Therapeutics Inc / Spotify Technology SA / Fox Corp / Vistra Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Albertsons Companies Inc / Zendesk Inc / Wayfair Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BA.N / CL.N / CVS.N / EL.N / LLY.N / MRK.N / PFE.N / TMO.N / WMB.N / MCD.N / WEC.N / XOM.N / V.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / TSLA.OQ / NXPI.OQ / NOW.N / ABBV.N / GOOGL.OQ / TMUS.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Boeing Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / McDonald's Corp / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Abbvie Inc / Alphabet Inc / T-Mobile US Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for LLY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY 1Q21 earnings preview</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company climbs 14% in 2021, outperforming Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, April 26 - Sunday, May 2</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000054470 / US00971T1016 / US0116591092 / US0311621009 / US0378331005 / US0463531089 / US0718131099 / US1101221083 / US1266501006 / US2855121099 / US37733W1053 / US45337C1027 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US8636671013 / US8740541094 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US2538681030 / US0491642056 / PAP310761054 / NL0000687663 / US01748X1028 / US2473617023 / US53261M1045 / US00922R1059 / US00507V1098 / US58933Y1055 / US9100471096 / US98986T1088 / US00287Y1091 / US00912X3026 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US29444U7000 / US20717E1010 / US36165L1089 / US87105L1044 / US8760301072 / US19626G1085 / US5904791358 / CH0499880968 / US22041X1028 / US72815L1070 / US35909R1086</td><td class="leftalignment">Ubisoft Entertainment SA / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / AstraZeneca PLC / Baxter International Inc / Bristol-Myers Squibb Co / CVS Health Corp / Electronic Arts Inc / GlaxoSmithKline PLC / Incyte Corp / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Stryker Corp / Take-Two Interactive Software Inc / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Digital Realty Trust Inc / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Merck & Co Inc / United Airlines Holdings Inc / Zynga Inc / Abbvie Inc / Air Lease Corp / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Equinix Inc / Conformis Inc / GDS Holdings Ltd / Switch Inc / Tapestry Inc / DigitalBridge Group Inc / Mesa Air Group Inc / ADC Therapeutics SA / Corsair Gaming Inc / Playtika Holding Corp / Frontier Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AXP.N / BA.N / CL.N / EL.N / KMB.N / LLY.N / MRK.N / SLB.N / TMO.N / WMB.N / MCD.N / HON.N / WEC.N / XOM.N / V.N / CVX.N / RF.N / AAPL.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / TSLA.OQ / NXPI.OQ / NOW.N / ABBV.N / GOOGL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">American Express Co / Boeing Co / Colgate-Palmolive Co / Estee Lauder Companies Inc / Kimberly-Clark Corp / Eli Lilly and Co / Merck & Co Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Williams Companies Inc / McDonald's Corp / Honeywell International Inc / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Regions Financial Corp / Apple Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Abbvie Inc / Alphabet Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 1Q Earnings Season : What to Watch for the Week Ahead (LLY, BMY, MRK, ABBV)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N / ABBV.N / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Eli Lilly and Co / Abbvie Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Maintain Momentum - Week 56</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech - Targeted Degradation Meets Synthetic Lethality? AMBRA1 as a Novel & Potentially Actionable Biomarker in Cancer Therapy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0989529 / 0925288 / 2516152 / 2576941 / 2684703 / 7103065 / BK0VHF6 / BMQ5T49 / BWY52P3</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Exelixis Inc / Pfizer Inc / Novartis AG / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / LLY=US / PFE=US / BMY=US / INTC=US / AMD=US / RRC=US / EFX=US / AMZN=US / T=US / GL=US / NVDA=US / DGX=US / TRU=US / MTN=US / VZ=US / CCI=US / VRM=US / EWBC=US / BRO=US / EXPE=US / LSTR=US / HCA=US / CVS=US / UNH=US / AVGO=US / AJG=US / SAFE=US / HZO=US / MAT=US / RARE=US / SNAP=US / TRIP=US / WIX=US / BXS=US / BKNG=US / FAF=US / FB=US / MKL=US / PTON=US / JRVR=US / BIIB=US / NUVA=US / KAR=US / CADE=US / EIG=US / KNSL=US / AR=US / ANGI=US / TMUS=US / GOOGL=US / ASMB=US / BABA=US / CMPR=US / ANTM=US / GDDY=US / LOB=US / WLTW=US / ANAB=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / SITC=US / LYFT=US / UBER=US / PLMR=US</td><td class="leftalignment">CACI International Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Amazon.com Inc / AT&T Inc / Globe Life Inc / NVIDIA Corp / Quest Diagnostics Inc / TransUnion / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Vroom Inc / East West Bancorp Inc / Brown & Brown Inc / Expedia Group Inc / Landstar System Inc / HCA Healthcare Inc / CVS Health Corp / UnitedHealth Group Inc / Broadcom Inc / Arthur J Gallagher & Co / Safehold Inc / MarineMax Inc / Mattel Inc / Ultragenyx Pharmaceutical Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cadence Bank / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Markel Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Biogen Inc / NuVasive Inc / KAR Auction Services Inc / Cadence Bank / Employers Holdings Inc / Kinsale Capital Group Inc / Antero Resources Corp / Angi Inc / T-Mobile US Inc / Alphabet Inc / Assembly Biosciences Inc / Alibaba Group Holding Ltd / Cimpress PLC / Anthem Inc / GoDaddy Inc / Live Oak Bancshares Inc / Willis Towers Watson PLC / AnaptysBio Inc / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / Palomar Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AXP.N / BA.N / CL.N / KMB.N / LLY.N / MO.N / SLB.N / T.N / TMO.N / DHR.N / CAT.N / UNP.N / HON.N / XOM.N / AMT.N / HCA.N / V.N / CVX.N / RF.N / INTC.OQ / AAPL.OQ / MSFT.OQ / QCOM.OQ / SBAC.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / TSLA.OQ / NXPI.OQ / NOW.N / ABBV.N / GOOGL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">American Express Co / Boeing Co / Colgate-Palmolive Co / Kimberly-Clark Corp / Eli Lilly and Co / Altria Group Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Danaher Corp / Caterpillar Inc / Union Pacific Corp / Honeywell International Inc / Exxon Mobil Corp / American Tower Corp / HCA Healthcare Inc / Visa Inc / Chevron Corp / Regions Financial Corp / Intel Corp / Apple Inc / Microsoft Corp / Qualcomm Inc / SBA Communications Corp / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Abbvie Inc / Alphabet Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: Sustainable Investing: is it 'Dot.com' in disguise?</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0257.HK / 0551.HK / 0895.HK / 1038.HK / 1093.HK / ABT.N / ACC.BO / AES.N / AHT.L / AIRP.PA / ALSO.PA / ALVG.DE / ANA.MC / APD.N / ARDS.AS / ASMI.AS / ASML.AS / BH.BK / BMWG.DE / BMY.N / BOUY.PA / CCK.N / CRH.I / DSMN.AS / ECL.N / ED.N / EL.N / ELUXB.ST / EMG.L / ERICB.ST / FLS.N / HEXAB.ST / IMI.L / IP.N / KPJH.KL / LLY.N / NIBEB.ST / PNW.N / PSON.L / ROR.L / SCC.BK / SCHN.PA / SGEF.PA / SMDS.L / SN.L / T.TO / TOM.OL / TOTF.PA / UU.L / VERB.VI / VLOF.PA / VNT.N / WPL.AX / 0371.HK / CONG.DE / OHL.MC / ETN.N / AMAR.BO / BWA.N / URI.N / WCC.N / PH.N / REE.MC / TRP.TO / CAT.N / ABBN.S / SIEGN.DE / ACE.MI / ROCKB.CO / HON.N / MFC.TO / VOPA.AS / EMR.N / ENEI.MI / MGA.N / DTEGN.F / IFXGN.DE / LIN.N / BLL.N / EXID.BO / GBFG.DE / VIE.PA / APA.AX / NZYMB.CO / KMI.N / PWR.N / MTZ.N / EPD.N / AXL.N / PCAR3.SA / FLR.N / KRC.N / NDXG.DE / DOW.AX / BLDP.TO / AMS.S / 600690.SS / NLS.N / BSL.AX / WG.L / 1211.HK / CNP.N / 600008.SS / 600009.SS / 000651.SZ / CGNX.OQ / FAST.OQ / TROW.OQ / REGN.OQ / TRMB.OQ / YORW.OQ / TTEK.OQ / SCHL.OQ / AZPN.OQ / BRKS.OQ / GRMN.OQ / MNST.OQ / UMI.BR / 012330.KS / 012630.KS / STMN.S / 0451.HK / 2628.HK / TRQ.TO / 600170.SS / 0981.HK / YAR.OL / 2338.HK / 2318.HK / 2331.HK / CPFE3.SA / 600820.SS / 600884.SS / 002008.SZ / 3311.HK / EDF.PA / 600491.SS / PFC.L / SGM.AX / SPWR.OQ / 600835.SS / 600845.SS / CSMG3.SA / ZUMV.VI / CPX.TO / 3899.HK / ERIC.OQ / ASHM.L / 1800.HK / 2006.HK / 3898.HK / 601628.SS / 601318.SS / SKG.I / 000338.SZ / ACM.N / DAIGN.DE / PGRD.BO / GL9.I / APEI.OQ / 3800.HK / FLUI.MC / 601390.SS / 0806.HK / 0390.HK / 601601.SS / 601186.SS / BIP.N / WRT1V.HE / LABB.MX / ERII.OQ / SEVI.PA / HOLI.OQ / AIPJ.J / 2009.HK / LOPE.OQ / 601727.SS / 1313.HK / 601888.SS / 002294.SZ / AQN.TO / 2601.HK / GNRC.N / 002431.SZ / 300073.SZ / 300024.SZ / LHCJ.J / TSLA.OQ / BASFN.DE / 002527.SZ / 1590.TW / KEY.TO / APAM.AS / WWD.OQ / FHI.N / 601992.SS / 002594.SZ / QUAL3.SA / UNFI.N / REGI.OQ / WETF.OQ / VAC.N / ENPH.OQ / 601800.SS / 002672.SZ / TAEE11.SA / SIIC.SI / BFAM.N / WSKT.JK / COTY.N / CAV1V.HE / CORB.AS / CHGG.N / ARMK.N / LNTAQ.L / APPS.MC / 2186.HK / MDLY.N / XXLA.OL / 1317.HK / SEDG.OQ / CLNX.MC / WRK.N / PLNT.N / IEL.AX / 1565.HK / MDCM.L / LHN.S / BFIT.AS / BEDU.N / SGREN.MC / REDU.OQ / ORSTED.CO / 0807.HK / DWSG.DE / EQNR.OL / 300750.SZ / ARCE.OQ / LTHM.N / 1797.HK / COGN3.SA / BRBR.N / DQ.ZY / J.N / 688339.SS / ENR1N.DE / ALGM.OQ / 6690.HK</td><td class="leftalignment">China Everbright Environment Group Ltd / Yue Yuen Industrial (Holdings) Ltd / Dongjiang Environmental Co Ltd / CK Infrastructure Holdings Ltd / CSPC Pharmaceutical Group Ltd / Abbott Laboratories / ACC Ltd / AES Corp / Ashtead Group PLC / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Alstom SA / Allianz SE / Acciona SA / Air Products and Chemicals Inc / Arcadis NV / ASM International NV / ASML Holding NV / Bumrungrad Hospital PCL / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Bouygues SA / Crown Holdings Inc / CRH PLC / Koninklijke DSM NV / Ecolab Inc / Consolidated Edison Inc / Estee Lauder Companies Inc / Electrolux AB / Man Group PLC / Telefonaktiebolaget LM Ericsson / Flowserve Corp / Hexagon AB / IMI PLC / International Paper Co / KPJ Healthcare Bhd / Eli Lilly and Co / Nibe Industrier AB / Pinnacle West Capital Corp / Pearson PLC / Rotork PLC / Siam Cement PCL / Schneider Electric SE / Vinci SA / DS Smith PLC / Smith & Nephew PLC / Telus Corp / Tomra Systems ASA / TotalEnergies SE / United Utilities Group PLC / Verbund AG / Valeo SE / Vontier Corp / Woodside Petroleum Ltd / Beijing Enterprises Water Group Ltd / Continental AG / Obrascon Huarte Lain SA / Eaton Corporation PLC / Amara Raja Batteries Ltd / Borgwarner Inc / United Rentals Inc / Wesco International Inc / Parker-Hannifin Corp / Red Electrica Corporacion SA / TC Energy Corp / Caterpillar Inc / Abb Ltd / Siemens AG / Acea SpA / Rockwool International A/S / Honeywell International Inc / Manulife Financial Corp / Koninklijke Vopak NV / Emerson Electric Co / Enel SpA / Magna International Inc / Deutsche Telekom AG / Infineon Technologies AG / Linde PLC / Ball Corp / Exide Industries Ltd / Bilfinger SE / Veolia Environnement SA / APA Group / Novozymes A/S / Kinder Morgan Inc / Quanta Services Inc / MasTec Inc / Enterprise Products Partners LP / American Axle & Manufacturing Holdings Inc / Companhia Brasileira de Distribuicao / Fluor Corp / Kilroy Realty Corp / Nordex SE / Downer EDI Ltd / Ballard Power Systems Inc / ams AG / Haier Smart Home Co Ltd / Nautilus Inc / BlueScope Steel Ltd / John Wood Group PLC / BYD Co Ltd / CenterPoint Energy Inc / Beijing Capital Eco-Environment Protection Group Co Ltd / Shanghai International Airport Co Ltd / Gree Electric Appliances Inc of Zhuhai / Cognex Corp / Fastenal Co / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trimble Inc / York Water Co / Tetra Tech Inc / Scholastic Corp / Aspen Technology Inc / Azenta Inc / Garmin Ltd / Monster Beverage Corp / Umicore SA / Hyundai Mobis Co Ltd / HDC Holdings Co Ltd / Straumann Holding AG / GCL New Energy Holdings Ltd / China Life Insurance Co Ltd / Turquoise Hill Resources Ltd / Shanghai Construction Group Co Ltd / Semiconductor Manufacturing International Corp / Yara International ASA / Weichai Power Co Ltd / Ping An Insurance Group Co of China Ltd / Li Ning Co Ltd / CPFL Energia SA / Shanghai Tunnel Engineering Co Ltd / Ningbo Shanshan Co Ltd / Han's Laser Technology Industry Group Co Ltd / China State Construction International Holdings Ltd / Electricite de France SA / Long Yuan Construction Group Co Ltd / Petrofac Ltd / Sims Ltd / SunPower Corp / Shanghai Mechanical & Electrical Industry Co Ltd / Shanghai Baosight Software Co Ltd / Companhia de Saneamento de Minas Gerais Copasa MG / Zumtobel Group AG / Capital Power Corp / CIMC Enric Holdings Ltd / Telefonaktiebolaget LM Ericsson / Ashmore Group PLC / China Communications Construction Co Ltd / Shanghai Jin Jiang Capital Co Ltd / Zhuzhou CRRC Times Electric Co Ltd / China Life Insurance Co Ltd / Ping An Insurance Group Co of China Ltd / Smurfit Kappa Group PLC / Weichai Power Co Ltd / AECOM / Daimler AG / Power Grid Corporation of India Ltd / Glanbia PLC / American Public Education Inc / GCL-Poly Energy Holdings Ltd / Fluidra SA / China Railway Group Ltd / Value Partners Group Ltd / China Railway Group Ltd / China Pacific Insurance Group Co Ltd / China Railway Construction Corp Ltd / Brookfield Infrastructure Partners LP / Wartsila Oyj Abp / Genomma Lab Internacional SAB de CV / Energy Recovery Inc / Suez SA / Hollysys Automation Technologies Ltd / Adcock Ingram Holdings Ltd / BBMG Corp / Grand Canyon Education Inc / Shanghai Electric Group Co Ltd / China Resources Cement Holdings Ltd / China Tourism Group Duty Free Corp Ltd / Shenzhen Salubris Pharmaceuticals Co Ltd / Algonquin Power & Utilities Corp / China Pacific Insurance Group Co Ltd / Generac Holdings Inc / Palm Eco-Town Development Co Ltd / Beijing Easpring Material Technology CO LTD / SIASUN Robot & Automation Co Ltd / Life Healthcare Group Holdings Ltd / Tesla Inc / BASF SE / Shanghai STEP Electric Corp / Airtac International Group / Keyera Corp / Aperam SA / Woodward Inc / Federated Hermes Inc / BBMG Corp / BYD Co Ltd / Qualicorp Consultoria e Corretora de Seguros SA / United Natural Foods Inc / Renewable Energy Group Inc / Wisdom Tree Investments Inc / Marriott Vacations Worldwide Corp / Enphase Energy Inc / China Communications Construction Co Ltd / Dongjiang Environmental Co Ltd / Transmissora Alianca de Energia Eletrica SA / SIIC Environment Holdings Ltd / Bright Horizons Family Solutions Inc / Waskita Karya (Persero) Tbk PT / Coty Inc / Caverion Oyj / Corbion NV / Chegg Inc / Aramark / Lenta Plc / Applus Services SA / Luye Pharma Group Ltd / Medley Management Inc / XXL ASA / China Maple Leaf Educational Systems Ltd / Solaredge Technologies Inc / Cellnex Telecom SA / Westrock Co / Planet Fitness Inc / IDP Education Ltd / Virscend Education Company Ltd / Mediclinic International PLC / Holcim AG / Basic Fit NV / Bright Scholar Education Holdings Ltd / Siemens Gamesa Renewable Energy SA / Rise Education Cayman Ltd / Orsted A/S / SIIC Environment Holdings Ltd / DWS Group GmbH & Co KgaA / Equinor ASA / Contemporary Amperex Technology Co Ltd / Arco Platform Ltd / Livent Corp / Koolearn Technology Holding Ltd / Cogna Educacao SA / Bellring Brands Inc / Daqo New Energy Corp / Jacobs Engineering Group Inc / Beijing SinoHytec Co Ltd / Siemens Energy AG / Allegro Microsystems Inc / Haier Smart Home Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Brazil / Canada / Switzerland / China / Cayman Islands / Cyprus / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Indonesia / India / Ireland / Italy / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / Norway / New Zealand / Singapore / Sweden / Thailand / United States / Virgin Islands, British / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Environmental, Social, Governance</td><td class="leftalignment">Global ESG Team / Eugene Klerk / Bahar Sezer Longworth / Ms. Betty Jiang / Phineas Glover</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from our Expert call on BMY’s LAG-3 inhibitor relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US / LLY=US / PFE=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AXP.N / BA.N / FCX.N / KMB.N / LLY.N / MRK.N / SLB.N / TMO.N / DHR.N / UNP.N / MCD.N / HON.N / VZ.N / HCA.N / V.N / RF.N / INTC.OQ / AAPL.OQ / LRCX.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / SBAC.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / CMG.N / NEE.N / TSLA.OQ / NXPI.OQ / NOW.N / GOOGL.OQ / ANTM.N / FB.PS / OTIS.N</td><td class="leftalignment">American Express Co / Boeing Co / Freeport-McMoRan Inc / Kimberly-Clark Corp / Eli Lilly and Co / Merck & Co Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Danaher Corp / Union Pacific Corp / McDonald's Corp / Honeywell International Inc / Verizon Communications Inc / HCA Healthcare Inc / Visa Inc / Regions Financial Corp / Intel Corp / Apple Inc / Lam Research Corp / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / SBA Communications Corp / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Chipotle Mexican Grill Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Alphabet Inc / Anthem Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Jiangsu Hengrui Medicine Co. Ltd: Though 2022 growth faces pressure, sustained R&D and globalisation drive long-term growth. Upgrade to OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">600276.SS / LLY.N / PFE.N</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Exposure Of Big Cap Pharma To Biden Tax Reform Proposal</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">ECONOMIC REPORTS / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">valuationLAB AG</td><td class="leftalignment">“Growing the base” Cresemba shines, cancer pipeline growing apace</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">BSLN=CH / MRK=US / LLY=US / PFE=US / 4503=JP / ROG=CH</td><td class="leftalignment">Basilea Pharmaceutica AG / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Astellas Pharma Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Bob Pooler</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Eli Lilly and Company (lLLY) -INITIATING COVERAGE - Sale of Key Products and COVID-19 therapies added to growth</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0028241000 / US02553E1064 / US0378331005 / US0463531089 / US1101221083 / US1264081035 / US2435371073 / US25179M1036 / US28176E1082 / US2944291051 / US3377381088 / US37733W1053 / US4282911084 / US4781601046 / US5324571083 / US5398301094 / US6541061031 / US6558441084 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US87612E1064 / US9078181081 / US92532F1003 / US9311421039 / CA1363751027 / CA13645T1003 / US37940X1028 / US64110L1061 / US80105N1054 / US2533931026 / US31620M1062 / US82706C1080 / US57636Q1040 / US4103451021 / US92826C8394 / US58933Y1055 / US78454L1008 / US39304D1028 / US3390411052 / US96208T1043 / US00287Y1091 / NL0010273215 / US69327R1014 / US5764852050 / PR30040P1032 / US89400J1079 / US70450Y1038 / US8522341036 / US15136A1025 / US8760301072 / US2997341035 / US26927E1047 / US46571Y1073 / VGG312491084 / US74275G1076 / US98585X1046 / US69047Q1022 / US13123X5086 / CA67079A1021</td><td class="leftalignment">Abbott Laboratories / American Eagle Outfitters Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Deckers Outdoor Corp / Devon Energy Corp / Edwards Lifesciences Corp / Equifax Inc / Fiserv Inc / GlaxoSmithKline PLC / Hexcel Corp / Johnson & Johnson / Eli Lilly and Co / Lockheed Martin Corp / Nike Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Target Corp / Union Pacific Corp / Vertex Pharmaceuticals Inc / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Netflix Inc / Sanofi SA / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Mastercard Inc / HanesBrands Inc / Visa Inc / Merck & Co Inc / SM Energy Co / Green Dot Corp / Fleetcor Technologies Inc / WEX Inc / Abbvie Inc / ASML Holding NV / PDC Energy Inc / Matador Resources Co / Evertec Inc / TransUnion / PayPal Holdings Inc / Block Inc / Centennial Resource Development Inc / Tapestry Inc / Evelo Biosciences Inc / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Priority Technology Holdings Inc / Yeti Holdings Inc / Ovintiv Inc / Callon Petroleum Co / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / Puerto Rico / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 Biotech Earnings Consensus Cheat Sheet: BIIB</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / BAYGN.DE / ABBV.N</td><td class="leftalignment">Biogen Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABT.N / AXP.N / BA.N / CCI.N / FCX.N / JNJ.N / KMB.N / LLY.N / PM.N / SLB.N / PG.N / DHR.N / UNP.N / HON.N / VZ.N / HCA.N / V.N / RF.N / INTC.OQ / AAPL.OQ / LRCX.OQ / MSFT.OQ / QCOM.OQ / SBAC.OQ / NFLX.OQ / TXN.OQ / CDNS.OQ / NEE.N / TSLA.OQ / NXPI.OQ / NOW.N / GOOGL.OQ / ANTM.N / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Crown Castle International Corp / Freeport-McMoRan Inc / Johnson & Johnson / Kimberly-Clark Corp / Eli Lilly and Co / Philip Morris International Inc / Schlumberger NV / Procter & Gamble Co / Danaher Corp / Union Pacific Corp / Honeywell International Inc / Verizon Communications Inc / HCA Healthcare Inc / Visa Inc / Regions Financial Corp / Intel Corp / Apple Inc / Lam Research Corp / Microsoft Corp / Qualcomm Inc / SBA Communications Corp / Netflix Inc / Texas Instruments Inc / Cadence Design Systems Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Alphabet Inc / Anthem Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : April - June 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Commending LLY's "BRAVEry" With Second Positive Phase 3 AA Study</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE=US / TME=US / MRK=US / LLY=US / MSFT=US / INSP=US / DNLI=US / NVDA=US / RMD=US / SPOT=US / TTWO=US / ATVI=US / HEAR=US / PHG=US / SAGE=US / GME=US / MTCH=US / NFLX=US / BIIB=US / ALNY=US / 700-HK=US / UBI-PAR=US / TCEHY=US / ZNGA=US / EA=US / YY=US / LOVE=US / MOMO=US / SPXC=US / LIVN=US / IQ=US / BILI=US / HUYA=US / DOYU=US / TARA=US / CRSR=US / PLTK=US</td><td class="leftalignment">Deere & Co / Tencent Music Entertainment Group / Merck & Co Inc / Eli Lilly and Co / Microsoft Corp / Inspire Medical Systems Inc / Denali Therapeutics Inc / NVIDIA Corp / Resmed Inc / Spotify Technology SA / Take-Two Interactive Software Inc / Activision Blizzard Inc / Turtle Beach Corp / Koninklijke Philips NV / SAGE Therapeutics Inc / GameStop Corp / Match Group Inc / Netflix Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tencent Holdings Ltd / Zynga Inc / Electronic Arts Inc / JOYY Inc / Lovesac Co / Hello Group Inc / SPX Corp / LivaNova PLC / iQIYI Inc / Bilibili Inc / HUYA Inc / Douyu International Holdings Ltd / Protara Therapeutics Inc / Corsair Gaming Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / HD=US / KO=US / MCD=US / WEN=US / PLD=US / AMZN=US / BLD=US / INCY=US / PEB=US / H=US / MTN=US / LOW=US / MAR=US / LEG=US / TNL=US / VMC=US / HLT=US / MLM=US / CBRL=US / KIDS=US / CHH=US / DRI=US / DRH=US / GFF=US / HXL=US / IBP=US / MAS=US / MHK=US / REGI=US / WAL=US / SNOW=US / HIW=US / ZION=US / PRI=US / DIN=US / PNFP=US / TPX=US / EXP=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / TAST=US / QSR=US / LLNW=US / PRPL=US / WH=US / JACK=US / TREX=US / HGV=US / APTS=US / RLJ=US / VAC=US / FBHS=US / RHP=US / ABBV=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / LOCO=US / SHAK=US / WING=US / SPNE=US / WLTW=US / 82982L103 / PK=US / PVAC=US / JELD=US / PLYA=US / AXNX=US / FERG=US / GOCO=US / ARQT=US / AZEK=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Western Alliance Bancorp / Snowflake Inc. / Highwoods Properties Inc / Zions Bancorporation NA / Primerica Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Limelight Networks Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Hilton Grand Vacations Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Axonics Inc / Ferguson PLC / Gohealth Inc / Arcutis Biotherapeutics Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB=US / LLY=US / DNLI=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Denali Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">INCY: Incyte Corporation - BRAVE-AA1 and AA-2 studies demonstrated baricitinib achieved primary end point of hair regrowth for AA patients -- encouraged by the consistency of results, but focus remains on rux cream approval for AD</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INCY.OQ / LLY.N</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABT.N / AXP.N / CCI.N / FCX.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / PM.N / SLB.N / PG.N / DHR.N / UNP.N / HON.N / VZ.N / HCA.N / V.N / PLD.N / MTB.N / RF.N / INTC.OQ / LRCX.OQ / MSFT.OQ / SBAC.OQ / NFLX.OQ / TXN.OQ / CDNS.OQ / NEE.N / TSLA.OQ / NXPI.OQ / GOOGL.OQ / ANTM.N / UAL.OQ / OTIS.N</td><td class="leftalignment">Abbott Laboratories / American Express Co / Crown Castle International Corp / Freeport-McMoRan Inc / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Philip Morris International Inc / Schlumberger NV / Procter & Gamble Co / Danaher Corp / Union Pacific Corp / Honeywell International Inc / Verizon Communications Inc / HCA Healthcare Inc / Visa Inc / Prologis Inc / M&T Bank Corp / Regions Financial Corp / Intel Corp / Lam Research Corp / Microsoft Corp / SBA Communications Corp / Netflix Inc / Texas Instruments Inc / Cadence Design Systems Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Alphabet Inc / Anthem Inc / United Airlines Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IKNA: Targeted Oncology Company with Attractive Novel Therapy Candidates; Initiating with an Outperform Rating and a $30 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">IKNA.OQ / 4502.T / 4528.T / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / AMGN.OQ / INCY.OQ / A2.MI / BAYGN.DE / MRTX.OQ</td><td class="leftalignment">Ikena Oncology Inc / Takeda Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Incyte Corp / A2A SpA / Bayer AG / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LBPS=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / DDDD=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">4D Pharma PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / 4D Pharma PLC / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, April 19 - Sunday, April 25</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">PD-(L)1 Market Model: Potential Price Erosion Offset By Adjuvant Visibility</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US80105N1054 / US58933Y1055 / US07725L1026</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2516152 / 2000019 / 2023607 / 2065159 / 2942605 / 2219224 / 2216850 / 2270726 / 2317087 / 2670519 / 2342034 / 2689560 / 2684703 / 2048804 / 2440637 / 2402121 / 2862532 / 2857817 / B125XQ6 / B02R1L6 / B3D7K31 / B7TL820 / BYNZGK1 / BK0VHF6 / B0SDJB4 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BFWK4R7 / BZ1LFG7 / BN2R582 / BGKG6M3 / BJNQGL0 / BLBLMD5 / BMC8SQ7 / BNTB3N8 / BMFPJK6</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Autodesk Inc / Avista Corp / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Fiserv Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nuance Communications Inc / E W Scripps Co / Netflix Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Meta Platforms Inc / Block Inc / IDEAYA Biosciences Inc / Zealand Pharma A/S / Fox Corp / Spire Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Roku Inc / Relay Therapeutics Inc / StoneCo Ltd / Rite Aid Corp / Array Technologies Inc / BTRS Holdings Inc / Vizio Holding Corp / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Zooming in: pharma out of favour, not out of mind</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / CH0013841017 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Lonza Group AG / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 EPS Preview: Biotech Headwinds Led to Underperformance in Q1, but M&A Could Provide Catalysts to Lift Sentiment</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / LLY.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / EXEL.OQ / SGEN.OQ / VRTX.OQ / GLPG.AS / EPZM.OQ / MRTX.OQ / BPMC.OQ / DCPH.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Exelixis Inc / Seagen Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Epizyme Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park / Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: TSHA now pivotal-stage; JNJ C19 safety pause</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 55</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.16.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">2021 revenue pushed out a quarter by COVID but reimbursement options continue to grow - Reiterate Buy and $7 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">QBIO.PK / LLY.N / ESALY.PK / ALC.N / OMER.OQ / CLVS.OQ / NAVB.A / AERI.OQ / AKBA.OQ / OCUL.OQ / LNTH.OQ / APLS.OQ / DE000BAY0199</td><td class="leftalignment">Q BioMed Inc / Eli Lilly and Co / Eisai Co Ltd / Alcon AG / Omeros Corp / Clovis Oncology Inc / Navidea Biopharmaceuticals Inc / Aerie Pharmaceuticals Inc / Akebia Therapeutics Inc / Ocular Therapeutix Inc / Lantheus Holdings Inc / Apellis Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Japan / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / CHANGE IN RECOMMENDATION / MORNING COMMENTS / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US1265011056 / US22284P1057 / US2254471012 / US2371941053 / US28176E1082 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4663671091 / US5150981018 / US5324571083 / US5370081045 / US5801351017 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7134481081 / US7170811035 / US7392761034 / US7711951043 / US7782961038 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US9029251066 / US9078181081 / US91324P1021 / US92343V1044 / US9282981086 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US00206R1023 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US64110D1046 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US95058W1009 / US9837931008 / US00287Y1091 / US98978V1035 / US8725901040 / US55405Y1001 / US69366J2006 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / US03937C1053 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / CA1380351009 / US74624M1027 / US00938A1043 / CA87241L1094 / CA35805P1071 / CA22717L1013 / US23753F1075 / US80689H1023 / US4990491049 / US09354A1007 / CA88105E1088 / US88688T1007 / US5904791358 / CA39342L1085 / US28414H1032 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA86730L1094 / US24984K1051 / CA1973091079 / CA05156X8843 / GB00BMVP7Y09 / US07373B1098 / US56854Q2003 / ACRGau.CD / US3441741077 / US74767V1098 / US7761531083 / US03743Q1085 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / CTS Corp / Covenant Logistics Group Inc / Wolfspeed Inc / Darden Restaurants Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / Littelfuse Inc / McDonald's Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PepsiCo Inc / Pfizer Inc / Power Integrations Inc / Roche Holding AG / Ross Stores Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Verizon Communications Inc / Vishay Intertechnology Inc / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / AT&T Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / NetApp Inc / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Wendys Co / XPO Logistics Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / PTC Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / ArcBest Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Canopy Growth Corp / Pure Storage Inc / Airgain Inc / TFI International Inc / Freshii Inc / Cronos Group Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Blink Charging Co / Terrascend Corp / Tilray Brands Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Sundial Growers Inc / DermTech Inc / Columbia Care Inc / Aurora Cannabis Inc / Royalty Pharma PLC / Beam Global / Marinus Pharmaceuticals Inc / Acreage Holdings Inc / Foghorn Therapeutics Inc. / Quantumscape Corp / Romeo Power Inc / APA Corp (US) / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Eli Lilly and Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended April 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Elliott Advisors takes stake in GSK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GSK.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - TP cut from £14 to £13 on Fx driven EPS cut & lower than consensus dividend expectations</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / HIK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Hikma Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2219224 / 2270726 / 2542049 / 2317087 / 2369174 / 2515030 / 2645409 / 2689560 / 2707677 / 2440637 / 2138158 / 2980906 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B7TL820 / B7VD3F2 / BJ3V905 / BJ0XLZ3 / BFLR866 / BFZCHN7 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BFNF1D6 / BD9GVY0 / BFMXGR0 / BYXJQG9 / BZ1LFG7 / BK71LY6 / BFFVVC1 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Gilead Sciences Inc / Lithia Motors Inc / NiSource Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sempra Energy / Foot Locker Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Heron Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Amneal Pharmaceuticals Inc / Zai Lab Ltd / Evergy Inc / Spire Inc / Roku Inc / WW International Inc / Bausch Health Companies Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">1Q21 Global Biopharma Preview: Drug Pricing & Macro Remain Overhangs; Group Fundamentals Solid & Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Our Latest Thinking On COVID Antibody Sales; Lowering 1Q21 See Upside To Full Year</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / INCY=US / TEVA=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / CHRS=US / BRO=US / MRO=US / LEG=US / DISH=US / CBRL=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / SBAC=US / CVX=US / SAGE=US / BXS=US / MKL=US / COP=US / DIN=US / JRVR=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / CLR=US / PRPL=US / NMTR=US / TIL=US / NOG=US / IAC=US / JACK=US / TREX=US / KNSL=US / AR=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / 82982L103 / CDEV=US / IRTC=US / CRSP=US / PVAC=US / JELD=US / SBOW=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / FBRX=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Marathon Oil Corp / Leggett & Platt Inc / DISH Network Corp / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / SBA Communications Corp / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Markel Corp / Conocophillips / Dine Brands Global Inc / James River Group Holdings Ltd / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Instil Bio Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2050832 / 2026242 / 2219224 / 2270726 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2440637 / 7103065 / B00FWN1 / B125XQ6 / B3D7K31 / B3D7KG4 / B7TL820 / B3V9F12 / BYVY8G0 / BP4GNK9 / BJLT387 / BMQ5T49 / BKVDFF7 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BJDX8Y8 / BJNQGL0 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Ameren Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Discovery Inc / Discovery Inc / Meta Platforms Inc / PVH Corp / Alphabet Inc / SAGE Therapeutics Inc / Avantor Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Evergy Inc / Spire Inc / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Rite Aid Corp / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assessing Pipeline Value</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">US Major Pharma – Assessing pipeline value and optionality</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / BMY=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma  : 1Q Earnings Preview – Many Moving Pieces But Underlying Trends Remain Healthy</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US -  Dividend Quality Analysis, for the period ended April 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, April 12 - Sunday, April 18</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: 6-mo MRNA C19 data; DRNA sells ALNY royalties</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ALNY.OQ / MRNA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FOCS=US / GANX=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / CAT=US / DIS=US / MO=US / WM=US / BWA=US / MSFT=US / CL=US / MDT=US / C=US / AMZN=US / A=US / RUN=US / CG=US / CSR=US / DOX=US / GS=US / MPWR=US / TMX=US / FCEL=US / PLUG=US / AXL=US / NVS=US / SMTC=US / MET=US / VRTS=US / TSM=US / UPS=US / ENR=US / CRY=US / RAD=US / CSL=US / JCI=US / JNJ=US / UCB=BE / DE=US / FLO=US / HCC=US / NUAN=US / RSG=US / AAII=US / ALB=US / AMED=US / ECOL=US / AMSC=US / APLS=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / B=US / BL=US / CMI=US / CALM=US / CSV=US / CENX=US / CME=US / CO=US / CRVL=US / CREE=US / DAKT=US / EW=US / EXAS=US / FDS=US / FIVE=US / HTLD=US / ITRI=US / MMS=US / MRCY=US / MS=US / MCO=US / ODFL=US / PZZA=US / PRVL=US / QDEL=US / RBC=US / ROK=US / POOL=US / TRMB=US / UTL=US / VCTR=US / VRTX=US / VG=US / WDFC=US / OSUR=US / PDFS=US / CCRN=US / RHHBY=US / PYPL=US / AGR=US / ACA=US / HR=US / NEP=US / PRA=US / UFCS=US / BIO=US / O=US / SWKS=US / ICAD=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / WCN=US / NDAQ=US / BIIB=US / RNG=US / CRI=US / ISR=US / NUVA=US / PBF=US / RMR=US / ENS=US / TWIN=US / ORA=US / WTI=US / FRPT=US / MORN=US / AMRS=US / PDD=US / SPWR=US / ICE=US / ATNI=US / EHTH=US / CSIQ=US / RSI=US / EBS=US / FSLR=US / FOLD=US / MASI=US / DAN=US / WPRT=US / ADXN=US / TBK=US / KKR=US / SWAV=US / AGCO=US / SWI=US / UTZ=US / ADUS=US / SRNE=US / GNRC=US / CBOE=US / TSLA=US / MSCI=US / AMRC=US / 2454-TW=US / HZNP=US / ANVS=US / ZNGA=US / ENPH=US / PRTA=US / HASI=US / CNHI=US / FATE=US / QURE=US / GOOGL=US / DNOW=US / COUP=US / BABA=US / LOVE=US / VCEL=US / BILL=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / VYGR=US / MIME=US / NTNX=US / NGVT=US / WKHS=US / MDGL=US / IRTC=US / CRSP=US / HLNE=US / SNDR=US / IOVA=US / RDFN=US / PETQ=US / SYBX=US / ROKU=US / MDB=US / APTV=US / MDNA=US / VOW3-DE=US / SMAR=US / CWEN=US / FTDR=US / ALLO=US / ESTC=US / FVRR=US / NBSE=US / MPNGF=US / PASG=US / LYS=US / MSGS=US / MSGE=US / ORIC=US / VLDR=US / HYLN=US / SIOX=US / SHLS=US / CHPT=US / AEVA=US</td><td class="leftalignment">Focus Financial Partners Inc / Gain Therapeutics Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Walt Disney Co / Altria Group Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Colgate-Palmolive Co / Medtronic PLC / Citigroup Inc / Amazon.com Inc / Agilent Technologies Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Amdocs Ltd / Goldman Sachs Group Inc / Monolithic Power Systems Inc / Terminix Global Holdings Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Novartis AG / Semtech Corp / MetLife Inc / Virtus Investment Partners Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / CryoLife Inc / Rite Aid Corp / Carlisle Companies Inc / Johnson Controls International PLC / Johnson & Johnson / Ucb SA / Deere & Co / Flowers Foods Inc / Warrior Met Coal Inc / Nuance Communications Inc / Republic Services Inc / Alabama Aircraft Industries Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Apellis Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Barnes Group Inc / Blackline Inc / Cummins Inc / Cal-Maine Foods Inc / Carriage Services Inc / Century Aluminum Co / CME Group Inc / Global Cord Blood Corp / CorVel Corp / Wolfspeed Inc / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Factset Research Systems Inc / Five Below Inc / Heartland Express Inc / Itron Inc / Maximus Inc / Mercury Systems Inc / Morgan Stanley / Moody's Corp / Old Dominion Freight Line Inc / Papa John's International Inc / Porvair PLC / Quidel Corp / Regal Rexnord Corp / Rockwell Automation Inc / Pool Corp / Trimble Inc / Unitil Corp / Victory Capital Holdings Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / WD-40 Co / OraSure Technologies Inc / PDF Solutions Inc / Cross Country Healthcare Inc / Roche Holding AG / PayPal Holdings Inc / Avangrid Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / ProAssurance Corp / United Fire Group Inc / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / ICAD Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / Biogen Inc / RingCentral Inc / Carter's Inc / IsoRay Inc / NuVasive Inc / PBF Energy Inc / RMR Group Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / W&T Offshore Inc / Freshpet Inc / Morningstar Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Intercontinental Exchange Inc / ATN International Inc / eHealth Inc / Canadian Solar Inc / Rush Street Interactive Inc / Emergent BioSolutions Inc / First Solar Inc / Amicus Therapeutics Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Addex Therapeutics Ltd / Triumph Bancorp Inc / KKR & Co Inc / Shockwave Medical Inc / AGCO Corp / SolarWinds Corp / UTZ Brands Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Generac Holdings Inc / Cboe Global Markets Inc / Tesla Inc / MSCI Inc / Ameresco Inc / MediaTek Inc / Horizon Therapeutics PLC / Annovis Bio Inc / Zynga Inc / Enphase Energy Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Fate Therapeutics Inc / Uniqure NV / Alphabet Inc / NOW Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Lovesac Co / Vericel Corp / Bill.com Holdings Inc / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Voyager Therapeutics Inc / Mimecast Ltd / Nutanix Inc / Ingevity Corp / Workhorse Group Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Hamilton Lane Inc / Schneider National Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Synlogic Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Medicenna Therapeutics Corp / Volkswagen AG / Smartsheet Inc / Clearway Energy Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Fiverr International Ltd / NeuBase Therapeutics Inc / Meituan / Passage Bio Inc / Lysogene SA / Madison Square Garden Sports Corp / Madison Square Garden Entertainment Corp / Oric Pharmaceuticals Inc / Velodyne Lidar Inc / Hyliion Holdings Corp / Sio Gene Therapies Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0116591092 / US0231351067 / US0463531089 / US1101221083 / US37733W1053 / US45253H1014 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US37940X1028 / US4771431016 / US64110L1061 / US4198791018 / US80105N1054 / US31620M1062 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US3390411052 / US30303M1027 / US96208T1043 / US00287Y1091 / US8485771021 / US60468T1051 / US21240E1055 / US5560991094 / US02376R1023 / US38000Q1022 / JE00BLG2ZQ72 / CA0089118776 / US8190471016 / US02079K1079 / US07725L1026 / IE00BY7QL619 / US83304A1060 / US8760301072 / US67022C1062 / US6085501095 / US59045L1061 / US5904791358 / KY30744W1070 / US76156B1070 / US70614W1009 / US76155X1000 / US44891N1090 / US5015751044 / US55406W1036 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / ImmunoGen Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Global Payments Inc / JetBlue Airways Corp / Netflix Inc / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Fleetcor Technologies Inc / Meta Platforms Inc / WEX Inc / Abbvie Inc / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / GlycoMimetics Inc / Quotient Ltd / Air Canada / Shake Shack Inc / Alphabet Inc / Beigene Ltd / Johnson Controls International PLC / Snap Inc / Tapestry Inc / NuCana PLC / Molecular Templates Inc / Mersana Therapeutics Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / Peloton Interactive Inc / Revolution Medicines Inc / IAC/Interactivecorp / Kymera Therapeutics Inc / MYT Netherlands Parent BV / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">An Emerging and Differentiated In-Silico Story; Initiating at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">GANX=US / LLY=US / PFE=US / NVS=US / JNJ=US / UCB=BE / PRVL=US / VRTX=US / RHHBY=US / BIIB=US / FOLD=US / ADXN=US / SRNE=US / ANVS=US / PRTA=US / VYGR=US / NBSE=US / PASG=US / LYS=US / SIOX=US</td><td class="leftalignment">Gain Therapeutics Inc / Eli Lilly and Co / Pfizer Inc / Novartis AG / Johnson & Johnson / Ucb SA / Porvair PLC / Vertex Pharmaceuticals Inc / Roche Holding AG / Biogen Inc / Amicus Therapeutics Inc / Addex Therapeutics Ltd / Sorrento Therapeutics Inc / Annovis Bio Inc / Prothena Corporation PLC / Voyager Therapeutics Inc / NeuBase Therapeutics Inc / Passage Bio Inc / Lysogene SA / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Regeneron Pharmaceuticals, Inc. - New data suggests Ab cocktail prevents progression to symptomatic infection in recently exposed patients; co to request expanded EUA</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / LLY.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Event to Discuss How Corporate Tax Increases Could Impact Pharma, THIS THURSDAY at 2PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large-Cap 1Q21 Earnings Preview Conference Call on Friday, 4/16 at 2:00pm ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / 0715.HK / LLY.N / PFE.N / IMAB.OQ</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / China Oceanwide Holdings Ltd / Eli Lilly and Co / Pfizer Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 54</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.9.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / LLY.N / MRK.N / AZN.L / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / CTLT.N / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Catalent Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Event to Discuss How Corporate Tax Increases Could Impact Pharma on Thursday, 4/15 at 2PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / PEB=US / H=US / MTN=US / PXD=US / BRO=US / MAR=US / TNL=US / HLT=US / AIR=US / ATRO=US / CCL=US / CHH=US / DRH=US / DCO=US / EQT=US / AJG=US / HEI=US / HXL=US / TRIP=US / TGI=US / MKL=US / SPR=US / NFLX=US / JRVR=US / SHO=US / REX=US / TDG=US / HST=US / GPRE=US / LUMN=US / WH=US / KNSL=US / HGV=US / RLJ=US / VAC=US / RHP=US / FANG=US / ABBV=US / 00770K202 / GDDY=US / EVBG=US / PK=US / PLYA=US / OKTA=US / PLMR=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Pioneer Natural Resources Co / Brown & Brown Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / AAR Corp / Astronics Corp / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Ducommun Inc / EQT Corp / Arthur J Gallagher & Co / HEICO Corp / Hexcel Corp / Tripadvisor Inc / Triumph Group Inc / Markel Corp / Spirit AeroSystems Holdings Inc / Netflix Inc / James River Group Holdings Ltd / Sunstone Hotel Investors Inc / REX American Resources Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Green Plains Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Aemetis Inc / GoDaddy Inc / Everbridge Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Palomar Holdings Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Introducing our JAK Tracker</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: Highlights from Our Breast Cancer KOL Discussion with a Focus on HER2 Low Disease</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2516152 / 2369174 / 2684703 / BFDV8K0 / BMQ5T49 / BYQHPK7 / BYWVTY5 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Gilead Sciences Inc / Pfizer Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Zymeworks Inc / CytomX Therapeutics Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Revisiting our Outperform and addressing investor pushbacks</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AZN.L / 1093.HK / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / FGEN.PS / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / First Gen Corp / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Philippines / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">You're Gonna Miss This Opportunity When It's Gone, Time To Take Another Look With The Pullback</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">LLY.N / JNJ.N / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">If You Build It, They May Not Come</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 mins — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th (Today) — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0989529 / 2367026 / 2516152 / 2000019 / 2486813 / 2542049 / 2317087 / 2613990 / 2471950 / 2689560 / 2707677 / 2138158 / 2900335 / B1F76F9 / 2212922 / 2857817 / 2951452 / B1HJLW5 / B7TL820 / BFH3N85 / BYRY499 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BYVFC94 / BYW36M8 / BJ2Z0H2 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BKC9SX3</td><td class="leftalignment">AstraZeneca PLC / General Mills Inc / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Dominion Energy Inc / Entergy Corp / Illumina Inc / Incyte Corp / PG&E Corp / Public Service Enterprise Group Inc / Sempra Energy / Tractor Supply Co / Western Union Co / NRG Energy Inc / Netflix Inc / J M Smucker Co / Emergent BioSolutions Inc / Meta Platforms Inc / Veeva Systems Inc / Kraft Heinz Co / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / US Foods Holding Corp / PayPal Holdings Inc / Pinterest Inc / Spire Inc / Vistra Corp / ViacomCBS Inc / Roku Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Eli Lilly and Co Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Olumiant's AD PDUFA Extension Another Clue that FDA May Be Gearing Up for a Deeper Review of JAK Safety</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US -  Dividend Quality Analysis, for the period ended March 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 Mins: Checkup with FTC Expert – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th (Tomorrow) — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Etzer Darout / Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Checkup with FTC Expert on April 6th (Today) – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: LLY - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 6 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MOGa / US0378331005 / US0463531089 / US1101221083 / US1570851014 / US1985161066 / US37733W1053 / US4523271090 / US5324571083 / US92343V1044 / US20030N1019 / US2533931026 / US00206R1023 / US25470M1099 / US58933Y1055 / US6936561009 / US7512121010 / US00287Y1091 / US8725901040 / US6951271005 / US4277461020 / JE00BLG2ZQ72 / US12685J1051 / US4622221004 / US16119P1084 / US02156K1034 / US1010441053 / US05351X1019 / US98585X1046 / US18453H1068 / US02875D1090 / US07373B1098 / US15961R1059 / 120248964</td><td class="leftalignment">Moog Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerus Corp / Columbia Sportswear Co / GlaxoSmithKline PLC / Illumina Inc / Eli Lilly and Co / Verizon Communications Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / DISH Network Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / T-Mobile US Inc / Pacira Biosciences Inc / Heron Therapeutics Inc / Quotient Ltd / Cable One Inc / Ionis Pharmaceuticals Inc / Charter Communications Inc / Altice USA Inc / Boston Omaha Corp / Avaya Holdings Corp / Yeti Holdings Inc / Clear Channel Outdoor Holdings Inc / American Outdoor Brands Inc / Beam Global / ChargePoint Holdings Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / TEVA=US / XOM=US / CHRS=US / RCL=US / CBRL=US / CCL=US / COLL=US / DRI=US / REGI=US / SHOP=US / STRA=US / BKNG=US / DIN=US / BDSI=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AMRX=US / TAST=US / QSR=US / APEI=US / JACK=US / CLNY=US / NCLH=US / NDLS=US / 00770K202 / COUP=US / LOCO=US / NVRO=US / WBA=US / SHAK=US / WING=US / SPNE=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Exxon Mobil Corp / Coherus BioSciences Inc / Royal Caribbean Cruises Ltd / Cracker Barrel Old Country Store Inc / Carnival Corp / Collegium Pharmaceutical Inc / Darden Restaurants Inc / Renewable Energy Group Inc / Shopify Inc / Strategic Education Inc / Booking Holdings Inc / Dine Brands Global Inc / BioDelivery Sciences International Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / American Public Education Inc / Jack in the Box Inc / DigitalBridge Group Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Nevro Corp / Walgreens Boots Alliance Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Israel / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Risk Of Drug Price Reform On Pharma; Stage Setting For PE Re-Rating?</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2317087 / 2100920 / 2613990 / 2459020 / 2632003 / 2689560 / 2684703 / 2048804 / 2138158 / 7103065 / B121557 / 2713317 / B1HJLW5 / B614LY3 / B7TL820 / B4MG4Z6 / BDZCRX3 / B8DPDT7 / BFLR866 / BVVN4Q8 / BYNZGK1 / BK0VHF6 / BJFSR88 / BJ2Z0H2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BJXBP30 / BWY52P3 / BYTJZL1 / BF3N4P3 / BKF9DQ8 / BMZ9Z11 / BLR6S36 / BMG5660</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Illumina Inc / Intuit Inc / New York Times Co / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Novartis AG / Mastercard Inc / ACADIA Pharmaceuticals Inc / Emergent BioSolutions Inc / Cielo SA / Meta Platforms Inc / AMC Networks Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / Block Inc / IDEAYA Biosciences Inc / Uniqure NV / Pinterest Inc / Evergy Inc / Spire Inc / Vistra Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Zogenix Inc / Arena Pharmaceuticals Inc / Phreesia Inc / Prometheus Biosciences Inc / Longboard Pharmaceuticals Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Alzheimer’s Survey Highlights – A Repeat of TRAILBLAZER Would Support Broad Donanemab Uptake</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Alzheimer’s Survey Highlights – A Repeat Of TRAILBLAZER Would Support Broad Donanemab Uptake</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / AAL.L / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Anglo American PLC / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: Precision Medicine Comes to IBD; Initiating with an Outperform Rating and a $30 TP</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">RXDX.OQ / 4502.T / BMY.N / JNJ.N / LLY.N / PFE.N / HUM.N / AZN.L / ROG.S / NOVN.S / UCB.BR / GILD.OQ / ARNA.OQ / GLPG.AS / ABBV.N / MCRB.OQ</td><td class="leftalignment">Prometheus Biosciences Inc / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Humana Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Ucb SA / Gilead Sciences Inc / Arena Pharmaceuticals Inc / Galapagos NV / Abbvie Inc / Seres Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mr. Tiago Fauth / Mark Connolly / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TPTX (BUY) - Early RET Data Still Looks Very Preliminary as Dose Finding Continues; Repo Updates, c-MET Data Next</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BJXBP30 / 2516152 / BD9GVY0 / BWY52P3</td><td class="leftalignment">Turning Point Therapeutics Inc / Eli Lilly and Co / Zai Lab Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Invite: Checkup with FTC Expert on April 6th (Tomorrow) – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IMTX=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US</td><td class="leftalignment">Immatics NV / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, April 5 - Sunday, April 11</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0126531013 / US01741R1023 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US88160R1014 / US9100471096 / US00287Y1091 / US00912X3026 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US4622221004 / US26856L1035 / CA53680Q2071 / US74275G1076 / US5904791358 / US53814L1089 / US89377M1099 / US4432011082 / LU2314763264 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Allegheny Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Abbvie Inc / Air Lease Corp / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Ionis Pharmaceuticals Inc / elf Beauty Inc / Lithium Americas Corp / Priority Technology Holdings Inc / Mesa Air Group Inc / Livent Corp / Transmedics Group Inc / Howmet Aerospace Inc / Arrival SA / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / SIBN.MM / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Gazprom Neft' PAO / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Russian Federation / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS THURSDAY: Please Join Our Virtual KOL Call to Discuss New and Emerging Treatments in Medical Dermatology at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS.O / ARQT.O / JNJ / LLY / PFE / VYNE.O</td><td class="leftalignment">Aclaris Therapeutics Inc / Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) update for QURE in hemB; new tech for DRNA</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">UQ1.F / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Uniqure NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Above Pre-Pandemic Baseline - Week 53</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Wiping Off The Sweat With Qbrexza Deal; Commercial Dermatology Business Continues To Grow</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FBIO.O / LLY</td><td class="leftalignment">Fortress Biotech Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Eli Lilly (Hold, TP=$202) - ESG integration - Insulin pricing controversy unlikely to overshadow ESG efforts - F. Cespedes (1p)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended March 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company lifts 11% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company lifts 11% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas In A Podcast, Please Join Our Weekly Discussion On How Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRX.O / ARCS.PK / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Arcis Resources Corp / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - First look at THOR-707 - novel cancer immunotherapy</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">SASY.PA / LLY.N / MRK.N / AZN.L / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Eli Lilly and Company MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / BLD=US / DVN=US / TEVA=US / CMA=US / APA=US / LOW=US / PB=US / CHRS=US / EWBC=US / TRMK=US / UMPQ=US / LEG=US / ATVI=US / WTFC=US / CBRL=US / CSTR=US / CNX=US / DRI=US / FCN=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / AUTL=US / UCBI=US / DIN=US / PNFP=US / SBCF=US / NOMD=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / IBTX=US / NDLS=US / MTNB=US / LOCO=US / SHAK=US / WING=US / LOB=US / ACBI=US / ZS=US / WVE=US / NTLA=US / 82982L103 / JELD=US / ROKU=US / MBIN=US / HWC=US / OZK=US / AMTB=US / TCRR=US / CRWD=US / FERG=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / APA Corp (US) / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Leggett & Platt Inc / Activision Blizzard Inc / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / CNX Resources Corp / Darden Restaurants Inc / FTI Consulting Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Nomad Foods Ltd / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Roku Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / TCR2 Therapeutics Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Singapore / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2434209 / 2126335 / 2516152 / 2000019 / 2640147 / 2026242 / 2270726 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2857817 / B02R1L6 / B7VD3F2 / BBGVT40 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BJFSR88 / BZ1HM42 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BJDX8Y8 / BP8XZL1 / BN0XTW4 / BMCC9R7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / American Electric Power Company Inc / Walt Disney Co / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / Netflix Inc / ALLETE Inc / Duke Energy Corp / News Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Uniqure NV / Adyen NV / Spire Inc / Vistra Corp / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Healthequity Inc / Orphazyme A/S / SCYNEXIS Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Introducing Berenberg DrugBank</td><td class="leftalignment">English</td><td class="rightalignment">123</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EXEL: 1L RCC Stalemate Averted; Initiate with an Outperform Rating, $30 TP</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">EXEL.OQ / 4523.T / BMY.N / LLY.N / MRK.N / PFE.N / ROG.S / SGEN.OQ / BAYGN.DE / ZYME.N / GMAB.CO</td><td class="leftalignment">Exelixis Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG / Seagen Inc / Bayer AG / Zymeworks Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ZYME: Zymeworks - OppHER2nities High and Low; Initiate with an Outperform Rating, $55 TP</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">ZYME.N / BMY.N / JNJ.N / LLY.N / MRK.N / GSK.L / EXEL.OQ / 4568.T / BGNE.OQ / 6160.HK</td><td class="leftalignment">Zymeworks Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Exelixis Inc / Daiichi Sankyo Co Ltd / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BPMC: Fearing an Indolent Drug Launch; Initiate with a Neutral Rating, $100 TP</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">BPMC.OQ / LLY.N / AZN.L / ROG.S / NOVN.S / DCPH.OQ</td><td class="leftalignment">Blueprint Medicines Corp / Eli Lilly and Co / AstraZeneca PLC / Roche Holding AG / Novartis AG / Deciphera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: What's an Oncology Drug Worth? Data from a Decade of Oncology M&A</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / BMY.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVN.S / MRCG.DE / 4768.T / GSK.L / AMGN.OQ / GILD.OQ / SGEN.OQ / 4568.T / JAZZ.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Jazz Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EGRX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EGRX.O / BMY / JNJ / LLY / NVS / AMGN.O / GSK / TEVA.K</td><td class="leftalignment">Eagle Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ATRS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ATRS.O / BDX / JNJ / LLY / PFE / WST / RVP / ANIP.O / TEVA.K</td><td class="leftalignment">Antares Pharma Inc / Becton Dickinson and Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / West Pharmaceutical Services Inc / Retractable Technologies Inc / ANI Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, March 29 - Sunday, April 4</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BBI=US / JEF=US / BSX=US / LLY=US / ABT=US / CAT=US / INTC=US / WM=US / BWA=US / MDT=US / RUN=US / CG=US / ED=US / FCEL=US / PLUG=US / CRY=US / JCI=US / DE=US / RSG=US / ALB=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / BLUE=US / CMI=US / CREE=US / EW=US / ITRI=US / NVR=US / ODFL=US / ROK=US / TRMB=US / NEP=US / BE=US / CLH=US / WCN=US / DBX=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / SPWR=US / CDW=US / CSIQ=US / FSLR=US / EHC=US / DAN=US / WPRT=US / AGCO=US / TSLA=US / AMRC=US / ENPH=US / HASI=US / FEYE=US / CNHI=US / SEDG=US / LIVN=US / AQMS=US / WKHS=US / APTV=US / CWEN=US / VLDR=US / SHLS=US / CHPT=US / AEVA=US</td><td class="leftalignment">Brickell Biotech Inc / Jefferies Financial Group Inc / Boston Scientific Corp / Eli Lilly and Co / Abbott Laboratories / Caterpillar Inc / Intel Corp / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Sunrun Inc / Carlyle Group Inc / Consolidated Edison Inc / Fuelcell Energy Inc / Plug Power Inc / CryoLife Inc / Johnson Controls International PLC / Deere & Co / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / bluebird bio Inc / Cummins Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Itron Inc / NVR Inc / Old Dominion Freight Line Inc / Rockwell Automation Inc / Trimble Inc / Nextera Energy Partners LP / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Dropbox Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / SunPower Corp / CDW Corp / Canadian Solar Inc / First Solar Inc / Encompass Health Corp / Dana Inc / Westport Fuel Systems Inc / AGCO Corp / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Mandiant Inc / CNH Industrial NV / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Workhorse Group Inc / Aptiv PLC / Clearway Energy Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Pharmaceuticals / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US3695501086 / US37733W1053 / US4433201062 / US4456581077 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US9837931008 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US9314271084 / CA87241L1094 / US23753F1075 / US80689H1023 / US4990491049 / US80706P1030 / US5904791358 / US89377M1099 / CA23126M1023 / US65487U1088 / US75943R1023 / US6877931096</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / XPO Logistics Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Walgreens Boots Alliance Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Scholar Rock Holding Corp / Mesa Air Group Inc / Transmedics Group Inc / Curaleaf Holdings Inc / Nkarta Inc / Relay Therapeutics Inc / Oscar Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Event Spotlights Sofpironium's Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BBI=US / LLY=US</td><td class="leftalignment">Brickell Biotech Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">BLUE Blood, Ide-Cel Approval Is Positive For Heme Malignancy Drug Development</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HGEN.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / US3755581036</td><td class="leftalignment">Humanigen Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss New and Emerging Treatments in Medical Dermatology on 4/8 at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS.O / ARQT.O / JNJ / LLY / PFE / VYNE.O</td><td class="leftalignment">Aclaris Therapeutics Inc / Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Continue Upward Trend-Week 52</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) results from PRQR & KRYS; ide-cel approved</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.26.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CERC=US / XFOR=US / BSX=US / CSII=US / LLY=US / ABT=US / MDT=US / WMT=US / DNLI=US / CMS=US / DGX=US / BBI=US / NVS=US / BWAY=US / GSK=US / CRY=US / RAD=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / PHG=US / LH=US / LIFE=US / USPH=US / UHS=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / BLFS=US / MD=US / SLF=US / BIIB=US / MBRX=US / GOOG=US / DXCM=US / LHCG=US / CBAY=US / CHNG=US / BNGO=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ADUS=US / HZNP=US / ACHC=US / XNCR=US / CTRE=US / EKTAY=US / APTO=US / VBLT=US / WBA=US / RLMD=US / CRBP=US / EVH=US / LIVN=US / IONS=US / SSKN=US / VRAY=US / IRTC=US / SYBX=US / NCNA=US / MBIO=US / TMDX=US / IDYA=US / AKRO=US / FREQ=US / ETNB=US / BXRX=US / PNTG=US / TARA=US / ORIC=US / AYLA=US / VRDN=US / SNSE=US</td><td class="leftalignment">Avalo Therapeutics Inc / X4 Pharmaceuticals Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Abbott Laboratories / Medtronic PLC / Walmart Inc / Denali Therapeutics Inc / CMS Energy Corp / Quest Diagnostics Inc / Brickell Biotech Inc / Novartis AG / Brainsway Ltd / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / General Electric Co / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / aTyr Pharma Inc / US Physical Therapy Inc / Universal Health Services Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / BioLife Solutions Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / Moleculin Biotech Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Bionano Genomics Inc / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Addus Homecare Corp / Horizon Therapeutics PLC / Acadia Healthcare Company Inc / Xencor Inc / CareTrust REIT Inc / Elekta AB (publ) / Aptose Biosciences Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Relmada Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Evolent Health Inc / LivaNova PLC / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / iRhythm Technologies Inc / Synlogic Inc / NuCana PLC / Mustang Bio Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / Akero Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Viridian Therapeutics Inc / Sensei Biotherapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2113393 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2632003 / 2680905 / 2684703 / 2730190 / 2829601 / 2883878 / B121557 / B7TL820 / BFDV8K0 / BBGVT40 / BYVY8G0 / BYVYD43 / BYZLV46 / BMQ5T49 / BGCYWN8 / BFZ1K46 / BZ8VJQ8 / BJ9NFQ3 / BN2R582 / BN7K304</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / New York Times Co / PPL Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Meta Platforms Inc / MacroGenics Inc / News Corp / Alphabet Inc / Performance Food Group Co / InflaRx NV / Zentalis Pharmaceuticals Inc / Xencor Inc / Spotify Technology SA / Vistra Corp / Neoleukin Therapeutics Inc / Relay Therapeutics Inc / Academy Sports and Outdoors Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: AstraZeneca BioPharma Meet Management event, March 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AZN.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / AMGN.OQ / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - 4Q Recap; ZN-c3 Initial Data at AACR; Trials Initiated as Planned</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMQ5T49 / 0989529 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SNSE=US / TMDX=US / LLY=US / C=US / DNLI=US / BAC=US / GS=US / JPM=US / MS=US / SAGE=US / JEF=US / BIIB=US / VBLT=US</td><td class="leftalignment">Sensei Biotherapeutics Inc / Transmedics Group Inc / Eli Lilly and Co / Citigroup Inc / Denali Therapeutics Inc / Bank of America Corp / Goldman Sachs Group Inc / JPMorgan Chase & Co / Morgan Stanley / SAGE Therapeutics Inc / Jefferies Financial Group Inc / Biogen Inc / Vascular Biogenics Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Financial Services / Healthcare</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Takeaways from Discussion with Management</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB=US / LLY=US / DNLI=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Denali Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / UBX / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / COX.F / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / CKPT.O / EYPT.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / UNITY Biotechnology Inc / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Colonial Coal International Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss New and Emerging Treatments in Medical Dermatology on 4/8 at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS.O / ARQT.O / JNJ / LLY / PFE / VYNE.O</td><td class="leftalignment">Aclaris Therapeutics Inc / Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Building On The Body Of Evidence, More Positive FIDES-01 Data Supports Best In Class Potential Of Derazantinib</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BSLN.S / LLY</td><td class="leftalignment">Basilea Pharmaceutica AG / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss the Recent FDA Regulatory Landscape on CRLs and Delays TODAY @ 10am ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / JNJ / MRK / PFE / OMER.O / HGEN.O</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Omeros Corp / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Biotech Sector - Some clarification on Innovent and Junshi's PD-1 commercial strategy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1801.HK / 1877.HK / LLY.N / AZN.L / CHRS.OQ / 600276.SS / 688180.SS</td><td class="leftalignment">Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Coherus BioSciences Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Zealand's Newly-Approved Zegalogue Not A Threat To Gvoke</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N / 98422L107 / 532457108</td><td class="leftalignment">Eli Lilly and Co / Xeris Biopharma Holdings Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / TEVA=US / CMA=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CHTR=US / H=US / MTN=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / MGY=US / SWN=US / MUR=US / CHRS=US / MAR=US / UMPQ=US / MRO=US / LEG=US / TNL=US / HLT=US / HUM=US / CMCSA=US / DISH=US / WTFC=US / CBRL=US / ELY=US / CHH=US / CNX=US / CW=US / DRI=US / DRH=US / EQT=US / GFF=US / IBP=US / MAS=US / MRCY=US / MHK=US / REGI=US / GOLF=US / HTH=US / CVX=US / SIVB=US / ABCB=US / FBK=US / NHI=US / COP=US / DIN=US / BCO=US / TCBI=US / TPX=US / EXP=US / FHN=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / LUMN=US / NMTR=US / WH=US / NOG=US / JACK=US / UTZ=US / TREX=US / AR=US / HGV=US / SBRA=US / PCRX=US / RLJ=US / ESTE=US / VAC=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / SPNE=US / CABO=US / WVE=US / WLTW=US / 82982L103 / CDEV=US / IRTC=US / PK=US / PVAC=US / JELD=US / PLYA=US / SBOW=US / MBIN=US / BTAI=US / RTLR=US / FERG=US / GOCO=US / OVV=US / AZEK=US / 96758W101 / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / Comcast Corp / DISH Network Corp / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CNX Resources Corp / Curtiss-Wright Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Acushnet Holdings Corp / Hilltop Holdings Inc / Chevron Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / National Health Investors Inc / Conocophillips / Dine Brands Global Inc / Brinks Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Lumen Technologies Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Jack in the Box Inc / UTZ Brands Inc / Trex Company Inc / Antero Resources Corp / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Gohealth Inc / Ovintiv Inc / Azek Company Inc / WideOpenWest Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2026242 / 2317087 / 2670519 / 2100920 / 2455965 / 2680905 / 2684703 / 2707677 / 2440637 / 2573083 / 2138158 / 7103065 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BK7Y2V9 / B0SDJB4 / BJFSR88 / BKVDFF7 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BMG75B4</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / American Electric Power Company Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Biogen Inc / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Novartis AG / Duke Energy Corp / Eversource Energy / Alphabet Inc / Akero Therapeutics Inc / Zealand Pharma A/S / Uniqure NV / Oric Pharmaceuticals Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Inventiva SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Regeneron Pharmaceuticals, Inc. - REGN-COV effective at lower 1,200 mg dose: We expect full realization of the $2.6B BARDA contract</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ / LLY.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Biologics Sector - Quick take: Looking ahead to EMA CHMP opinion this week</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / 091990.KQ / LLY.N / REGN.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Quick Thoughts On Fasinumab Given Availability Of Tanezumab Briefing Docs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">881624209 / 717081103 / 532457108 / 75886F107</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Pfizer Inc / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Eli Lilly (Hold, TP=$202) - 12m target upgrade - Attractive innovative company but market expectations are already high - F. Cespedes (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call on April 7th: The Emerging Breast Cancer Landscape – Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">FDA Documents a Painful Assessment of LLY/PFE's Tanezumab; No Upside, No Surprise</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Yatin Suneja / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1092</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0126531013 / US0311621009 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4581401001 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US45784P1012 / US58933Y1055 / US9100471096 / US92335C1062 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US00653A1079 / CA87241L1094 / US23753F1075 / US80689H1023 / US04016X1019 / US4990491049 / CA53680Q2071 / US02083G1004 / US09354A1007 / US5904791358 / US28414H1032 / US0197701065 / US53814L1089 / US07373B1098 / US5533681012 / US74767V1098 / US7761531083 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Intel Corp / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Insulet Corp / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Adaptimmune Therapeutics PLC / TFI International Inc / Daseke Inc / Schneider National Inc / argenx SE / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Blink Charging Co / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Livent Corp / Beam Global / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, March 22 - Sunday, March 28</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SLDB makes progress in DMD</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">SLDB.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Solid Biosciences Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Key Metrics Remain Above Pre-Pandemic Levels-Week 51</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / AVB=US / AMZN=US / GILD=US / MTN=US / VRM=US / EXPE=US / ESS=US / EQR=US / AIR=US / AMN=US / HOOK=US / SNAP=US / TRIP=US / WIX=US / CCRN=US / BKNG=US / CPT=US / FB=US / MAA=US / UDR=US / NLS=US / PTON=US / BIIB=US / APTS=US / ANGI=US / IBTX=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / GDDY=US / NXRT=US / CVNA=US / SFIX=US / SYNH=US / BTAI=US / FTDR=US / SVMK=US / LYFT=US / UBER=US / AIRC=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Avalonbay Communities Inc / Amazon.com Inc / Gilead Sciences Inc / Vail Resorts Inc / Vroom Inc / Expedia Group Inc / Essex Property Trust Inc / Equity Residential / AAR Corp / AMN Healthcare Services Inc / HOOKIPA Pharma Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cross Country Healthcare Inc / Booking Holdings Inc / Camden Property Trust / Meta Platforms Inc / Mid-America Apartment Communities Inc / UDR Inc / Nautilus Inc / Peloton Interactive Inc / Biogen Inc / Preferred Apartment Communities Inc / Angi Inc / Independent Bank Group Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / NexPoint Residential Trust Inc / Carvana Co / Stitch Fix Inc / Syneos Health Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Lyft Inc / Uber Technologies Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on donanemab</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LLY=US / MRK=US / BIIB=US / BTAI=US</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Biogen Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / MDT=US / PD=US / BLD=US / CMA=US / PEB=US / REI=US / H=US / MTN=US / PB=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TNL=US / VMC=US / HLT=US / MLM=US / WTFC=US / AIR=US / CHH=US / CSTR=US / DRH=US / ENDP=US / IBP=US / PACW=US / REGI=US / WAL=US / HTH=US / SAGE=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / BIIB=US / TCBI=US / FNB=US / FHN=US / SHO=US / RNST=US / BLDR=US / HST=US / CADE=US / WH=US / 45665G303 / HGV=US / RLJ=US / VAC=US / RHP=US / ABBV=US / IBTX=US / SHAK=US / SUM=US / LOB=US / ACBI=US / PK=US / PLYA=US / YEXT=US / MBIN=US / MAXR=US / HWC=US / OZK=US / AMTB=US / UBER=US / FERG=US / AHCO=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Medtronic PLC / PagerDuty Inc / TopBuild Corp / Comerica Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Wintrust Financial Corp / AAR Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Endo International PLC / Installed Building Products Inc / PacWest Bancorp / Renewable Energy Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / SAGE Therapeutics Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / Builders FirstSource Inc / Host Hotels & Resorts Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Shake Shack Inc / Summit Materials Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Yext Inc / Merchants Bancorp / Maxar Technologies Inc / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / Uber Technologies Inc / Ferguson PLC / Adapthealth Corp / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Eli Lilly And Company (Lly) In Peptide Therapeutics Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">ABBV, LLY, PFE: JAKs running into a brick wall, or just another bump in the road</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">532457108 / 00287Y109 / PFE.N / 717081103</td><td class="leftalignment">Eli Lilly and Co / Abbvie Inc / Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Rinvoq news could create a temporary overhang for Rinvoq and other JAKs</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABBV=US / LLY=US / PFE=US / ARQT=US</td><td class="leftalignment">Abbvie Inc / Eli Lilly and Co / Pfizer Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DMAC (BUY): Keeping Up with the Kallikreins - Raising Stroke PoS Ahead of Phase 2/3 IND; Previewing DKD Data in 2Q; PT to $25 (from $16)</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">BGT0PL8 / 0989529 / 2516152 / 2369174</td><td class="leftalignment">DiaMedica Therapeutics Inc / AstraZeneca PLC / Eli Lilly and Co / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CYCC-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CYCC.O / BAX / JNJ / LLY / ARRY.O / SPPI.O / ONTX.O / CASI.O</td><td class="leftalignment">Cyclacel Pharmaceuticals Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Array Technologies Inc / Spectrum Pharmaceuticals Inc / Onconova Therapeutics Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ONCY-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ONCY.O / BMY / LLY / HBP.TO / AEZS.O / AVEO.O / MRTX.O / TEVA.K / SPHS.PK</td><td class="leftalignment">Oncolytics Biotech Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Helix Biopharma Corp / Aeterna Zentaris Inc / Aveo Pharmaceuticals Inc / Mirati Therapeutics Inc / Teva Pharmaceutical Industries Ltd / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Rethinking Pharma Merger Reviews Could Create Some Headline Risks For The Industry</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / ZTS.N / IMAB.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Eli Lilly (LLY US) - Alzheimer's: perception versus potential</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Miri, Miri on the Wall, Who's Got The Best UC Treatment Of Them All</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY / JNJ / PFE / IMAB</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Pfizer Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Donanemab Details Gleaned From LLY Meeting, Cowen KOL Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2026242 / 2942605 / 2317087 / 2328915 / 2342034 / 2369174 / 2630513 / 2684703 / 2048804 / 2980906 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B2R3PV1 / B28TS42 / B7TL820 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BP7RS48 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BDD1B07 / BP8XZL1 / BFY7DC4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Entergy Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / New Jersey Resources Corp / Pfizer Inc / Pinnacle West Capital Corp / Foot Locker Inc / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / American Water Works Company Inc / Ulta Beauty Inc / Meta Platforms Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Intersect Ent Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / ViacomCBS Inc / Rubius Therapeutics Inc / Healthequity Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Few Waves of Innovation Tsunami During 2021 in Alz/Park’s Disease - Post AD/PD’21</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY.N / US1101221083 / BIIB.OQ / US0042251084 / PRTA.OQ / US05464T1043 / US0327973006 / US24823R1059 / SAVA.OQ</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Biogen Inc / ACADIA Pharmaceuticals Inc / Prothena Corporation PLC / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc / Cassava Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Where Today’s Updates / Stock Move Leave Us on Donanemab</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: Conference call highlights from donanemab at AD/PD</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from Expert call on donanemab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">KOL believes adu could be approved but initial uptake could be small</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Investor questions about donanemab and read to adu</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Mar. 15, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, March 15 - Sunday, March 21</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000054470 / BE0165385973 / US0079731008 / US0116591092 / US0320951017 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1925761066 / US2371941053 / US2855121099 / US37733W1053 / US45167R1041 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6284641098 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8793601050 / US8807701029 / US9021041085 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US0003752047 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / JE00B783TY65 / US98986T1088 / US00287Y1091 / NL0010273215 / US72919P2020 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US98138J2069 / US45073V1089 / KYG4740B1059 / US05351X1019 / US92336X1090 / US5904791358 / US1567271093 / US92537N1081 / US22041X1028 / US33813J1060 / US72815L1070</td><td class="leftalignment">Ubisoft Entertainment SA / Melexis NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Amphenol Corp / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / Electronic Arts Inc / GlaxoSmithKline PLC / IDEX Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Myers Industries Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teledyne Technologies Inc / Teradyne Inc / II-VI Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Abb Ltd / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / ASML Holding NV / Plug Power Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Workhorse Group Inc / ITT Inc / Ichor Holdings Ltd / Avaya Holdings Corp / Veoneer Inc / Mesa Air Group Inc / Cerence Inc / Vertiv Holdings Co / Corsair Gaming Inc / Fisker Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PEP=US / CAG=US / DIS=US / KO=US / CL=US / PG=US / BXP=US / T=US / CMA=US / SLG=US / CRM=US / VZ=US / ENR=US / SCOR=US / SPOT=US / ATVI=US / CLI=US / MANH=US / NWL=US / FLO=US / STZ=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / HAS=US / PDM=US / SMG=US / POST=US / OPT=US / BXS=US / HIW=US / CFR=US / SNV=US / BDN=US / OFC=US / CUZ=US / VNO=US / WRE=US / CRTO=US / NFLX=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / TCBI=US / FRPT=US / WMG=US / XM=US / THS=US / SCPL=US / ELF=US / NOG=US / AAN=US / NXPI=US / ZNGA=US / EA=US / MODN=US / TMUS=US / QTWO=US / FIVN=US / WK=US / DEA=US / EVBG=US / PETQ=US / ROKU=US / HWC=US / KDP=US / BRBR=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Eli Lilly and Co / PepsiCo Inc / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / Boston Properties Inc / AT&T Inc / Comerica Inc / SL Green Realty Corp / Salesforce.Com Inc / Verizon Communications Inc / Energizer Holdings Inc / Comscore Inc / Spotify Technology SA / Activision Blizzard Inc / Veris Residential Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Hasbro Inc / Piedmont Office Realty Trust Inc / Scotts Miracle-Gro Co / Post Holdings Inc / Opthea Ltd / Cadence Bank / Highwoods Properties Inc / Cullen/Frost Bankers Inc / Synovus Financial Corp / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Vornado Realty Trust / Washington Real Estate Investment Trust / Criteo SA / Netflix Inc / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Texas Capital Bancshares Inc / Freshpet Inc / Warner Music Group Corp / Qualtrics International Inc / TreeHouse Foods Inc / Sciplay Corp / elf Beauty Inc / Northern Oil and Gas Inc / Aaron's Company Inc / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Model N Inc / T-Mobile US Inc / Q2 Holdings Inc / Five9 Inc / Workiva Inc / Easterly Government Properties Inc / Everbridge Inc / PetIQ Inc / Roku Inc / Hancock Whitney Corp / Keurig Dr Pepper Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / France / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2516152 / 2000019 / 2023607 / 2008154 / 2050832 / 2026242 / 2175672 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2455965 / 2613990 / 2459020 / 2645409 / 2048804 / 2707677 / 2795393 / 2857817 / B2R3PV1 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / B95N910 / BFH3N85 / BYW36M8 / BFM2GV1 / BQT3XY6 / BFZ1K46 / BZ8VJQ8 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BL71K91 / BGKG6M3 / BFY7DC4 / 021513106 / BNRQM83</td><td class="leftalignment">Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Cardinal Health Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Biogen Inc / Illumina Inc / Intuit Inc / NiSource Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Amerisourcebergen Corp / Netflix Inc / American Water Works Company Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / PTC Inc / Veeva Systems Inc / PayPal Holdings Inc / GreenSky Inc / Cyberark Software Ltd / Spotify Technology SA / Vistra Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Revolution Medicines Inc / StoneCo Ltd / Altimmune Inc / Alto Ingredients Inc / Petco Health and Wellness Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RNA: Q4 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RNA.OQ / BMY.N / LLY.N</td><td class="leftalignment">Avidity Biosciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mark Connolly / Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Donanemab TRAILBLAZER-ALZ Trends Compelling, But Short Of High Expectations</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">TRAILBLAZER-ALZ Detailed Data Create More Questions</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - LLY's Full TRAILBLAZER Results Are Competitive with Aducanumab but Likely Need One More Study; FDA Decision on Adu Coming in June</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / 2455965 / 2516152</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Donanemab Results Encouraging but Modest Effect Suggests Confirmatory Study Likely Required; Data Supports Anti-Amyloid Plaque Treatments</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2516152 / 2455965</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARRY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARRY.O / LLY / NVS / AMGN.O / AZN.O / ONTX.O</td><td class="leftalignment">Array Technologies Inc / Eli Lilly and Co / Novartis AG / Amgen Inc / AstraZeneca PLC / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Advertising / Media / Telecommunications</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BNTX/PFE efficacy in C19; (+) LentiGlobin news</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Pfizer Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: New Trial Starts Continue to Increase - Week 50</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Blazing a trail or following in aducanumab's footsteps? Donanemab full phase 2 data demonstrates difficulty of developing an AD Tx</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - Donanemab results solid, but important questions remain...</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Donanemab First Impressions: Trailblazer-Alz Results Mixed but Overall Profile Remains Promising</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Raising PT to $225 following impressive donanemab data at AD/PD</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">my take on alzh data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Group Meeting With CEO and CFO On 5/6 at 1pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Blazing New TRAILs With More Alzheimer's Data, But LLY Needs To Show More Before It Can Cut Down The Competition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.12.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / ALDX=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Key Abstract Titles For 2021 AACR</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5324571083 / US66987V1098 / US80105N1054</td><td class="leftalignment">Eli Lilly and Co / Novartis AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON To Discuss Emerging Therapies for Alzheimer’s Disease Ahead of AD/PD 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 0925288 / 2516152 / 2000019 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2345022 / 2100920 / 2415204 / 2459020 / 2638625 / 2657802 / 2730190 / 2799351 / 2895163 / 2795393 / B121557 / 2769796 / B125XQ6 / B7TL820 / BFLR866 / BYVY8G0 / BYW36M8 / BF4VBS8 / BFM2GV1 / BQT3XY6 / B0SDJB4 / BFZ1K46 / BZ8VJQ8 / BKTNTR9 / BMVWYW8 / BG0Q4Y1 / BGKG6M3 / BMPRZV5 / BGT0PL8 / BMTVQT8 / 021513106</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Amazon.com Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Macy's Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Intuit Inc / National Beverage Corp / OGE Energy Corp / Regeneron Pharmaceuticals Inc / Sinclair Broadcast Group Inc / United Natural Foods Inc / Amerisourcebergen Corp / Mastercard Inc / Fidelity National Information Services Inc / Portland General Electric Co / Meta Platforms Inc / Twitter Inc / Alphabet Inc / PayPal Holdings Inc / BioXcel Therapeutics Inc / GreenSky Inc / Cyberark Software Ltd / Zealand Pharma A/S / Spotify Technology SA / Vistra Corp / ViacomCBS Inc / Protara Therapeutics Inc / Exicure Inc / StoneCo Ltd / Kymera Therapeutics Inc / DiaMedica Therapeutics Inc / Goodrx Holdings Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2021 Catalysts - How We Are Thinking About Key Updates From Here</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / JNJ.N / LLY.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Johnson & Johnson / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / DNLI.O / PRTA.O / SAVA.O</td><td class="leftalignment">Eli Lilly and Co / Denali Therapeutics Inc / Prothena Corporation PLC / Cassava Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's The Lowdown On AACR This Year? Takeaways From Release Of Abstracts And Titles</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / MRK / JNJ / PFE / HCM.O / IMAB.O</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Johnson & Johnson / Pfizer Inc / HUTCHMED (China) Ltd / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Latest Thoughts Ahead of Donanemab AD/PD Data This Weekend</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / BIIB.OQ / PRTA.OQ / AVXL.OQ / DNLI.OQ</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Prothena Corporation PLC / Anavex Life Sciences Corp / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Donanemab TRAILBLAZER-ALZ: Results Could Surpass Expectations</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 4031976 / 0925288 / 2868165 / 2516152 / 2000019 / 2050832 / 2026242 / 2270726 / 2328915 / 2455965 / 2471950 / 2459020 / 2630513 / 2689560 / 2825933 / B1F76F9 / 2969637 / B2R3PV1 / B5B2106 / 2982924 / B7TL820 / BCBVTX1 / BBFL7S1 / B7VD3F2 / BBPK0J0 / BDZCRX3 / BFLR866 / BJ36RM8 / BYW36M8 / BYZLV46 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BKVDFF7 / BZ8VJQ8 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BWY52P3 / BL71K91 / BDD1B07 / BLBLMD5</td><td class="leftalignment">American Express Co / Visa Inc / Adidas AG / GlaxoSmithKline PLC / Sysco Corp / Eli Lilly and Co / Amazon.com Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / Biogen Inc / Incyte Corp / Intuit Inc / New Jersey Resources Corp / PG&E Corp / South Jersey Industries Inc / Western Union Co / DICK'S Sporting Goods Inc / American Water Works Company Inc / Fortinet Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Duke Energy Corp / Mirati Therapeutics Inc / RingCentral Inc / Twitter Inc / Pacira Biosciences Inc / PayPal Holdings Inc / InflaRx NV / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Oric Pharmaceuticals Inc / Vistra Corp / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Rubius Therapeutics Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH: Previewing LLY's Donanemab Results Ahead of "Amyloid" Showcase at AD/PD</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / 2516152 / 2455965</td><td class="leftalignment">Eli Lilly and Co / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Yatin Suneja / Tarun Soni / Mr. Evan B. Wang / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Synthetic Lethality Primer - A Prelude to Innovative IDEAYAs in DNA Damage Repare and Next-Generation Targeted Oncology</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 2730190 / 5531000 / 7103065 / 2982924 / BCBVTX1 / BBFL7S1 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BF3NP05 / BMDJ397</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / MorphoSys AG / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mali / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / DRRX.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / VFF.TO / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / MRNS.OQ / CFRX.OQ / VNRX.A / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / XLY.V / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / STOK.OQ / SNDL.OQ / IMAB.OQ / ARQT.OQ / LUMO.OQ / AH.TO / PCVX.OQ / AWH.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / DURECT Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Village Farms International Inc / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / Marinus Pharmaceuticals Inc / ContraFect Corp / VolitionRX Ltd / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Auxly Cannabis Group Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Stoke Therapeutics Inc / Sundial Growers Inc / I-Mab / Arcutis Biotherapeutics Inc / Lumos Pharma Inc / Aleafia Health Inc / Vaxcyte Inc / Aspira Women's Health Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: These two questions likely matter more than this weekend's data on donanemab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">More Positive Combo Data Supports Use of LLY's Antibodies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended March 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / NEOS.BO / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Neo Corp International Ltd / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Mar. 09, 2021 / 9:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Updated; 2021 EPS And PT Raised</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US28414H1032 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Elanco Animal Health Inc / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / TEVA=US / GILD=US / LOW=US / CHRS=US / LEG=US / CI=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / AMSF=US / DIN=US / BIIB=US / TPX=US / EXP=US / CRD.B=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / RPRX=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / LOCO=US / SHAK=US / WING=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / SFIX=US / GOCO=US / AZEK=US / VTRS=US / DHT.UN=CA</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Lowe's Companies Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Cigna Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Crawford & Co / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Royalty Pharma PLC / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Gohealth Inc / Azek Company Inc / Viatris Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2050832 / 2026242 / 2270726 / 2328915 / 2100920 / 2369174 / 2689560 / 2672689 / 2684703 / 2048804 / 2402121 / 2980906 / 7103065 / B1F76F9 / B121557 / 2769796 / B2R3PV1 / BCZS820 / BFZNYB7 / BDHF4K6 / BMQ5T49 / BWFKZT2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BDRW1L7 / BZ4CHH2 / BNG3RZ7 / BMC8SQ7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Pinnacle West Capital Corp / Nuance Communications Inc / Foot Locker Inc / Novartis AG / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / American Water Works Company Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Zentalis Pharmaceuticals Inc / Cellectis SA / Evergy Inc / Spire Inc / Vistra Corp / AnaptysBio Inc / Soleno Therapeutics Inc / Leslie's Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, March 8 - Sunday, March 14</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED To Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease Ahead of AD/PD 2021 THIS FRIDAY at 11 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IVA=FR / PASG=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / PRVL=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / LYS=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Inventiva SA / Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Porvair PLC / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Lysogene SA / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / REGN.OQ / AMRN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / AKBA.OQ / ALDX.OQ / ADVM.OQ / TVTY.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Regeneron Pharmaceuticals Inc / Amarin Corporation PLC / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Akebia Therapeutics Inc / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / Tivity Health Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 08 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0079731008 / US00846U1016 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1925761066 / US22284P1057 / US2358511028 / US3021301094 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4523271090 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US62855J1043 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US68389X1054 / US7140461093 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US8835561023 / US9029251066 / US9078181081 / US91347P1057 / US9418481035 / US9507551086 / CA1363751027 / US30063P1057 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US1167941087 / US3463751087 / US2533931026 / US90385V1070 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US1920051067 / US9100471096 / US69404D1081 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US09609G1004 / US63009R1095 / US8485771021 / US21240E1055 / US02376R1023 / US09062W2044 / US03937C1053 / CA0089118776 / US46185L1035 / US6323071042 / KYG4740B1059 / CA87241L1094 / NL0012169213 / US23753F1075 / US80689H1023 / US6904691010 / US03236M2008 / US4990491049 / US74766Q1013 / US2575541055 / US5904791358 / US28414H1032 / US40131M1099 / US90184D1000 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US75513E1010 / US12233L1070 / US7602731025 / GB00BMVP7Y09 / US57667L1070 / US0843101017 / US86646P1030 / US6873051022 / US81578P1066 / US65443P1021 / US03783T1034 / US12047B1052 / US67080N1019</td><td class="leftalignment">Advanced Energy Industries Inc / Agilent Technologies Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cohu Inc / Covenant Logistics Group Inc / Danaher Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Illumina Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Myriad Genetics Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Oracle Corp / PerkinElmer Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Thermo Fisher Scientific Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / Waters Corp / Werner Enterprises Inc / Canadian National Railway Co / Exact Sciences Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Bruker Corp / FormFactor Inc / DICK'S Sporting Goods Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / bluebird bio Inc / NanoString Technologies Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / BioLife Solutions Inc / ArcBest Corp / Air Canada / Invitae Corp / Natera Inc / Ichor Holdings Ltd / TFI International Inc / Qiagen NV / Daseke Inc / Schneider National Inc / Ovid Therapeutics Inc / Amyris Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Raytheon Technologies Corp / Burning Rock Biotech Ltd / Repare Therapeutics Inc / Royalty Pharma PLC / Match Group Inc / Berkeley Lights Inc / Sumo Logic Inc / Orphazyme A/S / Seer Inc / 908 Devices Inc. / AppHarvest Inc / Bumble Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABCL: Revisiting ABCL's Fundamentals - Attractive  LT Entry Point for a Disruptive Drug Discovery Platform</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ABCL.OQ / LLY.N / ADPT.OQ</td><td class="leftalignment">Abcellera Biologics Inc / Eli Lilly and Co / Adaptive Biotechnologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Dr. Martin Auster, M.D. / Mr. Thomas Deal / Mark Connolly / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Big Cap Pharma Highlights From Cowen's 41st Annual Health Care Conference</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Emerging Markets Q4 update – China roars back, but EM growth still lags other geographies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">00287Y109 / 0989529 / 5671735 / 0925288 / 7103065 / 7110388 / 717081103 / 110122108 / 532457108 / 58933Y105</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease Ahead of AD/PD 2021 THIS FRIDAY at 11 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Most Key Metrics Continue To Move Favorably - Week 49</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 booster developments; 4Q20 & FY20 earnings</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HCM.L / LLY.N / DRRX.OQ / VRAY.OQ / EYPT.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / DURECT Corp / ViewRay Inc / EyePoint Pharmaceuticals Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.5.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Raising PT to $7 from $6 on earnings outlook for biotech maker Q BioMed - Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">QBIO.PK / LLY.N / ESALY.PK / ALC.N / OMER.OQ / CLVS.OQ / NAVB.A / AERI.OQ / AKBA.OQ / OCUL.OQ / LNTH.OQ / APLS.OQ / DE000BAY0199</td><td class="leftalignment">Q BioMed Inc / Eli Lilly and Co / Eisai Co Ltd / Alcon AG / Omeros Corp / Clovis Oncology Inc / Navidea Biopharmaceuticals Inc / Aerie Pharmaceuticals Inc / Akebia Therapeutics Inc / Ocular Therapeutix Inc / Lantheus Holdings Inc / Apellis Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Japan / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / CHANGE IN RECOMMENDATION / MORNING COMMENTS / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US00971T1016 / US0311621009 / US0378331005 / US0382221051 / US1265011056 / US22160K1051 / US2910111044 / US4581401001 / US4824801009 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US5950171042 / US5951121038 / US67066G1040 / US6821891057 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US9282981086 / US9581021055 / US9839191015 / CA0977512007 / US98956P1021 / US83088M1027 / US6098391054 / US19239V3024 / US82706C1080 / US1717793095 / US55616P1049 / NL0009538784 / US8725901040 / US55405Y1001 / US1220171060 / US14862Q1004 / US74736K1016 / US09627Y1091 / US20717E1010 / US74624M1027 / US87184Q1076 / US02081G2012 / IE00BY7QL619 / US36165L1089 / US67022C1062 / US89854H1023 / US11135F1012 / CA74319B5027 / IE00BK9ZQ967 / US39813G1094 / US14448C1045 / US8317541063 / US05380C1027 / US12769G1004 / US05479K1060 / US05875B1061 / US21077C1071 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Akamai Technologies Inc / Amgen Inc / Apple Inc / Applied Materials Inc / CTS Corp / Costco Wholesale Corp / Emerson Electric Co / Intel Corp / KLA Corp / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microchip Technology Inc / Micron Technology Inc / NVIDIA Corp / ON Semiconductor Corp / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Vishay Intertechnology Inc / Western Digital Corp / Xilinx Inc / Bombardier Inc / Zimmer Biomet Holdings Inc / Skyworks Solutions Inc / Monolithic Power Systems Inc / Cogent Communications Holdings Inc / Silicon Motion Technology Corp / Ciena Corp / Macy's Inc / NXP Semiconductors NV / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / Burlington Stores Inc / Castlight Health Inc / Qorvo Inc / Blueprint Medicines Corp / Conformis Inc / Pure Storage Inc / Syros Pharmaceuticals Inc / Alphatec Holdings Inc / Johnson Controls International PLC / GDS Holdings Ltd / NuCana PLC / TTEC Holdings Inc / Broadcom Inc / Profound Medical Corp / Trane Technologies PLC / Grid Dynamics Holdings Inc / Carrier Global Corp / Smith & Wesson Brands Inc / AVITA Medical Inc / Caesars Entertainment Inc / Aziyo Biologics Inc / Bally's Corp / ContextLogic Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Big Cap Pharma Highlights - Day 4</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2701271 / 2360326 / 2516152 / 2000019 / 2023607 / 2026242 / 2544960 / 2219224 / 2222631 / 2270726 / 2829515 / 2382892 / 2317087 / 2670519 / 2345022 / 2100920 / 2471950 / 2459020 / 2684703 / 2048804 / 2746711 / 2862532 / 2799351 / 2989301 / B121557 / 2212922 / B0T7YX2 / B2R3PV1 / 2390817 / 2949758 / BF311Y5 / B7VD3F2 / B7JYSG3 / B8L2798 / B424494 / BFLR866 / BYY8XK8 / BYVY8G0 / BD9GVY0 / BJ2Z0H2 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BDFZSP1 / BJVR9Y9 / BYSGPK2 / BDVLM39 / BZ0P3Z5 / BP84RX0 / BKT6B38 / BFY7DC4</td><td class="leftalignment">Visa Inc / Costco Wholesale Corp / Gap Inc / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / Beasley Broadcast Group Inc / CMS Energy Corp / Cooper Companies Inc / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelon Corp / Macy's Inc / FirstEnergy Corp / Incyte Corp / Intuit Inc / Pfizer Inc / Pinnacle West Capital Corp / Ross Stores Inc / E W Scripps Co / Sinclair Broadcast Group Inc / TJX Companies Inc / Mastercard Inc / NRG Energy Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Burlington Stores Inc / Duke Energy Corp / Guidewire Software Inc / Hemisphere Media Group Inc / Splunk Inc / Twitter Inc / WEC Energy Group Inc / Alphabet Inc / Zai Lab Ltd / Pinterest Inc / Evergy Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Okta Inc / iHeartMedia Inc / ViewRay Inc / argenx SE / Tegna Inc / Townsquare Media Inc / SmileDirectClub Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / JNJ.N / LLY.N / MRK.N / AZN.L / SASY.PA / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Cash Conversion Cycle 2010-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: New tirzepatide results continue to show "euglycemia" as differentiation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : SURPASS-2 Further Confirms Best-in-Class Tirzepatide Efficacy Profile</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">tirzepatide looks v good vs sema</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Tirzepatide SURPASSES NVO's Semaglutide; New Era of Combination Incretins Begin With TZP's GLP-1/GIP</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Mar. 04, 2021 / 9:10AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">SURPASS-2 Data Rings Tirzepatide As The Clear Winner In The H2H vs Ozempic, In Our View</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease Ahead of AD/PD 2021 on Friday, March 12, 2021 at 11 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BSX=US / LLY=US / ICLR=US / WEN=US / PEB=US / H=US / MTN=US / XOM=US / VRM=US / MAR=US / TTMI=US / TNL=US / HLT=US / ARW=US / CHH=US / CPRT=US / DRH=US / MCHP=US / MNRO=US / ST=US / CVX=US / SNOW=US / NFLX=US / COP=US / KAR=US / BDC=US / SHO=US / HST=US / TAST=US / IAA=US / WH=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / SPLK=US / LKQ=US / RHP=US / ANTM=US / GSBD=US / VVV=US / PK=US / ANAB=US / PLYA=US / OKTA=US / YEXT=US / SBOW=US / MPWR-US / EQH=US / BTAI=US</td><td class="leftalignment">Boston Scientific Corp / Eli Lilly and Co / ICON PLC / Wendys Co / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Vroom Inc / Marriott International Inc / TTM Technologies Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Arrow Electronics Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Microchip Technology Inc / Monro Inc / Sensata Technologies Holding PLC / Chevron Corp / Snowflake Inc. / Netflix Inc / Conocophillips / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Carrols Restaurant Group Inc / IAA Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Splunk Inc / LKQ Corp / Ryman Hospitality Properties Inc / Anthem Inc / Goldman Sachs BDC Inc / Valvoline Inc / Park Hotels & Resorts Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / Okta Inc / Yext Inc / SilverBow Resources Inc / Monolithic Power Systems Inc / Equitable Holdings Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 2516152 / 2050832 / 2026242 / 2544960 / 2437071 / 2216850 / 2270726 / 2542049 / 2272476 / 2382892 / 2670519 / 2342034 / 2100920 / 2471950 / 2672689 / 2048804 / 2862532 / 2799351 / B0T7YX2 / B2R3PV1 / 2390817 / B44C366 / 2949758 / B7TL820 / B8L2798 / BFLR866 / BFH3N85 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BYQHP96 / BF4VBS8 / BF5L3T2 / BKTHM05 / BZ8VJQ8 / BDFZSP1 / BJVR9Y9 / BHZSB82 / BDH65C8 / BGT3960 / BZ0P3Z5 / BYP71H7 / BP84RX0 / BZ4CHH2</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Beasley Broadcast Group Inc / Biomarin Pharmaceutical Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Dollar Tree Inc / Audacy Inc / Exelon Corp / Fiserv Inc / FirstEnergy Corp / Incyte Corp / Patterson Companies Inc / Pinnacle West Capital Corp / E W Scripps Co / Sinclair Broadcast Group Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Gray Television Inc / Heska Corp / Nexstar Media Group Inc / Meta Platforms Inc / Hemisphere Media Group Inc / Twitter Inc / Veeva Systems Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / BioXcel Therapeutics Inc / Elanco Animal Health Inc / Passage Bio Inc / Vistra Corp / Okta Inc / iHeartMedia Inc / Covetrus Inc / PetIQ Inc / Orchard Therapeutics PLC / Tegna Inc / National Vision Holdings Inc / Townsquare Media Inc / Soleno Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: The first BLA filing from a China biotech started by Junshi's PD-1. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1877.HK / LLY.N / NOVN.S / CHRS.OQ / BGNE.OQ / 1801.HK</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Novartis AG / Coherus BioSciences Inc / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">2269.HK: Wuxi Biologics - Vir COVID neutrializing antibody trial failure expected to have limited rev impact to WuXi</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2269.HK / LLY.N / GSK.L / BIIB.OQ</td><td class="leftalignment">WuXi Biologics (Cayman) Inc / Eli Lilly and Co / GlaxoSmithKline PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / SELB.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / ARNA.OQ / RIGL.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / TGTX.OQ / ANIP.OQ / AXGN.OQ / HTBX.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / NNOX.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Selecta Biosciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Arena Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / TG Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heat Biologics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Nano-X Imaging Ltd / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: With No MACE Events, LLY's Positive Baricitinib Phase 3 Study Suggests More Hair on Heads than on Safety</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152 / 2471950</td><td class="leftalignment">Eli Lilly and Co / Incyte Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Eli Lilly and Company Net Profit down 25.5%; Institutional Ownership up 6%</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW Group Meeting With CEO and CFO On 5/6 at 1pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Being BRAVE, Positive Phase 3 Data Expands Growing List Of Indications For Baricitinib</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q20: COVID-19 Data on Deck and Increased Interest in Rigel's Earlier-Stage Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RIGL.OQ / LLY.N</td><td class="leftalignment">Rigel Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / LLY.N / NCOX.PA / NVAX.OQ / FOLD.OQ / INO.OQ / OMER.OQ / SRPT.OQ / SPNE.OQ / UQ1.F / RETA.OQ / ADVM.OQ / SRGA.OQ / AZYO.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Nicox SA / Novavax Inc / Amicus Therapeutics Inc / Inovio Pharmaceuticals Inc / Omeros Corp / Sarepta Therapeutics Inc / SeaSpine Holdings Corp / Uniqure NV / Reata Pharmaceuticals Inc / Adverum Biotechnologies Inc / Surgalign Holdings Inc / Aziyo Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD (BUY) - Pipeline on Track Heading into Multiple 2021-2022 Milestones; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BL71K91 / 0989529 / 2516152 / 2023607 / 2778844 / BBPK0J0</td><td class="leftalignment">Revolution Medicines Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended January 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended March 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Eli Lilly and Company Net Profit down 25.5%; Institutional Ownership up 6%</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Paragon Intel</td><td class="leftalignment">Pharmaceuticals: Where does your CEO's MT Score rank?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / CTLT.N / JNJ.N / LLY.N / NKTR.OQ / JAZZ.OQ / HZNP.OQ / ZTS.N / PRGO.N / ELAN.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Catalent Inc / Johnson & Johnson / Eli Lilly and Co / Nektar Therapeutics / Jazz Pharmaceuticals PLC / Horizon Therapeutics PLC / Zoetis Inc / Perrigo Company PLC / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / CAPITALIZATION / MISCELLANEOUS / INDEX</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paragon Intel</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Eli Lilly and Company - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 2 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0378331005 / US0382221051 / US1011371077 / US1570851014 / US1727551004 / US2620371045 / US4581401001 / US5324571083 / US58155Q1031 / US5951121038 / US66987V1098 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US8807701029 / US91347P1057 / US92532F1003 / US9581021055 / CA8265161064 / US87157D1090 / US83088M1027 / US64111Q1040 / US1572101053 / US1281261099 / US6707041058 / US8936411003 / US1696561059 / US82706C1080 / US1717793095 / US58933Y1055 / NL0010273215 / US85916J4094 / US8486371045 / US63009R1095 / US00847X1046 / NL0010696654 / JE00BLG2ZQ72 / US0465131078 / US31572Q8087 / US74736K1016 / US05464T1043 / US98138J2069 / US00773U1088 / US02081G2012 / US45782B1044 / US91325V1089 / US87105L1044 / US5011471027 / US89854H1023 / US05351X1019 / US11135F1012 / US92537N1081 / US6833731044 / US8334451098 / US05479K1060 / US03476J1079 / US8808811074</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Apple Inc / Applied Materials Inc / Boston Scientific Corp / Cerus Corp / Cirrus Logic Inc / Dril-Quip Inc / Intel Corp / Eli Lilly and Co / Mckesson Corp / Micron Technology Inc / Novartis AG / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vertex Pharmaceuticals Inc / Western Digital Corp / Sierra Wireless Inc / Synaptics Inc / Skyworks Solutions Inc / NETGEAR Inc / CEVA Inc / CalAmp Corp / NuVasive Inc / TransDigm Group Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Ciena Corp / Merck & Co Inc / ASML Holding NV / Stereotaxis Inc / Splunk Inc / NanoString Technologies Inc / Agios Pharmaceuticals Inc / Uniqure NV / Quotient Ltd / Atara Biotherapeutics Inc / FibroGen Inc / Qorvo Inc / Axsome Therapeutics Inc / Workhorse Group Inc / Adverum Biotechnologies Inc / Alphatec Holdings Inc / Inseego Corp / Uniti Group Inc / Switch Inc / Krystal Biotech Inc / TTEC Holdings Inc / Avaya Holdings Corp / Broadcom Inc / Vertiv Holdings Co / Ontrak Inc / Snowflake Inc. / Aziyo Biologics Inc / Angion Biomedica Corp / Terns Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Big Cap Pharma Highlights - Day 1</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US5324571083 / US66987V1098 / US58933Y1055</td><td class="leftalignment">Eli Lilly and Co / Novartis AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / KMI=US / AMT=US / AKAM=US / CHTR=US / CONE=US / VZ=US / LOW=US / PAA=US / CCI=US / HSII=US / CHRS=US / BYD=US / LEG=US / TNL=US / KFRC=US / MGM=US / PENN=US / CMCSA=US / DISH=US / AIR=US / KFY=US / AMN=US / CBRL=US / DRI=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MPLX=US / MHK=US / MCRI=US / ASGN=US / OKE=US / PRGO=US / REGI=US / RHI=US / SBAC=US / SGMO=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / SNOW=US / SGMS=US / CCRN=US / DCP=US / DIN=US / MMP=US / TPX=US / EXP=US / CZR=US / CDLX=US / BECN=US / DLR=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SPWR=US / SCPL=US / CMG=US / REX=US / CCOI=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / PAGP=US / JACK=US / CLNY=US / TREX=US / HGV=US / NLSN=US / APTS=US / VAC=US / FBHS=US / ENPH=US / SMLP=US / TILE=US / TMUS=US / NDLS=US / CEQP=US / ASMB=US / LOCO=US / VCEL=US / SHAK=US / WING=US / SPNE=US / AXSM=US / ADVM=US / 82982L103 / CRSP=US / PVAC=US / GDS=US / JELD=US / ATNX=US / SWCH=US / RTLR=US / LHX=US / FERGY=US / RPAY=US / AZEK=US / CRMD.US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / American Tower Corp / Akamai Technologies Inc / Charter Communications Inc / CyrusOne Inc / Verizon Communications Inc / Lowe's Companies Inc / Plains All American Pipeline LP / Crown Castle International Corp / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Leggett & Platt Inc / Travel + Leisure Co / Kforce Inc / MGM Resorts International / Penn National Gaming Inc / Comcast Corp / DISH Network Corp / AAR Corp / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Monarch Casino & Resort Inc / ASGN Inc / ONEOK Inc / Perrigo Company PLC / Renewable Energy Group Inc / Robert Half International Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Snowflake Inc. / Scientific Games Corp / Cross Country Healthcare Inc / DCP Midstream LP / Dine Brands Global Inc / Magellan Midstream Partners LP / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Cardlytics Inc / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SunPower Corp / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Plains GP Holdings LP / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Preferred Apartment Communities Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Enphase Energy Inc / Summit Midstream Partners LP / Interface Inc / T-Mobile US Inc / Noodles & Co / Crestwood Equity Partners LP / Assembly Biosciences Inc / El Pollo Loco Holdings Inc / Vericel Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Ranger Oil Corp / GDS Holdings Ltd / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / Rattler Midstream LP / L3harris Technologies Inc / Ferguson PLC / Repay Holdings Corp / Azek Company Inc / CorMedix Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2065159 / 2544960 / 2229126 / 2270726 / 2382892 / 2657802 / 2684703 / 2707677 / 2862532 / 2799351 / 7103065 / B121557 / 2212922 / B1Y9TB3 / B19FQ48 / 2857817 / B2R3PV1 / 2390817 / 2949758 / B3SWPT2 / B7TL820 / B4MG4Z6 / B7VD3F2 / B8L2798 / BJ0KXV4 / BDZCRX3 / B8DPDT7 / BTN1Y11 / BVVN4Q8 / BYW36M8 / BD9GVY0 / BJFSR88 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJVR9Y9 / BJXBP30 / BHZSB82 / BKC9SX3 / BD6JX35 / BDVLM39 / BDZ30Q0 / BZ0P3Z5 / BYNPPC6 / BP84RX0 / BMDJ397</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / Autodesk Inc / Beasley Broadcast Group Inc / Columbia Sportswear Co / Walt Disney Co / Audacy Inc / OGE Energy Corp / Pfizer Inc / Public Service Enterprise Group Inc / E W Scripps Co / Sinclair Broadcast Group Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Danone SA / Amicus Therapeutics Inc / Netflix Inc / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Hemisphere Media Group Inc / ONE Gas Inc / RingCentral Inc / Sarepta Therapeutics Inc / Medtronic PLC / Eversource Energy / PayPal Holdings Inc / Zai Lab Ltd / Uniqure NV / Evergy Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Turning Point Therapeutics Inc / Covetrus Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Arvinas Inc / Tegna Inc / DENTSPLY SIRONA Inc / Townsquare Media Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Lightning Strikes Twice with Immune-Stimulating ADCs; Initiating with a BUY and $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMDJ397 / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2457864 / 2684703 / 7103065 / 2982924 / BFDV8K0 / BMQ5T49 / BKVDFF7 / BYQHPK7 / BL71K91 / BN2R582 / BG0Q4Y1 / BF3NP05</td><td class="leftalignment">Bolt Biotherapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Zymeworks Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Exicure Inc / Mersana Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Donanemab FAQs Ahead of TRAILBLAZER-ALZ Results - We Continue to See a Favorable Risk/Reward</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / AAL.OQ / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Eli Lilly and Company jumps 28.2% from 8 week low</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">305 Could Be In Ibrutinib's Zip Code, Discussion With LLY Underscores Best In Class Potential For Its BTKi</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EDIT=US / MRNA=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Editas Medicine Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006231004 / US0116591092 / US0463531089 / US09058V1035 / US1101221083 / US2254471012 / US30231G1022 / US37733W1053 / US4781601046 / US5324571083 / US5370081045 / US66987V1098 / US6701002056 / US6821891057 / US7170811035 / US7392761034 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US9021041085 / US9311421039 / US1667641005 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US13100M5094 / NL0009538784 / US9100471096 / US00164V1035 / US00287Y1091 / US55405Y1001 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US70432V1026 / US69888T2078 / US0465131078 / CA0089118776 / US74736K1016 / US00653A1079 / US05464T1043 / US00773U1088 / SE0009414576 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / US26142R1041 / CH0499880968 / US30233G2093</td><td class="leftalignment">Infineon Technologies AG / Alaska Air Group Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / Wolfspeed Inc / Exxon Mobil Corp / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Littelfuse Inc / Novartis AG / Novo Nordisk A/S / ON Semiconductor Corp / Pfizer Inc / Power Integrations Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / II-VI Inc / Walmart Inc / Chevron Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Calix Inc / NXP Semiconductors NV / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / MACOM Technology Solutions Holdings Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / Paycom Software Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Qorvo Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Oncopeptides AB / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / EyePoint Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">SNSE=US / WSC=US / AAPL=US / IBM=US / WMB=US / BSX=US / LLY=US / CSCO=US / ABT=US / AMGN=US / CAT=US / COST=US / INTC=US / KO=US / MCD=US / AMD=US / WM=US / BWA=US / EFX=US / MSFT=US / MDT=US / JNPR=US / K=US / AMZN=US / T=US / ORCL=US / WMT=US / RUN=US / D=US / ED=US / NTRS=US / WFC=US / NVDA=US / HBI=US / AKAM=US / YUM=US / SO=US / NTAP=US / JPM=US / FCEL=US / PLUG=US / FSR=US / TRU=US / NVS=US / VZ=US / PWR=US / PBR=US / EL=US / BJ=US / SAP=US / URI=US / TSM=US / BAX=US / CRIS=US / GSK=US / HON=US / JCI=US / JNJ=US / TTWO=US / LEG=US / CTXS=US / LRCX=US / DLTR=US / DE=US / EIX=US / UNH=US / AAON=US / RSG=US / ABMD=US / ALB=US / AMSC=US / APPS=US / ARRY=US / AVNT=US / AVGO=US / BMRN=US / HRB=US / CMI=US / CHD=US / CSGP=US / CREE=US / DHI=US / XRAY=US / EW=US / EQIX=US / GRTS=US / ISRG=US / ITRI=US / TREE=US / MS=US / MCO=US / OSIS=US / HOOK=US / ROK=US / HSIC=US / SJM=US / TRMB=US / UTL=US / VCTR=US / ALGN=US / PFG=US / PRVB=US / CINF=US / SIVB=US / ARE=US / NEP=US / O=US / SWKS=US / NFLX=US / BE=US / CLH=US / WCN=US / CMPI=US / MNST=US / PTON=US / ONCR=US / ACAD=US / ENS=US / TWIN=US / ORA=US / LHCG=US / AMRS=US / SPWR=US / CSIQ=US / FSLR=US / QSR=US / BX=US / LULU=US / VMW=US / DAN=US / SPGI=US / WPRT=US / CLDX=US / KKR=US / AGCO=US / VRSK=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / AMRC=US / FDUS=US / 2454-TW=US / ENPH=US / TMUS=US / HASI=US / MRTX=US / CNHI=US / GNCA=US / BABA=US / SEDG=US / ZBH=US / PSTG=US / AQMS=US / HPE=US / SQ=US / WKHS=US / OKTA=US / APTV=US / CWEN=US / UBER=US / KRTX=US / BNTX=US / NLOK=US / DKNG=US / VLDR=US / SHLS=US / 116973221</td><td class="leftalignment">Sensei Biotherapeutics Inc / Willscot Mobile Mini Holdings Corp / Apple Inc / International Business Machines Corp / Williams Companies Inc / Boston Scientific Corp / Eli Lilly and Co / Cisco Systems Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Equifax Inc / Microsoft Corp / Medtronic PLC / Juniper Networks Inc / Kellogg Co / Amazon.com Inc / AT&T Inc / Oracle Corp / Walmart Inc / Sunrun Inc / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / Wells Fargo & Co / NVIDIA Corp / HanesBrands Inc / Akamai Technologies Inc / Yum! Brands Inc / Southern Co / NetApp Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Fisker Inc / TransUnion / Novartis AG / Verizon Communications Inc / Quanta Services Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / BJ's Wholesale Club Holdings Inc / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Baxter International Inc / Curis Inc / GlaxoSmithKline PLC / Honeywell International Inc / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Leggett & Platt Inc / Citrix Systems Inc / Lam Research Corp / Dollar Tree Inc / Deere & Co / Edison International / UnitedHealth Group Inc / Aaon Inc / Republic Services Inc / ABIOMED Inc / Albemarle Corp / American Superconductor Corp / Digital Turbine Inc / Array Technologies Inc / Avient Corp / Broadcom Inc / Biomarin Pharmaceutical Inc / H & R Block Inc / Cummins Inc / Church & Dwight Co Inc / CoStar Group Inc / Wolfspeed Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Edwards Lifesciences Corp / Equinix Inc / Gritstone bio Inc / Intuitive Surgical Inc / Itron Inc / Lendingtree Inc / Morgan Stanley / Moody's Corp / OSI Systems Inc / HOOKIPA Pharma Inc / Rockwell Automation Inc / Henry Schein Inc / J M Smucker Co / Trimble Inc / Unitil Corp / Victory Capital Holdings Inc / Align Technology Inc / Principal Financial Group Inc / Provention Bio Inc / Cincinnati Financial Corp / SVB Financial Group / Alexandria Real Estate Equities Inc / Nextera Energy Partners LP / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Checkmate Pharmaceuticals Inc / Monster Beverage Corp / Peloton Interactive Inc / Oncorus Inc / ACADIA Pharmaceuticals Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / LHC Group Inc / Amyris Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Restaurant Brands International Inc / Blackstone Inc / Lululemon Athletica Inc / VMware Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / Celldex Therapeutics Inc / KKR & Co Inc / AGCO Corp / Verisk Analytics Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Ameresco Inc / Fidus Investment Corp / MediaTek Inc / Enphase Energy Inc / T-Mobile US Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Mirati Therapeutics Inc / CNH Industrial NV / Genocea Biosciences Inc / Alibaba Group Holding Ltd / Solaredge Technologies Inc / Zimmer Biomet Holdings Inc / Pure Storage Inc / Aqua Metals Inc / Hewlett Packard Enterprise Co / Block Inc / Workhorse Group Inc / Okta Inc / Aptiv PLC / Clearway Energy Inc / Uber Technologies Inc / Karuna Therapeutics Inc / BioNTech SE / NortonLifeLock Inc / DraftKings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / Joby Aviation Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Software / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Positive news flow: PD-1 co-promotion by AZ and COVID-19 NAb US government order. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1877.HK / LLY.N / AZN.L / REGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Highlights Progress on Multiple Fronts</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">KRTX=US / LLY=US / ACAD=US</td><td class="leftalignment">Karuna Therapeutics Inc / Eli Lilly and Co / ACADIA Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Up YoY for Most Companies- Week 48</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine boosters; BEAM acquires GuideTx</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RPRX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RPRX.O / ABT / LLY / ANIP.O / SPHS.PK</td><td class="leftalignment">Royalty Pharma PLC / Abbott Laboratories / Eli Lilly and Co / ANI Pharmaceuticals Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.26.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ICAD.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BIIB.OQ / ACAD.OQ / MNKD.OQ / MSB.AX / EBS.N / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / FATE.OQ / AUP.TO / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / TDOC.N / SPNE.OQ / GBT.OQ / ACRS.OQ / DRIO.OQ / TVTY.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / RCUS.N / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / ICAD Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Biogen Inc / ACADIA Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Teladoc Health Inc / SeaSpine Holdings Corp / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / DarioHealth Corp / Tivity Health Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / Arcus Biosciences Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) - KRAS Programs On-Track as Company Steps Into Synthetic Lethality with a New PRMT5 Inhibitor</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BBPK0J0 / 2516152 / 2023607 / 7103065 / BCBVTX1</td><td class="leftalignment">Mirati Therapeutics Inc / Eli Lilly and Co / Amgen Inc / Novartis AG / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Growth Driven By New Products, Margin Expansion</td><td class="leftalignment">English</td><td class="rightalignment">90</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1138</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Super-Cyclicals Revisited</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AEE.N / AES.N / BAX.N / BG.N / BMY.N / BSX.N / CCI.N / CI.N / CL.N / EL.N / FLT.N / KMB.N / KO.N / LLY.N / LSI.N / MDT.N / PM.N / PNW.N / PPCJ.J / SO.N / TAP.N / TMO.N / WMT.N / DRE.N / EQR.N / FLO.N / PG.N / WY.N / DELL.N / CPB.N / W.N / ETR.N / ADML.L / DHR.N / DIS.N / UNH.N / TFX.N / D.N / OGE.N / IPG.N / CLX.N / CAG.N / VNO.N / GLW.N / LH.N / KR.N / GIS.N / XRX.N / NI.N / PCG.N / AMT.N / RMD.N / TDS.N / DTEGN.F / MTD.N / IT.N / PKI.N / WST.N / COO.N / STZ.N / APH.N / NNN.N / PSA.N / ARW.N / EW.N / CPT.N / BXP.N / ACN.N / ARE.N / CHD.N / NUS.N / TWTR.N / ESS.N / HAE.N / FRT.N / UGI.N / OFC.N / CUZ.N / HRL.N / BDN.N / SAM.N / ABC.N / JNPR.N / IRM.N / CNP.N / INTC.OQ / CTSH.OQ / ABMD.OQ / AMGN.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CHE.N / CRUS.OQ / FISV.OQ / JKHY.OQ / LRCX.OQ / ATVI.OQ / PAYX.OQ / TEAM.OQ / REGN.OQ / SJM.N / TECH.OQ / TYL.N / QDEL.OQ / SNPS.OQ / ICUI.OQ / IDXX.OQ / QCOM.OQ / INTU.OQ / LFUS.OQ / COST.OQ / XRAY.OQ / NKTR.OQ / DISH.OQ / NTAP.OQ / AMED.OQ / PCTY.OQ / ANSS.OQ / LAMR.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / LITE.OQ / TTWO.OQ / VRSN.OQ / MANH.OQ / ZBRA.OQ / NVDA.OQ / MKSI.OQ / UTHR.OQ / SBAC.OQ / BMRN.OQ / HAIN.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / NXST.OQ / ACAD.OQ / MPWR.OQ / ELS.N / HLF.N / OLED.OQ / SRC.N / CDNS.OQ / LYV.N / FIS.N / ADP.PA / MA.N / WU.N / DEI.N / FSLR.OQ / IPGP.OQ / QGEN.N / PODD.OQ / VMW.N / TDC.N / SATS.OQ / NWSA.OQ / CACI.N / FICO.N / FTNT.OQ / HPP.N / BAH.N / ADSGN.F / HHC.N / MSI.N / HZNP.OQ / ACHC.OQ / ENPH.OQ / EPAM.N / GWRE.N / ADI.OQ / SRPT.OQ / GMED.N / HTA.N / ABBV.N / PRGO.N / WEX.N / CDW.OQ / FOXA.O / SFM.OQ / REXR.N / LDOS.N / PINC.OQ / AGIO.OQ / RNG.N / GLPI.OQ / BRX.N / PTC.OQ / FIVN.OQ / GLOB.N / CTLT.N / CDK.OQ / KEYS.N / PGRE.N / OUT.N / STOR.N / ANTM.N / NEWR.N / QRVO.OQ / SEDG.OQ / ON.OQ / ETSY.OQ / LBRDK.OQ / TDOC.N / CABO.N / ZBH.N / KHC.OQ / GBT.OQ / PEN.N / NVCR.OQ / PSTG.N / SQ.N / IONS.OQ / RETA.OQ / EVBG.OQ / TTD.OQ / LW.N / PK.N / FWONA.OQ / ROKU.OQ / EHC.N / XEL.OQ / SYNH.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / CBRE.N / CDAY.N / AVT.OQ / EVRG.N / ELAN.N / TER.OQ / LNT.OQ / EXC.OQ / MSGS.N / AEP.OQ / 120175706</td><td class="leftalignment">Agilent Technologies Inc / Ameren Corp / AES Corp / Baxter International Inc / Bunge Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Estee Lauder Companies Inc / Fleetcor Technologies Inc / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Life Storage Inc / Medtronic PLC / Philip Morris International Inc / Pinnacle West Capital Corp / PPC Ltd / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Walmart Inc / Duke Realty Corp / Equity Residential / Flowers Foods Inc / Procter & Gamble Co / Weyerhaeuser Co / Dell Technologies Inc / Campbell Soup Co / Wayfair Inc / Entergy Corp / Admiral Group PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Dominion Energy Inc / OGE Energy Corp / Interpublic Group of Companies Inc / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Corning Inc / Laboratory Corporation of America Holdings / Kroger Co / General Mills Inc / Xerox Holdings Corp / NiSource Inc / PG&E Corp / American Tower Corp / Resmed Inc / Telephone and Data Systems Inc / Deutsche Telekom AG / Mettler-Toledo International Inc / Gartner Inc / PerkinElmer Inc / West Pharmaceutical Services Inc / Cooper Companies Inc / Constellation Brands Inc / Amphenol Corp / National Retail Properties Inc / Public Storage / Arrow Electronics Inc / Edwards Lifesciences Corp / Camden Property Trust / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / NU Skin Enterprises Inc / Twitter Inc / Essex Property Trust Inc / Haemonetics Corp / Federal Realty Investment Trust / UGI Corp / Corporate Office Properties Trust / Cousins Properties Inc / Hormel Foods Corp / Brandywine Realty Trust / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / Iron Mountain Inc / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Amgen Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Chemed Corp / Cirrus Logic Inc / Fiserv Inc / Jack Henry & Associates Inc / Lam Research Corp / Activision Blizzard Inc / Paychex Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / J M Smucker Co / Bio-Techne Corp / Tyler Technologies Inc / Quidel Corp / Synopsys Inc / ICU Medical Inc / IDEXX Laboratories Inc / Qualcomm Inc / Intuit Inc / Littelfuse Inc / Costco Wholesale Corp / DENTSPLY SIRONA Inc / Nektar Therapeutics / DISH Network Corp / NetApp Inc / Amedisys Inc / Paylocity Holding Corp / ANSYS Inc / Lamar Advertising Co / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Lumentum Holdings Inc / Take-Two Interactive Software Inc / Verisign Inc / Manhattan Associates Inc / Zebra Technologies Corp / NVIDIA Corp / MKS Instruments Inc / United Therapeutics Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / Hain Celestial Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Nexstar Media Group Inc / ACADIA Pharmaceuticals Inc / Monolithic Power Systems Inc / Equity LifeStyle Properties Inc / Herbalife Nutrition Ltd / Universal Display Corp / Spirit Realty Capital Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Mastercard Inc / Western Union Co / Douglas Emmett Inc / First Solar Inc / IPG Photonics Corp / Qiagen NV / Insulet Corp / VMware Inc / Teradata Corp / EchoStar Corp / News Corp / CACI International Inc / Fair Isaac Corp / Fortinet Inc / Hudson Pacific Properties Inc / Booz Allen Hamilton Holding Corp / Adidas AG / Howard Hughes Corp / Motorola Solutions Inc / Horizon Therapeutics PLC / Acadia Healthcare Company Inc / Enphase Energy Inc / Epam Systems Inc / Guidewire Software Inc / Analog Devices Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Healthcare Trust Of America Inc / Abbvie Inc / Perrigo Company PLC / WEX Inc / CDW Corp / Fox Corp / Sprouts Farmers Market Inc / Rexford Industrial Realty Inc / Leidos Holdings Inc / Premier Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Gaming and Leisure Properties Inc / Brixmor Property Group Inc / PTC Inc / Five9 Inc / Globant SA / Catalent Inc / CDK Global Inc / Keysight Technologies Inc / Paramount Group Inc / OUTFRONT Media Inc / STORE Capital Corp / Anthem Inc / New Relic Inc / Qorvo Inc / Solaredge Technologies Inc / ON Semiconductor Corp / ETSY Inc / Liberty Broadband Corp / Teladoc Health Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Pure Storage Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Everbridge Inc / Trade Desk Inc / Lamb Weston Holdings Inc / Park Hotels & Resorts Inc / Liberty Media Corp / Roku Inc / Encompass Health Corp / Xcel Energy Inc / Syneos Health Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Avnet Inc / Evergy Inc / Elanco Animal Health Inc / Teradyne Inc / Alliant Energy Corp / Exelon Corp / Madison Square Garden Sports Corp / American Electric Power Company Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / AERI.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / BDSI.OQ / BIIB.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / NEOS.BO / OMER.OQ / ARDX.OQ / ACRX.OQ / AMRN.NS / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Aerie Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / BioDelivery Sciences International Inc / Biogen Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Neo Corp International Ltd / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / ADF Foods Ltd / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Veru Inc / TherapeuticsMD Inc / Evolus Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Feb. 24, 2021 / 1:40PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">KYG8807B1068 / IE00BTN1Y115 / US9741551033 / US70450Y1038 / US8522341036 / US4622221004 / US98138J2069 / US15136A1025 / CA87241L1094 / US83304A1060 / US23753F1075 / US80689H1023 / US24665A1034 / US4990491049 / US04206A1016 / US5904791358 / US28414H1032 / US89377M1099 / US85205L1070 / US26142R1041 / US15872M1045 / HEI.N / US02553E1064 / US0463531089 / US1264081035 / US1270971039 / US22284P1057 / US34354P1057 / US37733W1053 / US4228061093 / US4456581077 / US4781601046 / US5324571083 / US5370081045 / US62855J1043 / US6558441084 / US6795801009 / US7237871071 / US7711951043 / US8552441094 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US25754A2015 / US1696561059 / US42330P1075 / US78709Y1055 / US55616P1049 / US45784P1012 / US9837931008 / US98978V1035 / US09609G1004 / IE00B4Q5ZN47 / US5764852050 / US29428V1044 / US29664W1053 / US60468T1051 / US5253271028 / US14862Q1004 / US03937C1053</td><td class="leftalignment">Theravance Biopharma Inc / Medtronic PLC / Wingstop Inc / PayPal Holdings Inc / Block Inc / Ionis Pharmaceuticals Inc / Workhorse Group Inc / Centennial Resource Development Inc / TFI International Inc / Snap Inc / Daseke Inc / Schneider National Inc / Delek US Holdings Inc / Knight-Swift Transportation Holdings Inc / Arlo Technologies Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Transmedics Group Inc / SpringWorks Therapeutics Inc / DraftKings Inc / ChampionX Corp / HEICO Corp / American Eagle Outfitters Inc / AstraZeneca PLC / CSX Corp / Coterra Energy Inc / Covenant Logistics Group Inc / Flowserve Corp / GlaxoSmithKline PLC / HEICO Corp / J B Hunt Transport Services Inc / Johnson & Johnson / Eli Lilly and Co / Littelfuse Inc / Myriad Genetics Inc / Norfolk Southern Corp / Old Dominion Freight Line Inc / Pioneer Natural Resources Co / Roche Holding AG / Starbucks Corp / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Domino's Pizza Inc / Chipotle Mexican Grill Inc / Helix Energy Solutions Group Inc / Saia Inc / Macy's Inc / Insulet Corp / XPO Logistics Inc / Zoetis Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Matador Resources Co / Epizyme Inc / Esperion Therapeutics Inc / Mirati Therapeutics Inc / Leidos Holdings Inc / Castlight Health Inc / ArcBest Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / REGN.OQ / NVAX.OQ / HSTM.OQ / BIIB.OQ / CLDX.OQ / AXGN.OQ / PRQR.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novavax Inc / HealthStream Inc / Biogen Inc / Celldex Therapeutics Inc / AxoGen Inc / ProQR Therapeutics NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Wednesday, February 24 - Sunday, February 28</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PANW=US / XM=US / BSX=US / LLY=US / PFE=US / ABT=US / HD=US / MDT=US / AMZN=US / QCOM=US / ORCL=US / ADBE=US / INCY=US / U=US / NVDA=US / EVER=US / CRM=US / NVS=US / EL=US / LOW=US / SAP=US / ZEN=US / RSG=US / ARNA=US / ADSK=US / BL=US / CHD=US / DOCU=US / LPSN=US / NOW=US / NDSN=US / PCTY=US / REGN=US / SHOP=US / TWOU=US / FB=US / RNG=US / SPSC=US / GOOG=US / FRPT=US / SNSS=US / PUBM=US / UTZ=US / 2454-TW=US / ALSN=US / WDAY=US / GOOGL=US / PAYC=US / COUP=US / HUBS=US / NVRO=US / BILL=US / TTD=US / YEXT=US / CNNE=US / SVMK=US / ARQT=US / FBRX=US</td><td class="leftalignment">Palo Alto Networks Inc / Qualtrics International Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Home Depot Inc / Medtronic PLC / Amazon.com Inc / Qualcomm Inc / Oracle Corp / Adobe Inc / Incyte Corp / Unity Software Inc / NVIDIA Corp / EverQuote Inc / Salesforce.Com Inc / Novartis AG / Estee Lauder Companies Inc / Lowe's Companies Inc / SAP SE / Zendesk Inc / Republic Services Inc / Arena Pharmaceuticals Inc / Autodesk Inc / Blackline Inc / Church & Dwight Co Inc / DocuSign Inc / LivePerson Inc / ServiceNow Inc / Nordson Corp / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Shopify Inc / 2U Inc / Meta Platforms Inc / RingCentral Inc / SPS Commerce Inc / Alphabet Inc / Freshpet Inc / Viracta Therapeutics Inc / PubMatic Inc / UTZ Brands Inc / MediaTek Inc / Allison Transmission Holdings Inc / Workday Inc / Alphabet Inc / Paycom Software Inc / Coupa Software Inc / HubSpot Inc / Nevro Corp / Bill.com Holdings Inc / Trade Desk Inc / Yext Inc / Cannae Holdings Inc / Momentive Global Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Ireland / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Retailing / Semiconductors</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / LSI=US / PFE=US / AMGN=US / MCD=US / OXY=US / WEN=US / TEVA=US / GL=US / AMT=US / REI=US / V=US / CCI=US / HSII=US / MGY=US / CHRS=US / SPOT=US / MRO=US / CVS=US / RCL=US / DISH=US / KFY=US / CBRL=US / ELY=US / DRI=US / ABG=US / OKE=US / REGI=US / SBAC=US / VRTX=US / GOLF=US / CVX=US / ADC=US / PRI=US / NHI=US / PRA=US / NLS=US / DIN=US / EXR=US / PLAY=US / DENN=US / XM=US / KBR=US / CMG=US / REX=US / MA=US / GPRE=US / AMRX=US / TAST=US / QSR=US / JACK=US / CLNY=US / HTA=US / TREX=US / GDOT=US / SBRA=US / PANW=US / FANG=US / TMUS=US / NDLS=US / FIVN=US / VNOM=US / LOCO=US / SHAK=US / SUM=US / NSA=US / BWXT=US / WING=US / ZG=US / SQ=US / FRTA=US / RDFN=US / BTAI=US / ZI=US / BIGC=US / VTRS=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / McDonald's Corp / Occidental Petroleum Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Globe Life Inc / American Tower Corp / Ring Energy Inc / Visa Inc / Crown Castle International Corp / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Coherus BioSciences Inc / Spotify Technology SA / Marathon Oil Corp / CVS Health Corp / Royal Caribbean Cruises Ltd / DISH Network Corp / Korn Ferry / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Darden Restaurants Inc / Asbury Automotive Group Inc / ONEOK Inc / Renewable Energy Group Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Acushnet Holdings Corp / Chevron Corp / Agree Realty Corp / Primerica Inc / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Dine Brands Global Inc / Extra Space Storage Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Trex Company Inc / Green Dot Corp / Sabra Health Care REIT Inc / Palo Alto Networks Inc / Diamondback Energy Inc / T-Mobile US Inc / Noodles & Co / Five9 Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Summit Materials Inc / National Storage Affiliates Trust / BWX Technologies Inc / Wingstop Inc / Zillow Group Inc / Block Inc / Forterra Inc / Redfin Corp / BioXcel Therapeutics Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Liberia / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2973821 / 2050832 / 2026242 / 2270726 / 2542049 / 2345022 / 2100920 / 2367480 / 2638625 / 2645409 / 2680905 / 2684703 / 2048804 / 2730190 / 7103065 / 2971029 / B125XQ6 / B2R3PV1 / B3D7K31 / B3WNNP3 / B7254K9 / B7VD3F2 / B87ZMX0 / BFLR866 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BJ5FZ74 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BMDCDP2 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Macy's Inc / FirstEnergy Corp / Genuine Parts Co / National Beverage Corp / NiSource Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / LKQ Corp / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Green Dot Corp / AxoGen Inc / Duke Energy Corp / Palo Alto Networks Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Adaptive Biotechnologies Corp / Evergy Inc / Fox Corp / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Bigcommerce Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: Atopic Dermatitis (Eczema)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / INCY=US / NVS=US / ARNA=US / REGN=US / ALSN=US / ARQT=US / FBRX=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Incyte Corp / Novartis AG / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Allison Transmission Holdings Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Where We Think The Stock Could Trade On TRAILBLAZER Data At AD/PD And Key AD Updates Expected In The Next 12-18 Months</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY.N / JNJ.N / PFE.N / BIIB.OQ</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Pfizer Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FR0000121014 / GB0004544929 / GB0002875804 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1912161007 / US1925761066 / US2254471012 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6556641008 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US9182041080 / US4771431016 / US4198791018 / US80105N1054 / US02209S1033 / US3463751087 / US90385V1070 / US2538681030 / US19239V3024 / US2090341072 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US03027X1000 / US00287Y1091 / NL0010273215 / US4576693075 / US23283R1005 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / US3623931009 / US14862Q1004 / CA0089118776 / US22822V1017 / US29444U7000 / US36165L1089 / KYG4740B1059 / US78410G1040 / US91325V1089 / US83418M1036 / US87105L1044 / US19626G1085 / US5904791358 / KY30744W1070 / US76156B1070 / US55406W1036 / US82489W1071</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Imperial Brands PLC / British American Tobacco PLC / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Cohu Inc / Wolfspeed Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / VF Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Altria Group Inc / FormFactor Inc / Ultra Clean Holdings Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / American Tower Corp / Abbvie Inc / ASML Holding NV / Insmed Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / GTT Communications Inc / Castlight Health Inc / Air Canada / Crown Castle International Corp / Equinix Inc / GDS Holdings Ltd / Ichor Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Solaris Oilfield Infrastructure Inc / Switch Inc / DigitalBridge Group Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CTP2021-ALSEN, MGTX, SIGHT; LentiGlobin BLUEs</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MGTX.OQ / SIGHT.PA / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">MeiraGTx Holdings PLC / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 47</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.19.21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">UTHR=US / XAIR=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / TEVA=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BWAY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / BLUE=US / CHE=US / CYH=US / EW=US / EXAS=US / EXEL=US / GEN=US / ICPT=US / PHG=US / LH=US / REGN=US / USPH=US / UHS=US / VRTX=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / MASI=US / EHC=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / SRPT=US / AGIO=US / CTRE=US / OTIC=US / VBLT=US / WBA=US / NVTA=US / CLLS=US / VKTX=US / EVH=US / CFMS=US / CERC=US / EDIT=US / MDGL=US / IRTC=US / CRSP=US / VERU=US / MBIO=US / MDNA=US / SESN=US / ARVN=US / FREQ=US / BXRX=US / PNTG=US / TARA=US / AYLA=US / FMTX=US / MNKKQ=US / CHGCY=US</td><td class="leftalignment">United Therapeutics Corp / Beyond Air Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Teva Pharmaceutical Industries Ltd / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Brainsway Ltd / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Masimo Corp / Encompass Health Corp / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Evolent Health Inc / Conformis Inc / Avalo Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Sesen Bio Inc / Arvinas Inc / Frequency Therapeutics Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mallinckrodt PLC / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eli Lilly and Company in top 5% performers of S&P 500 Index in past quarter; Institutional Ownership up 6%</td><td class="leftalignment">English</td><td class="rightalignment">81</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Eli Lilly and Company jumps 24.8% from 6 week low</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Orion's Brightest Star Today and Everyday; Reiterate OW, Raising PT to $7/share</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">RIGL.OQ / LLY.N / CRIS.OQ / ACRS.OQ</td><td class="leftalignment">Rigel Pharmaceuticals Inc / Eli Lilly and Co / Curis Inc / Aclaris Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">V / 0989529 / 2868165 / 2516152 / 2681511 / 2486813 / 2778844 / 2050832 / 2026242 / 2732635 / 2113393 / 2270726 / 2542049 / 2829515 / 2100920 / 2415204 / 2457864 / 2459020 / 2515030 / 2645409 / 2657802 / 2689560 / 2048804 / 2440637 / 2416962 / 2862532 / 2900335 / 2931034 / B121557 / 2951452 / B02R1L6 / B2R3PV1 / B7TL820 / B7VD3F2 / BJ0KXV4 / BDZCRX3 / BFZCHN7 / BTN1Y44 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BD8DJ71 / BJ9NDZ8 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BZ1LFG7 / BWY52P3 / BKX9VD3 / BF2G3Y5 / BKS3RS7 / BFY7DC4</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Sysco Corp / Eli Lilly and Co / PepsiCo Inc / Kellogg Co / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / AutoNation Inc / Boston Beer Company Inc / Walt Disney Co / Dominion Energy Inc / Edison International / FirstEnergy Corp / Hawaiian Electric Industries Inc / ImmunoGen Inc / Intuit Inc / Lithia Motors Inc / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Henry Schein Inc / E W Scripps Co / Tractor Supply Co / Vertex Pharmaceuticals Inc / Mastercard Inc / J M Smucker Co / ALLETE Inc / American Water Works Company Inc / Meta Platforms Inc / Duke Energy Corp / ONE Gas Inc / RingCentral Inc / Wix.Com Ltd / Walgreens Boots Alliance Inc / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Snap Inc / NeuBase Therapeutics Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / Roku Inc / Blueprint Medicines Corp / Arcutis Biotherapeutics Inc / AVROBIO Inc / 10X Genomics Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Tirzepatide SURPASS-3 and 5 Trials Show Robust Efficacy, but Discontinuations Start to Confirm 15 mg as Niche Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: New tirzepatide results continue to suggest a very differentiated product</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Tirzepatide SURPASS 3/5 Data Confirm Highly Competitive Efficacy and Weight Loss Profile</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Solid Efficacy But Tolerability A Question For Tirzepatide</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">quick summary on all GIP-GLP Ph 3s to date</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Still SURPASSING The Competition With More Positive Tirzepatide Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DNB / MRK=US / LLY=US / PFE=US / HD=US / MCD=US / EFX=US / WEN=US / DVN=US / TEVA=US / TRU=US / CRK=US / LOW=US / WLL=US / DIOD=US / CHRS=US / BYD=US / MAR=US / LEG=US / VMC=US / ESS=US / MGM=US / BKI=US / EQR=US / CVS=US / STZ=US / ARCC=US / CBRL=US / CSGP=US / DRI=US / EXAS=US / MEDP=US / MHK=US / REGI=US / SGMO=US / VRTX=US / WIX=US / NET=US / UDR=US / VNO=US / DIN=US / MGP=US / MOH=US / RNG=US / TPX=US / KAR=US / AINV=US / PLAY=US / DENN=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / IAA=US / JACK=US / ZTS=US / SBRA=US / FBHS=US / PANW=US / NDLS=US / NMIH=US / 70806A106 / LOCO=US / SHAK=US / NXRT=US / GSBD=US / CHCT=US / WING=US / CRSP=US / PVAC=US / JELD=US / IMVT=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Home Depot Inc / McDonald's Corp / Equifax Inc / Wendys Co / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / TransUnion / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Diodes Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Essex Property Trust Inc / MGM Resorts International / Black Knight Inc / Equity Residential / CVS Health Corp / Constellation Brands Inc / Ares Capital Corp / Cracker Barrel Old Country Store Inc / CoStar Group Inc / Darden Restaurants Inc / Exact Sciences Corp / Medpace Holdings Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Cloudflare Inc / UDR Inc / Vornado Realty Trust / Dine Brands Global Inc / MGM Growth Properties LLC / Molina Healthcare Inc / RingCentral Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Apollo Investment Corp / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / IAA Inc / Jack in the Box Inc / Zoetis Inc / Sabra Health Care REIT Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Noodles & Co / NMI Holdings Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Shake Shack Inc / NexPoint Residential Trust Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Wingstop Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Immunovant Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2577609 / 2126335 / 2516152 / 2778844 / 2026242 / 2208073 / 2280220 / 2270726 / 2542049 / 2100920 / 2415204 / 2459020 / 2684703 / 7103065 / 2822019 / B121557 / 2857817 / B2R3PV1 / B4Y1MH7 / BBFL7S1 / B7VD3F2 / B8CKK03 / BFZCHN7 / B95WG16 / BYRY499 / BYY8XK8 / BYVFC94 / BJF8Q81 / BDHF4K6 / BZ1HM42 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BGT3960 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / CVS Health Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / American Electric Power Company Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Intuit Inc / Pfizer Inc / Novartis AG / Advance Auto Parts Inc / Mastercard Inc / Netflix Inc / American Water Works Company Inc / KAR Auction Services Inc / bluebird bio Inc / Duke Energy Corp / Mondelez International Inc / Wix.Com Ltd / Zoetis Inc / Kraft Heinz Co / WEC Energy Group Inc / US Foods Holding Corp / IAA Inc / CRISPR Therapeutics AG / Adyen NV / Warner Music Group Corp / Evergy Inc / Vistra Corp / Orchard Therapeutics PLC / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, February 15 - Sunday, February 21</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALSEN=FR / MGTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / REPL=US / KOD=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Sensorion SA / MeiraGTx Holdings PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / Replimune Group Inc / Kodiak Sciences Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Global Pharma Model Sweep: Reopening and Washington Headwinds Should Abate in 2H21 as Key Potential Catalysts Approach</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AIMC=US / MCO=US / AAPL=US / BSX=US / CSII=US / LLY=US / PFE=US / SBUX=US / ABT=US / CAT=US / COST=US / INTC=US / AMD=US / WM=US / BWA=US / MSFT=US / MDT=US / JNPR=US / AMZN=US / QCOM=US / WMT=US / TXN=US / TEVA=US / RUN=US / NVDA=US / MPWR=US / FCEL=US / PLUG=US / CRM=US / SCI=US / EL=US / SMTC=US / BJ=US / DAL=US / TSM=US / HELE=US / CTAS=US / JCI=US / JNJ=US / TTWO=US / LSTR=US / DE=US / HUM=US / LECO=US / UNH=US / INTU=US / RSG=US / ALB=US / AMSC=US / ARRY=US / AVNT=US / AVGO=US / CMI=US / CHE=US / CREE=US / DHI=US / DG=US / EW=US / EGAN=US / EXEL=US / ITRI=US / PHG=US / MS=US / TEAM=US / PZZA=US / REGN=US / ROK=US / SNAP=US / TRMB=US / TYL=US / UTHR=US / VG=US / WIX=US / RDWR=US / NET=US / ACA=US / FB=US / NEP=US / JBLU=US / NFLX=US / VRNT=US / BE=US / CLH=US / WCN=US / NDAQ=US / RNG=US / MRNA=US / MNKD=US / ENS=US / GOOG=US / TWIN=US / ORA=US / OLED=US / FRPT=US / LHCG=US / AMRS=US / SPWR=US / AXON=US / XPO=US / ELF=US / TEL=US / CSIQ=US / FSLR=US / LULU=US / MASI=US / ULTA=US / TNDM=US / DAN=US / SPGI=US / WPRT=US / KKR=US / AGCO=US / ADUS=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / WDAY=US / HASI=US / CNHI=US / COUP=US / OTIC=US / VBLT=US / QRVO=US / NVTA=US / ETSY=US / SEDG=US / AQMS=US / WKHS=US / TTD=US / EVBG=US / IRTC=US / CRSP=US / OKTA=US / IOVA=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / FOCS=US / CWEN=US / FTDR=US / ESTC=US / UBER=US / CRWD=US / DKNG=US / VLDR=US</td><td class="leftalignment">Altra Industrial Motion Corp / Moody's Corp / Apple Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Starbucks Corp / Abbott Laboratories / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Medtronic PLC / Juniper Networks Inc / Amazon.com Inc / Qualcomm Inc / Walmart Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Sunrun Inc / NVIDIA Corp / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / Salesforce.Com Inc / Service Corporation International / Estee Lauder Companies Inc / Semtech Corp / BJ's Wholesale Club Holdings Inc / Delta Air Lines Inc / Taiwan Semiconductor Manufacturing Co Ltd / Helen of Troy Ltd / Cintas Corp / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Landstar System Inc / Deere & Co / Humana Inc / Lincoln Electric Holdings Inc / UnitedHealth Group Inc / Intuit Inc / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / Avient Corp / Broadcom Inc / Cummins Inc / Chemed Corp / Wolfspeed Inc / D R Horton Inc / Dollar General Corp / Edwards Lifesciences Corp / eGain Corp / Exelixis Inc / Itron Inc / Koninklijke Philips NV / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Snap Inc / Trimble Inc / Tyler Technologies Inc / United Therapeutics Corp / Vonage Holdings Corp / Wix.Com Ltd / Radware Ltd / Cloudflare Inc / Arcosa Inc / Meta Platforms Inc / Nextera Energy Partners LP / JetBlue Airways Corp / Netflix Inc / Verint Systems Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / RingCentral Inc / Moderna Inc / MannKind Corp / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Universal Display Corp / Freshpet Inc / LHC Group Inc / Amyris Inc / SunPower Corp / Axon Enterprise Inc / XPO Logistics Inc / elf Beauty Inc / TE Connectivity Ltd / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Masimo Corp / Ulta Beauty Inc / Tandem Diabetes Care Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / AGCO Corp / Addus Homecare Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Workday Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Coupa Software Inc / Otonomy Inc / Vascular Biogenics Ltd / Qorvo Inc / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Aqua Metals Inc / Workhorse Group Inc / Trade Desk Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / CrowdStrike Holdings Inc / DraftKings Inc / Velodyne Lidar Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0382221051 / US0463531089 / US0530151036 / US0997241064 / US1101221083 / US1311931042 / US30161Q1040 / US3614481030 / US3647601083 / US37733W1053 / US4234521015 / US4663671091 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US87612E1064 / US9311421039 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US2533931026 / US25754A2015 / US0491642056 / US1696561059 / PAP310761054 / US79546E1047 / US01748X1028 / US2473617023 / US90384S3031 / US00922R1059 / US58933Y1055 / US9100471096 / US92335C1062 / US00287Y1091 / US5017971046 / IE00B4Q5ZN47 / US55345K1034 / US8485771021 / US21240E1055 / US1220171060 / CA05156V1022 / US02376R1023 / US70438V1061 / US70432V1026 / US0404131064 / US67576A1007 / IE00BQPVQZ61 / US0994061002 / CA0089118776 / US12685J1051 / US26856L1035 / US01345P1066 / CA1350861060 / US8760301072 / US15677J1088 / US5904791358 / CA39342L1085 / CA23126M1023 / US81181C1045 / US55406W1036</td><td class="leftalignment">Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Borgwarner Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Exelixis Inc / GATX Corp / Gap Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Jack in the Box Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / Target Corp / Walmart Inc / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / DICK'S Sporting Goods Inc / Domino's Pizza Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Sally Beauty Holdings Inc / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Air Transport Services Group Inc / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / Abbvie Inc / Bath & Body Works Inc / Jazz Pharmaceuticals PLC / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / Arista Networks Inc / Ocular Therapeutix Inc / Horizon Therapeutics PLC / Boot Barn Holdings Inc / Air Canada / Cable One Inc / elf Beauty Inc / Albireo Pharma Inc / Canada Goose Holdings Inc / Tapestry Inc / Ceridian HCM Holding Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Curaleaf Holdings Inc / Seagen Inc / MYT Netherlands Parent BV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Reports 4Q; Litigation Uncertainty Remains Key Overhang</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">TEVA=US / LLY=US / PFE=US / REGN=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2126335 / 2516152 / 2023607 / 2778844 / 2026242 / 2111955 / 2280220 / 2270726 / 2542049 / 2576941 / 2100920 / 2455965 / 2457864 / 2459020 / 2048804 / 2730190 / 2402121 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / B76LYJ2 / BFH3N85 / BYY8XK8 / BP4GNK9 / BYW36M8 / BFZNYB7 / BD9GVY0 / BDHF4K6 / BZBY005 / BKS3SM8 / BQT3XY6 / BZ1HM42 / BR4T3B3 / BMQ5T49 / BWFKZT2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJXBP30 / BYQHPK7 / BJ9NFQ3 / BK71LY6 / BM8MM05 / BP8XZL1</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Borgwarner Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / FirstEnergy Corp / Biogen Inc / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Nuance Communications Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Veeva Systems Inc / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Adyen NV / HubSpot Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Neoleukin Therapeutics Inc / WW International Inc / Madison Square Garden Entertainment Corp / Healthequity Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 46</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Faricimab Competitive On Efficacy, Safety, But More Convenient; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US7711951043 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Roche Holding AG / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Ex vivo GT sees positive readouts</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Takeaways from Guggenheim Oncology Day Fireside Chat with Management:</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.12.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: ZN-c5 Updates & ZN-c3 Initial Data in 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMQ5T49 / 5671735 / 0989529 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TPTX (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Validation of Best-In-Class TKIs</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BJXBP30 / 2516152 / 2684703 / BD9GVY0 / BWY52P3</td><td class="leftalignment">Turning Point Therapeutics Inc / Eli Lilly and Co / Pfizer Inc / Zai Lab Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Feb. 12, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US0323325045 / US0997241064 / US1266501006 / US1924221039 / US3377381088 / US4523271090 / US5324571083 / US7134481081 / US87612E1064 / US9311421039 / US1667641005 / US60855R1005 / US02043Q1076 / US2538681030 / RDSa.AS / US31620M1062 / US57636Q1040 / US2521311074 / US53261M1045 / US03152W1099 / US30212P3038 / US9837931008 / US69318G1067 / US55345K1034 / US8485771021 / US90400D1081 / US68906L1052 / US4435731009 / CA76131D1033 / US70450Y1038 / BMG637AM1024 / US8760301072 / US98585X1046 / CA05156X8843 / US05380C1027 / US38246G1085 / US81181C1045 / US05479K1060</td><td class="leftalignment">Amtech Systems Inc / Borgwarner Inc / CVS Health Corp / Cognex Corp / Fiserv Inc / Illumina Inc / Eli Lilly and Co / PepsiCo Inc / Target Corp / Walmart Inc / Chevron Corp / Molina Healthcare Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Royal Dutch Shell PLC / Fidelity National Information Services Inc / Mastercard Inc / Dexcom Inc / Limelight Networks Inc / Amicus Therapeutics Inc / Expedia Group Inc / XPO Logistics Inc / PBF Energy Inc / MRC Global Inc / Spirit Airlines Inc / Ultragenyx Pharmaceutical Inc / Otonomy Inc / HubSpot Inc / Restaurant Brands International Inc / PayPal Holdings Inc / Myovant Sciences Ltd / Tapestry Inc / Yeti Holdings Inc / Aurora Cannabis Inc / AVITA Medical Inc / Goodrx Holdings Inc / Seagen Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Meeting Highlighted Many Key Growth Drivers/Upcoming Events; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFIZ.NS / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / ALNY.OQ / MNKD.OQ / MSB.AX / EBS.N / ACB.TO / FOLD.OQ / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / VCRA.N / ABBV.N / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / OTIC.OQ / CFRX.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Ltd / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / Alnylam Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Aurora Cannabis Inc / Amicus Therapeutics Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Vocera Communications Inc / Abbvie Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / Otonomy Inc / ContraFect Corp / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt – ORIC-101 Initial PoC Data On Track in 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BKVDFF7 / 0989529 / 2126335 / 2516152 / 2684703 / 7103065 / 2982924 / BBPK0J0</td><td class="leftalignment">Oric Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ABBV.N / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Abbvie Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Emerging Array of RAS Pathway Inhibitors</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BL71K91 / 2516152 / 2023607 / 7103065 / BBPK0J0 / BN2R582</td><td class="leftalignment">Revolution Medicines Inc / Eli Lilly and Co / Amgen Inc / Novartis AG / Mirati Therapeutics Inc / Relay Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Confidence Across KRAS & Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBPK0J0 / 0989529 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Mirati Therapeutics Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended February 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FISV=US / LLY=US / TWTR=US / PG=US / AMZN=US / DVN=US / INCY=US / EOG=US / AKAM=US / WLL=US / PAA=US / THC=US / TRMK=US / MRO=US / TTWO=US / EQR=US / MLM=US / UNH=US / AIZ=US / EPC=US / HAIN=US / MAS=US / MAT=US / DOC=US / BXS=US / GPN=US / HIW=US / CNC=US / PRI=US / EGP=US / NHI=US / OHI=US / UDR=US / COP=US / RRR=US / RPD=US / RNST=US / MPW=US / CHNG=US / FIS=US / TDG=US / GPRE=US / CLR=US / NMTR=US / NOG=US / CLNY=US / HTA=US / SBRA=US / YELP / ENPH=US / FANG=US / MODN=US / MBUU=US / NXRT=US / CHCT=US / WVE=US / WLTW=US / AYX=US / HWC=US / AMTB=US / LYFT=US / OVV=US / ARQT=US / REYN=US / FBRX=US</td><td class="leftalignment">Fiserv Inc / Eli Lilly and Co / Twitter Inc / Procter & Gamble Co / Amazon.com Inc / Devon Energy Corp / Incyte Corp / EOG Resources Inc / Akamai Technologies Inc / Whiting Petroleum Corp / Plains All American Pipeline LP / Tenet Healthcare Corp / Trustmark Corp / Marathon Oil Corp / Take-Two Interactive Software Inc / Equity Residential / Martin Marietta Materials Inc / UnitedHealth Group Inc / Assurant Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Masco Corp / Mattel Inc / Physicians Realty Trust / Cadence Bank / Global Payments Inc / Highwoods Properties Inc / Centene Corp / Primerica Inc / Eastgroup Properties Inc / National Health Investors Inc / Omega Healthcare Investors Inc / UDR Inc / Conocophillips / Red Rock Resorts Inc / Rapid7 Inc / Renasant Corp / Medical Properties Trust Inc / Change Healthcare Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Green Plains Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Sabra Health Care REIT Inc / Yelp Inc / Enphase Energy Inc / Diamondback Energy Inc / Model N Inc / Malibu Boats Inc / NexPoint Residential Trust Inc / Community Healthcare Trust Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / Alteryx Inc / Hancock Whitney Corp / Amerant Bancorp Inc / Lyft Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Forte Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2216850 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2100920 / 2471950 / 2689560 / 2684703 / 2138158 / 5531000 / 7103065 / 2712013 / B17HG57 / B121557 / 2769796 / 2857817 / B2R3PV1 / B7VD3F2 / BFLR866 / BFZCHN7 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BXDZ9Z0 / BJT1RW7 / BZ1LFB2 / BD8DJ71 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BGT3960 / BMDCDP2 / BJRFSB7 / 021513106</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Incyte Corp / PG&E Corp / Pfizer Inc / Sempra Energy / MorphoSys AG / Novartis AG / Global Payments Inc / Cardiovascular Systems Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / American Water Works Company Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / Shopify Inc / Lyft Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Orchard Therapeutics PLC / Bigcommerce Holdings Inc / Immunovant Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: 4Q EPS Drivers in Animal Health; Sustained Strength in Companion Animal</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ELAN.N / LLY.N / MRK.N / VIRB.PA / IDXX.OQ / NEOG.OQ / PETS.OQ / BAYGN.DE / ZTS.N / CHWY.N</td><td class="leftalignment">Elanco Animal Health Inc / Eli Lilly and Co / Merck & Co Inc / Virbac SA / IDEXX Laboratories Inc / Neogen Corp / Petmed Express Inc / Bayer AG / Zoetis Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">1877.HK: Shanghai Junshi Biosciences Co., Ltd - Lilly's COVID-19 neutralising antibody cocktail (one antibody licensed from Junshi) receives FDA EUA</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1877.HK / LLY.N / AMGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 02 09</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BLKB.OQ / FRT.N / LLY.N / UHS.N / MCD.N / HD.N / XOM.N / DVA.N / CVX.N / CBRL.OQ / VGR.N / WGO.N / TPR.N / NTCT.OQ / HES.N / VMW.N / CME.OQ / KEYS.N / TGNA.N / AYX.N / WDAY.OQ</td><td class="leftalignment">Blackbaud Inc / Federal Realty Investment Trust / Eli Lilly and Co / Universal Health Services Inc / McDonald's Corp / Home Depot Inc / Exxon Mobil Corp / DaVita Inc / Chevron Corp / Cracker Barrel Old Country Store Inc / Vector Group Ltd / Winnebago Industries Inc / Tapestry Inc / Netscout Systems Inc / Hess Corp / VMware Inc / CME Group Inc / Keysight Technologies Inc / Tegna Inc / Alteryx Inc / Workday Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Electronics / Financial Services / Healthcare / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Real Estate / Retailing / Telecommunications / Oil & Gas</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Eli Lilly and Company</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Dermatology in focus, w/ 1H21 approval likely in atopic derm; INCY says launch prep right on track.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INCY=US / LLY=US / ARQT=US / FBRX=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / FISV=US / MRK=US / BSX=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / ADI=US / WEN=US / AMZN=US / BLD=US / TEVA=US / NVDA=US / SLG=US / LOW=US / ENR=US / DIOD=US / IGT=US / CHRS=US / BYD=US / TTWO=US / LEG=US / TTMI=US / ATVI=US / KFRC=US / MGM=US / HUM=US / PENN=US / BKI=US / AVGO=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HAS=US / IBP=US / MAS=US / MHK=US / MCRI=US / REGI=US / SGMO=US / SPG=US / SGMS=US / GPN=US / AUTL=US / DIN=US / ECPG=US / PRAA=US / RRR=US / BIIB=US / TPX=US / EXP=US / CZR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / REX=US / FIS=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / NXPI=US / FBHS=US / ZNGA=US / EA=US / ENPH=US / TILE=US / NDLS=US / VRNS=US / GOOGL=US / LOCO=US / HQY=US / OSH=US / SHAK=US / WING=US / TDOC=US / EDIT=US / 82982L103 / IRTC=US / JELD=US / MPWR-US / CARG=US / BTAI=US / ALLO=US / HARP=US / TCRR=US / FERGY=US / OPCH=US / DKNG=US / AZEK=US / BALY=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / SL Green Realty Corp / Lowe's Companies Inc / Energizer Holdings Inc / Diodes Inc / International Game Technology PLC / Coherus BioSciences Inc / Boyd Gaming Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / TTM Technologies Inc / Activision Blizzard Inc / Kforce Inc / MGM Resorts International / Humana Inc / Penn National Gaming Inc / Black Knight Inc / Broadcom Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hasbro Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Simon Property Group Inc / Scientific Games Corp / Global Payments Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Red Rock Resorts Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / NXP Semiconductors NV / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / Varonis Systems Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Teladoc Health Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Monolithic Power Systems Inc / CarGurus Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Option Care Health Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Eli Lilly and Co: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR deal termination; big pharma engages GRTS</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GRTS.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 8 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1156372096 / US1266501006 / US14149Y1082 / US1912161007 / US1925761066 / US2546871060 / US37733W1053 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US9021041085 / US9029251066 / US91347P1057 / US03073E1055 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US3463751087 / US60855R1005 / US90385V1070 / US60871R2094 / US15135B1017 / RDSa.AS / PAP310761054 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US25470F3029 / US9100471096 / US00164V1035 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US61174X1090 / US87918A1051 / KYG4740B1059 / LGFb / LGFa / US53115L1044 / US05351X1019 / US49271V1008 / US5904791358 / US28414H1032 / US1255231003 / US35137L1052 / US92556H2067 / US92537N1081 / US6833731044 / US03044L1052 / US62955J1034 / US73739W1045 / 120175706 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / CVS Health Corp / Cardinal Health Inc / Coca-Cola Co / Cohu Inc / Walt Disney Co / GlaxoSmithKline PLC / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / II-VI Inc / USA Truck Inc / Universal Display Corp / Amerisourcebergen Corp / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / FormFactor Inc / Molina Healthcare Inc / Ultra Clean Holdings Inc / Molson Coors Beverage Co / Centene Corp / Royal Dutch Shell PLC / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / Discovery Inc / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Monster Beverage Corp / Teladoc Health Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / Liberty Oilfield Services Inc / Avaya Holdings Corp / Keurig Dr Pepper Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Fox Corp / ViacomCBS Inc / Vertiv Holdings Co / Ontrak Inc / American Well Corp / Nov Inc / Poshmark Inc / Cisco Systems Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, February 8 - Sunday, February 14</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NBIX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NBIX.O / LLY / PFE / PTN / RGEN.O / RPRX.O / ATHX.O / ANIP.O / ABBV.K / CASI.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Eli Lilly and Co / Pfizer Inc / Palatin Technologies Inc / Repligen Corp / Royalty Pharma PLC / Athersys Inc / ANI Pharmaceuticals Inc / Abbvie Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : 4Q Earnings Season Takeaways - Solid Results, Mixed Stock Performance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/06/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.5.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, LLY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung / Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">IBK Securities</td><td class="leftalignment">Eli Lilly-대사질환과 항암 중심의 실적 성장세-02/04/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">7</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Gyeongjun Moon</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACAD=US / MBRX=US / AAPL=US / BSX=US / CSII=US / LLY=US / INTC=US / ADI=US / AMD=US / MDT=US / JNPR=US / QCOM=US / SNE=US / T=US / ORCL=US / ADBE=US / TXN=US / CG=US / NVDA=US / CRM=US / VZ=US / GWW=US / ZEN=US / XLNX=US / IEX=US / HUM=US / APPS=US / AVGO=US / BL=US / CRUS=US / CREE=US / DOCU=US / EGAN=US / PHG=US / LFUS=US / LPSN=US / NOW=US / MCHP=US / NBIX=US / SHOP=US / SAGE=US / APO=US / PYPL=US / SWKS=US / ENSG=US / BIIB=US / RNG=US / MWA=US / ELF=US / BX=US / KKR=US / NXPI=US / WDAY=US / TMUS=US / CNHI=US / COUP=US / HUBS=US / QRVO=US / BILL=US / APTV=US / BILI=US / KRTX=US / 120175706</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / Apple Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Medtronic PLC / Juniper Networks Inc / Qualcomm Inc / Sony Group Corp / AT&T Inc / Oracle Corp / Adobe Inc / Texas Instruments Inc / Carlyle Group Inc / NVIDIA Corp / Salesforce.Com Inc / Verizon Communications Inc / W W Grainger Inc / Zendesk Inc / Xilinx Inc / IDEX Corp / Humana Inc / Digital Turbine Inc / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Wolfspeed Inc / DocuSign Inc / eGain Corp / Koninklijke Philips NV / Littelfuse Inc / LivePerson Inc / ServiceNow Inc / Microchip Technology Inc / Neurocrine Biosciences Inc / Shopify Inc / SAGE Therapeutics Inc / Apollo Global Management Inc / PayPal Holdings Inc / Skyworks Solutions Inc / Ensign Group Inc / Biogen Inc / RingCentral Inc / Mueller Water Products Inc / elf Beauty Inc / Blackstone Inc / KKR & Co Inc / NXP Semiconductors NV / Workday Inc / T-Mobile US Inc / CNH Industrial NV / Coupa Software Inc / HubSpot Inc / Qorvo Inc / Bill.com Holdings Inc / Aptiv PLC / Bilibili Inc / Karuna Therapeutics Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Ireland / Japan / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Egypt / Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Outlines Adu Plan for Success</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB=US / LLY=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary of 141 page Covid-19 Multilateralism Agility and Innovation TLSD Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">22UAy.DE / GSK.L / 4507.T / JNJ / LLY / PFE / AZN.L / BAVA.CO / REGN.O / 4563.T / IMM.L / CADI.NS / NVAX.O / SYNG.L / MRNA.O / 1099.HK / SVA.O / 4142.TW / ARCT.O / VBIV.O / ALT.O / VXRT.O / POLX.L / BNTX.O / VIR.O / 688185.SS</td><td class="leftalignment">BioNTech SE / GlaxoSmithKline PLC / Shionogi & Co Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Bavarian Nordic A/S / Regeneron Pharmaceuticals Inc / AnGes Inc / ImmuPharma PLC / Cadila Healthcare Ltd / Novavax Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Adimmune Corp / Arcturus Therapeutics Holdings Inc / VBI Vaccines Inc / Altimmune Inc / Vaxart Inc / Polarean Imaging PLC / BioNTech SE / Vir Biotechnology Inc / CanSino Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Canada / China / Germany / Denmark / United Kingdom / India / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / CORPORATE SUMMARY / STRATEGY / STRATEGIC ANALYSIS / EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Key takes from BIIB 4Q call that ended: 2021 guide hopefully is the floor for BIIB with or without aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O / LLY</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Eli Lilly and Company(LLY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Our Thoughts Post the 4Q20 Call: 2021 a 'reset' year or the year of aducanumab? It really needs to be both.</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB.OQ / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: 2021 Catalysts & NPV sensitivity analysis</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 4Q20 Earnings Highlights — What Mattered for Credit Part II</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY.N / TMO.N / MCK.N</td><td class="leftalignment">Eli Lilly and Co / Thermo Fisher Scientific Inc / Mckesson Corp</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2576941 / 2328915 / 2100920 / 2415204 / 2684703 / 2048804 / 2931034 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B1HJLW5 / 2390817 / B7TL820 / B7VD3F2 / BJ0XLZ3 / BH65L93 / BFLR866 / BYY8XK8 / BQPVQZ6 / BFNF1D6 / BJLKVS6 / BFZ1K46 / BLGJ610 / BFMXGR0 / BKTNTR9 / BKX9VD3 / BDVLM39 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Pfizer Inc / Pinnacle West Capital Corp / Vertex Pharmaceuticals Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Emergent BioSolutions Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Heron Therapeutics Inc / Seacoast Banking Corporation of Florida / Twitter Inc / WEC Energy Group Inc / Horizon Therapeutics PLC / Amneal Pharmaceuticals Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / ViacomCBS Inc / Arcutis Biotherapeutics Inc / argenx SE / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Licensing out PD-1 to Coherus improves commercial prospect in North America; raise TP to HK$100. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1877.HK / CHRS.OQ / LLY.N / NOVN.S / BGNE.OQ / 1801.HK</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Coherus BioSciences Inc / Eli Lilly and Co / Novartis AG / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / GILD.OQ / AMRN.OQ / BSLN.S / AXSM.OQ / BHVN.N / ARAV.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Amarin Corporation PLC / Basilea Pharmaceutica AG / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aravive Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary Covid-19 Multilateralism Agility and Innovation The Life Sciences Division Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / NVAX.OQ / JNJ.N / LLY.N / PFE.N / GSK.L / IMM.L / REGN.OQ / SYNG.L / MRNA.OQ / 1099.HK / SVA.OQ / ARCT.OQ / POLX.L / 6185.HK / VIR.OQ</td><td class="leftalignment">AstraZeneca PLC / Novavax Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / GlaxoSmithKline PLC / ImmuPharma PLC / Regeneron Pharmaceuticals Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Arcturus Therapeutics Holdings Inc / Polarean Imaging PLC / CanSino Biologics Inc / Vir Biotechnology Inc</td><td class="leftalignment">RESEARCH OVERVIEW - INVESTMENT STRATEGY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / CORPORATE SUMMARY / COMPANY REPORT</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MOGa / US0079731008 / US0116591092 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US14149Y1082 / US1925761066 / US22284P1057 / US2910111044 / US3021301094 / US3695501086 / US37733W1053 / US4385161066 / US4433201062 / US4448591028 / US4456581077 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US58155Q1031 / US6558441084 / US6668071029 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8552441094 / US87612E1064 / US8807701029 / US9029251066 / US9078181081 / US91324P1021 / US91347P1057 / US9311421039 / US9507551086 / CA1363751027 / US03073E1055 / CA13645T1003 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US25754A2015 / US0042251084 / US02043Q1076 / US15135B1017 / US12541W2098 / ACOR.OQ / US1696561059 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US8485771021 / US60468T1051 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US70450Y1038 / US40434L1052 / US05464T1043 / US00773U1088 / US16119P1084 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US1010441053 / US05351X1019 / US5904791358 / US0197701065 / US1255231003 / US8740602052 / US24703L2025 / US0144421072 / US55087P1049 / US90353T1007 / US18453H1068 / US70614W1009 / US09203E1055 / US4432011082 / CH0499880968</td><td class="leftalignment">Moog Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cardinal Health Inc / Cohu Inc / Covenant Logistics Group Inc / Emerson Electric Co / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Honeywell International Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Mckesson Corp / Norfolk Southern Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Target Corp / Teradyne Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Universal Display Corp / Walmart Inc / Werner Enterprises Inc / Canadian National Railway Co / Amerisourcebergen Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Centene Corp / CH Robinson Worldwide Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / HP Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Avaya Holdings Corp / Mesa Air Group Inc / Allogene Therapeutics Inc / Cigna Corp / Takeda Pharmaceutical Co Ltd / Dell Technologies Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Clear Channel Outdoor Holdings Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / Howmet Aerospace Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">WMB=US / LLY=US / AMGN=US / BMY=US / CL=US / AMZN=US / INCY=US / KMI=US / AMT=US / CHTR=US / CRM=US / PAA=US / CCI=US / BRO=US / MANH=US / CMCSA=US / CHD=US / COLL=US / AJG=US / MPLX=US / OKE=US / SBAC=US / TRGP=US / WIX=US / HTH=US / CVX=US / EPD=US / CGEN=US / CFR=US / SIVB=US / ABCB=US / DCP=US / SSB=US / BDSI=US / MMP=US / BIIB=US / MOG.A=US / EXP=US / BAH=US / EHTH=US / PAGP=US / SMLP=US / MODN=US / PTCT=US / CEQP=US / GOOGL=US / WVE=US / WLTW=US / EVBG=US / IRTC=US / RTLR=US / LHX=US</td><td class="leftalignment">Williams Companies Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Amazon.com Inc / Incyte Corp / Kinder Morgan Inc / American Tower Corp / Charter Communications Inc / Salesforce.Com Inc / Plains All American Pipeline LP / Crown Castle International Corp / Brown & Brown Inc / Manhattan Associates Inc / Comcast Corp / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Arthur J Gallagher & Co / MPLX LP / ONEOK Inc / SBA Communications Corp / Targa Resources Corp / Wix.Com Ltd / Hilltop Holdings Inc / Chevron Corp / Enterprise Products Partners LP / Compugen Ltd / Cullen/Frost Bankers Inc / SVB Financial Group / Ameris Bancorp / DCP Midstream LP / SouthState Corp / BioDelivery Sciences International Inc / Magellan Midstream Partners LP / Biogen Inc / Moog Inc / Eagle Materials Inc / Booz Allen Hamilton Holding Corp / eHealth Inc / Plains GP Holdings LP / Summit Midstream Partners LP / Model N Inc / PTC Therapeutics Inc / Crestwood Equity Partners LP / Alphabet Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / Everbridge Inc / iRhythm Technologies Inc / Rattler Midstream LP / L3harris Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Downgrade To Market Perform Pending Greater Clarity On Outlook</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US66987V1098 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Novartis AG / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 2936921 / 2516152 / 2681511 / 2496113 / 2008154 / 2486813 / 2206657 / 2270726 / 2542049 / 2037170 / 2100920 / 2366799 / 2455965 / 2459202 / 2459020 / 2657802 / 2680905 / 2048804 / 7123870 / B1F76F9 / B121557 / B067BM3 / B1Y9TB3 / B2R3PV1 / B3P93Y7 / B3SWPT2 / B7TL820 / B7VD3F2 / BFLR866 / B95WG16 / BZ07BW4 / BYRY499 / BVVN4Q8 / BYY8XK8 / BD3W133 / BYNZGK1 / BFMXGR0 / BFNR303 / BJXBP30 / BYWMQJ2 / BDH65C8 / BD6D4Y5 / BZ1LFG7 / BMH0MR7 / BDVLM39 / BMDCDP2 / BJRFSB7 / BN7K304 / BLBLMD5 / 021513106</td><td class="leftalignment">Visa Inc / Walmart Inc / Eli Lilly and Co / PepsiCo Inc / Kohls Corp / Adobe Inc / Kellogg Co / Coca-Cola Co / Walt Disney Co / Dominion Energy Inc / 8x8 Inc / FirstEnergy Corp / Gentex Corp / Biogen Inc / IDEXX Laboratories Inc / Intuit Inc / OGE Energy Corp / PPL Corp / Pinnacle West Capital Corp / Nestle SA / Western Union Co / Mastercard Inc / Molson Coors Beverage Co / Danone SA / American Water Works Company Inc / Anheuser Busch Inbev SA / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Zoetis Inc / Monster Beverage Corp / Kraft Heinz Co / Eversource Energy / WEC Energy Group Inc / Keurig Dr Pepper Inc / Block Inc / Evergy Inc / Northwest Natural Holding Co / Turning Point Therapeutics Inc / Alteryx Inc / PetIQ Inc / Altair Engineering Inc / Roku Inc / Zendesk Inc / argenx SE / Bigcommerce Holdings Inc / Immunovant Inc / Academy Sports and Outdoors Inc / Array Technologies Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : Post 4Q Model Update - Thoughts on Donanemab Alz Oppty and LLY Shares from Here</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / CAT.N / HON.N / ITW.N / XOM.N / LIN.N / ARE.N / CVX.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / CHTR.OQ / GPN.N / VRTX.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Caterpillar Inc / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Charter Communications Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 4Q Earnings Season : What to Watch for the Week Ahead (ABBV, BMY, MRK, PFE)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ABBV.N / BMY.N / MRK.N / PFE.N / LLY.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, February 1 - Sunday, February 7</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Solid 4Q results; PT to $215, maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccines vs variants; IND cleared for PASG</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PASG.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's New At WCLC This Year; Takeaways Keep Us Positive on MRK, JNJ and HCM</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ / MRK / HCM.L / LLY / PFE / AMGN.O / BSLN.S / ARAV.O / IMAB.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / HUTCHMED (China) Ltd / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 4Q20 Biotech Earnings Consensus Cheat Sheet for VRTX, AMGN, BIIB, GILD, NBIX, and REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / AMGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ABBV.N</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 4Q Takeaways – We See Positive Setup into Donanemab Alzheimer's Data in March</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 1.29.21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: 4Q20 - They Said What?! Highlights From Conference Call That Just Ended</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Alzheimer's Tidbits from Lilly Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / BIIB=US / ACIU=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Raising PT To $245 From $200 Post Solid 4Q20 And Positive Outlook For 2021+</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Jan. 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CHE=US / HUM=US / BSX=US / CSII=US / LLY=US / ABT=US / AMGN=US / GBT=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / SYK=US / RMD=US / RAD=US / HCA=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CYH=US / EW=US / GEN=US / LH=US / LIFE=US / PHAR=US / PRVL=US / SILK=US / USPH=US / UTHR=US / UHS=US / SGEN=US / SAGE=US / OPT=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CASI=US / SLF=US / BIIB=US / MRNA=US / MNKD=US / GOOG=US / LHCG=US / SNSS=US / CHNG=US / EHC=US / NMTR=US / SWAV=US / ADUS=US / IRWD=US / ACHC=US / AGIO=US / CTRE=US / AUPH=US / VBLT=US / NVRO=US / WBA=US / CLLS=US / EVH=US / CATB=US / PEN=US / BGNE=US / IRTC=US / ZEAL=US / ZLAB=US / FIXX=US / BHC=US / NBSE=US / PNTG=US</td><td class="leftalignment">Chemed Corp / Humana Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Resmed Inc / Rite Aid Corp / HCA Healthcare Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Pharming Group NV / Porvair PLC / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Sun Life Financial Inc / Biogen Inc / Moderna Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Shockwave Medical Inc / Addus Homecare Corp / Ironwood Pharmaceuticals Inc / Acadia Healthcare Company Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Walgreens Boots Alliance Inc / Cellectis SA / Evolent Health Inc / Astria Therapeutics Inc / Penumbra Inc / Beigene Ltd / iRhythm Technologies Inc / Zealand Pharma A/S / Zai Lab Ltd / Homology Medicines Inc / Bausch Health Companies Inc / NeuBase Therapeutics Inc / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY: 4Q20 quicktake – beat on rev/EPS; overall looks good; nothing new on donanemab (Alzheimer's)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">532457108</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Eli Lilly & Company : 4Q First Impression: No Major Surprises On Qtr And 2021 Guidance Reiterated, Focus Remains On Upcoming Pipeline Readouts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 Beat; 2021 Guidance Reiterated; Call Tone Very Upbeat</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: 4Q Sales Beat Led By Trulicity & Stocking; EPS Beat Mostly on OOI; 2021 Guidance May Be Conservative</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Jan 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CVX.N / BP.L / CL.N / IBM.N / LLY.N / SLB.N / WY.N / HAL.N / ROP.N / CAT.N / HON.N / XOM.N / JCI.N / CHD.N / AAPL.OQ / FBP.N / MSFT.OQ / SBUX.OQ / AMZN.OQ / CHTR.OQ / 0700.HK / RDSa.L / ROLL.OQ / 9999.HK / BAH.N / LYB.N / BKR.N / PSX.N / SYF.N / SGREN.MC / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / LHX.N / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Chevron Corp / BP PLC / Colgate-Palmolive Co / International Business Machines Corp / Eli Lilly and Co / Schlumberger NV / Weyerhaeuser Co / Halliburton Co / Roper Technologies Inc / Caterpillar Inc / Honeywell International Inc / Exxon Mobil Corp / Johnson Controls International PLC / Church & Dwight Co Inc / Apple Inc / First Bancorp / Microsoft Corp / Starbucks Corp / Amazon.com Inc / Charter Communications Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / RBC Bearings Inc / NetEase Inc / Booz Allen Hamilton Holding Corp / LyondellBasell Industries NV / Baker Hughes Co / Phillips 66 / Synchrony Financial / Siemens Gamesa Renewable Energy SA / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / L3harris Technologies Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Spain / United Kingdom / Ireland / Netherlands / Puerto Rico / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Brief of Eli Lilly and Co conference call, Jan. 29, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Jan. 29, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended January 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4:20 EPS, Sales Beat; 2021 Guidance Reaffirmed</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Look at 4Q20 Sales and EPS Beat</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABCL: Strong Q4 Bamlanivimab Sales</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABCL.OQ / LLY.N</td><td class="leftalignment">Abcellera Biologics Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Dr. Martin Auster, M.D. / Mr. Thomas Deal / Mark Connolly / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / ITW.N / XOM.N / LIN.N / V.N / ARE.N / CVX.N / AMGN.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / VRTX.OQ / CMCSA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / OTIS.N</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for LLY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Sotorasib Registration Data at WCLC Looks Solid; Raises Bar for MRTX's Adagrasib</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2023607 / MRTX.OQ / 2516152 / 2778844 / 7103065 / BBPK0J0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MPWR=US / NDAQ=US / AAPL=US / IBM=US / BSX=US / LLY=US / ABT=US / INTC=US / ADI=US / MSFT=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / TXN=US / VZ=US / SYK=US / SMTC=US / SAP=US / URI=US / TSM=US / CCI=US / HELE=US / LSTR=US / SEIC=US / CMCSA=US / DISH=US / AVGO=US / CRUS=US / CREE=US / EW=US / LIFE=US / NOW=US / MNRO=US / MSI=US / PHAR=US / TYL=US / UTHR=US / WDC=US / SAGE=US / OPT=US / FB=US / SWKS=US / BIIB=US / MRNA=US / OLED=US / FRPT=US / SNSS=US / AXON=US / TEL=US / BX=US / OSS=US / MXL=US / TSLA=US / NXPI=US / TMUS=US / QRVO=US / CLLS=US / CATB=US / AKTS=US / FIXX=US / REZI=US / NBSE=US / HXGBY=US</td><td class="leftalignment">Monolithic Power Systems Inc / Nasdaq Inc / Apple Inc / International Business Machines Corp / Boston Scientific Corp / Eli Lilly and Co / Abbott Laboratories / Intel Corp / Analog Devices Inc / Microsoft Corp / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Texas Instruments Inc / Verizon Communications Inc / Stryker Corp / Semtech Corp / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / Helen of Troy Ltd / Landstar System Inc / SEI Investments Co / Comcast Corp / DISH Network Corp / Broadcom Inc / Cirrus Logic Inc / Wolfspeed Inc / Edwards Lifesciences Corp / aTyr Pharma Inc / ServiceNow Inc / Monro Inc / Motorola Solutions Inc / Pharming Group NV / Tyler Technologies Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Opthea Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Biogen Inc / Moderna Inc / Universal Display Corp / Freshpet Inc / Viracta Therapeutics Inc / Axon Enterprise Inc / TE Connectivity Ltd / Blackstone Inc / One Stop Systems Inc / Maxlinear Inc / Tesla Inc / NXP Semiconductors NV / T-Mobile US Inc / Qorvo Inc / Cellectis SA / Astria Therapeutics Inc / Akoustis Technologies Inc / Homology Medicines Inc / Resideo Technologies Inc / NeuBase Therapeutics Inc / Hexagon AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Germany / France / Ireland / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Eli Lilly (LLY US) - Shares up to speed</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US5324571083</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BMY.N / BSX.N / CI.N / LLY.N / MRK.N / PFE.N / PM.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / QCOM.OQ / GILD.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / CMCSA.OQ / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Lilly's Ph 3 trial of COVID-19 neutralising antibody cocktail met primary endpoints. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">1877.HK / LLY.N / REGN.OQ / BGNE.OQ / 6160.HK</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 4Q Results</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB=US / LLY=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2270726 / 2542049 / 2829515 / 2382892 / 2670519 / 2328915 / 2459020 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2862532 / 2138158 / 2503529 / 4595739 / 5531000 / 7103065 / B121557 / B2R3PV1 / B7TL820 / BCBVTX1 / B7VD3F2 / BFLR866 / B76LYJ2 / BTN1Y44 / BYY8XK8 / BNGY4Q0 / BF5L3T2 / BYNZGK1 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BKLCX50</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Walt Disney Co / Dominion Energy Inc / Edison International / Audacy Inc / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / World Wrestling Entertainment Inc / Genmab A/S / MorphoSys AG / Novartis AG / Mastercard Inc / American Water Works Company Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Walgreens Boots Alliance Inc / WEC Energy Group Inc / Nextera Energy Partners LP / Elanco Animal Health Inc / Block Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Health Catalyst Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BSX.N / JNJ.N / LLY.N / PFE.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / VZ.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / TXN.OQ / CMCSA.OQ / NEE.N / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Boston Scientific Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Verizon Communications Inc / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Nextera Energy Inc / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.OQ / GILD.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">2021 Access to Medicine Index (26 Jan 2021)</td><td class="leftalignment">English</td><td class="rightalignment">237</td><td class="leftalignment">4502.T / 4503.T / 4523.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 4568.T / BAYGn.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Bayer AG / Abbvie Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">LLY's Antibody Combo Reduces Deaths and Hospitalizations Due To COVID-19</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / AMGN.O / REGN.O / HGEN.O</td><td class="leftalignment">Eli Lilly and Co / Amgen Inc / Regeneron Pharmaceuticals Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Brief of Eli Lilly and Co conference call, Jan. 26, 2021 / 12:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">LLY.N - Event Transcript of Eli Lilly and Co conference call, Jan. 26, 2021 / 12:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">CoroNation Update: REGN/LLY Antibody Cocktails Are Very Effective, May See Significant Use In Light Of Slow Vaccine Rollout</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY.N / REGN.OQ / 2516152 / 2730190</td><td class="leftalignment">Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Kushal Patel / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Covid-19 Antibody Update: REGN-CoV2 shows promising potential as a prophylaxis, while Lilly's combo therapy significantly reduces hospitalizations and risk of death</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / LLY.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for LLY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, January 25 - Sunday, January 31</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LJPC=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">La Jolla Pharmaceutical Co / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Competition for BTKs Heating Up With AZN's Positive H2H Topline Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY / JNJ / MRK</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079731008 / US0116591092 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1727551004 / US1924461023 / US1925761066 / US2017231034 / US22284P1057 / US2371941053 / US2829141009 / US3021301094 / US3156161024 / US37733W1053 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5801351017 / US5949181045 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6703461052 / US6795801009 / US7170811035 / US7392761034 / US7475251036 / US7595091023 / US7711951043 / AN8068571086 / US8068821060 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8581191009 / US8610121027 / US8807701029 / US9029251066 / US9078181081 / US91347P1057 / US9182041080 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US9129091081 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US12541W2098 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US3020811044 / US92932M1018 / US01748X1028 / US2473617023 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US9100471096 / US95058W1009 / US03027X1000 / US29414B1044 / US9837931008 / US00287Y1091 / NL0010273215 / US45845P1084 / US8485771021 / US21240E1055 / US76680R2067 / CA05156V1022 / US02376R1023 / US03937C1053 / US8873991033 / LU0974299876 / CA0089118776 / US22822V1017 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / US5588681057 / US01345P1066 / KYG4740B1059 / US2067871036 / CA87241L1094 / US78410G1040 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US4990491049 / US1858991011 / US30057T1051 / US89854H1023 / US05351X1019 / US11135F1012 / US05455M1009 / US29260V1052 / US5904791358 / US62921N1054 / CA59935V1076 / US4833791035 / US92537N1081 / US39813G1094 / 120175706</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Cohu Inc / Commercial Metals Co / Covenant Logistics Group Inc / Darden Restaurants Inc / 8x8 Inc / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Microsoft Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Nucor Corp / Old Dominion Freight Line Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Reliance Steel & Aluminum Co / Roche Holding AG / Schlumberger NV / Schnitzer Steel Industries Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Steel Dynamics Inc / STMicroelectronics NV / Teradyne Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / VF Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / United States Steel Corp / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / United Airlines Holdings Inc / Wendys Co / American Tower Corp / Epam Systems Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Intercept Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / RingCentral Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / ArcBest Corp / TimkenSteel Corp / Globant SA / Air Canada / Crown Castle International Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Madrigal Pharmaceuticals Inc / Albireo Pharma Inc / Ichor Holdings Ltd / Conduent Inc / TFI International Inc / SBA Communications Corp / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Cleveland-Cliffs Inc / Evoqua Water Technologies Corp / TTEC Holdings Inc / Avaya Holdings Corp / Broadcom Inc / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / NGM Biopharmaceuticals Inc / Milestone Pharmaceuticals Inc / Kaleyra Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MCD=US / SCI=US / AAPL=US / IBM=US / WMB=US / BSX=US / CSII=US / LLY=US / SBUX=US / ABT=US / CAT=US / COST=US / INTC=US / KO=US / MO=US / AMD=US / WM=US / BWA=US / MSFT=US / WEN=US / MDT=US / GNSS=US / JNPR=US / K=US / AMZN=US / T=US / ORCL=US / WMT=US / RUN=US / D=US / ED=US / SRE=US / WFC=US / NVDA=US / HBI=US / AKAM=US / YUM=US / PCG=US / FCEL=US / PLUG=US / VZ=US / EL=US / GIS=US / SAP=US / URI=US / BAX=US / GSK=US / JCI=US / JNJ=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / KR=US / DE=US / EIX=US / UNH=US / RSG=US / ABMD=US / ALB=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVGO=US / HRB=US / CMI=US / CHD=US / CSGP=US / CREE=US / DHI=US / XRAY=US / DG=US / EW=US / EQIX=US / FMC=US / ISRG=US / ITRI=US / MS=US / PCAR=US / PRVL=US / REGN=US / ROK=US / SBAC=US / HSIC=US / SILK=US / SJM=US / TRMB=US / ALGN=US / PFG=US / CINF=US / SIVB=US / FB=US / NEP=US / O=US / SWKS=US / NFLX=US / BE=US / CLH=US / WCN=US / TCOM=US / DPZ=US / ENS=US / TWIN=US / ORA=US / AMRS=US / SPWR=US / ICE=US / CSIQ=US / FSLR=US / QSR=US / BX=US / LULU=US / VMW=US / DAN=US / SPGI=US / WPRT=US / KKR=US / SWAV=US / 700-HK=US / AGCO=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / NXPI=US / AMRC=US / EA=US / ENPH=US / TMUS=US / HASI=US / CNHI=US / SIEGY=US / BABA=US / NVRO=US / SEDG=US / ZBH=US / PEN=US / AQMS=US / HPE=US / SQ=US / WKHS=US / OKTA=US / APTV=US / VOW3-DE=US / CWEN=US / VLDR=US / 120175706 / 120248964</td><td class="leftalignment">McDonald's Corp / Service Corporation International / Apple Inc / International Business Machines Corp / Williams Companies Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Starbucks Corp / Abbott Laboratories / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / Altria Group Inc / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Wendys Co / Medtronic PLC / Genasys Inc / Juniper Networks Inc / Kellogg Co / Amazon.com Inc / AT&T Inc / Oracle Corp / Walmart Inc / Sunrun Inc / Dominion Energy Inc / Consolidated Edison Inc / Sempra Energy / Wells Fargo & Co / NVIDIA Corp / HanesBrands Inc / Akamai Technologies Inc / Yum! Brands Inc / PG&E Corp / Fuelcell Energy Inc / Plug Power Inc / Verizon Communications Inc / Estee Lauder Companies Inc / General Mills Inc / SAP SE / United Rentals Inc / Baxter International Inc / GlaxoSmithKline PLC / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Kroger Co / Deere & Co / Edison International / UnitedHealth Group Inc / Republic Services Inc / ABIOMED Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Broadcom Inc / H & R Block Inc / Cummins Inc / Church & Dwight Co Inc / CoStar Group Inc / Wolfspeed Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Dollar General Corp / Edwards Lifesciences Corp / Equinix Inc / FMC Corp / Intuitive Surgical Inc / Itron Inc / Morgan Stanley / Paccar Inc / Porvair PLC / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / SBA Communications Corp / Henry Schein Inc / Silk Road Medical Inc / J M Smucker Co / Trimble Inc / Align Technology Inc / Principal Financial Group Inc / Cincinnati Financial Corp / SVB Financial Group / Meta Platforms Inc / Nextera Energy Partners LP / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Trip.com Group Ltd / Domino's Pizza Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / SunPower Corp / Intercontinental Exchange Inc / Canadian Solar Inc / First Solar Inc / Restaurant Brands International Inc / Blackstone Inc / Lululemon Athletica Inc / VMware Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / Shockwave Medical Inc / Tencent Holdings Ltd / AGCO Corp / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / NXP Semiconductors NV / Ameresco Inc / Electronic Arts Inc / Enphase Energy Inc / T-Mobile US Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Siemens AG / Alibaba Group Holding Ltd / Nevro Corp / Solaredge Technologies Inc / Zimmer Biomet Holdings Inc / Penumbra Inc / Aqua Metals Inc / Hewlett Packard Enterprise Co / Block Inc / Workhorse Group Inc / Okta Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Velodyne Lidar Inc / Cisco Systems Inc / Frontier Communications Parent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Leisure & Entertainment / Lodging & Restaurants / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine from GRTS; TSHA designations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GRTS.OQ / TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 44</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ANTO.L / AVMD.PA / BARC.L / BHP.AX / BNPP.PA / CRH.I / ERICB.ST / HEIN.AS / HSBA.L / JNJ.N / KGF.L / LLY.N / MRK.N / NHY.OL / PFE.N / PRU.L / RIO.AX / SAPJ.J / SHBA.ST / SOGN.PA / SOLB.BR / VOD.L / SASY.PA / ROG.S / DBKGN.F / NOVOB.CO / NOVN.S / BOL.ST / CARLB.CO / GSK.L / NWG.L / MAERSKB.CO / NKELYQ.L / ASOS.L / ABI.BR / 0486.HK / BNRGN.DE / BASFN.DE / 1299.HK / SHLG.DE / GLEN.L / ABBV.N / FBK.MI / IMB.L / UBSG.S / DHER.DE / TEPRF.PA</td><td class="leftalignment">Antofagasta PLC / Dassault Aviation SA / Barclays PLC / BHP Group Ltd / BNP Paribas SA / CRH PLC / Telefonaktiebolaget LM Ericsson / Heineken NV / HSBC Holdings PLC / Johnson & Johnson / Kingfisher PLC / Eli Lilly and Co / Merck & Co Inc / Norsk Hydro ASA / Pfizer Inc / Prudential PLC / Rio Tinto Ltd / Sappi Ltd / Svenska Handelsbanken AB / Societe Generale SA / Solvay SA / Vodafone Group PLC / Sanofi SA / Roche Holding AG / Deutsche Bank AG / Novo Nordisk A/S / Novartis AG / Boliden AB / Carlsberg A/S / GlaxoSmithKline PLC / Natwest Group PLC / AP Moeller - Maersk A/S / GMK Noril'skiy Nikel' PAO / ASOS PLC / Anheuser Busch Inbev SA / OK Rusal MKPAO / Brenntag SE / BASF SE / AIA Group Ltd / Siemens Healthineers AG / Glencore PLC / Abbvie Inc / FinecoBank Banca Fineco SpA / Imperial Brands PLC / UBS Group AG / Delivery Hero SE / Teleperformance SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Ireland / Italy / Netherlands / Norway / Russian Federation / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / AAXN=US / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Axon Enterprise Inc / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Dropping Coverage</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMTK=US / VERU=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / GBT=US / MDT=US / DYN=US / WMT=US / CMS=US / GILD=US / DGX=US / NVS=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CSTL=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / PHG=US / LH=US / REGN=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / CCRN=US / CNC=US / ACA=US / STSA=US / NTRA=US / ENSG=US / MIST=US / MD=US / NKTR=US / SLF=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / TPTX=US / IVA=US / EHC=US / NEO=US / ADUS=US / BEAM=US / ACHC=US / SRPT=US / AGIO=US / FATE=US / VCYT=US / CTRE=US / WBA=US / NVTA=US / VKTX=US / EVH=US / VRAY=US / MDGL=US / IRTC=US / NCNA=US / GH=US / ARVN=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / APLT=US / IDYA=US / BCYC=US / BCEL=US / KRTX=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PNTG=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">DermTech Inc / Veru Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Dyne Therapeutics Inc / Walmart Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Castle Biosciences Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Satsuma Pharmaceuticals Inc / Natera Inc / Ensign Group Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Inventiva SA / Encompass Health Corp / Neogenomics Inc / Addus Homecare Corp / Beam Therapeutics Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Veracyte Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Viking Therapeutics Inc / Evolent Health Inc / ViewRay Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / NuCana PLC / Guardant Health Inc / Arvinas Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Atreca Inc / Karuna Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Pennant Group Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: Cantor Research Call - Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / HCM.L / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">Eli Lilly and Co / HUTCHMED (China) Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000121014 / CH0012221716 / US0028962076 / US02553E1064 / US0311001004 / US0320951017 / US0378331005 / US0463531089 / US0530151036 / US1011371077 / US1101221083 / US1264081035 / US1271903049 / US1924221039 / US22160K1051 / US2310211063 / US28176E1082 / US34354P1057 / US3647601083 / US37733W1053 / US45167R1041 / US4581401001 / US4698141078 / US5324571083 / US5949181045 / US66987V1098 / US6701002056 / US7010941042 / US7043261079 / US7170811035 / US7711951043 / US7739031091 / US7766961061 / US7782961038 / US8636671013 / US8725401090 / US87612E1064 / US8793601050 / US9078181081 / US9297401088 / US9311421039 / US9427491025 / US5645631046 / US80105N1054 / US0003752047 / US2538681030 / US6247581084 / US48242W1062 / US92932M1018 / US90384S3031 / US0231112063 / US1940141062 / CA0585861085 / CH0102993182 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US0995021062 / US7512121010 / US98419M1009 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US23283R1005 / US8086251076 / US5253271028 / CH0210483332 / US70438V1061 / US70432V1026 / US98936J1016 / IE00BLS09M33 / US0994061002 / US29444U7000 / US72703H1014 / GB00BZ09BD16 / US45073V1089 / US34959J1088 / US90138F1021 / US36165L1089 / US74967X1037 / CA1350861060 / US05722G1004 / US87105L1044 / US8760301072 / US30057T1051 / GB00BFMBMT84 / US15677J1088 / US2575541055 / US0937121079 / US28414H1032 / KY30744W1070 / VGG1890L1076 / US70202L1026 / US35952H6018 / US76156B1070 / US88339P1012 / US30068X1037 / US6541101050 / GB00BMVP7Y09 / US6873051022</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abb Ltd / Abercrombie & Fitch Co / American Eagle Outfitters Inc / AMETEK Inc / Amphenol Corp / Apple Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / CSX Corp / CACI International Inc / Cognex Corp / Costco Wholesale Corp / Cummins Inc / Edwards Lifesciences Corp / Flowserve Corp / Gap Inc / GlaxoSmithKline PLC / IDEX Corp / Intel Corp / Jacobs Engineering Group Inc / Eli Lilly and Co / Microsoft Corp / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Paychex Inc / Pfizer Inc / Roche Holding AG / Rockwell Automation Inc / Roper Technologies Inc / Ross Stores Inc / Stryker Corp / TJX Companies Inc / Target Corp / Teledyne Technologies Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Walmart Inc / Watts Water Technologies Inc / ManTech International Corp / Sanofi SA / Abb Ltd / Digital Realty Trust Inc / Mueller Water Products Inc / KBR Inc / WNS (Holdings) Ltd / Ulta Beauty Inc / Amarin Corporation PLC / Colfax Corp / Ballard Power Systems Inc / TE Connectivity Ltd / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Xylem Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / CyrusOne Inc / Science Applications International Corp / Leidos Holdings Inc / Compagnie Financiere Richemont SA / Paylocity Holding Corp / Paycom Software Inc / Zendesk Inc / Pentair PLC / Boot Barn Holdings Inc / Equinix Inc / Planet Fitness Inc / Atlassian Corporation PLC / ITT Inc / Fortive Corp / Twilio Inc / GDS Holdings Ltd / RH / Canada Goose Holdings Inc / Baker Hughes Co / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Sensata Technologies Holding PLC / Ceridian HCM Holding Inc / Domo Inc / Bloom Energy Corp / Elanco Animal Health Inc / Farfetch Ltd / Capri Holdings Ltd / Parsons Corp / Fuelcell Energy Inc / Revolve Group Inc / RealReal Inc / Exagen Inc / Nikola Corp / Royalty Pharma PLC / Orphazyme A/S</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / IBM.N / JNJ.N / KMB.N / LLY.N / PPG.N / SLB.N / T.N / TRV.N / DHR.N / DIS.N / CAT.N / UNP.N / MCD.N / HON.N / VZ.N / V.N / CVX.N / RF.N / INTC.OQ / AAPL.OQ / HBAN.OQ / MSFT.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / NEE.N / TSLA.OQ / MDLZ.OQ / GOOGL.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Abbott Laboratories / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Eli Lilly and Co / PPG Industries Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Danaher Corp / Walt Disney Co / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Honeywell International Inc / Verizon Communications Inc / Visa Inc / Chevron Corp / Regions Financial Corp / Intel Corp / Apple Inc / Huntington Bancshares Inc / Microsoft Corp / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Nextera Energy Inc / Tesla Inc / Mondelez International Inc / Alphabet Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Biotech Sector: Pipeline updates and recent license-out deals accentuate LT potential of high-flying biotechs</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">1952.HK / BGNE.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / MGNX.OQ / TPB.N / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / GTH.OQ</td><td class="leftalignment">Everest Medicines Ltd / Beigene Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / MacroGenics Inc / Turning Point Brands Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Genetron Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4:20 Results Preview/2021 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TOMORROW AM: Cantor Research Call - Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / HCM.O / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">Eli Lilly and Co / HUTCHMED (China) Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">LLY's COVID Ab Results in Nursing Homes Validates Prophylaxis; REGN Up Next</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / REGN=US / LLY=US</td><td class="leftalignment">Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID-19 Risk Reduction Meaningful With LLY Bamlanivimab; Positive for ABCL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / ABCL=US / LLY=US</td><td class="leftalignment">Eli Lilly and Co / Abcellera Biologics Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Puneet Souda</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABCL: Feedback from Launch - Base Business Remains the Key Driver Despite Near-Term Focus on Bamlanivimab</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABCL.OQ / LLY.N</td><td class="leftalignment">Abcellera Biologics Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Dr. Martin Auster, M.D. / Mr. Thomas Deal / Mark Connolly / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2050832 / 2270726 / 2542049 / 2415204 / 2455965 / 2657802 / 2684703 / 2048804 / 7103065 / B1F76F9 / B121557 / 2857817 / B02R1L6 / B2R3PV1 / 2679204 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BFMXGR0 / BKC9SX3 / BYTJZL1 / BKT6B38</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Western Union Co / Mastercard Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Align Technology Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Snap Inc / Pinterest Inc / Warner Music Group Corp / Evergy Inc / Arcturus Therapeutics Holdings Inc / Zogenix Inc / SmileDirectClub Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Donanemab Pot'l Precious Jewel in LLY's Crown; Will Aducanumab Get FDA Approval?; Raising PT to $210/shr</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2516152</td><td class="leftalignment">Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Novo Nordisk: Concerns over sustainability of returns overdone</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Selim Gogus</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Downgrade to Underperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Downgrading to Neutral; Reiterate DKK470/share Price Target</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / GILD.OQ / MSB.AX / ARDX.OQ / ZTS.N / BHVN.N / XELA.OQ / XGN.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Mesoblast Ltd / Ardelyx Inc / Zoetis Inc / Biohaven Pharmaceutical Holding Company Ltd / Exela Technologies Inc / Exagen Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5889505 / 126650100 / 007903107 / 458140100 / 478160104 / 038222105 / 91324P102 / 532457108 / 166764100 / 92343V104 / 747525103 / 055622104 / 191216100 / 880770102 / 682189105 / 30231G102 / 037833100 / 595017104 / 713448108 / 482480100 / 501242101 / 512807108 / 983919101 / 826919102 / 115637209 / 101137107 / 861012102 / 60871R209 / 15135B101 / 60855R100 / 291011104 / 90385V107 / 67066G104 / 444859102 / 21036P108 / 007973100 / 55306N104 / 346375108 / 172755100 / RDSa.AS / 518415104 / 89151E109 / 00206R102 / 192422103 / 254543101 / 37733W105 / 100557107 / 609839105 / 046353108 / 157210105 / 192576106 / 526107107 / 624580106 / 91347P105 / 26884L109 / 771195104 / B505PN7 / 29414B104 / 69327R101 / 872590104 / 98978V103 / 036752103 / 099406100 / 61174X109 / 40434L105 / 72703H101 / 05156V102 / BTN1Y11 / 31572Q808 / 11135F101 / 49271V100 / 138035100 / 28414H103 / ACRGu.CD / 29260V105 / 125523100 / 39342L108 / 22717L101 / 88688T100 / B929F46 / 16106R109 / 61775R105 / BY7QL61 / B7KH3G6 / 86730L109 / 395330103 / BD2B5Y0 / 22587M106 / 23126M102 / 58507M107 / 76156B107 / BP40HF4 / 64079L105 / BK9ZQ96 / BZ8FXC4 / 14448C104 / 05156X884 / 126654102 / 24703L202 / 14147L108 / 39813G109 / 5962343</td><td class="leftalignment">Infineon Technologies AG / CVS Health Corp / Advanced Micro Devices Inc / Intel Corp / Johnson & Johnson / Applied Materials Inc / UnitedHealth Group Inc / Eli Lilly and Co / Chevron Corp / Verizon Communications Inc / Qualcomm Inc / BP PLC / Coca-Cola Co / Teradyne Inc / ON Semiconductor Corp / Exxon Mobil Corp / Apple Inc / Microchip Technology Inc / PepsiCo Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Xilinx Inc / Silicon Laboratories Inc / Brown-Forman Corp / Boston Scientific Corp / STMicroelectronics NV / Molson Coors Beverage Co / Centene Corp / Molina Healthcare Inc / Emerson Electric Co / Ultra Clean Holdings Inc / NVIDIA Corp / Humana Inc / Constellation Brands Inc / Advanced Energy Industries Inc / MKS Instruments Inc / FormFactor Inc / Cirrus Logic Inc / Royal Dutch Shell PLC / Lattice Semiconductor Corp / TotalEnergies SE / AT&T Inc / Cognex Corp / Diodes Inc / GlaxoSmithKline PLC / Boston Beer Company Inc / Monolithic Power Systems Inc / AstraZeneca PLC / CEVA Inc / Cohu Inc / Lennox International Inc / Movado Group Inc / Universal Display Corp / EQT Corp / Roche Holding AG / NXP Semiconductors NV / Epam Systems Inc / PDC Energy Inc / T-Mobile US Inc / Zoetis Inc / Anthem Inc / Boot Barn Holdings Inc / Monster Beverage Corp / HP Inc / Planet Fitness Inc / Aurinia Pharmaceuticals Inc / Medtronic PLC / FibroGen Inc / Broadcom Inc / Keurig Dr Pepper Inc / Canopy Growth Corp / Elanco Animal Health Inc / Acreage Holdings Inc / Endava PLC / Cigna Corp / Green Thumb Industries Inc / Cronos Group Inc / Tilray Brands Inc / ASML Holding NV / Charlotte's Web Holdings Inc / Morphic Holding Inc / Johnson Controls International PLC / Ambarella Inc / Sundial Growers Inc / Greenlane Holdings Inc / Ichor Holdings Ltd / Cresco Labs Inc / Curaleaf Holdings Inc / Medmen Enterprises Inc / Revolve Group Inc / Globant SA / Neptune Wellness Solutions Inc / Trane Technologies PLC / Biohaven Pharmaceutical Holding Company Ltd / Carrier Global Corp / Aurora Cannabis Inc / CV Sciences Inc / Dell Technologies Inc / Cardiff Oncology Inc / Grid Dynamics Holdings Inc / STMicroelectronics NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 0925288 / 2516152 / 2050832 / 2026242 / 2544960 / 2115902 / 2270726 / 2542049 / 2317087 / 2459020 / 2048804 / 2730190 / 2853688 / 2883878 / 7103065 / B067BM3 / 2212922 / B19FQ48 / 2857817 / B125XQ6 / B2R3PV1 / B1HJLW5 / BFRTDG1 / B6RS2B3 / B7VD3F2 / BJ3V905 / BJ0XLZ3 / B3X26D8 / BFLR866 / B6WXT12 / BJ36RM8 / BTN1Y11 / BYY8XK8 / BQPVQZ6 / BYVY8G0 / BS7K7C9 / BYVYD43 / BFNF1D6 / BXDZ9Z0 / BJXBP41 / BKS3SM8 / BNFWR44 / BJJMGL2 / BYXJQG9 / BG31GH0 / BKTNTR9 / BYQHPK7 / BZ1LFG7 / BX7RSN3 / BFFVVC1 / BGKG6M3 / BYXR425</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Beasley Broadcast Group Inc / OPKO Health Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Stryker Corp / Teva Pharmaceutical Industries Ltd / Novartis AG / Molson Coors Beverage Co / NRG Energy Inc / Amicus Therapeutics Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Emergent BioSolutions Inc / Aerie Pharmaceuticals Inc / Clovis Oncology Inc / Duke Energy Corp / Endo International PLC / Heron Therapeutics Inc / Pacira Biosciences Inc / Twitter Inc / TherapeuticsMD Inc / Pacira Biosciences Inc / Medtronic PLC / WEC Energy Group Inc / Horizon Therapeutics PLC / Alphabet Inc / Nevro Corp / Performance Food Group Co / Amneal Pharmaceuticals Inc / Shopify Inc / Alcon AG / IGM Biosciences Inc / Worldline SA / Fox Corp / Spire Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Roku Inc / Collegium Pharmaceutical Inc / Bausch Health Companies Inc / StoneCo Ltd / RH</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Pharma : Takeaways from the 2021 J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / LLY.N / ABBV.N / BHC.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Abbvie Inc / Bausch Health Companies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova / Xiling Chen</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">This Week In Pharmaceuticals - Monday, January 18 - Sunday, January 24</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">478160104 / 532457108 / 37733W105 / 046353108 / 771195104 / 98978V103 / 28414H103</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / GlaxoSmithKline PLC / AstraZeneca PLC / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY: Cantor Research Call- Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / HCM.O / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">Eli Lilly and Co / HUTCHMED (China) Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : January - April 2020</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCAb.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / 114556048 / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Svenska Cellulosa SCA AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Stellantis NV / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
</tbody></table>
</body>
</html>